Sentence,class,file
"Molecular Vision  2016; 22:319-331 <http://www.molvis.org/molvis/v 22/319> © 2016 Molecular Vision  324(RPGRIP1L, DFNB31, and RAB8A) directly interact with  RPGR.",OADS,/arxiv_data1/oa_pdf/39/1c/mv-v22-319.PMC4830396.pdf
Molecular Vision  2016; 22:319-331 <http://www.molvis.org/molvis/v 22/319> © 2016 Molecular Vision  325compartment play key roles in the function and maintenance  of photoreceptor cells.,Non-OADS,/arxiv_data1/oa_pdf/39/1c/mv-v22-319.PMC4830396.pdf
Molecular Vision  2016; 22:319-331 <http://www.molvis.org/molvis/v 22/319> © 2016 Molecular Vision  326was a putative correlation between genotype or haplotype and  disease phenotype.,Non-OADS,/arxiv_data1/oa_pdf/39/1c/mv-v22-319.PMC4830396.pdf
"Molecular Vision  2016; 22:319-331 <http://www.molvis.org/molvis/v 22/319> © 2016 Molecular Vision  327XLPRA1-affected dogs, suggesting at first that it could be  associated with disease.",Non-OADS,/arxiv_data1/oa_pdf/39/1c/mv-v22-319.PMC4830396.pdf
Molecular Vision  2016; 22:319-331 <http://www.molvis.org/molvis/v 22/319> © 2016 Molecular Vision  328pedigree.,Non-OADS,/arxiv_data1/oa_pdf/39/1c/mv-v22-319.PMC4830396.pdf
"Molecular Vision  2016; 22:319-331 <http://www.molvis.org/molvis/v 22/319> © 2016 Molecular Vision  329research was supported by Foundation Fighting Blindness,  R01EY06855, R01EY17549, P30EY-001583, Macula Vision  Research Foundation, Hope for Vision and Van Sloun Fund.",Non-OADS,/arxiv_data1/oa_pdf/39/1c/mv-v22-319.PMC4830396.pdf
Molecular Vision  2016; 22:319-331 <http://www.molvis.org/molvis/v 22/319> © 2016 Molecular Vision  33021.,Non-OADS,/arxiv_data1/oa_pdf/39/1c/mv-v22-319.PMC4830396.pdf
Molecular Vision  2016; 22:319-331 <http://www.molvis.org/molvis/v 22/319> © 2016 Molecular Vision  33146.,Non-OADS,/arxiv_data1/oa_pdf/39/1c/mv-v22-319.PMC4830396.pdf
"Eight-week-old female  C57BL/6 mice purchased from the Jackson Laboratory (Bar  Harbor, ME) were housed in an Assessment and Accreditation Molecular Vision  2016; 22:332-341 <http://www.molvis.org/molvis/v 22/332> Received 15 December 2015 | Accepted 8 April 2016 | Published 11 April 2016© 2016 Molecular Vision 332Myelin-specific Th17 cells induce severe relapsing optic neuritis  with irreversible loss of retinal ganglion cells in C57BL/6 mice Chelsea M. Larabee,1,2 Yang Hu,3 Shruti Desai,2 Constantin Georgescu,3 Jonathan D. Wren,3 Robert C. Axtell,3  Scott M. Plafker1,2 1Oklahoma Center for Neuroscience, University of Oklahoma Health Sciences Center, Oklahoma City, OK; 2Aging and  Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK; 3Arthritis and Clinical  Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK Purpose:  Optic neuritis affects most patients with multiple sclerosis (MS), and current treatments are unreliable.",Non-OADS,/arxiv_data1/oa_pdf/2b/4b/mv-v22-332.PMC4830397.pdf
"Molecular Vision  2016; 22:332-341 <http://www.molvis.org/molvis/v 22/332> © 2016 Molecular Vision  333of Laboratory Animal Care–approved vivarium, given ad  libitum access to chow and water, and exposed to a standard  14 h:10 h light-dark cycle.",Non-OADS,/arxiv_data1/oa_pdf/2b/4b/mv-v22-332.PMC4830397.pdf
"Molecular Vision  2016; 22:332-341 <http://www.molvis.org/molvis/v 22/332> © 2016 Molecular Vision  334binning method with a score of 0 indicating no Ly6G signal, 1  indicating 1–15 Ly6G-positive cells throughout the section, 2  indicating 16–30 Ly6G-positive cells, and 3 indicating greater  than 30 Ly6G-positive cells.",Non-OADS,/arxiv_data1/oa_pdf/2b/4b/mv-v22-332.PMC4830397.pdf
Molecular Vision  2016; 22:332-341 <http://www.molvis.org/molvis/v 22/332> © 2016 Molecular Vision  335same eye (Figure 2A–C).,Non-OADS,/arxiv_data1/oa_pdf/2b/4b/mv-v22-332.PMC4830397.pdf
Molecular Vision  2016; 22:332-341 <http://www.molvis.org/molvis/v 22/332> © 2016 Molecular Vision  336 Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/2b/4b/mv-v22-332.PMC4830397.pdf
"Molecular Vision  2016; 22:332-341 <http://www.molvis.org/molvis/v 22/332> © 2016 Molecular Vision  337Th17-EAE mice exhibit more RGC cell death relative to  Th1-EAE:  To determine whether loss of RGCs accompanies  visual acuity deficits, the retinas isolated at 13 and 21 DPI  were flatmounted and immunolabeled for RGCs.",Non-OADS,/arxiv_data1/oa_pdf/2b/4b/mv-v22-332.PMC4830397.pdf
"Molecular Vision  2016; 22:332-341 <http://www.molvis.org/molvis/v 22/332> © 2016 Molecular Vision  338and neuromyelitis optic (NMO), respectively.",Non-OADS,/arxiv_data1/oa_pdf/2b/4b/mv-v22-332.PMC4830397.pdf
"Molecular Vision  2016; 22:332-341 <http://www.molvis.org/molvis/v 22/332> © 2016 Molecular Vision  339At 21 DPI in Th17-mediated EAE, we observed signifi - cant loss of medial and central RGCs, whereas at 13 DPI, only  central RGC loss was evident.",Non-OADS,/arxiv_data1/oa_pdf/2b/4b/mv-v22-332.PMC4830397.pdf
"Molecular Vision  2016; 22:332-341 <http://www.molvis.org/molvis/v 22/332> © 2016 Molecular Vision  340neuritis is exacerbated in Th17-EAE relative to Th1-EAE  in terms of visual acuity loss, inflammation of the optic  nerve, and degeneration of the RGCs.",Non-OADS,/arxiv_data1/oa_pdf/2b/4b/mv-v22-332.PMC4830397.pdf
Molecular Vision  2016; 22:332-341 <http://www.molvis.org/molvis/v 22/332> © 2016 Molecular Vision  341multiple sclerosis and experimental encephalomyelitis.,Non-OADS,/arxiv_data1/oa_pdf/2b/4b/mv-v22-332.PMC4830397.pdf
Geneva: World Health Organization; 2015 http://www.who.int/tb/post2015_strategy/en/ [accessed 28 December 2015].,Non-OADS,/arxiv_data1/oa_pdf/c8/fb/trw016.PMC4830404.pdf
Geneva: World Health Organization; 2014. http://www.who.int/tb/publications/ global_report/gtbr14_supplement_web_v3.pdf [accessed 28 December 2015].,Non-OADS,/arxiv_data1/oa_pdf/c8/fb/trw016.PMC4830404.pdf
2013. https://clinicaltrials.gov/ct2/show/NCT01979900 [accessed 28 December 2015].,Non-OADS,/arxiv_data1/oa_pdf/c8/fb/trw016.PMC4830404.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/32/36/agv109.PMC4830407.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License(http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium,provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f7/5d/dkv486.PMC4830415.pdf
http://www.who.int/iris/bitstream/10665/112642/1/ 9789241564748_eng.pdf?ua=1.,OADS,/arxiv_data1/oa_pdf/f7/5d/dkv486.PMC4830415.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided theoriginal work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/16/d2/dkv498.PMC4830417.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided theoriginal work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5f/75/dkv499.PMC4830418.pdf
http://www.who.int/tb/pu blications/global_report/gtbr14_ main_text.pdf.,OADS,/arxiv_data1/oa_pdf/5f/75/dkv499.PMC4830418.pdf
2008; WHO/HTM/TB/ 2008.392. http://apps.who.int/iris/bitstream/10665/70500/1/WHO_HTM_ TB_2008.392_eng.pdf.,OADS,/arxiv_data1/oa_pdf/5f/75/dkv499.PMC4830418.pdf
http://apps.who.,Non-OADS,/arxiv_data1/oa_pdf/5f/75/dkv499.PMC4830418.pdf
2001; WHO/CDS/TB/ 2001.288. http://apps.who.int/iris/bitstream/10665/83807/1/WHO_CDS_TB_2001.288_eng.pdf.,OADS,/arxiv_data1/oa_pdf/5f/75/dkv499.PMC4830418.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/7b/rjw055.PMC4830459.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/5e/rjw051.PMC4830460.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8e/95/rjw054.PMC4830466.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/00/a5/nss-8-091.PMC4830627.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Nature and Science of Sleep Nature and Science of Sleep 2016:8 91–106Dove press submit your manuscript | www.dovepress.co m Dove press  Reviewopen access to scientific and medical research Open Access Full T ext Article 91 http: //dx.doi.org/10.2147/NSS.S8584 9Delayed sleep phase disorder: clinical perspective  with a focus on light therapy Mariana G Figueiro Lighting Research Center, Rensselaer  Polytechnic institute, Troy, NY, USA Correspondence: Mariana G Figueiro   Lighting Research Center, Rensselaer  Polytechnic institute, 21 Union Street,  Troy, NY 12180, USA   T el +1 518 687 7100   Fax +1 518 687 7120   email figuem@rpi.ed uAbstract:  Delayed sleep phase disorder (DSPD) is common among adolescents and further  increases their susceptibility to chronic sleep restriction and associated detrimental outcomes,  including increased risk of depression, drug and alcohol use, behavioral problems, and poor  scholastic performance.",Non-OADS,/arxiv_data1/oa_pdf/00/a5/nss-8-091.PMC4830627.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/00/a5/nss-8-091.PMC4830627.pdf
Available from:  https://sleepfoundation.org/sites/default/files/sleep_and_teens_report1.,Non-OADS,/arxiv_data1/oa_pdf/00/a5/nss-8-091.PMC4830627.pdf
"Nature and Science of Sleep Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/nature-and-science-of-sleep-journa lNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine,  including the neurophysiology and functions of sleep, the genetics of  sleep, sleep and society, biological rhythms, dreaming, sleep disorders and  therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/00/a5/nss-8-091.PMC4830627.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/00/a5/nss-8-091.PMC4830627.pdf
Available from:  http://lrt.sagepub.com/content/early/2015/05/06/1477153515584979.,Non-OADS,/arxiv_data1/oa_pdf/00/a5/nss-8-091.PMC4830627.pdf
"Available from http://www.lrc.rpi.edu/resources/newsroom/pdf/2014/ SleepMask8511.pd f. Accessed on March 11, 2016.",Non-OADS,/arxiv_data1/oa_pdf/00/a5/nss-8-091.PMC4830627.pdf
"Supplemental Digital Content 1 (http://links.lww.com/ AA/B335) contains safety tips, and information regarding  clinical lidocaine toxicity, case reports of tumescent lido- caine toxicity, tumescent lidocaine pharmacokinetics, for - mulation of TLA solution, tumescent infiltration techniques, detumescence, technique for calculating AUC∞, tolerance intervals, and R-Code to compute tolerance intervals.",Non-OADS,/arxiv_data1/oa_pdf/ad/1f/ane-122-1350.PMC4830750.pdf
Supplemental Digital Content 2 (http://links.lww.com/ AA/B336) is a video of the technique for painless subcuta- neous infiltration of large volumes of tumescent lidocaine.,Non-OADS,/arxiv_data1/oa_pdf/ad/1f/ane-122-1350.PMC4830750.pdf
Supplemental Digital Content 3 (http://links.lww.com/ AA/B337) presents patient-level raw data and additional anal- ysis including tables in comma-separated values (cvs) format.,Non-OADS,/arxiv_data1/oa_pdf/ad/1f/ane-122-1350.PMC4830750.pdf
http://www.jointcommission.org/assets/1/6/SEA_53_ Connectors_8_19_14_final.pdf.,OADS,/arxiv_data1/oa_pdf/ad/1f/ane-122-1350.PMC4830750.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)PML stabilizes telomeres in normal human cells M Marchesini et al 1821 © 2016 Macmillan Publishers Limited Oncogene (2016) 1811 –1821",Non-OADS,/arxiv_data1/oa_pdf/43/33/onc2015246a.PMC4830905.pdf
Thecomplete gene expression data set is available at Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/; data set GSE48672).,OADS,/arxiv_data1/oa_pdf/5a/0d/onc2015241a.PMC4830906.pdf
( a) HSF2 mRNA expression in cancer patient samples compared with control tissue analyzed by the Oncomine database (https://www.oncomine.org).,Non-OADS,/arxiv_data1/oa_pdf/5a/0d/onc2015241a.PMC4830906.pdf
"Finally, Oncomine, a cancer microarray database and web-based data-mining platform, was used for comprehensive gene pro ﬁling of patients across different cancer types (https://www.oncomine.org/ resource/login.html).",OADS,/arxiv_data1/oa_pdf/5a/0d/onc2015241a.PMC4830906.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)Role of HSF2 in prostate cancer JK Björk et al 1784 Oncogene (2016) 1770 –1784 © 2016 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/5a/0d/onc2015241a.PMC4830906.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/55/42/ehv529.PMC4830908.pdf
"This is an Open Access article distributed under the terms of the Creative Com mons Attribution Non-Com mercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in a ny medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/34/ba/ehv690.PMC4830909.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/86/63/kev427.PMC4830910.pdf
Graphical Abstract This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a8/81/nihms-767509.PMC4830920.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes six figures and can be found with this article online at http://dx.doi.org/10.1016/j.celrep.,OADS,/arxiv_data1/oa_pdf/a8/81/nihms-767509.PMC4830920.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/65/41/10.1177_2325967116642173.PMC4831028.pdf
The data are available from the Western Sydney  University Research Data Repository at http://handle.uws.edu.,OADS,/arxiv_data1/oa_pdf/15/44/10.1177_0956797615625973.PMC4831030.pdf
The complete Open Practices Disclosure for this article can be found at http://pss.sagepub.com/content/by/supplemental-data.,Non-OADS,/arxiv_data1/oa_pdf/15/44/10.1177_0956797615625973.PMC4831030.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).CD40/CD40 LIGAND INTERACTIONS IN IMMUNE  RESPONSES AND PULMONARY IMMUNITY TSUTOMU  KAWABE1,2, MIYOKO  MATSUSHIMA1,2, NAOZUMI  HASHIMOTO3,   KAZUYOSHI  IMAIZUMI3 and Y OSHINORI  HASEGAWA3 1Department of Medical Technology, Nagoya University School of Health Sciences, Nagoya, Japan  2Innovative Research Center for Preventive Medical Engineering, Nagoya University, Nagoya, Japan  3Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan ABSTRACT The CD40 ligand/CD40 pathway is widely recognized for its prominent role in immune regulation  and homeostasis.",Non-OADS,/arxiv_data1/oa_pdf/e6/65/2186-3326-73-0069.PMC4831216.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/3d/1c/2186-3326-73-0079.PMC4831217.pdf
"to view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/59/4d/2186-3326-73-0091.PMC4831218.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/63/01/2186-3326-73-0107.PMC4831219.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).Spatial and temporal diStribution of   growth factorS receptorS in the calluS:   implicationS for improvement of   diStraction oSteogeneSiS KArOLINA  A S IwICKA1,2, HIrOSHI  KITOH1, MOTOAKI  KAwASuMI1   and N AOKI  ISHIgur O1 1Nagoya University Graduate School of Medicine, Department of Orthopaedic Surgery, Nagoya, Japan  2Medical University of Gdansk, Department of Orthopaedics, Gdansk, Poland ABSTrACT Management of bone deficits by distraction osteogenesis is an appreciated but lengthy procedure.",Non-OADS,/arxiv_data1/oa_pdf/3c/d9/2186-3326-73-0117.PMC4831220.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/e3/fe/2186-3326-73-0129.PMC4831221.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/21/04/2186-3326-73-0137.PMC4831222.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/da/f4/2186-3326-73-0147.PMC4831223.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/4f/d4/2186-3326-73-0157.PMC4831224.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/a9/78/2186-3326-73-0169.PMC4831225.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).HEALTHCARE WORKERS’ KNOWLEDGE AND  PRACTICES REGARDING EXPANDED PROGRAM ON  IMMUNIZATION IN KALASIN, THAILAND ONPRASONK  WIDSANUGORN1, ONPRASONK  SUWATTANA2,   MD.",Non-OADS,/arxiv_data1/oa_pdf/03/87/2186-3326-73-0177.PMC4831226.pdf
Available from: http://giskls.moph.go.th/.,Non-OADS,/arxiv_data1/oa_pdf/03/87/2186-3326-73-0177.PMC4831226.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).STUDY PROFILE ON BASELINE SURVEY OF   DAIKO STUDY IN THE JAPAN MULTI-INSTITUTIONAL  COLLABORATIVE COHORT STUDY (J-MICC STUDY) EMI MOrITA1, NObuyukI  HAMAJIMA1, ASAHI  HISHIDA1, kyOkO AOyAMA2,   rIEkO OkADA1, SAyO kAwAI1, kOuTAr O TOMITA1, SAyAkA kurIkI1,   TAkASHI  TAMurA1, MArIk O NAITO1, TAkAAkI  kONDO3, JuN uEyAMA3,   AkIkO kIMATA3, kANAMI  yAMAMOTO3, yOkO HOrI4, JuNk O HOSHINO5,   rITSuk O HAMAMOTO5, SANAE  TSukAMOTO4, JOJI ONISHI6, SHOICHI  HAgIkurA7,   HISAO  NAITO8, SATOSHI  HIbI9, yOSHINOrI  ITO1 and k ENJI wAkAI1 1Department of Preventive Medicine, Nagoya University Graduate School of Medicine, Japan  2Department of Food and Nutritional Sciences, Chubu University, Japan  3Program in Radiological and Medical Laboratory Sciences,   Nagoya University Graduate School of Medicine, Japan  4Program in Nursing, Nagoya University Graduate School of Medicine, Japan  5Department of Nursing, Sugiyama Jogakuen University, Japan  6Research Center of Health, Physical Fitness and Sports, Nagoya University, Japan  7Department of Urology, Nagoya University Graduate School of Medicine, Japan  8Department of Occupational and Environmental Health,   Nagoya University Graduate School of Medicine, Japan  9Department of Gastroenterology, Nagoya University Graduate School of Medicine, Japan AbSTrACT The Japan Multi-Institutional Collaborative Cohort Study (J-MICC Study) is a long-term cohort study  to investigate the interactions among genotypes, lifestyles, and lifestyle-related diseases, especially cancer.",Non-OADS,/arxiv_data1/oa_pdf/cf/b8/2186-3326-73-0187.PMC4831227.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/84/e4/2186-3326-73-0197.PMC4831228.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).A CASE OF AUTOIMMUNE HEPATITIS WITH GRA VES’  DISEASE TREATED BY PROPYLTHIOURACIL IKUKO  SATO*1, TAKU TSUNEKAWA1, YURI SHINOHARA1, YUICHIRO  NISHIO1,   YUKO SHIMIZU2, YASUHIKO  SUZUKI3 and S HUKO  YOSHIOKA1 1Department of Endocrinology and Diabetes, Tosei General Hospital  2Department of Gastroenterology, Tosei General Hospital  3Department of Pathology, Tosei General Hospital ABSTRACT A 58-year-old woman was referred to our hospital because of liver dysfunction.",Non-OADS,/arxiv_data1/oa_pdf/a3/8b/2186-3326-73-0205.PMC4831229.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUBTROCHANTERIC FRACTURE IN A PATIENT  RECEIVING ZOLEDRONIC ACID THERAPY FOR  METASTATIC BREAST CANCER YASuzuMI  KIShIMOTO1, TOShIKI  IwASe1, ATSuShI  KOYAMA1, TeTSuO  MASuI1,   GO YOShIDA1, hIDeO  MATSuO1 and N AOKI  IShIGur O2 1Department of Orthopedic Surgery, Hamamatsu Medical Center, 328 Tomitsuka-cho, Hamamatsu,   Shizuoka 432-8580, Japan  2Department of Orthopedic Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho,  Showaku, Nagoya 466-8550, Japan ABSTrACT A 61-year-old woman presented with acute pain of the right thigh after falling on a public street.",Non-OADS,/arxiv_data1/oa_pdf/cb/b6/2186-3326-73-0211.PMC4831230.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).IMMUNOREGULATION OF HEPATITIS B VIRUS  INFECTION   –RATIONALE AND CLINICAL APPLICATION– TETSUYA  ISHIKAWA Division of Pathophysiological Laboratory Sciences, Department of Radiological and Medical Laboratory  Sciences, Nagoya University Graduate School of Medicine ABSTRACT Hepatitis B virus (HBV) is susceptible to the cellular immune responses, especially to the signal of  interferon (IFN)-g .",Non-OADS,/arxiv_data1/oa_pdf/e2/b2/2186-3326-74-0217.PMC4831231.pdf
http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/e2/b2/2186-3326-74-0217.PMC4831231.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/70/df/2186-3326-74-0233.PMC4831232.pdf
Available at: http://www.eip.gov.eg/nds/nds_view.aspx?id=5313; 2009 [accessed 30.04.11].,OADS,/arxiv_data1/oa_pdf/70/df/2186-3326-74-0233.PMC4831232.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/a0/eb/2186-3326-74-0241.PMC4831233.pdf
"(Accessed September  9, 2011, at http://www.mhlw.go.jp/english/database/db-hw/lifetb10/1.html.)",OADS,/arxiv_data1/oa_pdf/a0/eb/2186-3326-74-0241.PMC4831233.pdf
"(Accessed November 25, 2006, at http://ctep.cancer.gov/reporting/ctc.html.)",Non-OADS,/arxiv_data1/oa_pdf/a0/eb/2186-3326-74-0241.PMC4831233.pdf
"(Accessed  November 25, 2006, at:http://www.hartfordign.org/publications/trythis/issue02.pdfx.)",Non-OADS,/arxiv_data1/oa_pdf/a0/eb/2186-3326-74-0241.PMC4831233.pdf
"22) National Health and Nutrition Examination Survey: Healthy weight, overweight, and obesity among US adults, 2003 (Accessed, October 28, 2009, at http://www.cdc.gov/nchs/data/nhanes/databriefs/adultweight.pdf) 23) Bamgbade OA, Rutter TW, Nafiu OO, Dorje P. Postoperative complications in obese and nonobese patients.",Non-OADS,/arxiv_data1/oa_pdf/a0/eb/2186-3326-74-0241.PMC4831233.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/ca/df/2186-3326-74-0253.PMC4831234.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/20/c7/2186-3326-74-0261.PMC4831235.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).SOCIAL CORRELATES OF FEMALE INFERTILITY   IN UZBEKISTAN IZATULLA  JUMAYEV1,2, MD.",Non-OADS,/arxiv_data1/oa_pdf/68/83/2186-3326-74-0273.PMC4831236.pdf
"New York MedicineNet, Inc.; 2012 [02 January 2012]; Available  from: http://www.medicinenet.com/infertility/article.htm.",Non-OADS,/arxiv_data1/oa_pdf/68/83/2186-3326-74-0273.PMC4831236.pdf
"Washington, DC 20009 USA:  Population Reference Bureau 2003 [cited 2012 15 April 2012]; Available from: http://www.prb.org/pdf/ ReproductiveHealthTrendsEE.pdf.",Non-OADS,/arxiv_data1/oa_pdf/68/83/2186-3326-74-0273.PMC4831236.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).ASSOCIATION OF OBESITY AND DIABETES WITH  SERUM PROSTATE-SPECIFIC ANTIGEN LEVELS IN  JAPANESE MALES MARIKO  NAITO1*, Y ATAMI  ASAI2, ATSUYOSHI  MORI3, YUKO FUKADA4,   MAYUMI  KUWABARA3, SHIRO  KATASE4, ASAHI  HISHIDA1, EMI MORITA1,   SAYO KAWAI1, RIEKO  OKADA1, KAZUKO  NISHIO1, AKIKO  TAMAKOSHI5,   KENJI WAKAI1 and N OBUYUKI  HAMAJIMA1 1Department of Preventive Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan  2Mikatabara Bethel Home, Hamamatsu, Japan  3Seirei Preventive Health Care Center, Hamamatsu, Japan  4Seirei Health Support Center Shizuoka, Shizuoka, Japan  5Department of Public Health, Hokkaido University Graduate School of Medicine, Sapporo, Japan ABSTRACT Patients with diabetes have been reported to be at an increased risk for cancers of the pancreas, liver,  and colon; however, recent studies have suggested that men with diabetes are at a decreased risk for  prostate cancer.",Non-OADS,/arxiv_data1/oa_pdf/e8/0b/2186-3326-74-0285.PMC4831237.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/f0/38/2186-3326-74-0293.PMC4831238.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/b9/ae/2186-3326-74-0303.PMC4831239.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).INFLAMMATORY INDEX AND TREATMENT   OF BRAIN ABSCESS HIROFUMI  OYAMA , AKIRA  KITO, HIDEKI  MAKI, KENICHI  HATTORI ,   TOMOYUKI  NODA and K ENTARO  WADA Department of Neurosurgery, Ogaki Municipal Hospital, Ogaki 503-8502, Japan ABSTRACT This study retrospectively analyzed 12 patients with brain abscesses.",Non-OADS,/arxiv_data1/oa_pdf/44/9e/2186-3326-74-0313.PMC4831240.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).TREATMENT OF A CEREBRAL DISSECTING  ANEURYSM IN ANTERIOR CIRCULATION: REPORT   OF 11 SUBARACHNOID HEMORRHAGE CASES HIROFUMI  OYAMA , AKIRA  KITO, HIDEKI  MAKI, KENICHI  HATTORI ,  TOMOYUKI  NODA and K ENTARO  WADA Department of Neurosurgery, Ogaki Municipal Hospital, Ogaki, Japan ABSTRACT This report presents 8 cases of internal carotid artery aneurysms, 1 case of a middle cerebral artery  aneurysm, and 2 cases of anterior cerebral artery aneurysms, together with a discussion of the treatment  of aneurysms in anterior circulation.",Non-OADS,/arxiv_data1/oa_pdf/60/9b/2186-3326-74-0325.PMC4831241.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).AIR VENT OF VEIN GRAFT IN   EXTRACRANIAL-INTRACRANIAL BYPASS SURGERY HIROFUMI  OYAMA , AKIRA  KITO, HIDEKI  MAKI, KENICHI  HATTORI ,   TOMOYUKI  NODA and K ENTARO  WADA Department of Neurosurgery, Ogaki Municipal Hospital, Ogaki, Japan ABSTRACT Revascularization with a vein graft is a mandatory method for treatment of dissecting or pseudoaneu- rysms of the internal carotid artery.",Non-OADS,/arxiv_data1/oa_pdf/1e/ad/2186-3326-74-0339.PMC4831242.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).METASTATIC BREAST CANCER TO THE UTERINE  CERVIX MIMICKING A GIANT CERVICAL  LEIOMYOMA MAI HORIKAWA , YUKIKO  MORI, SACHI  NAGAI , SHIHO  TANAKA ,   SHIGEKO  SAITO  and T OMOMITSU  OKAMOTO Department of Obstetrics and Gynecology, Chukyo Hospital, Nagoya, Japan ABSTRACT Metastasis to the uterine cervix is a complication of breast cancer that is not commonly known.",Non-OADS,/arxiv_data1/oa_pdf/39/b7/2186-3326-74-0347.PMC4831243.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/d4/39/2186-3326-74-0353.PMC4831244.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/e5/bd/2186-3326-74-0359.PMC4831245.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/d0/e8/2186-3326-74-0019.PMC4831247.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/2a/67/2186-3326-74-0031.PMC4831248.pdf
REFERENCES 1) http://www8.cao.go.jp/kourei/whitepaper/w-2011/zenbun/23pdf_index.html.,Non-OADS,/arxiv_data1/oa_pdf/2a/67/2186-3326-74-0031.PMC4831248.pdf
2) http://www8.cao.go.jp/kourei/whitepaper/w-2010/zenbun/22pdf_index.html.,Non-OADS,/arxiv_data1/oa_pdf/2a/67/2186-3326-74-0031.PMC4831248.pdf
"Annual Health, Labour and Welfare Report 2008–2009 White Papers & reports MHLW.Japan; [http://www.mhlw.go.jp/english/wp/wp-hw3/dl/10-06.pdf], Accessed: November 10, 2011.",Non-OADS,/arxiv_data1/oa_pdf/2a/67/2186-3326-74-0031.PMC4831248.pdf
6) http://www.mhlw.go.jp/toukei/list/20-19.html.,Non-OADS,/arxiv_data1/oa_pdf/2a/67/2186-3326-74-0031.PMC4831248.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/7a/51/2186-3326-74-0039.PMC4831249.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).CARDIOV ASCULAR DISEASE RISK FACTORS   AMONG RURAL KAZAKH POPULATION GULNARA  KULKAYEV A1,2, MD.",Non-OADS,/arxiv_data1/oa_pdf/05/5b/2186-3326-74-0051.PMC4831250.pdf
"Copenhagen Ø, Denmark 2005 [March 15, 2009]; Available from: http://www.euro.who.",Non-OADS,/arxiv_data1/oa_pdf/05/5b/2186-3326-74-0051.PMC4831250.pdf
"Geneva,  Switzerland: WHO Press; 2005 [Feb 28, 2009]; Available from: http://www.who.int/chp/chronic_disease_re- port/full_report.pdf.",Non-OADS,/arxiv_data1/oa_pdf/05/5b/2186-3326-74-0051.PMC4831250.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/2a/45/2186-3326-74-0063.PMC4831251.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/2e/a4/2186-3326-74-0071.PMC4831252.pdf
2006;  Available from: http://www.unfpa.org/swp/2006/pdf/en_sowp06.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2e/a4/2186-3326-74-0071.PMC4831252.pdf
2007; 9(3): Available from: http://www.euro.who.int/__data/assets/ pdf_file/0004/96421/E90673.pdf.,OADS,/arxiv_data1/oa_pdf/2e/a4/2186-3326-74-0071.PMC4831252.pdf
"Washington, D.C. 007 [15 September 2011]; Available from: http://www.scribd.com/doc/16060172/World-Development-Indicators-2007-.",Non-OADS,/arxiv_data1/oa_pdf/2e/a4/2186-3326-74-0071.PMC4831252.pdf
Tashkent: United Nations Development Programme; 2006; Available from: http://www2.lse.,Non-OADS,/arxiv_data1/oa_pdf/2e/a4/2186-3326-74-0071.PMC4831252.pdf
2001; Available from: http://www.adb.org/Documents/Books/ Country_Briefing_Papers/Women_in_Uzbekistan/women_in_uzbekistan.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2e/a4/2186-3326-74-0071.PMC4831252.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/46/a2/2186-3326-74-0083.PMC4831253.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/82/43/2186-3326-74-0093.PMC4831254.pdf
"http://www.cdc.gov/ncidod/dhqp/pdf/ar/mdroGuideline2006.pdf15) Natsch S, Hekster YA, de Jong R, Heerdink ER, Herings RM, van der Meer JW.",OADS,/arxiv_data1/oa_pdf/82/43/2186-3326-74-0093.PMC4831254.pdf
http://www.whocc.no/atcddd/17) Clinical and Laboratory Standards Institute.,Non-OADS,/arxiv_data1/oa_pdf/82/43/2186-3326-74-0093.PMC4831254.pdf
26) http://www.jshp.or.jp/senmon/senmon2.html (in Japanese) 27) Centers for Disease Control and Prevention (CDC).,Non-OADS,/arxiv_data1/oa_pdf/82/43/2186-3326-74-0093.PMC4831254.pdf
"Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC), MMWR 44, No.RR-12, 1995.  http://ftp.cdc.gov/pub/Publications/mmwr/rr/rr4412.pdf 28) Hirschman S, Meyers BR, Bradbury K, Mehl B, Gendelman S, Kimelblatt B.",Non-OADS,/arxiv_data1/oa_pdf/82/43/2186-3326-74-0093.PMC4831254.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/89/ca/2186-3326-74-0105.PMC4831255.pdf
"http://www.cdc.gov/ncidod/dhqp/pdf/ar/mdroGuideline2006.pdf 22) Miró E, Mirelis B, Navarro F, Rivera A, Mesa RJ, Roig MC, Gómez L, Coll P. Surveillance of extended- spectrum beta-lactamases from clinical samples and faecal carriers in Barcelona, Spain.",OADS,/arxiv_data1/oa_pdf/89/ca/2186-3326-74-0105.PMC4831255.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/c6/4c/2186-3326-74-0115.PMC4831256.pdf
(http://www.jshr.jp/).,Non-OADS,/arxiv_data1/oa_pdf/c6/4c/2186-3326-74-0115.PMC4831256.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).GERANYLGERANYLACETONE ATTENUATES  CISPLATIN-INDUCED REDUCTIONS IN   CELL VIABILITY BY SUPPRESSING THE ELEV ATION   OF INTRACELLULAR P53 CONTENT   WITHOUT HEAT SHOCK PROTEIN INDUCTION MOTOFUSA  HASEGAWA1, KAZUHIRO  ISHIGURO2, TAKAFUMI  ANDO1   and H IDEMI  GOTO1 1Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine,   Nagoya, Japan  2Department of Advanced Research of Gastroenterology, Nagoya University Graduate School of Medicine,  Nagoya, Japan ABSTRACT Geranylgeranylacetone (GGA) was originally used as an anti-ulcer drug to protect gastric mucosa  from various stresses, and it is also known to induce heat shock proteins (HSPs), especially HSP70.",Non-OADS,/arxiv_data1/oa_pdf/41/6f/2186-3326-74-0123.PMC4831257.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/88/b5/2186-3326-74-0133.PMC4831258.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/77/c7/2186-3326-74-0141.PMC4831259.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).INCIDENCE OF YOUNG ONSET INSULIN-REQUIRING  DIABETES MELLITUS AMONG 18- TO 30-YEAR-OLDS  IN DHAKA, BANGLADESH (1994−2003) SAIKA  NIZAM1, MD.",Non-OADS,/arxiv_data1/oa_pdf/90/e3/2186-3326-74-0149.PMC4831260.pdf
2008; http://www.who.int/mediacentre/factsheets/fs312/en/index.,OADS,/arxiv_data1/oa_pdf/90/e3/2186-3326-74-0149.PMC4831260.pdf
http://apps.who.int/bmi/index.,OADS,/arxiv_data1/oa_pdf/90/e3/2186-3326-74-0149.PMC4831260.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/c3/5c/2186-3326-74-0157.PMC4831261.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/48/53/2186-3326-74-0167.PMC4831262.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).SIMULTANEOUS SURGICAL RESECTIONS OF   TWO DISTANT METASTATIC MALIGNANT   MELANOMA LESIONS   — CASE REPORT — TAKAFUMI  TANEI ,1,2 NORIMOTO  NAKAHARA ,1 SHIGENORI  TAKEBAYASHI ,1   MASAKI  HIRANO1 and T OSHIHIKO  WAKABAYASHI2 1Department of Neurosurgery, Nagoya Central Hospital, Nagoya, Japan  2Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan ABSTRACT A 41-year-old woman presented with disturbance of consciousness, right hemiparesis, and symptoms  of Gerstmann syndrome.",Non-OADS,/arxiv_data1/oa_pdf/5d/b7/2186-3326-74-0173.PMC4831263.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).POSTOPERATIVE RECOVERY FROM   UNILATERAL BLINDNESS   CAUSED BY TUBERCULUM SELLAE MENINGIOMA HIROFUMI  OYAMA , AKIRA  KITO, HIDEKI  MAKI, KENICHI  HATTORI ,   TOMOYUKI  NODA and K ENTARO  WADA Department of Neurosurgery, Ogaki Municipal Hospital, Ogaki, Japan ABSTRACT A 47-year-old female had noticed diminished visual acuity in both eyes 2 months previously.",Non-OADS,/arxiv_data1/oa_pdf/bd/72/2186-3326-74-0181.PMC4831264.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).EXTRA V ASATION OF PEGYLATED-LIPOSOMAL  DOXORUBICIN: FA VORABLE OUTCOME AFTER  IMMEDIATE SUBCUTANEOUS ADMINISTRATION OF  CORTICOSTEROIDS AYAKO  MITSUMA1, MASATAKA  SAWAKI1, TAKASHI  SHIBATA1, SACHI  MORITA1,  MEGUMI  INADA1, TOMOYA  SHIMOKATA1, MIHOKO  SUGISHITA1,  KOICHI  KITAGAWA1, MASAKI  SAWADA2, AKIHIRO  NAWA3 and Y UICHI  ANDO1 1Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan  2Department of Dermatology, Nagoya University Hospital, Nagoya, Japan  3Department of Obstetrics and Gynecology, Nagoya University School of Medicine, Nagoya, Japan ABSTRACT A massive extravasation of pegylated-liposomal doxorubicin (Doxil®) accidentally occurred, affecting the  right forearm of a 54-year-old woman with metastatic ovarian cancer who was receiving an intravenous  infusion of the drug.",Non-OADS,/arxiv_data1/oa_pdf/83/0e/2186-3326-74-0189.PMC4831265.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).REPAIR OF CAROTID BLOW-OUT   USING A CAROTID SHEATH IN A PATIENT   WITH RECURRENT THYROID CANCER HIROFUMI  OYAMA , AKIRA  KITO, HIDEKI  MAKI, KENICHI  HATTORI ,   TOMOYUKI  NODA and K ENTARO  WADA Department of Neurosurgery, Ogaki Municipal Hospital, Ogaki 503-8502, Japan ABSTRACT The patient had thyroid cancer and underwent subtotal thyroidectomy.",Non-OADS,/arxiv_data1/oa_pdf/3d/d7/2186-3326-74-0193.PMC4831266.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).SCHWANNOMA ORIGINATING FROM   LOWER CRANIAL NERVES:   REPORT OF 4 CASES HIROFUMI  OYAMA , AKIRA  KITO, HIDEKI  MAKI, KENICHI  HATTORI ,   TOMOYUKI  NODA and K ENTARO  WADA Department of Neurosurgery, Ogaki Municipal Hospital, Ogaki, Japan ABSTRACT Four cases of schwannoma originating from the lower cranial nerves are presented.",Non-OADS,/arxiv_data1/oa_pdf/6b/7b/2186-3326-74-0199.PMC4831267.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).A SPINAL EPIDURAL HEMATOMA WITH SYMPTOMS  MIMICKING CEREBRAL STROKE HIROSHI  SHIMA1,2, MUNEYOSHI  YASUDA2, MOTOHIRO  NOMURA1, KENTARO  MORI1,  KATSUYOSHI  MIYASHITA1, AKIRA  TAMASE1, YOSHIHISA  KITAMURA1,   KOJI OSUKA2 and M ASAKAZU  TAKAYASU2 1Department of Neurosurgery, Yokohama Sakae Kyosai Hospital, Yokohama, Japan  2Department of Neurological Surgery, Aichi Medical University, Nagakute, Aichi, Japan ABSTRACT A spontaneous cervical epidural hematoma (SCEH) is a rare condition, which usually requires urgent  treatment.",Non-OADS,/arxiv_data1/oa_pdf/5a/2d/2186-3326-74-0207.PMC4831268.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).SURGICAL RESULTS OF PARASAGITTAL   AND FALX MENINGIOMA HIrOfuMI  OyAMA , AkIrA  kITO, HIDekI  MAkI, keNICHI  HATTOrI ,   TOMO yukI  NODA and k eNTAr O WADA Department of Neurosurgery, Ogaki Municipal Hospital ABSTrACT Sixteen operative cases of parasagittal and falx meningioma were analyzed retrospectively.",Non-OADS,/arxiv_data1/oa_pdf/6a/59/2186-3326-74-0211.PMC4831269.pdf
4. http://www.mhlw.go.jp/ﬁle/06-Seisakujouhou-10900000- Kenkoukyoku/0000089884.pdf (in Japanese).,Non-OADS,/arxiv_data1/oa_pdf/a8/a9/CCR3-4-369.PMC4831386.pdf
"http://books.google.com/books?hl=en&lr=&id=dUI4J JzIsikC&oi=fnd&pg=PR1&dq=Provider+Satisfaction+with+an+Inpatient+Tobacco+Treatment+Program&ots= Tqxyd71qH1&sig=0XB_r-bRDs_RaPUFI2UDDyR76ss (accessed January 28, 2015).",Non-OADS,/arxiv_data1/oa_pdf/8a/98/CCR3-4-409.PMC4831396.pdf
"http://www.fda.gov/ ForConsumers/ConsumerUpdates/ucm198176.htm (accessed May 26, 2015).",Non-OADS,/arxiv_data1/oa_pdf/8a/98/CCR3-4-409.PMC4831396.pdf
Available from:  http://cdsco.nic.in/writereaddata/approved%20FDC%20list%20by%20 DCG(I)%20Till%20July%202014.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d1/c3/JPP-7-1.PMC4831482.pdf
Available from: http://cdsco.nic.in/ writereaddata/1971‑98.doc.,Non-OADS,/arxiv_data1/oa_pdf/d1/c3/JPP-7-1.PMC4831482.pdf
Available  from: https://www.mims.com/India/home/Index.,Non-OADS,/arxiv_data1/oa_pdf/d1/c3/JPP-7-1.PMC4831482.pdf
Available from:  https://www.mims.com/USA/home/Index.,Non-OADS,/arxiv_data1/oa_pdf/d1/c3/JPP-7-1.PMC4831482.pdf
Available from: http://cdsco.nic.in/html/ copy%20of%201.%20d and cact121.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d1/c3/JPP-7-1.PMC4831482.pdf
Available from: http://www.change.org/p/,Non-OADS,/arxiv_data1/oa_pdf/d1/c3/JPP-7-1.PMC4831482.pdf
Available from: http://cdsco.nic.in/ writereaddata/588E30thAug2013.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d1/c3/JPP-7-1.PMC4831482.pdf
Available from: http://www.alzheimer.org.in/dementia_ex_2010.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ad/48/JPP-7-24.PMC4831485.pdf
"Available from: http://www.accessdata.fda.gov/ drugsatfda_docs/label/2012/020690s035,021720s008,022568s005lbl.",Non-OADS,/arxiv_data1/oa_pdf/ad/48/JPP-7-24.PMC4831485.pdf
"Available from: http://www.accessdata.fda.gov/ drugsatfda_docs/label/2012/020690s035,021720s008,022568s005lbl.",Non-OADS,/arxiv_data1/oa_pdf/1f/13/JPP-7-26.PMC4831486.pdf
Available from: http://www.who‑umc.org/graphics/4409.,Non-OADS,/arxiv_data1/oa_pdf/8d/f2/JPP-7-31.PMC4831488.pdf
Available from: http://www.stattools.net/index.php.,OADS,/arxiv_data1/oa_pdf/8d/f2/JPP-7-31.PMC4831488.pdf
Available from: http://www.apps.who.int/medicinedocs/en/d/Js6160e/.,OADS,/arxiv_data1/oa_pdf/99/33/JPP-7-51.PMC4831494.pdf
Available from: http://www.who.int/medicines/areas/ access/OMS_Medicine_prices.pdf.,Non-OADS,/arxiv_data1/oa_pdf/99/33/JPP-7-51.PMC4831494.pdf
Available from:  http://www.who.int/medicines/areas/policy/world_medicines_situation/ en/.,Non-OADS,/arxiv_data1/oa_pdf/99/33/JPP-7-51.PMC4831494.pdf
Available from: http://www.apps.who.int/medicinedocs/documents/s16222e/ s16222e.pdf.,Non-OADS,/arxiv_data1/oa_pdf/99/33/JPP-7-51.PMC4831494.pdf
Available from: http://www.who.int/medicines/publications/ WHOTCM2006.2A.pdf.,OADS,/arxiv_data1/oa_pdf/99/33/JPP-7-51.PMC4831494.pdf
"10. http://www.censusindia.gov.in published by the Registrar General and  Census Commissioner, India, Ministry of Home Affairs.",Non-OADS,/arxiv_data1/oa_pdf/8f/70/IJU-32-103.PMC4831497.pdf
Those interested in attending the workshop(s) should fill the application form (which asks for a summary of  experience and expertise in clinical research; available at https://sites.google.com/site/sgpgimsnihcourses/ ) and send  it as an email attachment to sgpgi.courses@gmail.com .,Non-OADS,/arxiv_data1/oa_pdf/ce/a9/IJU-32-89.PMC4831513.pdf
Available from: http://www3.niddk.nih.gov/fund/other/MOMUS.pdf.,Non-OADS,/arxiv_data1/oa_pdf/70/f5/IJU-32-91.PMC4831514.pdf
Available from: http://www.cebm.net/mod_product/ design/files/CEBM -Levels -of-Evidence -2.1.pdf.,OADS,/arxiv_data1/oa_pdf/1e/eb/IJU-32-93.PMC4831515.pdf
"Trial Registration:  Chinese Clinical Trial Registry, ChiCTR‑TRC‑11001143; http://www.chictr.org.cn/showproj.aspx?proj=8395.",Non-OADS,/arxiv_data1/oa_pdf/fa/50/CMJ-129-883.PMC4831520.pdf
doi: http://dx.doi.org/10.1210/jc.2007‑0282.,Non-OADS,/arxiv_data1/oa_pdf/fa/50/CMJ-129-883.PMC4831520.pdf
"The celecoxib Trial Registration:  Chinese Clinical Trial Registry, ChiCTR‑IPR‑15007267; http://www.medresman.org/uc/project/projectedit.",Non-OADS,/arxiv_data1/oa_pdf/e3/50/CMJ-129-891.PMC4831521.pdf
"Trial Registration:  ClinicalTrials.gov, NCT01979627; https://clinicaltrials.gov/ct2/show/NCT01979627?term = NCT01979627 and rank = 1.",Non-OADS,/arxiv_data1/oa_pdf/73/ee/CMJ-129-898.PMC4831522.pdf
Available from: http://www.cbo.gov/ftpdocs/113×x/doc11379/ AmendReconProp.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4a/a9/CMJ-129-953.PMC4831531.pdf
Available from: http://www.nice.org.uk/guidance/ cg129.,Non-OADS,/arxiv_data1/oa_pdf/10/5a/CMJ-128-1137.PMC4831537.pdf
"Resting‑state functional magnetic resonance imaging  analysis Data preprocessing The RS‑fMRI data were preprocessed using SPM8 (http:// www.fil.ion.ucl.ac.uk/spm ) and a pipeline analysis toolbox,  DPARSF (http://www.restfmri.net/ ).",OADS,/arxiv_data1/oa_pdf/fd/23/CMJ-128-1171.PMC4831543.pdf
Available  from:  http://www.usrds.org/atlas.aspx.,OADS,/arxiv_data1/oa_pdf/ea/55/CMJ-128-1196.PMC4831547.pdf
Available from: http://www.ctep.cancer.gov/ protocolDevelopment/electronic_applications/ctc.htm#ctc_v3.0.,Non-OADS,/arxiv_data1/oa_pdf/0d/e5/CMJ-128-1215.PMC4831550.pdf
Avail- able at: http://drought.unl.edu/dm.,Non-OADS,/arxiv_data1/oa_pdf/6e/7c/JVIM-29-1667.PMC4831564.pdf
R package version 1.1-7 ed; 2014. https://CRAN.R-project.org/package=lme4.,Non-OADS,/arxiv_data1/oa_pdf/6e/7c/JVIM-29-1667.PMC4831564.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1a/30/ofw053.PMC4831579.pdf
Available at: https://aidsinfo.nih.gov/content ﬁles/ lvguidelines/adultandadolescentgl.pdf .,Non-OADS,/arxiv_data1/oa_pdf/1a/30/ofw053.PMC4831579.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/10/1e/tcrm-12-505.PMC4831589.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and clinical risk Management 2016:12 505–513submit your manuscript | www.dovepress.co m Dove press  505 http: //dx.doi.org/10.2147/TCRM.S9660 6Dysfunction of the thyroid gland during amiodarone  therapy: a study of 297 cases agata czarnywojtek1,2,* Maria T eresa Płazińska3,* Małgorzata Zgorzalewicz- stachowiak4 Kosma Woliński1 adam stangierski1 izabela Miechowicz5 Joanna Waligórska- stachura1 Paweł Gut1 leszek Królicki3 Maja Zioncheck6 Marek Ruchała1 1Department of endocrinology,   Metabolism and internal Medicine,   2Department of Pharmacology,   Poznan University of Medical  sciences, Poznan, 3nuclear Medicine  Department, Medical University of  Warsaw, Warsaw, 4Department of  health Prophylaxis, laboratory  of Medical electrodiagnostics,   5Department of computer science  and statistics, 6Poznan University of  Medical sciences, Poznan, Poland *These authors contributed equally  to this workAim:  This study aims to explore and compare the efficacy of radioiodine treatment (RIT)  in hyperthyroid and euthyroid patients who have been treated with amiodarone (AM) in the  past or are currently undergoing AM treatment.",Non-OADS,/arxiv_data1/oa_pdf/10/1e/tcrm-12-505.PMC4831589.pdf
"Of this, 10%/d is deiodinated into free iodine,4,5 which  means that with a daily dose of 200–400 mg AM, the human body receives 6–12 mg correspondence: agata czarnywojtek Department of endocrinology,  Metabolism and internal Medicine,  Poznan University of Medical sciences,  49 Przybyszewskiego street,  60-355 Poznan, Poland Tel +48 60 546 3322 Fax +48 61 869 1682 email agata.rat@wp.p l Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Czarnywojtek et al Running head recto: Thyroid gland during amiodarone therapy DOI: http://dx.doi.org/10.2147/TCRM.S96606",Non-OADS,/arxiv_data1/oa_pdf/10/1e/tcrm-12-505.PMC4831589.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/10/1e/tcrm-12-505.PMC4831589.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/10/1e/tcrm-12-505.PMC4831589.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6a/38/ppa-10-443.PMC4831590.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 443–447Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  443OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10182 5relationships among satisfaction, treatment  motivation, and expectations in orthodontic  patients: a prospective cohort study Weihong li shimei Wang Yanzhen Zhang The second Affiliated hospital,   Zhejiang University school of  Medicine, hangzhou, Zhejiang,   People’s republic of chinaBackground:  Few research projects have looked at patient satisfaction with treatment outcome  and factors contributing to satisfaction.",Non-OADS,/arxiv_data1/oa_pdf/6a/38/ppa-10-443.PMC4831590.pdf
"We know that patient satisfaction after orthodontic treatment is influenced by  a number of factors, such as sex, age, duration of treatment, compliance, and dento - facial improvement,7–9 but so far no correlations have been found among treatment  expectation, motivation, and satisfaction with treatment outcome.correspondence: Yanzhen Zhang The Second Affiliated Hospital, Zhejiang  University school of Medicine, 88 Jiefang  road, hangzhou, Zhejiang 310009,  People’s republic of china Tel +86 571 8778 3608 email zhangyanzhen1@126.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Li et al Running head recto: Patient satisfaction in orthodontic patients DOI: http://dx.doi.org/10.2147/PPA.S101825",Non-OADS,/arxiv_data1/oa_pdf/6a/38/ppa-10-443.PMC4831590.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/6a/38/ppa-10-443.PMC4831590.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/93/8d/ijn-11-1395.PMC4831591.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 1395–1412International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1395OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9686 2Folate receptor-targeted liposomes loaded with  a diacid metabolite of norcantharidin enhance  antitumor potency for h22 hepatocellular  carcinoma both in vitro and in vivo Min-chen liu1 lin liu1 Xia-rong Wang1 Wu-Ping shuai2 Ying hu3 Min han1 Jian-Qing gao1 1Institute of Pharmaceutics, college  of Pharmaceutical sciences, 2First  affiliated hospital, college of  Medicine, Zhejiang University,   hangzhou, 3Zhejiang Pharmaceutical  college, Ningbo, People’s republic  of chinaAbstract:  The diacid metabolite of norcantharidin (DM-NCTD) is clinically effective against  hepatocellular carcinoma (HCC), but is limited by its short half-life and high incidence of  adverse effects at high doses.",Non-OADS,/arxiv_data1/oa_pdf/93/8d/ijn-11-1395.PMC4831591.pdf
"Keywords:  active targeting, PEGylated liposome, diacid metabolite of norcantharidin, hepatic  cancer Introduction Hepatocellular carcinoma (HCC) is the sixth-most prevalent cancer and one of the  leading causes of cancer-related death worldwide.1 Unfortunately, only approximately  20% of patients with HCC are eligible for curative treatments that may achieve long- term complete response and improved survival, as most patients present with advanced  or unresectable disease and are suitable only for palliative approaches.2–4 Systemic  chemotherapy is commonly used as a palliative treatment to improve survival of  patients with HCC.3correspondence: Jian-Qing gao Institute of Pharmaceutics, college  of Pharmaceutical sciences, Zhejiang  University, 866 Yuhangtang road,  hangzhou, Zhejiang 310058,   People’s republic of china Tel +86 571 8820 8436 Fax +86 571 8820 8436 email gaojianqing@zju.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Liu et al Running head recto: Diacid metabolite of norcantharidin liposomes for HCC DOI: http://dx.doi.org/10.2147/IJN.S96862",Non-OADS,/arxiv_data1/oa_pdf/93/8d/ijn-11-1395.PMC4831591.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/93/8d/ijn-11-1395.PMC4831591.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/93/8d/ijn-11-1395.PMC4831591.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8d/11/btt-10-075.PMC4831592.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Biologics: Targets and Therapy 2016:10 75–80Biologics: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  75Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/BTT .S10295 4Efficacy of anti-IL-1 treatment in familial  Mediterranean fever: a systematic review of the  literature Jeroen ch van der hilst1,2 Michel Moutschen3 Peter e Messiaen1,2 Bernard r lauwerys4,5 steven Vanderschueren6 1Department of infectious diseases  and immunity, Jessa hospital,   hasselt, 2Biomedical research  institute, University of hasselt,   hasselt, 3Department of immunity  and infectious Diseases, University  hospital of liège, liège, 4service  de rhumatologie, cliniques  Universitaires Saint-Luc, 5institut de  recherche expérimentale et clinique,   Université catholique de louvain,   Brussels, 6KU leuven, laboratory of  clinical infectious and inflammatory  Disorders, University hospitals  leuven, leuven, Belgium correspondence: Jeroen ch van der hilst  Department of infectious Diseases and  immunity, Jessa hospital, stadsomvaart 11,  3500 hasselt, Belgium   T el +32 11 309 485   Fax +32 11 309 488   email jeroen.vanderhilst@jessazh.b eIntroduction:  In 5%–10% of patients with familial Mediterranean fever (FMF), colchicine  is not effective in preventing inflammatory attacks.",Non-OADS,/arxiv_data1/oa_pdf/8d/11/btt-10-075.PMC4831592.pdf
"Biologics: Targets & Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/biologics-targets--therapy-journa lBiologics: Targets & Therapy is an international, peer-reviewed journal  focusing on the patho-physiological rationale for and clinical applica - tion of Biologic agents in the management of autoimmune diseases,  cancers or other pathologies where a molecular target can be identified.",Non-OADS,/arxiv_data1/oa_pdf/8d/11/btt-10-075.PMC4831592.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/8d/11/btt-10-075.PMC4831592.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6b/07/ott-9-1953.PMC4831593.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1953–1960OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1953Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S8023 9Profile of ramucirumab in the treatment of   metastatic non-small-cell lung cancer Maryann R Cooper1 Chelsea Binkowski2,3 Jessica Hartung2,4 Jennifer T owle1 1Department of Pharmacy Practice,   School of Pharmacy – Worcester/ Manchester, MCPHS University,   Manchester, NH, 2School of Pharmacy  – Boston, MCPHS University, Boston,   MA, 3North America Medical Affairs,   4Global Medical Affairs, Sanofi  Oncology, Cambridge, MA, USAAbstract:  The interaction between vascular endothelial growth factor and its receptor is an  important therapeutic target due to the importance of this pathway in carcinogenesis.",Non-OADS,/arxiv_data1/oa_pdf/6b/07/ott-9-1953.PMC4831593.pdf
"Bevacizumab (Avastin®; Genentech, Inc., South San Francisco, CA, USA), a fully  humanized monoclonal antibody that potently binds VEGF-A preventing its interac - tion with VEGFR-1 and VEGFR-2, has been shown to improve OS in patients with  recurrent or advanced NSCLC.10,11 Major hemoptysis occurred more frequently in  patients with squamous cell histology; therefore, the drug is recommended only for  patients with nonsquamous histologies.10,12 Currently, bevacizumab is the only approved  anti-VEGF-targeted therapy for first-line treatment of unresectable, locally advanced,  recurrent, or metastatic NSCLC in combination with standard chemotherapy.Correspondence: Maryann R Cooper School of Pharmacy – Worcester/ Manchester, Massachusetts College  of Pharmacy and Health Sciences  University, 1260 elm Street, Manchester,  NH 03101, USA Tel +1 603 314 1737 Fax +1 603 314 0209 email maryann.cooper@mcphs.ed u Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Cooper et al Running head recto: Ramucirumab for NSCLC DOI: http://dx.doi.org/10.2147/OTT.S80239",Non-OADS,/arxiv_data1/oa_pdf/6b/07/ott-9-1953.PMC4831593.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/6b/07/ott-9-1953.PMC4831593.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6b/07/ott-9-1953.PMC4831593.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/90/cf/ott-9-1961.PMC4831594.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1961–1968OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1961Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10168 7Prognostic and clinicopathological significance of   gankyrin overexpression in cancers: evidence  from a meta-analysis Xiaotong Zhao1,* Fangzhou liu2,* Yuan Zhang2 Peihua li1 1Department of Otolaryngology,   Affiliated Hospital of XuZhou Medical  college, Xuzhou, 2Department of  Otolaryngology, The Affiliated Cancer  Hospital, Nanjing Medical University,   nanjing, Jiangsu, People’s republic  of China *These authors contributed equally  to this workAbstract:  Many studies have indicated that Gankyrin is a promising and novel prognostic  tumor biomarker.",Non-OADS,/arxiv_data1/oa_pdf/90/cf/ott-9-1961.PMC4831594.pdf
"To overcome the limitation of the single study, this meta- analysis was conducted to investigate the relationship between Gankyrin expression  and its prognostic value in cancers.correspondence: Yuan Zhang Department of Otolaryngology,  The Affiliated Cancer Hospital, Nanjing  Medical University, No 42, Baiziting  road, nanjing 210000, Jiangsu, People’s  Republic of China Tel +86 25 8328 4685 email yzhang1963@163.co m  Peihua li Department of Otolaryngology, Affiliated  Hospital of XuZhou Medical College,  no 99, West huaihai road, Xuzhou  221000, Jiangsu, People’s Republic of  china Tel +86 516 8580 7087 email l ipeihua000@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Zhao et al Running head recto: Significance of Gankyrin overexpression in cancers DOI: http://dx.doi.org/10.2147/OTT.S101687",Non-OADS,/arxiv_data1/oa_pdf/90/cf/ott-9-1961.PMC4831594.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/90/cf/ott-9-1961.PMC4831594.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/90/cf/ott-9-1961.PMC4831594.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9b/21/ott-9-1981.PMC4831595.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1981–1988OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1981Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10106 3Prognostic values of aldehyde dehydrogenase 1  isoenzymes in ovarian cancer Yu-mei Ma1 shan Zhao2 1Department of Pathology,   2Department of cancer second  Division, The second hospital of  hebei Medical University, shijiazhuang  city, People’s republic of chinaAbstract:  Aldehyde dehydrogenase 1 (ALDH1) activity has been used as a functional stem cell  marker to isolate cancer stem cells in different cancer types, including ovarian cancer.",Non-OADS,/arxiv_data1/oa_pdf/9b/21/ott-9-1981.PMC4831595.pdf
"Elevated aldehyde dehydrogenase 1 (ALDH1) activity has been detected in the stem  cell populations of human acute myeloid leukemia, multiple myeloma, and a number correspondence: Yu-mei Ma Department of Pathology, The second  hospital of hebei Medical University,  215 heping West road, shijiazhuang city  050000, People’s republic of china Tel +86 0311 8704 6901 email yumeimamd@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Ma and Zhao Running head recto: Prognostic role of ALDH1 isoenzymes in ovarian cancer DOI: http://dx.doi.org/10.2147/OTT.S101063",Non-OADS,/arxiv_data1/oa_pdf/9b/21/ott-9-1981.PMC4831595.pdf
"Ovarian cancer patients in the database were  identified from the cancer Biomedical Informatics Grid  (http://cabig.cancer.gov /, microarray samples are published  in the caArray project), on The Cancer Genome Atlas  (http://cancergenome.nih.go v), and the Gene Expression  Omnibus ( http://www.ncbi.nlm.nih.gov/geo /) ovarian can - cer datasets.26 They provided clinical data, including age,  histology, grade, stage, TP53  mutation status, and applied  chemotherapy for all patients in WinStat 2013.",OADS,/arxiv_data1/oa_pdf/9b/21/ott-9-1981.PMC4831595.pdf
Available from: http://www.ovariancancer.org/about-ovarian-cancer/ statistics /.,Non-OADS,/arxiv_data1/oa_pdf/9b/21/ott-9-1981.PMC4831595.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/9b/21/ott-9-1981.PMC4831595.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/21/ott-9-1981.PMC4831595.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ac/3a/copd-11-711.PMC4831596.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 711–718submit your manuscript | www.dovepress.co m Dove press  711 http: //dx.doi.org/10.2147/COPD.S9666 3Dove press OrIg Inal researChopen access to scientific and medical research Open access Full T ext article effects of combined training vs aerobic training  on cognitive functions in COPD: a randomized  controlled trial giovanna aquino1 enzo Iuliano1 alessandra di Cagno2 angela Vardaro3 giovanni Fiorilli1 stefano Moffa1 alfonso Di Costanzo1 giuseppe De simone3 giuseppe Calcagno1 1Department of Medicine and  health sciences “Vincenzo Tiberio”,   University of Molise, Campobasso,   2Department of health science,   University ForoItalico, rome, 3“Villa  Margherita”, Benevento, ItalyAim:  The aim of this study was to investigate the effects of high-intensity aerobic training (AT)  and high-intensity aerobic training combined with resistance training (ie, combined training  [CT]) on cognitive function in patients with COPD.",Non-OADS,/arxiv_data1/oa_pdf/ac/3a/copd-11-711.PMC4831596.pdf
"Patients with COPD have an altered cerebral perfusion due to arterial  oxygen desaturation4 that may result in cognitive impairments.5,6 Cognitive impairment associated with COPD differs from Alzheimer disease.7,8  The neuropsychological impairment associated with COPD has a specific pattern  characterized by moderate-to-severe deficits in isolated domains, such as attention,  memory, executive functions, language skill, psychomotor speed, and complex visual- motor processes.9 Exercise training is associated with maintenance and improvement  of physical and cognitive functioning and psychological well-being.10,11 A meta-analysis of randomized controlled trials showed that a 14% improvement  in aerobic activity coincided with an improvement in cognitive capacity.12 However, Correspondence: giovanna aquino Department of Medicine and health  sciences “Vincenzo Tiberio”, University  of Molise, 86100 Campobasso, Italy Tel +39 874 40 4899 Fax +39 874 40 4763 email giovanna.aquino@unimol.i t Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Aquino et al Running head recto: Combined training on cognitive functions in COPD DOI: http://dx.doi.org/10.2147/COPD.S96663",Non-OADS,/arxiv_data1/oa_pdf/ac/3a/copd-11-711.PMC4831596.pdf
"statistics Participants’ randomization into the two groups was per - formed using a random number list, generated using the  online software ( https://www.random.org/sequences /,  Dublin, Ireland).",OADS,/arxiv_data1/oa_pdf/ac/3a/copd-11-711.PMC4831596.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/ac/3a/copd-11-711.PMC4831596.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ac/3a/copd-11-711.PMC4831596.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d9/a3/jpr-9-187.PMC4831597.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Journal of Pain research 2016:9 187–193submit your manuscript | www.dovepress.co m Dove press  187 http: //dx.doi.org/10.2147/JPR.S10172 0is blood glucose associated with descending  modulation of spinal nociception as measured by  the nociceptive flexion reflex?",Non-OADS,/arxiv_data1/oa_pdf/d9/a3/jpr-9-187.PMC4831597.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/d9/a3/jpr-9-187.PMC4831597.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d9/a3/jpr-9-187.PMC4831597.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d8/b7/ppa-10-479.PMC4831598.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2016:10 479–499Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  479Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S9304 6Appointment reminder systems are effective but  not optimal: results of a systematic review and  evidence synthesis employing realist principles Sionnadh Mairi McLean1 Andrew Booth2 Melanie Gee3 Sarah Salway2 Mark Cobb4 Sadiq Bhanbhro3 Susan A Nancarrow5 1Faculty of Health and wellbeing,   Sheffield Hallam University, Sheffield,   UK; 2School of Health and Related  Research, University of Sheffield,   Sheffield, UK; 3Centre for Health  and Social Care Research, Sheffield  Hallam University, Sheffield, UK;   4Therapeutics & Palliative Care,   Sheffield T eaching Hospitals, Sheffield,   UK; 5School of Health and Human  Science, Southern Cross University,   east Lismore, NSw , AustraliaAbstract:  Missed appointments are an avoidable cost and resource inefficiency which impact  upon the health of the patient and treatment outcomes.",Non-OADS,/arxiv_data1/oa_pdf/d8/b7/ppa-10-479.PMC4831598.pdf
"Data on non-attendance vary,  however studies from around the world consistently report non-attendance rates of  between 15% and 30% in outpatient health clinics.1–4 In England, more than 12  million  appointments at consultant led clinics,5 and a similar number of general practice  appointments are missed each year.6 The cost of missed appointments to the UK  National Health Service (NHS) has tripled since 1999.7 In 2009, non-attendance was  estimated to cost over £600 million (around US$970 million).8Correspondence: Sionnadh Mairi McLean Collegiate Campus, Sheffield Hallam  University, 38 Collegiate Crescent,  Sheffield, S10 2BP, UK Tel +44 114 225 2271 email s.mclean@shu.ac.u k Journal name: Patient Preference and Adherence Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: McLean et al Running head recto: Effectiveness and optimization of appointment reminders DOI: http://dx.doi.org/10.2147/PPA.S93046",Non-OADS,/arxiv_data1/oa_pdf/d8/b7/ppa-10-479.PMC4831598.pdf
Available from: http://citeseerx.ist.psu.,Non-OADS,/arxiv_data1/oa_pdf/d8/b7/ppa-10-479.PMC4831598.pdf
Available from: http://transparency.dh.gov.uk/?p =1970 1.,OADS,/arxiv_data1/oa_pdf/d8/b7/ppa-10-479.PMC4831598.pdf
Available from: http://www.digitaljournal.com/ article/27752 9.,Non-OADS,/arxiv_data1/oa_pdf/d8/b7/ppa-10-479.PMC4831598.pdf
Available from: http://media.wix.,Non-OADS,/arxiv_data1/oa_pdf/d8/b7/ppa-10-479.PMC4831598.pdf
"Avail - able from: https://www.york.ac.uk/media/crd/em62.pd f. Accessed  October 21, 2015.",Non-OADS,/arxiv_data1/oa_pdf/d8/b7/ppa-10-479.PMC4831598.pdf
"Available from: http://medicina.med.up.pt/im/trabalhos06_07/sites/ Turma4/minhaweb/images/IntroMed%20Annual%20Assignment%20-   %20Class%204%20-%20Paper.pd f. Accessed December 1, 2015.",Non-OADS,/arxiv_data1/oa_pdf/d8/b7/ppa-10-479.PMC4831598.pdf
Available from: http://slideplayer.com/slide/5101460/.,Non-OADS,/arxiv_data1/oa_pdf/d8/b7/ppa-10-479.PMC4831598.pdf
"Available from: http://mighealth.net/uk/images/8/84/Dix1.pd f.  Accessed October 21, 2015.",Non-OADS,/arxiv_data1/oa_pdf/d8/b7/ppa-10-479.PMC4831598.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/d8/b7/ppa-10-479.PMC4831598.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/33/c8/ott-9-1927.PMC4831599.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1927–1943OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1927Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S9372 0Molecularly targeted therapy for the treatment  of head and neck cancer: a review of the erbB  family inhibitors Assuntina G Sacco1 Francis P worden2 1Department of internal Medicine,   Division of Hematology/Oncology,   University of California at San Diego  Moores Cancer Center, La Jolla,   CA, USA; 2Department of internal  Medicine, Division of Hematology/ Oncology, University of Michigan  Health System, Ann Arbor, M i, USAAbstract:  The majority of patients with head and neck squamous cell carcinoma (HNSCC)  present with locally advanced disease, which requires site-specific combinations of surgery,  radiation, and chemotherapy.",Non-OADS,/arxiv_data1/oa_pdf/33/c8/ott-9-1927.PMC4831599.pdf
"Keywords:  head and neck cancer, epidermal growth factor receptor, monoclonal antibody,  tyrosine kinase inhibitor Introduction Head and neck cancer is the seventh most common cancer worldwide.1 In the United  States, head and neck squamous cell carcinoma (HNSCC) accounts for 3% of cancers  diagnosed annually and 2% of cancer-related deaths.2 The 2014 estimates for the number  of new cases of HNSCC and anticipated deaths from HNSCC in the United States are  approximately 55,000 and 12,000, respectively.2 Tobacco and alcohol use remain the  strongest risk factors for HNSCC, act synergistically, and are implicated in the majority  of diagnoses.3,4 Viral etiologies have also been implicated; specifically, Epstein–Barr virus  is present in a significant proportion of nasopharyngeal cancers, whereas high-risk human  papillomavirus (HPV) is now the primary cause of oropharyngeal cancers (OPCs).5–7 More than half the patients with HNSCC present with potentially curable, locally  advanced (LA) disease, or disease that has spread to nearby tissue or lymph nodes, but  has not metastasized.8 Historically, surgery was the mainstay of treatment for HNSCC; Correspondence: Francis P worden Department of internal Medicine,  Division of Hematology/Oncology,  University of Michigan Health System,  C369 Med inn Building, SPC 5848,  1500 e. Medical Center Drive,  Ann Arbor, Mi 48109, USA Tel +1 734 936 0453 Fax +1 734 615 2109 email fworden@med.umich.ed u Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Sacco and Worden Running head recto: ErbB family inhibition in head and neck cancer DOI: http://dx.doi.org/10.2147/OTT.S93720",Non-OADS,/arxiv_data1/oa_pdf/33/c8/ott-9-1927.PMC4831599.pdf
"Available from: http://www.nccn.org/professionals/physician_gls/PDF/ head-and-neck.pd f. Accessed September 22, 2014.",Non-OADS,/arxiv_data1/oa_pdf/33/c8/ott-9-1927.PMC4831599.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/33/c8/ott-9-1927.PMC4831599.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/33/c8/ott-9-1927.PMC4831599.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9d/18/ott-9-1945.PMC4831600.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1945–1951OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1945Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10069 9a genetic variant in large tumor suppressor  kinase 2 of hippo signaling pathway contributes  to prognosis of hepatocellular carcinoma lili shen1,2,* Juan Wen3,4,* Tingting Zhao1 Zhibin hu4,5 ci song4 Dongying gu1 Mingliang he6 nikki P lee7 Zhi Xu1 Jinfei chen1 1Department of Oncology, nanjing  First hospital, nanjing Medical  University, nanjing, 2Department of  Oncology, haimen People’s hospital,  haimen, 3nanjing Maternity and  child health care institute, nanjing  Maternity and child health care  hospital affiliated with nanjing Medical  University, nanjing, 4Department of  epidemiology and Biostatistics, Jiangsu  Key laboratory of cancer Biomarkers,  Prevention and Treatment, cancer  center, school of Public health,  nanjing Medical University, nanjing,  5state Key laboratory of reproductive  Medicine, nanjing Medical University,  nanjing, 6Department of Biomedical  sciences, city University of hong  Kong, hong Kong, 7Department of  surgery, The University of hong Kong,  hong Kong, People’s republic of china *These authors contributed equally  to this workAbstract:  The Hippo pathway plays an important role in the development of hepatocellular  carcinoma (HCC).",Non-OADS,/arxiv_data1/oa_pdf/9d/18/ott-9-1945.PMC4831600.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/9d/18/ott-9-1945.PMC4831600.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9d/18/ott-9-1945.PMC4831600.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e5/dd/copd-11-675.PMC4831601.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 675–685International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  675OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S9808 2The effect of benzodiazepines on insomnia in  patients with chronic obstructive pulmonary disease:  a meta-analysis of treatment efficacy and safety Xiao-Min lu* Ji-Ping Zhu* Xian-Mei Zhou Department of respiratory Medicine,   affiliated Jiangsu Province hospital of  Traditional Chinese Medicine, n anjing  University of Traditional Chinese  Medicine, nanjing, People’s republic  of China *These authors contributed equally  to this workBackground:  Insomnia is a common comorbidity associated with COPD.",Non-OADS,/arxiv_data1/oa_pdf/e5/dd/copd-11-675.PMC4831601.pdf
"Benzodiazepines (BZDs) are proven to influence  sleep quality beneficially, and are the first-choice hypnotics nowadays.5Correspondence: Xiao-Min lu Department of respiratory Medicine,  Affiliated Jiangsu Province Hospital  of Traditional Chinese Medicine,  nanjing University of Traditional  Chinese Medicine, 155 hanzhong  road, nanjing, Jiangsu 210029,  People’s republic of China Tel +86 25 8661 7141 ext 91 715 email xmlu78@126.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Lu et al Running head recto: BZD for insomnia in COPD DOI: http://dx.doi.org/10.2147/COPD.S98082",Non-OADS,/arxiv_data1/oa_pdf/e5/dd/copd-11-675.PMC4831601.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/e5/dd/copd-11-675.PMC4831601.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e5/dd/copd-11-675.PMC4831601.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/50/14/ceg-9-071.PMC4831602.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical and experimental Gastroenterology 2016:9 71–82submit your manuscript | www.dovepress.co m Dove press  71 http: //dx.doi.org/10.2147/CEG.S8401 9Clinical management of achalasia: current state of  the art Joseph T Krill Rishi D Naik Michael F vaezi Division of Gastroenterology,   Hepatology, and Nutrition, Center for  Swallowing and esophageal Disorders,   vanderbilt University Medical Center,   Nashville, TN, USA Correspondence: Michael F vaezi  1660 TvC Digestive Disease Center,  vanderbilt University Medical Center,  1301 Medical Center Drive, Nashville, TN  37232-5280, USA   T el +1 615 322 3739   Fax +1 615 322 8525   email Michael.v aezi@vanderbilt.ed uAbstract:  Achalasia is a primary disorder of esophageal motility.",Non-OADS,/arxiv_data1/oa_pdf/50/14/ceg-9-071.PMC4831602.pdf
"Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-and-experimental-gastroenterology-journa lClinical and Experimental Gastroenterology is an international, peer- reviewed, open access journal, publishing all aspects of gastroenterology  in the clinic and laboratory, including: Pathology, pathophysiology  of gastrointestinal disease; Investigation and treatment of gastointes - tinal disease; Pharmacology of drugs used in the alimentary tract; Immunology/genetics/genomics related to gastrointestinal disease.",Non-OADS,/arxiv_data1/oa_pdf/50/14/ceg-9-071.PMC4831602.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/50/14/ceg-9-071.PMC4831602.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/c1/15/jmdh-9-145.PMC4831603.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/c1/15/jmdh-9-145.PMC4831603.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Journal of Multidisciplinary Healthcare 2016:9 145–151Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  145Original researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JMDH.S9769 5chemotherapy-induced nausea and vomiting:  exploring patients’ subjective experience noor salihah1 nik Mazlan2 Pei lin lua3 1Faculty of Health sciences, Universiti  sultan Zainal abidin, Kampus gong  Badak, T erengganu, 2Kulliyyah of  allied Health sciences, international  islamic University Malaysia, Pahang  3community Health research cluster,   Faculty of Health sciences, Universiti  sultan Zainal abidin, T erengganu,   Malaysia correspondence: Pei lin lua   community Health research cluster,  Faculty of Health sciences, Universiti  sultan Zainal abidin, Kampus gong Badak,  21300 Kuala nerus, T erengganu, Malaysia   T el +60 9 668 8520   Fax +60 9 668 7896   email peilinlua@unisza.edu.m yBackground:  This study aimed to explore the subjective experience of nausea and vomiting  during  chemotherapy treatment among breast cancer patients and the impacts on their daily lives.",Non-OADS,/arxiv_data1/oa_pdf/c1/15/jmdh-9-145.PMC4831603.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/c1/15/jmdh-9-145.PMC4831603.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/15/jmdh-9-145.PMC4831603.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b8/6a/ppa-10-469.PMC4831604.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 469–477Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  469OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S9809 5Factors influencing inpatients’ satisfaction with  hospitalization service in public hospitals in  Shanghai, People’s Republic of China Haiping Chen1 Meina li1 Jingrui Wang1 chen Xue1 Tao Ding1 Xin Nong2 Yuan liu1 Lulu Zhang1 1Department of Military health  Management, College of Health  Service, Second Military Medical  University, Shanghai, 2Department of  Medical Research, Rizhao Maternity  and Infant Hospital, Shandong,   People’s Republic of ChinaObjective:  The aim of this study was to observe the current status of inpatient satisfaction and  analyze the possible factors influencing patient satisfaction during hospitalization.",Non-OADS,/arxiv_data1/oa_pdf/b8/6a/ppa-10-469.PMC4831604.pdf
"Higher satisfaction ratings indicate fewer complaints and medical disputes,  better patient recovery, and increased hospital assessment, so it is essential to conduct Correspondence: Lulu Zhang Department of Military health  Management, College of Health Service,  Second Military Medical University,  800 Xiangyin Road, Yangpu District,  Shanghai 200433, People’s Republic  of china Tel +86 21 8187 1421 Fax +86 21 8187 1436 email zllrmit@aliyun.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Chen et al Running head recto: Factors influencing inpatients’ satisfaction with hospitalization service DOI: http://dx.doi.org/10.2147/PPA.S98095",Non-OADS,/arxiv_data1/oa_pdf/b8/6a/ppa-10-469.PMC4831604.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/b8/6a/ppa-10-469.PMC4831604.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/80/14/jaa-9-071.PMC4831605.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Journal of Asthma and Allergy 2016:9 71–81submit your manuscript | www.dovepress.co m Dove press  71 http: //dx.doi.org/10.2147/JAA.S7804 9Benralizumab: a unique iL-5 inhibitor for severe  asthma Laren D Tan1 Jennifer M Bratt2 Dorottya Godor3 Samuel Louie2 Nicholas J Kenyon2 1Division of Pulmonary and Critical  Care Medicine, Department of  internal Medicine, School of Medicine,   Loma Linda University, Loma Linda,   CA, USA; 2Division of Pulmonary,   Critical Care and Sleep Medicine,   Department of internal Medicine,   School of Medicine, University of  California Davis, Sacramento, CA,   USA; 3School of Medicine, Semmelweis  University, Budapest, Hungary Correspondence: LD Tan   Division of Pulmonary and Critical  Care Medicine, Department of internal  Medicine, School of Medicine, Loma Linda  University, 11234 Anderson Street,  Room 6433, Loma Linda, CA 92354, USA   T el +1 909 558 4489   Fax +1 909 558 0581   email latan@llu.ed uAbstract:  The presence of eosinophilic inflammation is a characteristic feature of chronic and  acute inflammation in asthma.",Non-OADS,/arxiv_data1/oa_pdf/80/14/jaa-9-071.PMC4831605.pdf
Available from http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/80/14/jaa-9-071.PMC4831605.pdf
"Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-asthma-and-allergy-journa lThe Journal of Asthma and Allergy is an international, peer-reviewed  open-access journal publishing original research, reports, editorials  and commentaries on the following topics: Asthma; Pulmonary physi - ology; Asthma related clinical health; Clinical immunology and the  immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/80/14/jaa-9-071.PMC4831605.pdf
Visit http://www.dovepress.com/testimonials.ph p to read  real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/80/14/jaa-9-071.PMC4831605.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/li- censes/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly ci ted.",Non-OADS,/arxiv_data1/oa_pdf/c5/9e/omw008.PMC4831616.pdf
http://www.ncbi.nlm.nih.gov/ pmc/articles/PMC536075/ .,Non-OADS,/arxiv_data1/oa_pdf/c5/9e/omw008.PMC4831616.pdf
http://www.nejm.,Non-OADS,/arxiv_data1/oa_pdf/c5/9e/omw008.PMC4831616.pdf
http://www.sciencedirect.,Non-OADS,/arxiv_data1/oa_pdf/c5/9e/omw008.PMC4831616.pdf
2012; 76(1):15 –21.http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/c5/9e/omw008.PMC4831616.pdf
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1216614/ .,Non-OADS,/arxiv_data1/oa_pdf/c5/9e/omw008.PMC4831616.pdf
http://www.nejm.org/doi/full/10.1056/NEJM198808183190701 .,OADS,/arxiv_data1/oa_pdf/c5/9e/omw008.PMC4831616.pdf
http://content.onlinej acc.org/article.aspx?,Non-OADS,/arxiv_data1/oa_pdf/c5/9e/omw008.PMC4831616.pdf
http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC439698/ .,Non-OADS,/arxiv_data1/oa_pdf/c5/9e/omw008.PMC4831616.pdf
2012; 125(7): e369 –73.http://circ.ahajournals.org/content/125/7/e369.full .Educational Case |65,Non-OADS,/arxiv_data1/oa_pdf/c5/9e/omw008.PMC4831616.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a4/7a/emss-67632.PMC4831642.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/2f/f3/1181.PMC4831871.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/bf/94/1185.PMC4831872.pdf
"For  example, some journals accept manuscripts that have been posted  as preprints, whereas others that are well regarded in my field have  policies either completely incompatible or potentially compatible  with the posting of preprints (for journal compatibility with preprints,  see https://en.wikipedia.org/wiki/List_of_academic_journals_by   _preprint_policy).",Non-OADS,/arxiv_data1/oa_pdf/bf/94/1185.PMC4831872.pdf
Available at  http://asapbio.org/biorxiv.,Non-OADS,/arxiv_data1/oa_pdf/bf/94/1185.PMC4831872.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/fc/f0/1188.PMC4831873.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by- nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/26/95/1197.PMC4831874.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/44/17/1204.PMC4831875.pdf
The pla - narian sequence of WDR92 was obtained from the SmedGD Genome  Database (http://smedgd.neuro.utah.edu/; Robb et al.,OADS,/arxiv_data1/oa_pdf/44/17/1204.PMC4831875.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unport - ed Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/8d/64/1210.PMC4831876.pdf
"Quantification of FES1  mRNA levels Data for FES1  transcript levels were ex - ported from the University of California,  Santa Cruz, database (http://genome.ucsc   .edu/; Yassour et al ., 2009) as cumulative  reads per lane per thousand base pairs.",OADS,/arxiv_data1/oa_pdf/8d/64/1210.PMC4831876.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/53/86/1220.PMC4831877.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/06/55/1235.PMC4831878.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/06/97/1246.PMC4831879.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/79/c7/1262.PMC4831880.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/5a/c3/1272.PMC4831881.pdf
"Colocalization of  POML-1, MEC-4, MEC-2, and MEC-6 puncta in the TRN neurite was  analyzed by ImageJ plug-in Coloc 2 (http://fiji.sc/Coloc2) as de - scribed in Chen et al.",OADS,/arxiv_data1/oa_pdf/5a/c3/1272.PMC4831881.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/55/c9/1286.PMC4831882.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/29/01/1300.PMC4831883.pdf
The source code  is available at http://rusty.fhl.washington   .edu/celldynamics/downloads/simcode   .html.,OADS,/arxiv_data1/oa_pdf/29/01/1300.PMC4831883.pdf
In silico simulations of MT assembly Skeledyne was downloaded from http://rusty.fhl.washington.edu/ celldynamics/downloads/simcode.html.,OADS,/arxiv_data1/oa_pdf/29/01/1300.PMC4831883.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/b6/82/1310.PMC4831884.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f6/e4/1320.PMC4831885.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/82/47/1332.PMC4831886.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/45/ea/1346.PMC4831887.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/79/df/1358.PMC4831888.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/22/a7/1367.PMC4831889.pdf
"Raw diffraction data are available at the Diffraction Images  Repository (http://xr-diffraction.imb.uq.edu.au).Characterisation, and Analysis, University of Western Australia.",OADS,/arxiv_data1/oa_pdf/22/a7/1367.PMC4831889.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unport - ed Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/85/12/1383.PMC4831890.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f6/c4/1397.PMC4831891.pdf
"After  preprocessing, group ICA was performed using the MELODIC software from the FSL package (http://fsl.fmrib.",OADS,/arxiv_data1/oa_pdf/82/c3/nmc-56-158.PMC4831941.pdf
"Tel: +82-31-787-7651, Fax: +82-31-787-4019, E-mail: inah228@snu.ac.kr CC  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Radiat Oncol J 2016;34(1):1-9 http://dx.doi.org/10.3857/roj.2016.34.1.1pISSN 2234-1900 · eISSN 2234-3156  Review Article",Non-OADS,/arxiv_data1/oa_pdf/89/57/roj-34-1.PMC4831963.pdf
Taeryool Koo and In Ah Kim 2 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.1affinity of HER2-positive breast cancer for brain tissue has  been suggested.,Non-OADS,/arxiv_data1/oa_pdf/89/57/roj-34-1.PMC4831963.pdf
"3Brain metastasis in HER2-positive breast cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.1radiosurgery group compared to the radiosurgery alone group  (median, 6 months vs. 15 months).",Non-OADS,/arxiv_data1/oa_pdf/89/57/roj-34-1.PMC4831963.pdf
"Taeryool Koo and In Ah Kim 4 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.1clinical studies have reported that brain radiotherapy induces  BBB permeability, and resultant changes persist from several hours to several years [33,34].",Non-OADS,/arxiv_data1/oa_pdf/89/57/roj-34-1.PMC4831963.pdf
5Brain metastasis in HER2-positive breast cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.1 Table 2.,Non-OADS,/arxiv_data1/oa_pdf/89/57/roj-34-1.PMC4831963.pdf
"Taeryool Koo and In Ah Kim 6 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.1achieve a PR and had progressive disease 14 months and  10 months after the treatment, respectively.",Non-OADS,/arxiv_data1/oa_pdf/89/57/roj-34-1.PMC4831963.pdf
Ongoing Studies on the Concurrent Use of  Lapatinib and Radiation Radiation Therapy Oncology Group is performing a phase II randomized study to elucidate the effect of lapatinib with radiation on breast metastases in HER-positive breast cancer (https://clinicaltrials.gov/ct2/show/NCT01622868).,Non-OADS,/arxiv_data1/oa_pdf/89/57/roj-34-1.PMC4831963.pdf
7Brain metastasis in HER2-positive breast cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.1resonance imaging scan at 12 weeks post WBRT.,Non-OADS,/arxiv_data1/oa_pdf/89/57/roj-34-1.PMC4831963.pdf
"Recently, Stanford University initiated a phase II trial  investigating the efficacy of lapatinib and radiotherapy in  patients with locally advanced or locally recurrent breast cancer (https://clinicaltrials.gov/ct2/show/NCT01868503).",Non-OADS,/arxiv_data1/oa_pdf/89/57/roj-34-1.PMC4831963.pdf
The Hellenic Cooperative Oncology Group has designed a  phase II trial to evaluate the response rate of brain metastases from lung and breast tumors under treatment with WBRT and lapatinib (https://clinicaltrials.gov/ct2/show/NCT01218529).,Non-OADS,/arxiv_data1/oa_pdf/89/57/roj-34-1.PMC4831963.pdf
Taeryool Koo and In Ah Kim 8 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.1neurosurgery?,Non-OADS,/arxiv_data1/oa_pdf/89/57/roj-34-1.PMC4831963.pdf
9Brain metastasis in HER2-positive breast cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.1brain metastases in patients with human epidermal growth  factor receptor 2-positive breast cancer.,Non-OADS,/arxiv_data1/oa_pdf/89/57/roj-34-1.PMC4831963.pdf
"Tel: +82-53-420-5353, Fax: +82-53-426-3303, E-mail:  jelee@knu.ac.kr CC  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Radiat Oncol J 2016;34(1):10-17 http://dx.doi.org/10.3857/roj.2016.34.1.10pISSN 2234-1900 · eISSN 2234-3156  Original Article",Non-OADS,/arxiv_data1/oa_pdf/1b/b9/roj-34-10.PMC4831964.pdf
11Reduced volume approach for ENI in NPC www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.10skipping the second station.,OADS,/arxiv_data1/oa_pdf/1b/b9/roj-34-10.PMC4831964.pdf
"Ki Ho Seol and Jeong Eun Lee 12 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.10In IMRT planning, we used a simultaneously integrated  boost IMRT technique.",Non-OADS,/arxiv_data1/oa_pdf/1b/b9/roj-34-10.PMC4831964.pdf
13Reduced volume approach for ENI in NPC www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.10Results Forty-two male and 14 female patients were included in this  analysis.,OADS,/arxiv_data1/oa_pdf/1b/b9/roj-34-10.PMC4831964.pdf
Ki Ho Seol and Jeong Eun Lee 14 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.10surgery and postoperative RT.,Non-OADS,/arxiv_data1/oa_pdf/1b/b9/roj-34-10.PMC4831964.pdf
15Reduced volume approach for ENI in NPC www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.10Discussion and Conclusion There is an extensive submucosal lymphatic capillary  plexus in the nasopharynx.,Non-OADS,/arxiv_data1/oa_pdf/1b/b9/roj-34-10.PMC4831964.pdf
"Ki Ho Seol and Jeong Eun Lee 16 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.10They also concluded that prophylactic irradiation to the upper  neck (levels II, III, and VA) may be feasible for patients with neck lymph node-negative NPC.",Non-OADS,/arxiv_data1/oa_pdf/1b/b9/roj-34-10.PMC4831964.pdf
17Reduced volume approach for ENI in NPC www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.10Acknowledgments This research was supported by the Kyungpook National  University Research Fund in 2012.,OADS,/arxiv_data1/oa_pdf/1b/b9/roj-34-10.PMC4831964.pdf
Available from: http://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1b/b9/roj-34-10.PMC4831964.pdf
"CC  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Radiat Oncol J 2016;34(1):18-25 http://dx.doi.org/10.3857/roj.2016.34.1.18pISSN 2234-1900 · eISSN 2234-3156  Original Article",Non-OADS,/arxiv_data1/oa_pdf/7d/36/roj-34-18.PMC4831965.pdf
19VMAT for carotid sparing www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.18and consecutive ischemic strokes [7] as a complication of  radiotherapy.,Non-OADS,/arxiv_data1/oa_pdf/7d/36/roj-34-18.PMC4831965.pdf
"Young Suk Kim, et al 20 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.1860o, 40o, 320o, 300o, 260o, and 200o were preselected for IMRT  centered on the PTV, and the collimator angles for all IMRT  beam angles were 5o.",OADS,/arxiv_data1/oa_pdf/7d/36/roj-34-18.PMC4831965.pdf
21VMAT for carotid sparing www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.18significantly worse in the 3DCRT plan than in the other three  techniques (p < 0.001) because the anterior radiation field without beam modulation could not cover the target area effectively.,Non-OADS,/arxiv_data1/oa_pdf/7d/36/roj-34-18.PMC4831965.pdf
"Young Suk Kim, et al 22 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.18similar between IMRT and VMAT (p = 0.801).",OADS,/arxiv_data1/oa_pdf/7d/36/roj-34-18.PMC4831965.pdf
"23VMAT for carotid sparing www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.18of VMAT for early glottic cancer [2,8], there have been few  publications on qualitative comparison between VMAT and IMRT [9,11-13].",Non-OADS,/arxiv_data1/oa_pdf/7d/36/roj-34-18.PMC4831965.pdf
"Young Suk Kim, et al 24 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.18artery than the plans using only the anterior fields [2].",Non-OADS,/arxiv_data1/oa_pdf/7d/36/roj-34-18.PMC4831965.pdf
25VMAT for carotid sparing www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.18Mageras G. Volumetric modulated arc therapy: planning and  evaluation for prostate cancer cases.,Non-OADS,/arxiv_data1/oa_pdf/7d/36/roj-34-18.PMC4831965.pdf
"Tel: +82-55-750-9200, Fax: +82-55- 750-9095, E-mail: jsk92@gnu.ac.kr CC  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Radiat Oncol J 2016;34(1):26-33 http://dx.doi.org/10.3857/roj.2016.34.1.26pISSN 2234-1900 · eISSN 2234-3156  Original Article",Non-OADS,/arxiv_data1/oa_pdf/da/5b/roj-34-26.PMC4831966.pdf
27Carotid sparing IMRT for glottic cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.26other organs at risk (OAR).,Non-OADS,/arxiv_data1/oa_pdf/da/5b/roj-34-26.PMC4831966.pdf
"Hoon Sik Choi, et al 28 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.26were delineated as OARs.",OADS,/arxiv_data1/oa_pdf/da/5b/roj-34-26.PMC4831966.pdf
"29Carotid sparing IMRT for glottic cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.26precise treatment, a megavoltage portal image using the  electronic portal imaging devices was acquired at every week during the entire treatment course.",Non-OADS,/arxiv_data1/oa_pdf/da/5b/roj-34-26.PMC4831966.pdf
"Hoon Sik Choi, et al 30 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.26dose are denoted by a line.",OADS,/arxiv_data1/oa_pdf/da/5b/roj-34-26.PMC4831966.pdf
31Carotid sparing IMRT for glottic cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.26the incidence of carotid artery stenosis was higher in the  irradiated neck than that in the contralateral unirradiated neck.,Non-OADS,/arxiv_data1/oa_pdf/da/5b/roj-34-26.PMC4831966.pdf
"Hoon Sik Choi, et al 32 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.26and stenosis.",Non-OADS,/arxiv_data1/oa_pdf/da/5b/roj-34-26.PMC4831966.pdf
33Carotid sparing IMRT for glottic cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.26clinical results.,Non-OADS,/arxiv_data1/oa_pdf/da/5b/roj-34-26.PMC4831966.pdf
"Tel: +82-2-3410-2612, Fax: +82-2-3410-2619,  E-mail: hee.ro.park@samsung.com CC  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Radiat Oncol J 2016;34(1):34-44 http://dx.doi.org/10.3857/roj.2016.34.1.34pISSN 2234-1900 · eISSN 2234-3156  Original Article",Non-OADS,/arxiv_data1/oa_pdf/c4/71/roj-34-34.PMC4831967.pdf
"35WLI and hyperthermia in liver metastasis www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.34Introduction The liver is the most common metastatic site of gastrointestinal  tract malignancies, which are associated with the blood supply from the portal circulation [1].",Non-OADS,/arxiv_data1/oa_pdf/c4/71/roj-34-34.PMC4831967.pdf
"Jeong Il Yu, et al 36 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.34on CT images.",OADS,/arxiv_data1/oa_pdf/c4/71/roj-34-34.PMC4831967.pdf
37WLI and hyperthermia in liver metastasis www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.34further chemotherapy because of liver function deterioration.,Non-OADS,/arxiv_data1/oa_pdf/c4/71/roj-34-34.PMC4831967.pdf
"Jeong Il Yu, et al 38 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.34WLI is displayed in Table 2.",OADS,/arxiv_data1/oa_pdf/c4/71/roj-34-34.PMC4831967.pdf
39WLI and hyperthermia in liver metastasis www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.34factor for LPFS.,Non-OADS,/arxiv_data1/oa_pdf/c4/71/roj-34-34.PMC4831967.pdf
"Jeong Il Yu, et al 40 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.34Our group previously reported the results of a retrospective  study of WLI as 21 Gy in 7 fractions in 16 patients with hepatic  metastasis of colorectal cancer [20].",OADS,/arxiv_data1/oa_pdf/c4/71/roj-34-34.PMC4831967.pdf
41WLI and hyperthermia in liver metastasis www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.34Table 3.,Non-OADS,/arxiv_data1/oa_pdf/c4/71/roj-34-34.PMC4831967.pdf
"Jeong Il Yu, et al 42 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.34tolerated combination treatments of low-dose WLI and  hyperthermia.",Non-OADS,/arxiv_data1/oa_pdf/c4/71/roj-34-34.PMC4831967.pdf
43WLI and hyperthermia in liver metastasis www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.34toxicity of WLI and hyperthermia for patients with numerous  chemorefractory hepatic metastases from colorectal cancer.,Non-OADS,/arxiv_data1/oa_pdf/c4/71/roj-34-34.PMC4831967.pdf
Supplementary Materials Supplementary materials can be found via http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c4/71/roj-34-34.PMC4831967.pdf
"Jeong Il Yu, et al 44 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.34hepatocarcinogenesis: dysregulation of apoptosis signaling  pathways.",OADS,/arxiv_data1/oa_pdf/c4/71/roj-34-34.PMC4831967.pdf
"Tel: +82-32-280-6075, Fax:  +82-32-280-6024, E-mail: k41645@chol.com CC  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Radiat Oncol J 2016;34(1):45-51 http://dx.doi.org/10.3857/roj.2016.34.1.45pISSN 2234-1900 · eISSN 2234-3156  Original Article",Non-OADS,/arxiv_data1/oa_pdf/f9/8a/roj-34-45.PMC4831968.pdf
"Hye Jin Kang, et al 46 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.45radiotherapy was superior to conventional-dose radiotherapy  for biochemical control in prostate cancer patients [3-7].",OADS,/arxiv_data1/oa_pdf/f9/8a/roj-34-45.PMC4831968.pdf
47Hypofractionated IMRT in prostate cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.45were contoured.,Non-OADS,/arxiv_data1/oa_pdf/f9/8a/roj-34-45.PMC4831968.pdf
"Hye Jin Kang, et al 48 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.454.",OADS,/arxiv_data1/oa_pdf/f9/8a/roj-34-45.PMC4831968.pdf
49Hypofractionated IMRT in prostate cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.453.,Non-OADS,/arxiv_data1/oa_pdf/f9/8a/roj-34-45.PMC4831968.pdf
"Hye Jin Kang, et al 50 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.45incidences of grade ≥2 late GU and GI toxicities were 8%  and 7%, respectively, in the lower-dose group (64.8–70.2 Gy) compared to 15% and 16%, respectively, in the higher-dose group (75.6–81 Gy) (p = 0.004).",OADS,/arxiv_data1/oa_pdf/f9/8a/roj-34-45.PMC4831968.pdf
Available from: http://www.wcrf.org/int/cancer-facts-figures/worldwide-data.,Non-OADS,/arxiv_data1/oa_pdf/f9/8a/roj-34-45.PMC4831968.pdf
51Hypofractionated IMRT in prostate cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.459.,Non-OADS,/arxiv_data1/oa_pdf/f9/8a/roj-34-45.PMC4831968.pdf
Available from: http://www.nccn.org/patients/guidelines/prostate/files/assets/common/downloads/files/prostate.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f9/8a/roj-34-45.PMC4831968.pdf
"Tel: +46-701762871, Fax: +46-10-1033570, E-mail: Per.loftas@liu.se CC  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Radiat Oncol J 2016;34(1):52-58 http://dx.doi.org/10.3857/roj.2016.34.1.52pISSN 2234-1900 · eISSN 2234-3156  Original Article",Non-OADS,/arxiv_data1/oa_pdf/b1/c6/roj-34-52.PMC4831969.pdf
"53FXYD-3 in local recurrence of rectal cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.52of severe radio toxicity with leukopenia, abdominal pain and  diarrhoea is around 5% [7,8].",Non-OADS,/arxiv_data1/oa_pdf/b1/c6/roj-34-52.PMC4831969.pdf
"Per Loftas , et al 54 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.52Baseline data on included patients are presented in Table 1.",OADS,/arxiv_data1/oa_pdf/b1/c6/roj-34-52.PMC4831969.pdf
"55FXYD-3 in local recurrence of rectal cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.52known strong immunostaining for FXYD-3 were used in each  run, using either the primary antibody or universal mouse IgG (Dako).",Non-OADS,/arxiv_data1/oa_pdf/b1/c6/roj-34-52.PMC4831969.pdf
"Per Loftas , et al 56 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.52Statistical calculations were performed on both membrane  and cytoplasmic expression without any significant difference  in the results.",OADS,/arxiv_data1/oa_pdf/b1/c6/roj-34-52.PMC4831969.pdf
57FXYD-3 in local recurrence of rectal cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.52the effect of the differences in degree of differentiation and  tumour stage between the LR group and the control group we used a logistic regression analysis with LR as outcome variable and tumour stage and differentiation as predictor variable.,OADS,/arxiv_data1/oa_pdf/b1/c6/roj-34-52.PMC4831969.pdf
"Per Loftas , et al 58 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.52Int J Radiat Oncol Biol Phys 2006;65:1143-8.",OADS,/arxiv_data1/oa_pdf/b1/c6/roj-34-52.PMC4831969.pdf
"Tel: +82-53-420-5353,  Fax: +82-53-426-3303, E-mail: jelee@knu.ac.kr CC  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Radiat Oncol J 2016;34(1):59-63 http://dx.doi.org/10.3857/roj.2016.34.1.59pISSN 2234-1900 · eISSN 2234-3156  Original Article",Non-OADS,/arxiv_data1/oa_pdf/83/3e/roj-34-59.PMC4831970.pdf
Jeong Won Lee and Jeong Eun Lee 60 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.59symptoms caused by MM.,OADS,/arxiv_data1/oa_pdf/83/3e/roj-34-59.PMC4831970.pdf
"61Radiotherapy for multiple myeloma www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.59(median, 23.33 Gyα/β = 10).",Non-OADS,/arxiv_data1/oa_pdf/83/3e/roj-34-59.PMC4831970.pdf
"Jeong Won Lee and Jeong Eun Lee 62 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.59without regard to fractionation [7,10,12,14].",OADS,/arxiv_data1/oa_pdf/83/3e/roj-34-59.PMC4831970.pdf
63Radiotherapy for multiple myeloma www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.599.,Non-OADS,/arxiv_data1/oa_pdf/83/3e/roj-34-59.PMC4831970.pdf
Available from: http://www.nccn.org/professionals/physician_gls/pdf/myeloma.pdf.,Non-OADS,/arxiv_data1/oa_pdf/83/3e/roj-34-59.PMC4831970.pdf
"Tel: +82-2-3410-2605, Fax: +82-2-3410-2619,  E-mail: hee.ro.park@gmail.com CC  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Radiat Oncol J 2016;34(1):64-75 http://dx.doi.org/10.3857/roj.2016.34.1.64pISSN 2234-1900 · eISSN 2234-3156  Original Article",Non-OADS,/arxiv_data1/oa_pdf/18/87/roj-34-64.PMC4831971.pdf
65FLR on MRI following liver SABR www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.64for the treatment of liver cancer [5-7].,Non-OADS,/arxiv_data1/oa_pdf/18/87/roj-34-64.PMC4831971.pdf
"Sang Hoon Jung, et al 66 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.64The contrast-enhanced biphasic CT images were acquired  when the patient held their breath in complete exhalation,  then, free-breathing four-dimensional (4D)-CT scans were acquired with the visual prompting device.",OADS,/arxiv_data1/oa_pdf/18/87/roj-34-64.PMC4831971.pdf
67FLR on MRI following liver SABR www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.64orthogonal kV images and cone-beam CT were used in all the  treatments.,Non-OADS,/arxiv_data1/oa_pdf/18/87/roj-34-64.PMC4831971.pdf
"Sang Hoon Jung, et al 68 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.64of the liver parenchyma could be preserved.",Non-OADS,/arxiv_data1/oa_pdf/18/87/roj-34-64.PMC4831971.pdf
69FLR on MRI following liver SABR www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.64The intensity changes for all patients seem to increase with  increasing doses.,Non-OADS,/arxiv_data1/oa_pdf/18/87/roj-34-64.PMC4831971.pdf
"Sang Hoon Jung, et al 70 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.64FLR identified by a physician [21].",OADS,/arxiv_data1/oa_pdf/18/87/roj-34-64.PMC4831971.pdf
71FLR on MRI following liver SABR www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.64can evaluate potentially the quantitative relationship between  radiological changes and the dose delivered to normal liver parenchyma individually.,Non-OADS,/arxiv_data1/oa_pdf/18/87/roj-34-64.PMC4831971.pdf
"Sang Hoon Jung, et al 72 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.64patients with concordance less than 70% were excluded.",OADS,/arxiv_data1/oa_pdf/18/87/roj-34-64.PMC4831971.pdf
73FLR on MRI following liver SABR www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.64cause structural change internally.,Non-OADS,/arxiv_data1/oa_pdf/18/87/roj-34-64.PMC4831971.pdf
"Sang Hoon Jung, et al 74 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.643.",OADS,/arxiv_data1/oa_pdf/18/87/roj-34-64.PMC4831971.pdf
http://dx.doi.org/10.1111/1754-9485.12416.,Non-OADS,/arxiv_data1/oa_pdf/18/87/roj-34-64.PMC4831971.pdf
75FLR on MRI following liver SABR www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.64vs.,Non-OADS,/arxiv_data1/oa_pdf/18/87/roj-34-64.PMC4831971.pdf
"Tel: +91-4023489354, E-mail: drdeepajoseph@yahoo.com CC  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Radiat Oncol J 2016;34(1):76-80 http://dx.doi.org/10.3857/roj.2016.34.1.76pISSN 2234-1900 · eISSN 2234-3156  Case Report",Non-OADS,/arxiv_data1/oa_pdf/a1/7e/roj-34-76.PMC4831972.pdf
"77Aggressive cutaneous pseudolymphoma www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.76as a small nodule first noticed by him about 6 years ago and  recurred despite repeated excisions, each recurrence being more extensive and aggressive than the previous.",Non-OADS,/arxiv_data1/oa_pdf/a1/7e/roj-34-76.PMC4831972.pdf
"Deepa Joseph, et al 78 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.76the entire involved area with 2-cm superoinferior margins.",OADS,/arxiv_data1/oa_pdf/a1/7e/roj-34-76.PMC4831972.pdf
"79Aggressive cutaneous pseudolymphoma www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.76steroids, interferon α-2b [15], antimalarials, cephalosporins,  and minocycline [2].",Non-OADS,/arxiv_data1/oa_pdf/a1/7e/roj-34-76.PMC4831972.pdf
"Deepa Joseph, et al 80 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.7615.",OADS,/arxiv_data1/oa_pdf/a1/7e/roj-34-76.PMC4831972.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies the paper on the Neuropsychopharmacology website (http://www.nature.com/npp)Central nervous insulin and sleep GB Feld et al 1550 Neuropsychopharmacology",Non-OADS,/arxiv_data1/oa_pdf/f7/26/npp2015312a.PMC4832015.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Neuropsychopharmacology website (http://www.nature.com/npp)Effects of fluoxetine on fear extinction O Gunduz-Cinar et al 1609 Neuropsychopharmacology",Non-OADS,/arxiv_data1/oa_pdf/54/ff/npp2015318a.PMC4832021.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6d/53/main.PMC4832033.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.03.017 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/6d/53/main.PMC4832033.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/76/main.PMC4832034.pdf
Contrast-enhanced  computed  tomog- raphy  (CT)  performed  in  July  2015  revealed  that  the  tumor  had grown  to a 36-mm  maximum  diameter  and  was  well  enhanced in  the  arterial  phase  and  washed  out  in  the  portal  and  delayed http://dx.doi.org/10.1016/j.ijscr.2016.03.027 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/61/76/main.PMC4832034.pdf
This  is  an  open access article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/02/11/main.PMC4832035.pdf
The  border between  apical  and  basal  segments  was  progressively  stapled  and http://dx.doi.org/10.1016/j.ijscr.2016.03.008 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/02/11/main.PMC4832035.pdf
"[10]  J.J.  Gagnier,  G.  Kienle,  et  al.,  The  CARE  guidelines:  consensus-based  clinical case reporting  guideline  development,  BMJ  Case  Rep.  (2013),  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/02/11/main.PMC4832035.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: PCOS Phylogenetic analysisRMeVStringModellerRaptorXMicroarray 1.,Non-OADS,/arxiv_data1/oa_pdf/9b/2b/main.PMC4832036.pdf
http://dx.doi.org/10.1016/j.gdata.2016.03.008 2213-5960/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/9b/2b/main.PMC4832036.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/2b/main.PMC4832036.pdf
"95 (5) (2011) 1544 –1548, http://dx.doi.org/10.1016/j.fertnstert.",Non-OADS,/arxiv_data1/oa_pdf/9b/2b/main.PMC4832036.pdf
"2010 Retrieved April 24, 2012, from http://www.womenshealth.gov/publications/our-publications/fact- sheet/polycystic-ovary-syndrome.html .",Non-OADS,/arxiv_data1/oa_pdf/9b/2b/main.PMC4832036.pdf
"18 (3) (2014) 317 –324, http://dx.doi.org/10.4103/ 2230-8210.131162 .",Non-OADS,/arxiv_data1/oa_pdf/9b/2b/main.PMC4832036.pdf
"55 (5 –6) (1995) 515 –524, http://dx.doi.org/10.1016/0960-0760(95)00200-6 .",Non-OADS,/arxiv_data1/oa_pdf/9b/2b/main.PMC4832036.pdf
"278 (2003) 26380 –26390, http://dx.doi.org/10.1074/jbc.M300688200 .",Non-OADS,/arxiv_data1/oa_pdf/9b/2b/main.PMC4832036.pdf
"88 (4) (2003 Apr) 1528 –1533, http://dx.doi.org/10.1210/ jc.2002-020557 .",Non-OADS,/arxiv_data1/oa_pdf/9b/2b/main.PMC4832036.pdf
"82 (6) (Jun 1997) 1939 –1943, http://dx.doi.org/10.1210/jcem.",Non-OADS,/arxiv_data1/oa_pdf/9b/2b/main.PMC4832036.pdf
DOI: http://dx.doi.org/10.1155/2014/478972 .,Non-OADS,/arxiv_data1/oa_pdf/9b/2b/main.PMC4832036.pdf
"Department of Biomedical Science, CHA University, Bundang CHA Hospital, 502 463-840, Republic of Korea, Gene 527 (1) (Sep 15, 2013) 71 –74,http://dx.doi.org/10.1016/j.gene.2013.05.074 .",OADS,/arxiv_data1/oa_pdf/9b/2b/main.PMC4832036.pdf
"2015(2015), Article ID 927805. http://dx.doi.org/10.1155/2015/927805 .",Non-OADS,/arxiv_data1/oa_pdf/9b/2b/main.PMC4832036.pdf
doi: http://dx.doi.org/10.1007/s12020-012-9802-0 .,Non-OADS,/arxiv_data1/oa_pdf/9b/2b/main.PMC4832036.pdf
"Bioinformatics 31 (1) (2015) 143 –145, http://dx.doi.org/10.1093/ bioinformatics/btu613 .",Non-OADS,/arxiv_data1/oa_pdf/9b/2b/main.PMC4832036.pdf
"7 (2011) 539, http://dx.doi.org/10.1038/msb.2011.75 .",Non-OADS,/arxiv_data1/oa_pdf/9b/2b/main.PMC4832036.pdf
"43 (Database issue) (2015) D447 –D452, http://dx.doi.org/10.1093/nar/gku1003 .",OADS,/arxiv_data1/oa_pdf/9b/2b/main.PMC4832036.pdf
"ISBN 3- 900051-07-0, URL (http://www.R-project.org).",Non-OADS,/arxiv_data1/oa_pdf/9b/2b/main.PMC4832036.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: PsychrobacterWaterHydrocarbonsDegradingResistance metals 1.,Non-OADS,/arxiv_data1/oa_pdf/33/2b/main.PMC4832037.pdf
The genus currently com- prises 35 validly described species ( http://www.bacterio.net /).,Non-OADS,/arxiv_data1/oa_pdf/33/2b/main.PMC4832037.pdf
http://dx.doi.org/10.1016/j.gdata.2016.02.013 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/2b/main.PMC4832037.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/2b/main.PMC4832037.pdf
Quality of raw reads was assessed with the FastQC software ( http://www.bioinformatics.,OADS,/arxiv_data1/oa_pdf/33/2b/main.PMC4832037.pdf
"Antonie Van Leeuwen- hoek 101 (2012) 819 –835, http://dx.doi.org/10.1007/s10482-012-9697-z .",Non-OADS,/arxiv_data1/oa_pdf/33/2b/main.PMC4832037.pdf
This  is  an  open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cf/16/main.PMC4832038.pdf
The  cement  mantle  in  the  femoral  canal  was  burred  to  accommo- date  a  44  m  ×  125  Exeter  stem  and  a  cement  to  cement  revision http://dx.doi.org/10.1016/j.ijscr.2016.03.019 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/cf/16/main.PMC4832038.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cf/16/main.PMC4832038.pdf
This  is  an  open  access  article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8e/a0/main.PMC4832039.pdf
"FlexHD®PliableTM,  (Mentor  Worldwide  LLC,  Santa  Barbara,  CA and  Musculoskeletal  Transplant  Foundation,  Edison,  NJ)  (Flex  HD) is  an  acellular  dermal  matrix  derived  from  donated  human  skin (http://www.ethicon.com/healthcareprofessionals/products/- hernia-repair-and-ﬁxation/hernia-mesh-biologic-mesh/ﬂexhd-structural-acellular-hydrated-dermis#!description-and-specs ).",Non-OADS,/arxiv_data1/oa_pdf/8e/a0/main.PMC4832039.pdf
Both  breasts http://dx.doi.org/10.1016/j.ijscr.2016.02.040 2210-2612/© 2016  Published  by  Elsevier  Ltd.  on  behalf  of  IJS  Publishing  Group  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/8e/a0/main.PMC4832039.pdf
http://dx.doi.org/10.1016/j.ebcr.2016.03.0012213-3232/© 2016 (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2c/30/main.PMC4832041.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Mutant p53Gain-of-function Transcriptome Colorectal cancerFloxuridineChemoresistance Speci ﬁcations Organism/cell line/tissueHuman colorectal cancer cell line SW480 derived fromprimary adenocarcinoma of colon Sex Male Sequencer or array typeMicroarray: Illumina Human HT-12 V4.0 Expression BeadChip Data format Raw and processed data Experimental factorsSW480 cells were treated (10 μg/ml) with ﬂoxuridine (FUdR) for 24 h and compared to control untreated (DMSO vehicle)cells Experimental featuresTotal RNA was isolated from FUdR treated and untreated cellsand subjected to microarray experiments to identify the genes differentially expressed in response to drug treatment.,Non-OADS,/arxiv_data1/oa_pdf/ca/00/main.PMC4832042.pdf
Direct link to deposited data Deposited data can be found in the Gene Expression Omnibus (GEO) database: http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE77533 2.,OADS,/arxiv_data1/oa_pdf/ca/00/main.PMC4832042.pdf
http://dx.doi.org/10.1016/j.gdata.2016.03.0032213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ca/00/main.PMC4832042.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ca/00/main.PMC4832042.pdf
Functional classi ﬁcation of differentially regulated genes in GeneCodis The differentially regulated genes were analyzed in GeneCodis3 Gene Ontology software ( http://genecodis.cnb.csic.es /) with the default settings [8–10].,OADS,/arxiv_data1/oa_pdf/ca/00/main.PMC4832042.pdf
"PLoS One 6 (12) (2011), e28862, http://dx.doi.org/10.1371/journal.pone.0028862 (Epub 2011 Dec 15).[2]N.E.",Non-OADS,/arxiv_data1/oa_pdf/ca/00/main.PMC4832042.pdf
"8 (5) (2009 May) 1015 –1025, http://dx.doi.org/10.1158/1535-7163.",Non-OADS,/arxiv_data1/oa_pdf/ca/00/main.PMC4832042.pdf
"(2015 Oct 23), http://dx.doi.org/10.1038/cdd.2015.133 .",Non-OADS,/arxiv_data1/oa_pdf/ca/00/main.PMC4832042.pdf
"Bioinformatics 24 (13) (2008 Jul 1) 1547 –1548, http://dx.doi.org/10.1093/ bioinformatics/btn224 (Epub 2008 May 8).",Non-OADS,/arxiv_data1/oa_pdf/ca/00/main.PMC4832042.pdf
"37(Web Server issue) (2009 Jul) W317 –W322, http://dx.doi.org/10.1093/nar/gkp416 (Epub 2009 May 22).",Non-OADS,/arxiv_data1/oa_pdf/ca/00/main.PMC4832042.pdf
"40 (Web Server issue) (2012 Jul) W478 –W483, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ca/00/main.PMC4832042.pdf
"15 (1) (2013 Jan) 2–8,http://dx.doi.org/10.1038/ncb2641 .",Non-OADS,/arxiv_data1/oa_pdf/ca/00/main.PMC4832042.pdf
"2 (1) (2010 Jan)a001008, http://dx.doi.org/10.1101/cshperspect.a001008 .",Non-OADS,/arxiv_data1/oa_pdf/ca/00/main.PMC4832042.pdf
"5 (2015 Dec 10) 276, http://dx.doi.org/10.3389/fonc.2015.00276 (eCollection 2015).",Non-OADS,/arxiv_data1/oa_pdf/ca/00/main.PMC4832042.pdf
"41 (Database issue) (2013 Jan) D962 –D96  9,http://dx.doi.org/10.1093/nar/gks1033 (Epub 2012 Nov 17).",OADS,/arxiv_data1/oa_pdf/ca/00/main.PMC4832042.pdf
"21 (1)(2015 Jan 7) 84 –93,http://dx.doi.org/10.3748/wjg.v21.i1.84 .",Non-OADS,/arxiv_data1/oa_pdf/ca/00/main.PMC4832042.pdf
"Cancer Cell 25 (3) (2014 Mar 17) 304 –317, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/ca/00/main.PMC4832042.pdf
"26 (12) (2012 Jun 15) 1268 –1286, http://dx.doi.org/10.1101/gad.190678.112 .51 A. Datta et al.",OADS,/arxiv_data1/oa_pdf/ca/00/main.PMC4832042.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/55/52/main.PMC4832043.pdf
"In  emergency  room,  tube  thoracostomy  was  performed  for the  haemopneumothorax  and  closed  reduction  was  applied  to  the http://dx.doi.org/10.1016/j.ijscr.2016.02.041 2210-2612/© 2016  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/55/52/main.PMC4832043.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Colletotrichum acutatumAnthracnoseAscomycetePepperGenome sequence Speci ﬁcations Organism/cell line/tissue Colletotrichum acutatum Strain KC05Sequencer or array type PacBio RS II and Illumina MiSeq systemData format Raw and processedExperimental factors DNA extracted from a ﬁeld strain, no treatment Experimental features Genome sequencingConsent Data are publicly available Sample source location Pepper ﬁeld in Chuncheon, Kangwon, South Korea 1.",Non-OADS,/arxiv_data1/oa_pdf/7f/18/main.PMC4832045.pdf
Direct link to deposited data Deposited data can be found here: http://www.ncbi.nlm.nih.gov/ nuccore/LUXP00000000.1/ 2.,OADS,/arxiv_data1/oa_pdf/7f/18/main.PMC4832045.pdf
"A total of 39 contigs produced by HGAP were assembled for scaffolding with the Illumina 5-kb mate-pair library sequence data using SSPACE V3.0 software [11].T h eﬁnal assem- bly of the entire C. acutatum KC05 genome sequence was determined to be 52,190,760 bp with a G + C content of 51.73% in 27 scaffolds http://dx.doi.org/10.1016/j.gdata.2016.03.007 2213-5960/© 2016 The Authors.",OADS,/arxiv_data1/oa_pdf/7f/18/main.PMC4832045.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7f/18/main.PMC4832045.pdf
"The evidence gene data were obtained through de novo assembly of the transcriptome using Trinity v.2.06 software [12], and were mapped to the genome using PASA v2.0.1 software ( http://pasapipeline.github.io /).",OADS,/arxiv_data1/oa_pdf/7f/18/main.PMC4832045.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Vibrio alginolyticus Whole genome sequencing Giant marine myophage Speci ﬁcations Organism Myoviridae Genus T4-LikeSequencer Illumina (MiSeq)Data format Analyzed Experimental factorsBacteriophage strain Experimental featuresWhole genome analysis and gene annotation of Vibrio phage ValKK3 Consent N/ASample source locationMarine sediment, Kota Kinabalu, N 06° 02.270 ′, E 116° 06.710 ′ 1.",Non-OADS,/arxiv_data1/oa_pdf/72/62/main.PMC4832046.pdf
http://dx.doi.org/10.1016/j.gdata.2016.03.002 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/72/62/main.PMC4832046.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/72/62/main.PMC4832046.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: RNA-seq Transcription factor ABAFruit developmentTomato Speci ﬁcations Where applicable, please follow the Ontology for Biomedical Investigations: http://obi-ontology.org/page/Main_Page Organism/cell line/tissue Solanum pimpinellifolium LA1589/whole fruits at 2 days post anthesis Sex N/A Sequencer or array type Illumina Miseq systemData format Raw and processed Experimental factors Laboratory grown plants Experimental features RNA-seq dataset for gene expression pro ﬁling in young developing fruits of SlZFP2 RNAi line and the wild type Consent N/ASample source location Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, Shanghai, China 1.",Non-OADS,/arxiv_data1/oa_pdf/a8/77/main.PMC4832047.pdf
GSE63838) (http://www.ncbi.nlm.nih.gov/ bioproject/?term=GSE63838 ).,OADS,/arxiv_data1/oa_pdf/a8/77/main.PMC4832047.pdf
http://dx.doi.org/10.1016/j.gdata.2016.03.001 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a8/77/main.PMC4832047.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a8/77/main.PMC4832047.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Type 2 diabetesInsulin resistanceObesity Gene expression Mexican AmericansVAGESADH1BTranscriptomicsGWASeQTL 1.,Non-OADS,/arxiv_data1/oa_pdf/d2/a3/main.PMC4832048.pdf
http://dx.doi.org/10.1016/j.gdata.2015.12.0012213-5960/© 2015 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/d2/a3/main.PMC4832048.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d2/a3/main.PMC4832048.pdf
"Similarly, no signi ﬁcant eQTL were found for ADH1B in subcutaneous adipose or any of more than 60 tissues examined ( http://www.gtexportal.org / accessed 4/30/2015).",Non-OADS,/arxiv_data1/oa_pdf/d2/a3/main.PMC4832048.pdf
According to the EMBL-EBI Expression Atlas ( http://www-test.ebi.ac.,OADS,/arxiv_data1/oa_pdf/d2/a3/main.PMC4832048.pdf
"uk) using data obtained by microarray assay of 76 normal human tis- sues ( http://BioGPS.org ; accessed 5/12/2015), ADH1B was most highly expressed in adipose tissue, with almost double the expression levelfound in the next highest tissue, liver.",OADS,/arxiv_data1/oa_pdf/d2/a3/main.PMC4832048.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d2/93/kwv287.PMC4832053.pdf
"Our data set and a copy of the survey instrument are freely available for download ( 3), and code with which to replicate our analyses is available on-line ( https://dataverse.harvard.edu/dataset.xhtml?persistent Id=doi:10.7910/DVN/CCC6HF ).",OADS,/arxiv_data1/oa_pdf/d2/93/kwv287.PMC4832053.pdf
"Calverton, MD: ICF International; 2012. http://www.dhsprogram.com/pubs/ pdf/FR261/FR261.pdf .",Non-OADS,/arxiv_data1/oa_pdf/d2/93/kwv287.PMC4832053.pdf
"New York, NY: Columbia University; 2007. http://www.stat.columbia.edu/~tyler/pubs/ mccormick_recall.pdf .",Non-OADS,/arxiv_data1/oa_pdf/d2/93/kwv287.PMC4832053.pdf
"Vienna, Austria: R Foundation for Statistical Computing; 2014. http://www.R-project.org/ .",Non-OADS,/arxiv_data1/oa_pdf/d2/93/kwv287.PMC4832053.pdf
"Vienna, Austria: R Foundation for Statistical Computing; 2014.http://cran.r-project.org/package=networkreporting .",Non-OADS,/arxiv_data1/oa_pdf/d2/93/kwv287.PMC4832053.pdf
"Hlavac M. stargazer: LaTeX code and ASCII text for well-formatted regression and summary statistics tables.Vienna, Austria: R Foundation for Statistical Computing; 2014. http://CRAN.R-project.org/package=stargazer .",OADS,/arxiv_data1/oa_pdf/d2/93/kwv287.PMC4832053.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/ea/fd/ncomms11061.PMC4832059.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article : Kirst, C. et al.",Non-OADS,/arxiv_data1/oa_pdf/ea/fd/ncomms11061.PMC4832059.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms11061 ARTICLE NATURE COMMUNICATIONS | 7:11061 | DOI: 10.1038/ncomms11061 | www.nature.com/naturecommunications 9",Non-OADS,/arxiv_data1/oa_pdf/ea/fd/ncomms11061.PMC4832059.pdf
"The 0.7 cutoff was chosen because the overall distribution of DNA methylation levels for loci on the array was bimodal, with a peak centered at approximately beta 0.1 and another centered at approximately 0.85; a 0.7 cutoff value has also been used in other studies.28Statistical analyses were performed using R statistical software (R Foundation for Statistical Computing; Vienna, Austria; http://www.R-project.org).",OADS,/arxiv_data1/oa_pdf/8f/97/leu2015265a.PMC4832070.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu)CC-486 (oral azacitidine) in lower-risk MDS G Garcia-Manero et al 896 Leukemia (2016) 889 –896 © 2016 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/8f/97/leu2015265a.PMC4832070.pdf
"Moreover it has been shown previously that hematogones, plasmablasts and plasma cells can be easily differentiated from CLL cells based primarily on CD81and CD5 expression.13,31However, the core panel has now been or is being tested prospectively in several trials including ADMIRE,ARCTIC, COSMIC, FLAIR and GALACTIC (ISCRTN references 42165735, 16544962, 51382468, 01844152, 64035629 respectively, http://medhealth.leeds.ac.uk/info/443/haematological), and the LLR TAP IcICLLe trial of Ibrutinib monotherapy (ISRCTN12695354)with available data con ﬁrming that CLL MRD analysis in bone marrow is readily achievable with the six-marker core panel (abstract S794 EHA Learning Center.",Non-OADS,/arxiv_data1/oa_pdf/9c/33/leu2015313a.PMC4832072.pdf
"Assessment of interoperator variation was performed by participants at three educational courses provided by the Swiss Flow Cytometry School in May 2014 (http://www.cytometryschool.ch), the Prague School of Flow Cytometry in May 2014 (see http://www.escca.eu/meetings) and the ICCS/ESCCA Bi-society Practical Clinical Cytometry Course (http://www.",Non-OADS,/arxiv_data1/oa_pdf/9c/33/leu2015313a.PMC4832072.pdf
3 Research C for DE and News & Events —Public Workshop on Minimal Residual Disease (MRD) as a Surrogate Endpoint in Chronic Lymphocytic Leukemia (CLL).http://www.fda.gov/Drugs/NewsEvents/ucm340707.htm (accessed 2 February 2015).,Non-OADS,/arxiv_data1/oa_pdf/9c/33/leu2015313a.PMC4832072.pdf
http://ctru.leeds.ac.uk/ ﬂair (accessed 2 February 2015).,Non-OADS,/arxiv_data1/oa_pdf/9c/33/leu2015313a.PMC4832072.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu)ERIC CLL MRD ﬂow cytometry and high-throughput sequencing AC Rawstron et al 936 Leukemia (2016) 929 –936 © 2016 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/9c/33/leu2015313a.PMC4832072.pdf
"Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu) OPEN Inhibiting MEK in MAPK pathway-activated myeloma Leukemia (2016) 30,976–980; doi:10.1038/leu.2015.208 Over the last decade, new drugs have signi ﬁcantly changed the paradigm for treating multiple myeloma (MM), resulting inimproved outcomes and reduced toxicity.",Non-OADS,/arxiv_data1/oa_pdf/22/e9/leu2015208a.PMC4832073.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu) IDH1 andIDH2 mutations in myelodysplastic syndromes and role in disease progression Leukemia (2016) 30,980–984; doi:10.1038/leu.2015.211 Recurrent pathogenic mutations in IDH1 and IDH2 at the conserved amino acid sites IDH1-R132 ,IDH2-R140 and IDH2-R172 occur in ~ 20% of patients with acute myeloid leukemia (AML).1 A recent analysis of AML patients at our institution identi ﬁed IDH1/2 mutations in 20% ( n= 167) of 826 AML patients, with IDH1/2 mutations occurring most frequently in the setting of diploid karyotype or other intermediate-risk cytogenetics, parti- cularly trisomy 8 (77 vs 53%, Po0.0005).",Non-OADS,/arxiv_data1/oa_pdf/22/e9/leu2015208a.PMC4832073.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu)Ibrutinib affects CXCR4 expression and function S-S Chen et al 843 © 2016 Macmillan Publishers Limited Leukemia (2016) 833 –843",Non-OADS,/arxiv_data1/oa_pdf/1a/09/leu2015316a.PMC4832074.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7d/72/main.PMC4832080.pdf
The  intracranial  component  of  the  lesion  compressed  the  left http://dx.doi.org/10.1016/j.ijscr.2016.03.041 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/7d/72/main.PMC4832080.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: PhenylketonuriaBrainWhite matterDiffusion tensor imagingChildren 1.,Non-OADS,/arxiv_data1/oa_pdf/07/cd/main.PMC4832081.pdf
"1Abbreviations used: PKU, Phenylketonuria; PAH, phenylalanine hydroxylase; Phe, phenylalanine; MRI, magnetic resonance imaging; DTI, diffusion tensor imaging; MD, mean diffusivity; ROI, region of interest; CC, corpus callosum http://dx.doi.org/10.1016/j.ymgmr.2016.03.003 2214-4269/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/07/cd/main.PMC4832081.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/07/cd/main.PMC4832081.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/38/e0/main.PMC4832082.pdf
After  treatment  with  antibiotics http://dx.doi.org/10.1016/j.ijscr.2016.03.037 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/38/e0/main.PMC4832082.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the  online  version,  at  http://dx.doi.org/10.1016/j.ijscr.2016.03.037 References [1] T.  Neufang,  F.E.",OADS,/arxiv_data1/oa_pdf/38/e0/main.PMC4832082.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Mucopolysaccharidosis (MPS) Physical Symptom Score (PSS) Somatic disease burdenNeuropsychological measuresEnzyme replacement therapy 1.,Non-OADS,/arxiv_data1/oa_pdf/25/bf/main.PMC4832083.pdf
http://dx.doi.org/10.1016/j.ymgmr.2016.03.006 2214-4269/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/25/bf/main.PMC4832083.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/25/bf/main.PMC4832083.pdf
"[6] R Core Team, R: A Language and Environment for Statistical Computing, R Founda- tion for Statistical Computing, Vienna, Austria, 2014. http://www.R-project.org/ .",Non-OADS,/arxiv_data1/oa_pdf/25/bf/main.PMC4832083.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Attenuated mucopolysaccharidosis type IIBehavioral outcomesQuality of life Adaptive functions 1.,Non-OADS,/arxiv_data1/oa_pdf/8d/a7/main.PMC4832084.pdf
http://dx.doi.org/10.1016/j.ymgmr.2016.03.005 2214-4269/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/a7/main.PMC4832084.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8d/a7/main.PMC4832084.pdf
"Rep. (2015), http://dx.doi.org/10.1007/8904_ 2015_485 .",Non-OADS,/arxiv_data1/oa_pdf/8d/a7/main.PMC4832084.pdf
URL http://www.R-project.org /.,Non-OADS,/arxiv_data1/oa_pdf/8d/a7/main.PMC4832084.pdf
This  is  an  open access article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/69/fa/main.PMC4832085.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.03.047 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/69/fa/main.PMC4832085.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Holocarboxylase synthetase de ﬁciency Metabolic acidosis 1.,Non-OADS,/arxiv_data1/oa_pdf/07/3b/main.PMC4832086.pdf
http://dx.doi.org/10.1016/j.ymgmr.2016.03.007 2214-4269/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/07/3b/main.PMC4832086.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/07/3b/main.PMC4832086.pdf
"Chiang, E. Spector, I. Meneses-Morales, R. Cervantes- Roldan, A. Leon-Del-Rio, Management of a patient with holocarboxylase synthetase deﬁc i e n c y ,M o l .G e n e t .M e t a b .9 5( 2 0 0 8 )2 0 1 –205, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/07/3b/main.PMC4832086.pdf
"80 (2014) 184 –186, http://dx.doi.org/10.1016/j.anpedi.2013.05.",Non-OADS,/arxiv_data1/oa_pdf/07/3b/main.PMC4832086.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: TristetraprolinNuclear receptorCorepressorTransactivation activity Estrogen ProgesteroneGlucocorticoidAndrogenBreast cancer 1.,Non-OADS,/arxiv_data1/oa_pdf/0e/f2/main.PMC4832087.pdf
http://dx.doi.org/10.1016/j.ymgmr.2016.02.004 2214-4269/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0e/f2/main.PMC4832087.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0e/f2/main.PMC4832087.pdf
"To explore the relationship between TTP expression and breast cancer tumorigenesis, we compared TTP mRNA levels in normal tissues and different types of breast carcinomas using the Oncomine database ( http://www.oncomine.org , Compendia Bioscience, Ann Arbor, MI).",OADS,/arxiv_data1/oa_pdf/0e/f2/main.PMC4832087.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ef/a4/main.PMC4832091.pdf
http://dx.doi.org/10.1016/j.nicl.2016.03.0102213-1582/© 2016 Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/ef/a4/main.PMC4832091.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ef/a4/main.PMC4832091.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Bipolar disorderAdolescenceRewardBAS dysregulationfMRI 1.,Non-OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
http://dx.doi.org/10.1016/j.nicl.2016.03.0132213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
"The ﬁrst 2 TRs of each run were discarded to allow for longitudinal magnetization stabilization All processing and analyses of MRI data were conducted using FMRIB's Software Library (fsl) 4.1.9 software ( http://fsl.fmrib.ox.ac.uk/ fsl/; Jenkinson et al., 2012 ).",OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
"For multiple-comparisons correction, we used the 3dStimClust pro- gram (http://afni.nimh.nih.gov/pub/dis t/doc/program_help/3dClustSim.",OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
http://dx.doi.org/10.1037/ a0025877 .,Non-OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
http://dx.doi.org/10.1111/j.1399 –5618.2011.,Non-OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
http://dx.doi.org/10.1001/archpsy.63.10.1139 .,Non-OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
"University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinics, Pittsburgh, PA (Retrieved from http://www.wpic.pitt.edu/research/AssessmentTools/ChildAdolescent/ksads-pl_2009_working_draft_full.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
http://dx.doi.org/ 10.1001/archpsyc.1991.01810330031005 .,Non-OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
http://dx.doi.org/10.1111/j.1399 –5618.2009.,Non-OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
http://dx.doi.org/10.1002/hbm.20909 .,Non-OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
"Gen. Psychiatry 63, 175– 183. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
http://dx.doi.org/10.1371/journal.pone.0011440 .,Non-OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
http://dx.doi.org/10.1176/appi.ajp.2012.12020169 .,Non-OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
"15, 839–85 4.http://dx.doi.org/10.1111/bdi.12132 .",Non-OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
http://dx.doi.org/10.1146/annurev.ps.40.020189.002325 .,Non-OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
http://dx.doi.org/10.1016/j.jad.2004.05.022 .,OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
http://dx.doi.org/10.1177/0956797610373372 .,Non-OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
http://dx.doi.org/10.1016/j.jad.2008.07.001 .,OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
http://dx.doi.org/10.1176/appi.ajp.162.10.1975 .,Non-OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
http://dx.doi.org/10.1177/ 0963721411414632 .,Non-OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
http://dx.doi.org/10.1111/j.1399 –5618.2012.01023.x .,Non-OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
"Retrieved from http://www.yale.edu/sociology/ yjs/yjs_fall_2011.pdf Hwang, K., Velanova, K., Luna, B., 2010.",Non-OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
http://dx.doi.org/10.1523/JNEUROSCI.2825 –10.2010 .,Non-OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
http://dx.doi.org/10.1016/j.dcn.,OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.09.015 .,OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
http://dx.doi.org/10.1037/0021-843×.109.4.721 .,Non-OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
http://dx.doi.org/10.1146/ annurev-clinpsy-032511-143148 .,Non-OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
http://dx.doi.org/10.1001/archpsyc.60.3.261 .,Non-OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
http://dx.doi.org/10.1016/j.jaac.2011.09.,OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
http://dx.doi.org/10.1146/annurev.neuro.24.1.167 .,Non-OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
http://dx.doi.org/10.1177/0269881109353462 .,Non-OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
http://dx.doi.org/10.1037/0021-843×.116.1.105 .,Non-OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
http://dx.doi.org/10.1111/j.1399-5618.2012.01012.x .,Non-OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
"Psychiatry 52, 68 –83.http://dx.doi.org/10.1016/j.jaac.2012.10.004 .",Non-OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
http://dx.doi.org/10.1162/jocn.2010.21572 .,Non-OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
"15, 88 –94.http://dx.doi.org/10.1046/j.1365-3016.2001.00317.x .",Non-OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
http://dx.doi.org/10.1016/j.cpr.,OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
http://dx.doi.org/10.1037/ a0027502 .,Non-OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
http://dx.doi.org/ 10.1016/j.dugalcdep.2012.08.019 .,OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
http://dx.doi.org/10.1111/j.1399 –5618.2007.00563.x .485 S. Uro ševićet al.,OADS,/arxiv_data1/oa_pdf/16/2a/main.PMC4832096.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)TRIM32 mediates HIV-1-induced quiescence in hNPCs M Fatima et al 786 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/f1/e1/cdd2015138a.PMC4832097.pdf
"Rabbit immunization was performed according to SOP 406 of the McGillComparative Medicine and Animal Resource Centre (CMARC, http://www.mcgill.ca/ research/researchers/compliance/ animal/sop), with 0.1 mg of protein injected subcutaneously in incomplete Freund ’s adjuvant, boosting every 4 weeks.",Non-OADS,/arxiv_data1/oa_pdf/07/c2/cdd2015140a.PMC4832099.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)p53/PUMA axis repression by MYSM1 in hematopoiesis JI Belle et al 775 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/07/c2/cdd2015140a.PMC4832099.pdf
Oncomine database (https://www.oncomine.org/) was searched for the expression profiles of COMMD1 in normal tissues and tumors frompatients.,OADS,/arxiv_data1/oa_pdf/b0/2d/cdd2015147a.PMC4832103.pdf
MicroRNA target sites in the 3 ′-UTR of COMMD1 mRNA were analyzed using the algorithm miRanda (http://www.microrna.org/).,OADS,/arxiv_data1/oa_pdf/b0/2d/cdd2015147a.PMC4832103.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)Downregulation of COMMD1 promotes in ﬂammation and stemness D-W Yeh et al 852 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/b0/2d/cdd2015147a.PMC4832103.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/New TRAIL formulations for cancer treatment D de Miguel et al 747 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/14/56/cdd2015174a.PMC4832109.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)Cell Death and Differentiation (2016) 23, 912 &2016 Macmillan Publishers Limited All rights reserved 1350-9047/16 www.nature.com/cdd",Non-OADS,/arxiv_data1/oa_pdf/1b/84/cdd201612a.PMC4832110.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Necroptosis-based cancer therapy ZS u et al 756 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/c5/26/cdd20168a.PMC4832112.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Human isletsEndocannabinoid systemGene expression Insulin GlucagonApoptosis 1.,Non-OADS,/arxiv_data1/oa_pdf/8c/6f/main.PMC4832123.pdf
http://dx.doi.org/10.1016/j.bbacli.2016.03.0092214-6474/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8c/6f/main.PMC4832123.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8c/6f/main.PMC4832123.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Bipolar disorderPyruvateN-acetylglutamic acid β-alanine SerineArginine 1.,Non-OADS,/arxiv_data1/oa_pdf/b8/b6/main.PMC4832124.pdf
http://dx.doi.org/10.1016/j.bbacli.2016.03.008 2214-6474/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b8/b6/main.PMC4832124.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/b6/main.PMC4832124.pdf
"(2016), http://dx.doi.org/10.1017/neu.2015.59 .",Non-OADS,/arxiv_data1/oa_pdf/b8/b6/main.PMC4832124.pdf
"VCAlphaMed Press 1066-5099/2015/$30.00/0 http://dx.doi.org/ 10.1002/stem.2219 STEMCELLS 2016;34:55–66 www.StemCells.com VC2015 The Authors S TEMCELLSpublished by Wiley Periodicals, Inc. on behalf of AlphaMed PressCANCER STEMCELLS",Non-OADS,/arxiv_data1/oa_pdf/39/b5/STEM-34-55.PMC4832137.pdf
"MATERIALS AND METHODS Cell Culture, Plasmids and Reagents Breast cancer cell lines MCF-7, Hs578T, BT549, MDA-MB-231,human mammary epithelial cell line MCF10A were obtained from ATCC (Manassas, VA, http://www.atcc.org).",OADS,/arxiv_data1/oa_pdf/39/b5/STEM-34-55.PMC4832137.pdf
"MCF-7, Hs578T, BT549, andMDA-MB-231 cells were cultured in RPMI-1640 medium (Invi- trogen, Carlsbad, CA, http://www.invitrogen.com) with 10% FBS (Gibco, Grand Island, NY , http://www.invitrogen.com).",OADS,/arxiv_data1/oa_pdf/39/b5/STEM-34-55.PMC4832137.pdf
"pCMV- lncRNA-Hh was constructed by cloning human lncRNA-Hh cDNA into pCMV-HA (Clontech, PaloAlto, CA, http://www.clontech.",OADS,/arxiv_data1/oa_pdf/39/b5/STEM-34-55.PMC4832137.pdf
"The lncRNA-Hh promoter (22,000 to 1294 region) was inserted into the pGL3-basic vec- tor (Promega, Madison, WI, http://www.promega.com) at KpnI/XbaI sites to construct pGL3-lncRNA-Hh luciferase reporter plas-mid (pGL3-lncRNA-Hh-Luc).",Non-OADS,/arxiv_data1/oa_pdf/39/b5/STEM-34-55.PMC4832137.pdf
"The Hh signaling-speciﬁc inhibitorsGDC-0449 (Vismodegib, S1082) was bought from Seleckchem(Houston, TX, http://www.selleckchem.com/).",Non-OADS,/arxiv_data1/oa_pdf/39/b5/STEM-34-55.PMC4832137.pdf
"Essentially, cells or mammospheres were dissociated into single cells by 0.05% trypsin-EDTA solution and plated into six-well plates coated with 2% Poly-2-hydroxyethyl methacrylate (poly-HEMA) (Sigma, http://www.sigmaaldrich.com/) at a density of1310 4viable cells per milliliter in primary culture and 5 3103 cells per milliliter in following passages [35].",Non-OADS,/arxiv_data1/oa_pdf/39/b5/STEM-34-55.PMC4832137.pdf
"Sections were mounted in aqueous medium containing 4 0,6-diamidino-2-phenylindole (DAPI) as a nuclear counterstain (Vector Labs, Burlingame, CA,http://www.vectorlabs.com).",Non-OADS,/arxiv_data1/oa_pdf/39/b5/STEM-34-55.PMC4832137.pdf
"Quantitative real-time polymerase chainreaction (PCR) was performed using SYBR Premix Ex Taq(Takara Bio, Japan, http://www.takara.co.jp) according to the manufacturer’s protocol.",OADS,/arxiv_data1/oa_pdf/39/b5/STEM-34-55.PMC4832137.pdf
"abcam.com); OCT4, SOX2, E-cadherin, Histone H3, Vimentin, and ﬁbronectin antibodies were from Bioworld (St Louis Park, MN);p-SMAD3, SMAD3, p-SMAD1/5/8, SMAD1/5/8, p-Erk, Erk, and p-b-catenin antibodies were from Cell Signaling Technology (Bev- erly, MA, http://www.cellsignal.com); and b-Actin antibodies were from Zhongshan Golden Bridge (Beijing, China http://www.zsbio.com/).",Non-OADS,/arxiv_data1/oa_pdf/39/b5/STEM-34-55.PMC4832137.pdf
"Using gene annotations at UCSC(http://genome.ucsc.edu/), lncRNAs and potential target genes were paired and visualized using UCSC genome browser.",OADS,/arxiv_data1/oa_pdf/39/b5/STEM-34-55.PMC4832137.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/",Non-OADS,/arxiv_data1/oa_pdf/e5/52/srep23720.PMC4832188.pdf
HaloplexTMtarget enrich- ment kit G9901A/B was designed for 42 genes (Table SI)using Halodesign wizard available via Agilent (http://www.halogenomics.com).,OADS,/arxiv_data1/oa_pdf/a0/da/BJH-171-478.PMC4832260.pdf
TLDA data was analysed using Comparative Ctmethod according to User Bulletin #2 (Applied Biosystems).For details on TLDA analysis see Supporting Information.Principle Component Analysis (PCA) was performed using Rstatistics package “prcomp” (http://www.r-project.org/).,OADS,/arxiv_data1/oa_pdf/a0/da/BJH-171-478.PMC4832260.pdf
"VCAlphaMed Press 1066-5099/2016/$30.00/0 http://dx.doi.org/ 10.1002/stem.2282 This is an open access article under the terms of the Creative Commons Attribution NonCom- mercial License, which permitsuse, distribution and reproduc-tion in any medium, provided the original work is properly cited and is not used for com- mercial purposes.",Non-OADS,/arxiv_data1/oa_pdf/1c/42/STEM-34-699.PMC4832267.pdf
"Ex Vivo Differentiation One hundred LT-HSCs per well (96-well format) were lentivir- ally transduced (multiplicity of infection (MOI) 100) and cul- tured in serum-free expansion medium (SFEM) (Stem Cell Technologies, Vancouver, BC, Canada, http://www.stemcell.",OADS,/arxiv_data1/oa_pdf/1c/42/STEM-34-699.PMC4832267.pdf
"com) supplemented with 100 ng/ml SCF and Thrombopoietin (TPO) (both PeproTech, Rocky Hill, NJ, http://www.peprotech.",Non-OADS,/arxiv_data1/oa_pdf/1c/42/STEM-34-699.PMC4832267.pdf
"Inhibitors were used asfollows: VX-702 (1 lM), LY2228820 (0.1 lM, all from Selleck, http://www.selleckchem.com).",Non-OADS,/arxiv_data1/oa_pdf/1c/42/STEM-34-699.PMC4832267.pdf
"stem and progenitor cell (HSPC) populations were sorted with a FACS Aria I or III (BD, http://www.bd.com) or analyzed using aLSR Fortessa (BD).",OADS,/arxiv_data1/oa_pdf/1c/42/STEM-34-699.PMC4832267.pdf
"Cells were lysed for 30 minutes on ice in lysis buffer(50 mM Tris pH 7, 4, 150 mM NaCl, 2 mM EDTA, 1% Triton X-100, protease inhibitors (Roche, Basel, Switzerland, http://www.roche-applied-science.com)), and the supernatant was collected after centrifugation.",Non-OADS,/arxiv_data1/oa_pdf/1c/42/STEM-34-699.PMC4832267.pdf
"30 mg of protein was applied to SDS-PAGE and transferred to a Polyvinylidene diﬂuoride (PVDF) mem- brane using the Trans-Blot Turbo-Transfer System (Bio-Rad, Her- cules, CA, http://www.bio-rad.com).",Non-OADS,/arxiv_data1/oa_pdf/1c/42/STEM-34-699.PMC4832267.pdf
"The bound primary antibodies (GADD45A (D17E8) rabbit mAb and HSP90 rabbit mAb; both Cell Signaling, Beverly, MA, http://www.cellsignal.",Non-OADS,/arxiv_data1/oa_pdf/1c/42/STEM-34-699.PMC4832267.pdf
"The RNA was iso-lated and analyzed using TaqMan Gene Expression Cells-to-CTKit (Life Technologies, Rockville, MD, http://www.lifetech.",OADS,/arxiv_data1/oa_pdf/1c/42/STEM-34-699.PMC4832267.pdf
"The cDNA was pre-ampliﬁed for 14 cycles using the TaqMan PreAmp Master Mix (Life Technologies) according to the manufacturer’s protocol.The TaqMan Gene expression MasterMix (Life Technologies)was used for the quantitative polymerase chain reaction(qPCR) performed on a StepOne instrument (Applied Biosys-tems, Foster City, CA, http://www.appliedbiosystems.com).The expression of GADD45A (Mm00432802_m1) was normal- ized to Hypoxanthine guanine phosphoribosyl transferase (HPRT) (Mm00446968_m1) using the DCT method.",OADS,/arxiv_data1/oa_pdf/1c/42/STEM-34-699.PMC4832267.pdf
"Colony Formation Assay 100 LT-HSCs per plate and 300 MEPs (megakaryocyte-erythroid progenitor cell) per plate were lentivirally transduced (MOI100), seeded 24 hours later in M3434 medium (Stem Cell Tech- nologies), and scored microscopically after 9–12 (LT-HSCs) and 6–8 days (MEPs) days, respectively, for transduction and colonyformation (CellObserver, Zeiss, http://www.zeiss.com).",Non-OADS,/arxiv_data1/oa_pdf/1c/42/STEM-34-699.PMC4832267.pdf
"Time-Lapse Imaging FACS sorted LT-HSCs were seeded in 24-well plates (SFEM medium, 100 ng/ml SCF and TPO) equipped with silicon culture inserts (IBIDI, Martinsried, Germany http://www.ibidi.com) andimmediately transduced with lentiviral particles (MOI 100).",OADS,/arxiv_data1/oa_pdf/1c/42/STEM-34-699.PMC4832267.pdf
Available at: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/68/ae/IJC-138-705.PMC4832278.pdf
All catalogued germline copy number variantswere removed (Database of Genomic Variants: http://dgv.tcag.ca/dgv/app/home).,Non-OADS,/arxiv_data1/oa_pdf/c8/f6/GCC-54-668.PMC4832286.pdf
"acute myocardial infarction (http://clinicaltrials.gov/show/ NCT01741558); additionally, monoclonal antibodies are veryexpensive and usually have poor brain penetration when givensystemically.",Non-OADS,/arxiv_data1/oa_pdf/e4/24/IJS-10-469.PMC4832291.pdf
"Sequence data from genomic DNA and comple- mentary DNA were mapped to the reference human ge-nome (hg19) using the Burrows-Wheeler Aligner1 program and processed using publicly available SAM- tools2, Picard (http://picard.sourceforge.net), and GATK3(Broad Institute, Cambridge, MA).",OADS,/arxiv_data1/oa_pdf/40/ea/CNCR-121-3481.PMC4832308.pdf
2009. http://evs.nci.nih.gov/ftp1/ CTCAE/About.html.,OADS,/arxiv_data1/oa_pdf/40/ea/CNCR-121-3481.PMC4832308.pdf
"VCAlphaMed Press 1066-5099/2015/$30.00/0 http://dx.doi.org/ 10.1002/stem.2255 STEMCELLS 2016;34:756–767 www.StemCells.com VC2015 The Authors STEM CELLS published by Wiley Periodicals, Inc. on behalf of AlphaMed PressTISSUE-SPECIFIC STEMCELLS",Non-OADS,/arxiv_data1/oa_pdf/9a/3a/STEM-34-756.PMC4832316.pdf
Nuclei with DNA damage cH2AX foci were scored using ImageJ 1.45 software (http://rsbweb.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/9a/3a/STEM-34-756.PMC4832316.pdf
"Secondary HRP- conjugated anti-mouse and anti-rabbit IgG were use at 1:30,000 and 1:1,000, respectively (DAKO, Glostrup, Denmark).Detection was performed using ECL reaction kits according to manufacturer’s instruction (GE Healthcare, Buckinghamshire, U.K.) and quantiﬁcation of the signal was performed usingImageJ 1.45 software (http://rsbweb.nih.gov/ij/).",OADS,/arxiv_data1/oa_pdf/9a/3a/STEM-34-756.PMC4832316.pdf
The images were an alyzed using the NIH ImageJ 1.45 software (http://rsbweb.nih.gov/ij/) Colocalization of the t w op r o t e i n sw a ss h o w na st h em e r g e di m a g e s .,OADS,/arxiv_data1/oa_pdf/9a/3a/STEM-34-756.PMC4832316.pdf
"For each analyzed time point, gangliafrom at least 40 embryos were pooled for RNA extrac-tion using the Qiagen RNeasy micro kit (Qiagen, Hil-den, Germany) according to manufacturer’s instructions.Four replicate sample of each time point were obtained.For transcriptome analysis, 4 344K Agilent (Santa Clara, CA, USA) whole transcriptome arrays were used.The raw intensity reads for each array were backgroundcorrected by spatial detrending and subsequently quan-tile normalized for comparison across arrays using thelimma package from Bioconductor (http://www.biocon-ductor.org).",OADS,/arxiv_data1/oa_pdf/6a/0d/DNEU-75-1204.PMC4832352.pdf
"VCAlphaMed Press 1066-5099/2014/$30.00/0 http://dx.doi.org/ 10.1002/stem.2116 This is an open access article under the terms of the CreativeCommons Attribution-NonCom-mercial License, which permits use, distribution and reproduc- tion in any medium, providedthe original work is properly cited and is not used for com- mercial purposes.",Non-OADS,/arxiv_data1/oa_pdf/25/31/STEM-33-2961.PMC4832376.pdf
All primer pairs were conﬁrmed to be speciﬁc to the EZH2 gene on chromosome 7 (NC 000007.13: 148504464–148581441) rather than the pseudogene on chromo- some 21 (NC 000021.8: 36971977–36972553) using the BLAST function on NCBI at http://www.ncbi.nlm.nih.gov//blast/Blast.cgi (GRCh37.p13 assembly).,Non-OADS,/arxiv_data1/oa_pdf/db/3c/HUMU-37-301.PMC4832389.pdf
All nomenclature of described sequence vari- ants is based on this sequence and follows the guidelines des- cribed in http://www.hgvs.org/mutnomen/.,Non-OADS,/arxiv_data1/oa_pdf/db/3c/HUMU-37-301.PMC4832389.pdf
"Population frequen- cies for each variant were investigated in the dbSNP database, searchable at http://www.ncbi.nlm.nih.gov/projects/SNP/, and the exome variant server, found at http://evs.gs.washington.edu/EVS/.",OADS,/arxiv_data1/oa_pdf/db/3c/HUMU-37-301.PMC4832389.pdf
"Functional predictions for previously undescribed variants were done using the PROVEAN and SIFT tools, available at http://provean.jcvi.org/index.php (PROVEAN v1.1.3).",OADS,/arxiv_data1/oa_pdf/db/3c/HUMU-37-301.PMC4832389.pdf
All described pathogenic variants have been submitted to the LOVD locus-speciﬁc database and can be found at http://www.lovd.nl/EZH2.,Non-OADS,/arxiv_data1/oa_pdf/db/3c/HUMU-37-301.PMC4832389.pdf
Paired tissues werefrozen in liquid nitrogen within 15 min from resec-tion as recommended by the Canadian Tumor Repository Network [http://www.ctrnet.ca] and stored in liquid nitrogen until total RNA or proteinextraction.,Non-OADS,/arxiv_data1/oa_pdf/c3/f2/MC-55-671.PMC4832390.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d8/95/omw015.PMC4832398.pdf
"To define PD predisposition genes and loci, OMIM (http://www.ncbi.nlm.nih.gov/omim) wassearched with the words “Parkinson disease ”and“genes ”and “locus/loci.",Non-OADS,/arxiv_data1/oa_pdf/91/9d/NG2015001586.PMC4832432.pdf
"In this case, any data that were on hg18 werelifted over to hg19 using the Lift Genome Annotations tool available from UCSC (http://genome.ucsc.edu/cgi-bin/ hgLiftOver, UC Santa Cruz Software, The Regents of theUniversity of California, Santa Cruz, CA).",OADS,/arxiv_data1/oa_pdf/91/9d/NG2015001586.PMC4832432.pdf
J Appl Anthropol 2008. http://www.omertaa.,Non-OADS,/arxiv_data1/oa_pdf/36/db/IJCP-70-206.PMC4832440.pdf
http://www.kingshouse.,Non-OADS,/arxiv_data1/oa_pdf/36/db/IJCP-70-206.PMC4832440.pdf
"A Brief but Wide, History , 2015. https://commonreader.wustl.edu/c/ the-weight-of-obsession (accessed 28 October 2015).",Non-OADS,/arxiv_data1/oa_pdf/36/db/IJCP-70-206.PMC4832440.pdf
"87-781, 76 Stat 780, 1962. http://www.gpo.gov/fdsys/pkg/STATUTE-76/pdf/STATUTE-76-Pg780.pdf (ac-cessed 28 October 2015).",Non-OADS,/arxiv_data1/oa_pdf/36/db/IJCP-70-206.PMC4832440.pdf
"Guidance for the Clinical Evaluation of Weight-Control Drugs , 1996. http://www.fda.gov/ ohrms/dockets/98fr/03d-0570-gdl0001.pdf.",Non-OADS,/arxiv_data1/oa_pdf/36/db/IJCP-70-206.PMC4832440.pdf
http://www.fda.-gov/downloads/Drugs/ .../Guidances/ ucm071612.pdf (accessed 28 October 2015).,Non-OADS,/arxiv_data1/oa_pdf/36/db/IJCP-70-206.PMC4832440.pdf
"Council Regulation (EEC) No 2309/93 of 22 July 1993 Laying DownCommunity Procedures for the Authorization andSupervision of Medicinal Products for Human andVeterinary use and Establishing a European Agencyfor the Evaluation of Medicinal Products , 1993. http://ec.europa.eu/health/ﬁles/eudralex/vol-1/reg_1993_2309/reg_1993_2309_bg.pdf (accessed28 October 2015).",Non-OADS,/arxiv_data1/oa_pdf/36/db/IJCP-70-206.PMC4832440.pdf
"The New York Times , October 8, 1999. http://www.nytimes.com/ 1999/10/08/business/fen-phen-maker-to-pay-billions- in-settlement-of-diet-injury-cases.html (accessed 28 October 2015).",Non-OADS,/arxiv_data1/oa_pdf/36/db/IJCP-70-206.PMC4832440.pdf
"48 Beaston P. BPCA Executive Summary: Clinical Review for New Drug Application 20-632, SE5-021 , 2005. http://www.fda.gov/downloads/Drugs/Devel-opmentApprovalProcess/DevelopmentResources/UCM163209.pdf (accessed 28 October 2015).",Non-OADS,/arxiv_data1/oa_pdf/36/db/IJCP-70-206.PMC4832440.pdf
"Questions and Answers on the Suspension of Medicines ContainingSibutramine , 2010. http://www.ema.europa.eu/docs/ en_GB/document_library/Referrals_document/Sibutramine_107/WC500094238.pdf (accessed 28 October 2015).53 Caterson ID, Finer N, Coutinho W et al.",Non-OADS,/arxiv_data1/oa_pdf/36/db/IJCP-70-206.PMC4832440.pdf
"Xenical Summary of Product Characteristics , 2013. http://www.medicines.org.uk/emc/document.aspx?documentid=1746 (accessed 28 October 2015).",Non-OADS,/arxiv_data1/oa_pdf/36/db/IJCP-70-206.PMC4832440.pdf
"Brieﬁng Document NDA 21-888 Zimulti (Rimona- bant) Tablets, 20 mg , 2007. http://www.fda.gov/ ohrms/dockets/ac/07/brieﬁng/2007-4306b1-fda-backgrounder.pdf (accessed 28 October 2015).",Non-OADS,/arxiv_data1/oa_pdf/36/db/IJCP-70-206.PMC4832440.pdf
http://www.drugs.com/ acomplia.html (accessed 28 October 2015).,Non-OADS,/arxiv_data1/oa_pdf/36/db/IJCP-70-206.PMC4832440.pdf
"FDA Approves Belviq to Treat Some Overweight orObese Adults , 2012. http://www.fda.gov/NewsEvents/ Newsroom/PressAnnouncements/ucm309993.htm (accessed 28 October 2015).",Non-OADS,/arxiv_data1/oa_pdf/36/db/IJCP-70-206.PMC4832440.pdf
"Withdrawal of the Marketing Authorisation Application for Belviq(Lorcaserin) , 2013. http://www.ema.europa.eu/docs/ en_GB/document_library/Medicine_QA/2013/05/WC500143811.pdf (accessed 28 October 2015).",Non-OADS,/arxiv_data1/oa_pdf/36/db/IJCP-70-206.PMC4832440.pdf
"Refusal of the Mar- keting Authorisation for Qsiva (Phentermine/Topi-ramate) , 2012. http://www.ema.europa.eu/docs/ en_GB/document_library/Summary_of_opinion_-_Initial_authorisation/human/002350/WC500134085.pdf (assessed 28 October 2015).",Non-OADS,/arxiv_data1/oa_pdf/36/db/IJCP-70-206.PMC4832440.pdf
"Con- trave (Naltrexone 4 mg, 8 mg/Bupropion HCL 90 mg Extended Release Tablet) Brieﬁng Document, NDA200063 , 2010. http://www.fda.gov/downloads/ advisorycommittees/committeesmeetingmaterials/drugs/endocrinologicandmetabolicdrugsadvisorycommittee/ucm235671.pdf (accessed 28 October2015).",Non-OADS,/arxiv_data1/oa_pdf/36/db/IJCP-70-206.PMC4832440.pdf
"Summary Review, 2014. http://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/200063Orig1s000SumR.pdf (accessed28 October 2015).",Non-OADS,/arxiv_data1/oa_pdf/36/db/IJCP-70-206.PMC4832440.pdf
"Contrave NDA Approval Letter , 2014. http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/200063Orig1s000ltr.pdf (accessed28 October 2015).",Non-OADS,/arxiv_data1/oa_pdf/36/db/IJCP-70-206.PMC4832440.pdf
http://my.clevelandclinic.org/about-cleveland-clinic/newsroom/releases-videos-newsletters/2015-5-12-clinical-trial-testing-safety-of-obesity-drug-contrave-halted (accessed 28 October 2015).,Non-OADS,/arxiv_data1/oa_pdf/36/db/IJCP-70-206.PMC4832440.pdf
http://www.ema.eu ropa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003687/WC500185580.pdf (accessed 28 October 2015).,Non-OADS,/arxiv_data1/oa_pdf/36/db/IJCP-70-206.PMC4832440.pdf
http://www.ema.europa.eu/ docs/en_GB/document_library/EPAR_-_Product_Information/human/001026/WC500050017.pdf (ac-cessed 28 October 2015).,Non-OADS,/arxiv_data1/oa_pdf/36/db/IJCP-70-206.PMC4832440.pdf
http://www.accessdata.fda.- gov/drugsatfda_docs/label/2015/022341s023lbl.pdf (accessed 28 October 2015).,Non-OADS,/arxiv_data1/oa_pdf/36/db/IJCP-70-206.PMC4832440.pdf
"Saxenda NDA Approval Letter , 2014. http://www.accessdata.fda.gov/drugsatfda_docs/ap-pletter/2014/206321Orig1s000ltr.pdf (accessed 28October 2015).",Non-OADS,/arxiv_data1/oa_pdf/36/db/IJCP-70-206.PMC4832440.pdf
"Saxenda Summary of Product Characteristics , 2015. http://www.ema.eu- ropa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003780/WC500185786.pdf (accessed 28 October 2015).",Non-OADS,/arxiv_data1/oa_pdf/36/db/IJCP-70-206.PMC4832440.pdf
"FDA Approves Weight-Management Drug Saxenda , 2014. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm427913.htm (accessed28 October 2015).",Non-OADS,/arxiv_data1/oa_pdf/36/db/IJCP-70-206.PMC4832440.pdf
"Assessment Report: Saxenda , 2015. http://www.ema.europa.eu/docs/ en_GB/document_library/EPAR_-_Public_assess-ment_report/human/003780/WC500185788.pdf(accessed 28 October 2015).",Non-OADS,/arxiv_data1/oa_pdf/36/db/IJCP-70-206.PMC4832440.pdf
"Norgine and Takeda Announce the New Drug Application Approval of OBLEAN /C226Tablets 120 mg in Japan for the Treatment of Obesity WithComplications , 2013. http://www.takeda.com/news/ 2013/20130920_5991.html (accessed 28 October 2015).",Non-OADS,/arxiv_data1/oa_pdf/36/db/IJCP-70-206.PMC4832440.pdf
"Orexigen /C226Therapeutics Phase 2b Trial for EmpaticTMMeets Primary Efﬁcacy Endpoint Demon- strating Signiﬁcantly Greater Weight Loss Versus Com-parators in Obese Patients , 2015. http://ir.orexigen.",Non-OADS,/arxiv_data1/oa_pdf/36/db/IJCP-70-206.PMC4832440.pdf
https://clinicaltrials.gov/ct2/show/NCT02324491(accessed 28 October 2015).,Non-OADS,/arxiv_data1/oa_pdf/36/db/IJCP-70-206.PMC4832440.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bc/85/kbia-05-1-2-1080891.PMC4832442.pdf
Genes Dev 1993; 7:1-12; PMID:8422980; http://dx.doi.org/ 10.1101/gad.7.1.1 2.,OADS,/arxiv_data1/oa_pdf/bc/85/kbia-05-1-2-1080891.PMC4832442.pdf
WIREs Dev Biol 2012; 1:371-88; http://dx.doi.org/10.1002/wdev.29 3.,OADS,/arxiv_data1/oa_pdf/bc/85/kbia-05-1-2-1080891.PMC4832442.pdf
Mech Dev 1996; 57:191-8; PMID:8843396; http://dx.doi.org/10.1016/0925-4773(96)00546-1 5.,OADS,/arxiv_data1/oa_pdf/bc/85/kbia-05-1-2-1080891.PMC4832442.pdf
J CellBiol 1997; 136:1123-34; PMID:9060476; http://dx.doi.org/10.1083/jcb.136.5.112324 Welch and Pelegri,OADS,/arxiv_data1/oa_pdf/bc/85/kbia-05-1-2-1080891.PMC4832442.pdf
Cell 2009; 139:1056-8; PMID:20005801; http://dx.doi.org/ 10.1016/j.cell.2009.11.035 7.,OADS,/arxiv_data1/oa_pdf/bc/85/kbia-05-1-2-1080891.PMC4832442.pdf
Curr Biol 1997; 7:31-42; PMID:9024620; http://dx.doi.org/10.1016/S0960-9822(06)00025-X 8.,OADS,/arxiv_data1/oa_pdf/bc/85/kbia-05-1-2-1080891.PMC4832442.pdf
Mech Dev 1999; 81:51-63; PMID:10330484; http://dx.doi.org/10.1016/S0925- 4773(98)00202-0 9.,OADS,/arxiv_data1/oa_pdf/bc/85/kbia-05-1-2-1080891.PMC4832442.pdf
Dev Biol1999; 215:167-81; PMID:10545228; http://dx.doi.org/10.1006/dbio.1999.9455 10.,OADS,/arxiv_data1/oa_pdf/bc/85/kbia-05-1-2-1080891.PMC4832442.pdf
Devel- opment 2012; 139:3644-3652; PMID:22949618;http://dx.doi.org/10.1242/dev.082362 11.,Non-OADS,/arxiv_data1/oa_pdf/bc/85/kbia-05-1-2-1080891.PMC4832442.pdf
PLoS Genet 2014; 10: e1004422; PMID:24967891; http://dx.doi.org/10.1371/journal.pgen.1004422 14.,Non-OADS,/arxiv_data1/oa_pdf/bc/85/kbia-05-1-2-1080891.PMC4832442.pdf
Dev Dyn 2010; 239:2172-89; PMID:20568243; http://dx.doi.org/10.1002/dvdy.22349 16.,Non-OADS,/arxiv_data1/oa_pdf/bc/85/kbia-05-1-2-1080891.PMC4832442.pdf
Genes Cells 2002; 7:971-84;PMID:12296827; http://dx.doi.org/10.1046/j.1365- 2443.2002.00576.x17.,OADS,/arxiv_data1/oa_pdf/bc/85/kbia-05-1-2-1080891.PMC4832442.pdf
Mech Dev 2000; 93:205-9;PMID:10781958; http://dx.doi.org/10.1016/S0925- 4773(00)00270-7 18.,OADS,/arxiv_data1/oa_pdf/bc/85/kbia-05-1-2-1080891.PMC4832442.pdf
Dev Biol 2006;292:129-41; PMID:16457796; http://dx.doi.org/ 10.1016/j.ydbio.2005.12.045 20.,OADS,/arxiv_data1/oa_pdf/bc/85/kbia-05-1-2-1080891.PMC4832442.pdf
Dev Dyn 1995; 203:253-310; PMID:8589427; http://dx.doi.org/10.1002/aja.1002030302 22.,Non-OADS,/arxiv_data1/oa_pdf/bc/85/kbia-05-1-2-1080891.PMC4832442.pdf
Bioarchitecture 2013; 3:125-32; PMID:24721731; http://dx.doi.org/10.4161/ bioa.26538 23.,Non-OADS,/arxiv_data1/oa_pdf/bc/85/kbia-05-1-2-1080891.PMC4832442.pdf
Dev Cell 2001; 1:103-14;PMID:11703928; http://dx.doi.org/10.1016/S1534- 5807(01)00007-7 26.,OADS,/arxiv_data1/oa_pdf/bc/85/kbia-05-1-2-1080891.PMC4832442.pdf
Mech Dev 1999; 81:223-6; PMID:10330505; http://dx.doi.org/ 10.1016/S0925-4773(98)00242-1 27.,OADS,/arxiv_data1/oa_pdf/bc/85/kbia-05-1-2-1080891.PMC4832442.pdf
J Cell Biol 1991; 114:1017-28; PMID:1714912; http://dx.doi.org/10.1083/jcb.114.5.1017 30.,Non-OADS,/arxiv_data1/oa_pdf/bc/85/kbia-05-1-2-1080891.PMC4832442.pdf
Curr Biol 2003; 13:1429-34; PMID:12932328; http://dx.doi.org/10.10 16/S0960-9822(03)00537-2 34.,OADS,/arxiv_data1/oa_pdf/bc/85/kbia-05-1-2-1080891.PMC4832442.pdf
Dev Growth Differ 1998; 40:313-26; PMID:9639359; http://dx.doi.org/10.1046/j.1440-169X.1998.t01-1-00007.x 35.,Non-OADS,/arxiv_data1/oa_pdf/bc/85/kbia-05-1-2-1080891.PMC4832442.pdf
Dev Growth Differ 2000; 42: 29-40;PMID:10831041; http://dx.doi.org/10.1046/j.1440- 169x.2000.00484.x 36.,OADS,/arxiv_data1/oa_pdf/bc/85/kbia-05-1-2-1080891.PMC4832442.pdf
Mol Reprod Dev 1996; 43:536547; PMID:9052946;http://dx.doi.org/ 10.1002/(SICI)1098-2795(199604) 43:4%3c536::AID-MRD 17%3e3.0.CO;2-X 37.,OADS,/arxiv_data1/oa_pdf/bc/85/kbia-05-1-2-1080891.PMC4832442.pdf
Mech Dev 2000; 92:305-9;PMID:10727871; http://dx.doi.org/10.1016/S0925- 4773(00)00247-1 41.,OADS,/arxiv_data1/oa_pdf/bc/85/kbia-05-1-2-1080891.PMC4832442.pdf
Mech Dev 2007; 124:279-89; PMID:17293094; http://dx.doi.org/ 10.1016/j.mod.2007.01.003 42.,OADS,/arxiv_data1/oa_pdf/bc/85/kbia-05-1-2-1080891.PMC4832442.pdf
Dev Biol2002; 241:79-93; PMID:11784096; http://dx.doi.org/ 10.1006/dbio.2001.0488 43.,OADS,/arxiv_data1/oa_pdf/bc/85/kbia-05-1-2-1080891.PMC4832442.pdf
Development 2011; 138:3431-40;PMID:21752933; http://dx.doi.org/10.1242/ dev.065029 45.,Non-OADS,/arxiv_data1/oa_pdf/bc/85/kbia-05-1-2-1080891.PMC4832442.pdf
Dev Cell 2002; 3:157-66; PMID:12194847; http://dx.doi.org/10.1016/S1534-5807(02)00226-5 46.,OADS,/arxiv_data1/oa_pdf/bc/85/kbia-05-1-2-1080891.PMC4832442.pdf
Dev Biol 2007; 311: 554-65; PMID:17936745; http://dx.doi.org/10.1016/j.ydbio.2007.09.012 47.,OADS,/arxiv_data1/oa_pdf/bc/85/kbia-05-1-2-1080891.PMC4832442.pdf
Differentiation 2014; 88:17-26; PMID:24798204; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bc/85/kbia-05-1-2-1080891.PMC4832442.pdf
Development 2013; 140:2334-44; PMID:23615278; http://dx.doi.org/10.1242/ dev.094748 49.,OADS,/arxiv_data1/oa_pdf/bc/85/kbia-05-1-2-1080891.PMC4832442.pdf
Dev Biol 2013; 382:246-67; PMID:23891818; http://dx.doi.org/10.1016/j.ydbio.,OADS,/arxiv_data1/oa_pdf/bc/85/kbia-05-1-2-1080891.PMC4832442.pdf
"1Initially, caveolae were thought /C211Yosuke Senju and Shiro Suetsugu *Correspondence to: Shiro Suetsugu; Email: suetsugu@bs.naist.jp Submitted: 11/24/2015; Revised: 11/29/2015; Accepted: 12/01/2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
Nat Rev Mol Cell Biol 2013; 14:98-112; PMID:23340574; http://dx.doi.org/10.1038/nrm3512 2.,OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
J Cell Biol2005; 170:769-79; PMID:16129785; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
Cell 1992;68:673-82; PMID:1739974; http://dx.doi.org/ 10.1016/0092-8674(92)90143-Z 5.,OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
"PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function.Cell 2008; 132:113-24; PMID :18191225; http://dx.doi.",OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
Trends Cell Biol 2010; 20:177-86; PMID:20153650; http://dx.doi.org/ 10.1016/j.tcb.2010.01.005 7.,OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
J Biol Chem 1997; 272:33416-21; PMID:9407137; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
Mol Biol Cell 2012;23:1316-29; PMID:22323287; http://dx.doi.org/ 10.1091/mbc.E11-09-0787 10.,Non-OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
Mol Biol Cell 2000; 11:325-37; PMID:10637311; http://dx.doi.org/10.1091/mbc.11.1.325 11.,OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
"J Cell Sci 2012; 125:3097-113; PMID:22454521; http://dx.doi.org/10.1242/jcs.090134 1 2 .H a n s e nC G ,H o w a r dG ,N i c h o l sB J .P a c s i n2i s recruited to caveolae and functions in caveolar biogen- esis.",OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
J Cell Sci 2011; 124:2777-85; PMID:21807942;http://dx.doi.org/10.1242/jcs.084319 13.,OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
Dev Cell 2014; 31:405-19; PMID:25453557; http://dx.doi.org/10.1016/j.devcel.2014.10.002 15.,OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
PLoS Biol 2013; 11:e1001640; PMID:24013648; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
J Cell Biol 1998; 141:601-10; PMID:9566962; http://dx.doi.org/10.1083/jcb.141.3.601 17.,Non-OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
Science 2002; 296:535-9; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
Cell 2011; 144:402-13; PMID:21295700; http://dx.doi.org/ 10.1016/j.cell.2010.12.031 20.,OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
J Cell Sci 2015; 128:2766-80; PMID:26092940; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
Am J Physiol Heart Circulatory Physiol 2003;285:H1113-22; http://dx.doi.org/10.1152/ ajpheart.00302.2003 22.,Non-OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
Am J physiol Heart Circulatory Physiol 2003;285:H1720-9; http://dx.doi.org/10.1152/ ajpheart.00344.2002 23.,Non-OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
J Cell Sci 2011; 124:3581-90; PMID:22045729; http://dx.doi.org/10.1242/ jcs.084376 24.,OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
Trends Cardiovascular Med 2006; 16:50-5; http://dx.doi.org/10.1016/j.tcm.2005.11.007 25.,Non-OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
Science 2001; 293:2449-52; http://dx.doi.org/10.1126/science.1062688 27.,Non-OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
Physiol Rev 2014; 94:1219-48; PMID:25287863; http://dx.doi.org/ 10.1152/physrev.00040.2013 28.,Non-OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
Cell 2014; 156:882-92; PMID:24581490; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
Cell 2009; 137:191-6; PMID:19379681; http://dx.doi.org/10.1016/j.cell.2009.04.010 30.,OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
"Science (New York, NY) 2004; 303:495-9; http://dx.doi.org/10.1126/science.1092586 31.",Non-OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
Cell 2007; 129:761-72; PMID:17512409; http://dx.doi.org/ 10.1016/j.cell.2007.03.040 32.,OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
J Biol Chem 2006; 281:35347-58; PMID:17003044; http://dx.doi.org/10.1074/jbc.M606814200 33.,OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
FEBS Letters 2010; 584:1111- 8; PMID:20188097; http://dx.doi.org/10.1016/j.febslet.2010.02.058 36.,OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
EMBO J 2012; 31:3309-22; PMID:22751148; http://dx.doi.org/10.10 38/emboj.2012.176 37.,Non-OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
J Cell Sci 2011;124:2763-76; PMID:21807941; http://dx.doi.org/10.1242/jcs.080804 38.,OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
Seminars Cell Dev Biol 2010; 21:340- 9; http://dx.doi.org/10.101 6/j.semcdb.2009.12.002 39.,OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
J Cell Sci 2004; 117:3077-86; PMID:15226389; http://dx.doi.org/10.1242/jcs.01290 40.,OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
EMBO J 2012; 31:2350-64;PMID: 22505029; http://dx.doi.org/10.1038/emboj.,OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
Nature 2 007; 449:923-7; PMID: 17914359; http://dx.doi.or g/10.1038/nature06173 42.,OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
J Biol Chem 2006; 281:18753-62; PMID:16627472; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
J Biol Chem 2001; 276:26622-8; PMID:11352907; http://dx.doi.org/10.1074/jbc.M10059120046.,OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
J Cell Sci 2011; 124:2375-88; PMID: 21693584; http://dx.doi.org/10.1242/jcs.080630 47.,OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
EMBO Reports 2014; 15:1154-62; PMID:25216944; http://dx.doi.org/10.15252/embr.201439267 48.,Non-OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
PLoS Computa-tional Biol 2015; 11:e1004538; http://dx.doi.org/ 10.1371/journal.pcbi.1004538 49.,OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
PloS One 2012; 7:e43041; PMID:22912783; http://dx.doi.org/10.1371/journal.pone.0043041 50.,Non-OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
J Biol Chem 1997; 272:7381-9; PMID:9054438; http://dx.doi.org/10.1074/jbc.272.11.7381POSSIBLE REGULATION OF CAVEOLAR ENDOCYTOSIS 77,Non-OADS,/arxiv_data1/oa_pdf/ca/ed/kbia-05-5-6-1128604.PMC4832444.pdf
"GPI-anchored protein, lipid raft, ERM, leukocyte, integrin, uropod, polarization, migration, diapedesis /C211Dion D Richardson and Mar Fernandez-Borja *Correspondence to: Mar Fernandez-Borja; Email: m.fernandez@sanquin.nl Submitted: 11/19/2015; Accepted: 11/28/2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b4/3f/kbia-05-5-6-1127466.PMC4832445.pdf
Curr Opin Hematol 2010; 17:43-52; PMID:19996887; http://dx.doi.org/10.1097/MOH.0b013e3283333949 2.,Non-OADS,/arxiv_data1/oa_pdf/b4/3f/kbia-05-5-6-1127466.PMC4832445.pdf
Trends Immunol 2013; 34:27-32;PMID:23036434; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b4/3f/kbia-05-5-6-1127466.PMC4832445.pdf
Nat Rev Mol Cell Biol 2010; 11:366-78; PMID:20414258; http://dx.doi.org/10.1038/nrm2889 4.,OADS,/arxiv_data1/oa_pdf/b4/3f/kbia-05-5-6-1127466.PMC4832445.pdf
Proc Natl Acad Sci U S A2001; 98:9642-7; PMID:11493690; http://dx.doi.org/ 10.1073/pnas.171160298 7.,OADS,/arxiv_data1/oa_pdf/b4/3f/kbia-05-5-6-1127466.PMC4832445.pdf
Curr Opin Cell Biol 2003; 15:547-56; PMID:14519389; http://dx.doi.org/10.1016/j.ceb.2003.08.003 8.,OADS,/arxiv_data1/oa_pdf/b4/3f/kbia-05-5-6-1127466.PMC4832445.pdf
Nat Immunol 2005; 6:497-506;PMID:15834409; http://dx.doi.org/10.1038/ni1194ROLE OF GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED PROTEINS 67,Non-OADS,/arxiv_data1/oa_pdf/b4/3f/kbia-05-5-6-1127466.PMC4832445.pdf
Curr Opin Cell Biol 2012; 24:670-6; PMID:22770729; http://dx.doi.org/10.1016/j.ceb.2012.06.001 10.,OADS,/arxiv_data1/oa_pdf/b4/3f/kbia-05-5-6-1127466.PMC4832445.pdf
J Biol Chem 2003; 278:15217-24; PMID:12595537; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b4/3f/kbia-05-5-6-1127466.PMC4832445.pdf
"Viola A, Gupta N. Tether and trap: regulation of membrane-raft dynamics by actin-binding proteins.Nat Rev Immunol 2007; 7:889-96; PMID:17948020;http://dx.doi.org/10.1038/nri2193 16.",OADS,/arxiv_data1/oa_pdf/b4/3f/kbia-05-5-6-1127466.PMC4832445.pdf
Cell 2008; 135:1085-97; PMID:19070578; http://dx.doi.org/10.1016/j.cell.2008.11.032 17.,OADS,/arxiv_data1/oa_pdf/b4/3f/kbia-05-5-6-1127466.PMC4832445.pdf
Science1996; 273:1551-5; PMID:8703217; http://dx.doi.org/ 10.1126/science.273.5281.1551 18.,Non-OADS,/arxiv_data1/oa_pdf/b4/3f/kbia-05-5-6-1127466.PMC4832445.pdf
Nat Rev Mol Cell Biol 2002; 3:932-43; PMID:12461559; http://dx.doi.org/10.1038/nrm977 19.,OADS,/arxiv_data1/oa_pdf/b4/3f/kbia-05-5-6-1127466.PMC4832445.pdf
J Cell Sci2015; 128:3018-29; PMID:261 59734; http://dx.doi.org/ 10.1242/jcs.165365 21.,OADS,/arxiv_data1/oa_pdf/b4/3f/kbia-05-5-6-1127466.PMC4832445.pdf
J Clin Invest 1994; 93:1380-7; PMID:8163642; http://dx.do i.org/10.1172/JCI117114 22.,Non-OADS,/arxiv_data1/oa_pdf/b4/3f/kbia-05-5-6-1127466.PMC4832445.pdf
Nat Rev Mol Cell Biol 2010; 11:23-36; PMID:20027185; http://dx.doi.org/10.1038/nrm2821 24.,OADS,/arxiv_data1/oa_pdf/b4/3f/kbia-05-5-6-1127466.PMC4832445.pdf
J Exp Med 1995; 181:1381-90; PMID:7535337; http://dx.doi.org/ 10.1084/jem.181.4.1381 25.,Non-OADS,/arxiv_data1/oa_pdf/b4/3f/kbia-05-5-6-1127466.PMC4832445.pdf
J Cell Biol 2005; 168:501-11; PMID:15684035; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b4/3f/kbia-05-5-6-1127466.PMC4832445.pdf
PLoS Pathog2009; 5:e1000608; PMID:19798432; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b4/3f/kbia-05-5-6-1127466.PMC4832445.pdf
FASEB J 2012; 26:678-90; PMID:22038049; http://dx.doi.org/10.1096/fj.11-185579 30.,Non-OADS,/arxiv_data1/oa_pdf/b4/3f/kbia-05-5-6-1127466.PMC4832445.pdf
Trends Cell Biol 2010; 20:187-95; PMID:20133134; http://dx.doi.org/10.1016/j.tcb.2010.01.001 31.,OADS,/arxiv_data1/oa_pdf/b4/3f/kbia-05-5-6-1127466.PMC4832445.pdf
J Cell Biol 2005; 171:349-59; PMID:16230460; http://dx.doi.org/ 10.1083/jcb.200504029 32.,OADS,/arxiv_data1/oa_pdf/b4/3f/kbia-05-5-6-1127466.PMC4832445.pdf
J Cell Sci 2012; 125:2369-80; PMID:22366462; http://dx.doi.org/10.1242/jcs.091579 33.,OADS,/arxiv_data1/oa_pdf/b4/3f/kbia-05-5-6-1127466.PMC4832445.pdf
Nat Rev Mol Cell Biol 2010; 11:276-87; PMID:20308985;http://dx.doi.org/10.1038/nrm2866 34.,OADS,/arxiv_data1/oa_pdf/b4/3f/kbia-05-5-6-1127466.PMC4832445.pdf
Blood 2012; 119:445-53; PMID:22106344; http://dx.doi.org/10.1182/blood-2011-07-368860 36.,Non-OADS,/arxiv_data1/oa_pdf/b4/3f/kbia-05-5-6-1127466.PMC4832445.pdf
Eur J Neuro-sci 2006; 24:3255-64; PMI D:17156386; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b4/3f/kbia-05-5-6-1127466.PMC4832445.pdf
J Cell Sci 2007;120:1915-26; PMID:17504807; http://dx.doi.org/ 10.1242/jcs.03459 38.,OADS,/arxiv_data1/oa_pdf/b4/3f/kbia-05-5-6-1127466.PMC4832445.pdf
J Biol Chem2014; 289:15588-601; PMID:24753259; http://dx.doi.org/10.1074/jbc.M113.535070 39.,Non-OADS,/arxiv_data1/oa_pdf/b4/3f/kbia-05-5-6-1127466.PMC4832445.pdf
EMBO J 2014; 33:2458-72; PMID:25168639; http://dx.doi.org/10.15252/embj.201387611 41.,OADS,/arxiv_data1/oa_pdf/b4/3f/kbia-05-5-6-1127466.PMC4832445.pdf
J Cell Biol 2007; 177:927-39; PMID:17548516; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b4/3f/kbia-05-5-6-1127466.PMC4832445.pdf
JExp Med 2012; 209:1349-62; PMID:22711877; http://dx.doi.org/10.1084/jem.20111426 43.,Non-OADS,/arxiv_data1/oa_pdf/b4/3f/kbia-05-5-6-1127466.PMC4832445.pdf
Blood 2010; 115:1572-81; PMID:20023213; http://dx.doi.org/10.1182/blood-2009-08-237917 44.,Non-OADS,/arxiv_data1/oa_pdf/b4/3f/kbia-05-5-6-1127466.PMC4832445.pdf
Cell Rep 2013; 5:619-28; PMID:24210817; http://dx.doi.org/ 10.1016/j.celrep.2013.10.011 45.,OADS,/arxiv_data1/oa_pdf/b4/3f/kbia-05-5-6-1127466.PMC4832445.pdf
Mol Biol Cell 2001; 12:3031-45; PMID:11598189; http://dx.doi.org/10.1091/mbc.12.10.3031 48.,Non-OADS,/arxiv_data1/oa_pdf/b4/3f/kbia-05-5-6-1127466.PMC4832445.pdf
J Exp Med 2008; 205:195- 205; PMID:18195072; http://dx.doi.org/10.1084/jem.20071543 49.,Non-OADS,/arxiv_data1/oa_pdf/b4/3f/kbia-05-5-6-1127466.PMC4832445.pdf
Front Immunol 2013;4:84; PMID:23579783; http://dx.doi.org/10.3389/ ﬁmmu.2013.00084ROLE OF GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED PROTEINS 69,Non-OADS,/arxiv_data1/oa_pdf/b4/3f/kbia-05-5-6-1127466.PMC4832445.pdf
This is an open access article under the CC BY-NC-ND 3.0 license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/11/main.PMC4832486.pdf
http://dx.doi.org/10.1016/j.pmedr.2014.12.0012211-3355/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a6/11/main.PMC4832486.pdf
This is an open access article under the CC BY-NC-ND 3.0 license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/11/main.PMC4832486.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/a6/11/main.PMC4832486.pdf
"14, 485. http://dx.doi.org/10.1186/1471-2334- 14-485 .",Non-OADS,/arxiv_data1/oa_pdf/a6/11/main.PMC4832486.pdf
"13, 108. http://dx.doi.org/10.1186/ 1471-2334-13-108 .",Non-OADS,/arxiv_data1/oa_pdf/a6/11/main.PMC4832486.pdf
Available from http://www.who.int/ biologicals/vaccines/pneumococcal/en/ (accessed 05.11.14).,Non-OADS,/arxiv_data1/oa_pdf/a6/11/main.PMC4832486.pdf
Available from http://www.who.int/ith/diseases/pneumococcal/en/ (a  ccessed 05.11.14).,Non-OADS,/arxiv_data1/oa_pdf/a6/11/main.PMC4832486.pdf
With increasing heatingReceived: 1 June 2015 Revised: 28 August 2015 Accepted: 25 September 2015 Heliyon (2015) e00034 http://dx.doi.org/10.1016/j.heliyon.2015.e00034 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
All these studieshave demonstrated that morphological and molecular biosignatures may be Article No~e00034 2 http://dx.doi.org/10.1016/j.heliyon.2015.e00034 2405-8440/© 2015 The Authors.,OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
Article No~e00034 3 http://dx.doi.org/10.1016/j.heliyon.2015.e00034 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
Article No~e00034 4 http://dx.doi.org/10.1016/j.heliyon.2015.e00034 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
Article No~e00034 5 http://dx.doi.org/10.1016/j.heliyon.2015.e00034 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
"With increasing experimental durations at 360 °C, sporopollenin Article No~e00034 6 http://dx.doi.org/10.1016/j.heliyon.2015.e00034 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
Article No~e00034 7 http://dx.doi.org/10.1016/j.heliyon.2015.e00034 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
Article No~e00034 8 http://dx.doi.org/10.1016/j.heliyon.2015.e00034 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
The evolution of the C-XANES Article No~e00034 9 http://dx.doi.org/10.1016/j.heliyon.2015.e00034 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
Article No~e00034 10 http://dx.doi.org/10.1016/j.heliyon.2015.e00034 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
"[(Fig._4)TD$FIG] 2.02.12.22.32.42.5 0 200 400 Temperature (°C) 800 1000Oxygen Functions vs Temperature 2.02.12.22.32.42.5 0 100 Duration of pyrolysis at 360°C (in minutes) 900R² = 0,98481.01.52.02.53.0 0 200 400 Temperature (°C) 800 1000Aromaticity vs TemperatureHeat-treated Sporopollenin Vanoise Sporopollenin R² = 0,9994R² = 0,9999 1.01.21.41.6 0 100 Duration of pyrolysis at 360°C (in minutes) 900Aromaticity vs Time R² = 0,9978SASASO Oxygen Content vs Time SO280 290 300 310 285 295 305 Energy (eV) 286.7 287.2 288.6285.1 285.3 1 0X-ray Absorption 289.2 ~1 Ma ~1 Ma2.5 Article No~e00034 11 http://dx.doi.org/10.1016/j.heliyon.2015.e00034 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
Article No~e00034 12 http://dx.doi.org/10.1016/j.heliyon.2015.e00034 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
It has been anticipated from Article No~e00034 13 http://dx.doi.org/10.1016/j.heliyon.2015.e00034 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
"As geological time cannot be replicated in the laboratory, Article No~e00034 14 http://dx.doi.org/10.1016/j.heliyon.2015.e00034 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
"In contrast, these discrepancies may reside in the fact that the present experiments have been performed on pure sporopolleninin open crucibles under Article No~e00034 15 http://dx.doi.org/10.1016/j.heliyon.2015.e00034 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
Article No~e00034 16 http://dx.doi.org/10.1016/j.heliyon.2015.e00034 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
Article No~e00034 17 http://dx.doi.org/10.1016/j.heliyon.2015.e00034 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
Article No~e00034 18 http://dx.doi.org/10.1016/j.heliyon.2015.e00034 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
Article No~e00034 19 http://dx.doi.org/10.1016/j.heliyon.2015.e00034 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
Article No~e00034 20 http://dx.doi.org/10.1016/j.heliyon.2015.e00034 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
Article No~e00034 21 http://dx.doi.org/10.1016/j.heliyon.2015.e00034 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
Chemical alteration of a biological polymer “sporopollenin ”during coalification: Article No~e00034 22 http://dx.doi.org/10.1016/j.heliyon.2015.e00034 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
Article No~e00034 23 http://dx.doi.org/10.1016/j.heliyon.2015.e00034 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
Article No~e00034 24 http://dx.doi.org/10.1016/j.heliyon.2015.e00034 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
Article No~e00034 25 http://dx.doi.org/10.1016/j.heliyon.2015.e00034 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
Article No~e00034 26 http://dx.doi.org/10.1016/j.heliyon.2015.e00034 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
Article No~e00034 27 http://dx.doi.org/10.1016/j.heliyon.2015.e00034 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
Article No~e00034 28 http://dx.doi.org/10.1016/j.heliyon.2015.e00034 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/79/50/main.PMC4832518.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/4b/main.PMC4832603.pdf
"In the parallel IMF isola- tion procedure, the myo ﬁbrillar pellet was resuspended andContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/bbrepBiochemistry and Biophysics Reports http://dx.doi.org/10.1016/j.bbrep.2016.03.006 2405-5808/ &2016 The Authors.",OADS,/arxiv_data1/oa_pdf/6c/4b/main.PMC4832603.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/4b/main.PMC4832603.pdf
Appendix A. Transparency document Transparency document associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.bbrep.,Non-OADS,/arxiv_data1/oa_pdf/6c/4b/main.PMC4832603.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Lange RA, Hillis LD.",Non-OADS,/arxiv_data1/oa_pdf/1c/26/heartasia-2013-010296.PMC4832659.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Abbott JD, Voss MR, Nakamura M, et al.",Non-OADS,/arxiv_data1/oa_pdf/dc/b7/heartasia-2013-010316.PMC4832670.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/71/7e/JIPS-16-8.PMC4832799.pdf
Available	 from:	http://www.dental‑tribune.com/articles/specialities/implantology/13966_one‑visit_guided_treatment_thanks_to_ cadcam_and_cbct_.html.,Non-OADS,/arxiv_data1/oa_pdf/d5/e6/JIPS-16-3.PMC4832800.pdf
Available	from:	http://www.drnileshparmar.com/ publications_pdf/1359378785_FINAL.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d5/e6/JIPS-16-3.PMC4832800.pdf
Available 	 from:	http://www.endoexperience.com/documents/CAD0210_26‑31_ AlshehriAlamriAlshalhoob.pdf.,OADS,/arxiv_data1/oa_pdf/d5/e6/JIPS-16-3.PMC4832800.pdf
Available	from:	http://www.learndigital.,Non-OADS,/arxiv_data1/oa_pdf/d5/e6/JIPS-16-3.PMC4832800.pdf
Available	from:	https://www.youtube.com/watch?v=rDbab8MDWN4#t=76.,Non-OADS,/arxiv_data1/oa_pdf/d5/e6/JIPS-16-3.PMC4832800.pdf
Accessed	 from:	http://www.un.org/esa/population/publications/wpp2002/ WPP2002‑HIGHLIGHTSrev1.PDF.,Non-OADS,/arxiv_data1/oa_pdf/11/c5/JIPS-16-30.PMC4832801.pdf
Available	from:	http://www.ajphs.com/wp‑content/ uploads/2012/10/AJPHS‑Vol2‑Issue1‑12.pdf.,Non-OADS,/arxiv_data1/oa_pdf/11/c5/JIPS-16-30.PMC4832801.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/1c/0f/JIPS-16-91.PMC4832803.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/1c/0f/JIPS-16-91.PMC4832803.pdf
Germline mutations were excluded using the Human Genetic Variation Database (http://www.genome.med.kyoto-u.ac.jp/SnpDB).,OADS,/arxiv_data1/oa_pdf/a5/d5/CAS-107-461.PMC4832847.pdf
",(30)(adapted with permission under the CC BY-NC-ND license, http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/69/98/CAS-107-528.PMC4832848.pdf
"16 MPD - Home page ...Mouse Phenome Database at The Jackson Laboratory [http://phenome.jax.org/] 17 Mouse (Mus musculus) Genome Browser Gateway [http://genome.ucsc.edu/ cgi-bin/hgGateway?hgsid=408884495_ezZcmnkYN8XwWZZ0Lp8P8wIapcLe&clade=mammal&org=Mouse&db=mm9] 18 Alexandrov LB, Nik-Zainal S, Wedge DC et al.",OADS,/arxiv_data1/oa_pdf/69/98/CAS-107-528.PMC4832848.pdf
Hierarchical cluster analysis of all analyzed factorswas performed using TM4 MeV (http://www.tm4.org/in-dex.html).,OADS,/arxiv_data1/oa_pdf/61/8a/CAS-107-543.PMC4832853.pdf
Available from: http://ganjoho.jp/reg_stat/statistics/dl/index.html.,OADS,/arxiv_data1/oa_pdf/4e/44/CAS-107-521.PMC4832854.pdf
Available from: http://www.mhlw.go.jp/toukei/list/81-1.html.,OADS,/arxiv_data1/oa_pdf/4e/44/CAS-107-521.PMC4832854.pdf
"This is in contrast to other recent studies which report that FGFR1 mRNA expression in breast cancer is associated with survival, when assessing the effect ofsingle genes on breast cancer prognosis using tools such asKaplan –Meier –Plotter (www.kmplot.com) (37)and PrognoScan (http://www.abren.net/PrognoScan/).",Non-OADS,/arxiv_data1/oa_pdf/6e/cd/CAS-107-491.PMC4832856.pdf
Cell migration areas were determined using NIH imageJ software (http://imagej.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/c0/c6/CAS-107-433.PMC4832861.pdf
"http://imagej.nih.gov/ij/,1997-2012.",OADS,/arxiv_data1/oa_pdf/5f/77/CAS-107-536.PMC4832862.pdf
"Available from URL: http://www.un.org/sustainablede- velopment/health/ 2 Williams S, Chiong E, Lojanapiwat B et al.",OADS,/arxiv_data1/oa_pdf/8d/e2/CAS-107-556.PMC4832864.pdf
Available from URL: http://www.who.int/kobe_centre/ ageing/innovation-forum/en/ 5 [Cited 10 Oct 2015.],Non-OADS,/arxiv_data1/oa_pdf/8d/e2/CAS-107-556.PMC4832864.pdf
Available from URL: http://www.who.int/ageing/ events/world-report-2015-launch/en/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/e2/CAS-107-556.PMC4832864.pdf
"Available from URL: http://wsb.moh.gov.cn/htmlﬁles/ zwgkzt/ptjnj/year2011/index2011.html 8 Dai H, Yan Y, Wang P et al.",OADS,/arxiv_data1/oa_pdf/8d/e2/CAS-107-556.PMC4832864.pdf
"Available from URL: http://www.who.int/healthsys- tems/topics/ﬁnancing/healthreport/whr_background/en/10 Parkin DM, Bray F, Ferlay BJ et al.",OADS,/arxiv_data1/oa_pdf/8d/e2/CAS-107-556.PMC4832864.pdf
"Available from URL: http://www.who.int/mediacentre/factsheets/fs297/en/ 2 Schiller JH, Harrington D, Belani CP et al.",OADS,/arxiv_data1/oa_pdf/cd/89/CAS-107-444.PMC4832868.pdf
Available  from iVillage Limited: http://www.ivillage.co.uk/are-women- healthier-men/79324.,Non-OADS,/arxiv_data1/oa_pdf/b6/ab/JMH-7-15.PMC4832889.pdf
"Retrieved June 21, 2012 from Sixseconds: The  Emotional Intelligence Network: http://www.6seconds.org/ sei/media/WP_EQ_and_Age.pdf.",Non-OADS,/arxiv_data1/oa_pdf/b6/ab/JMH-7-15.PMC4832889.pdf
Available from http://www.lessons4living.,Non-OADS,/arxiv_data1/oa_pdf/b6/ab/JMH-7-15.PMC4832889.pdf
"Retrieved July 25,  2007 from About Relationship: http://divorcesupport.about.",Non-OADS,/arxiv_data1/oa_pdf/b6/ab/JMH-7-15.PMC4832889.pdf
"Retrieved June 15, 2012 from Gallup,  Inc: http://www.gallup.com/poll/102883/strong-relationship- between-income-mental-health.aspx.",Non-OADS,/arxiv_data1/oa_pdf/b6/ab/JMH-7-15.PMC4832889.pdf
"Galeon: Correlates of the health statuses of the faculty at midlife21 Journal of Mid-life Health  ¦ Jan-Mar 2016 ¦ Vol 7 ¦ Issue 1June 15, 2012 from Stanford News: http://news.stanford.",Non-OADS,/arxiv_data1/oa_pdf/b6/ab/JMH-7-15.PMC4832889.pdf
Availablefrom AOL Inc.: http://www.thatsfit.,Non-OADS,/arxiv_data1/oa_pdf/b6/ab/JMH-7-15.PMC4832889.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/b6/ab/JMH-7-15.PMC4832889.pdf
Available from:  http://www.naco.gov.in.,Non-OADS,/arxiv_data1/oa_pdf/1e/4e/JMH-7-38.PMC4832895.pdf
Available from: http://www.modernghana.com/ news2/7734/3/reggy-zippy-explodes-again.html.,Non-OADS,/arxiv_data1/oa_pdf/1b/6a/JMH-7-8.PMC4832898.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/1b/6a/JMH-7-8.PMC4832898.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/1b/6a/JMH-7-8.PMC4832898.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a5/7b/main.PMC4832925.pdf
"Furthermore, we provide evidence that GPC5 is localized exclusively to the cellular membrane, where it may re- press several oncogenic receptor tyrosine kinases, including RYK,ERBB2, and ERBB3, to exert its tumor suppressive function.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/bbrepBiochemistry and Biophysics Reports http://dx.doi.org/10.1016/j.bbrep.2016.03.010 2405-5808/ &2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/a5/7b/main.PMC4832925.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a5/7b/main.PMC4832925.pdf
Appendix A. Transparency document Transparency document associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.bbrep.,Non-OADS,/arxiv_data1/oa_pdf/a5/7b/main.PMC4832925.pdf
Available from: http://www.d.g.wanfangdata.,Non-OADS,/arxiv_data1/oa_pdf/67/55/CMJ-128-1000.PMC4832936.pdf
"Chinese Medical Journal  ¦ April 20, 2015 ¦ V olume 128 ¦ Issue 8 1007The HBV sequences were aligned and analyzed by MEGA  5.0 (http://www.megasoftware.net/) and Bioedit 7.0 software  packages (Ibis Therapeutics Carlsbad, CA, USA).",OADS,/arxiv_data1/oa_pdf/88/28/CMJ-128-1005.PMC4832937.pdf
"[22,23] Polymorphism selection and genotyping Phosphatase and tensin homolog SNPs in the promoter,  intronic, intron/exon boundary, exonic and 3’UTR  regions were initially screened using the International  HapMap Project tag SNP information in the Han Chinese  population (http://hapmap.ncbi.nlm.nih.gov/).",Non-OADS,/arxiv_data1/oa_pdf/88/28/CMJ-128-1005.PMC4832937.pdf
Available  from: http://www.csccm.org/cn/news.asp?id=111.html.,Non-OADS,/arxiv_data1/oa_pdf/3c/56/CMJ-128-1014.PMC4832938.pdf
Available from:  http://www.statistics.gov.hk/pub/B10100022013MM09B0100.pdf.,OADS,/arxiv_data1/oa_pdf/2e/c6/CMJ-128-1091.PMC4832951.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ec/4a/kfv039.PMC4833039.pdf
"(http://www.imi-marcar.eu/), aims to identify early biomarkers for nongenotoxic carcinogenesis using a range of transcriptomicand epigenetic approaches ( Braeuning et al.",OADS,/arxiv_data1/oa_pdf/ec/4a/kfv039.PMC4833039.pdf
"Doses reported to induce tumors in mice in vivo were chosen from publicly avail- able databases (eg, the Carcinogenic Potency Database: http://toxnet.nlm.nih.gov/cpdb/ and the NTP carcinogenicity data- base: http://ntp.niehs.nih.gov/) ( Gold et al.",Non-OADS,/arxiv_data1/oa_pdf/ec/4a/kfv039.PMC4833039.pdf
Reactions were carried out in triplicate on a 7500 real-time polymerase chain reactionmachine (Applied Biosystems) and HO-1 gene expression wascalculated in relative to 18S rRNA using the comparative C T method (http://www3.appliedbiosystems.com/cms/groups/ mcb_support/documents/generaldocuments/cms_041435.pdf).,OADS,/arxiv_data1/oa_pdf/ec/4a/kfv039.PMC4833039.pdf
"Biochemical analysis for creatinine, alanine aminotransferase, total bilirubin, glucose, and lactate dehydro- genase was conducted at the Clinical Pathology ServiceLaboratory, Medical Research Council, Harwell, Oxford, UK(http://www.har.mrc.ac.uk/services/pathology/clinical-pathology) according to standard procedures.",OADS,/arxiv_data1/oa_pdf/ec/4a/kfv039.PMC4833039.pdf
FUNDING This work was supported by the EU Innovative Medicine Initiative Joint Undertaking (115001); MARCAR project;http://www.imi-marcar.eu .,Non-OADS,/arxiv_data1/oa_pdf/ec/4a/kfv039.PMC4833039.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Chronic fatigue syndromeMRIAutonomicRegressionVasomotor centre Hypothalamus MidbrainNerve conductionPostureHeart rateBlood pressureAnxiety and depression 1.,Non-OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4833047.pdf
http://dx.doi.org/10.1016/j.nicl.2016.03.0172213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4833047.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4833047.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4833047.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.07.013 .,OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4833047.pdf
http://dx.doi.org/10.1097/HJH.,Non-OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4833047.pdf
"4, 32 –35.http://dx.doi.org/10.1186/1471-230X-4-32 .",Non-OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4833047.pdf
"NeuroImage 31, 754 –76  5.http://dx.doi.org/10.1016/j.neuroimage.2006.01.003 .",OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4833047.pdf
http://dx.doi.org/10.1111/j.1365-2362.2011.02567.x .,Non-OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4833047.pdf
http://dx.doi.org/ 10.1111/j.1365-2796.2009.02160.x .,Non-OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4833047.pdf
http://dx.doi.org/10.1002/hbm.20885 .,Non-OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4833047.pdf
http://dx.doi.org/10.1016/j.semarthrit.2013.03.00 .,OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4833047.pdf
http://dx.doi.org/10.1111/joim.,Non-OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4833047.pdf
http://dx.doi.org/10.1016/j.ijpsycho.2004.03.004 .,OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4833047.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Multimodal neuroimagingEpilepsyDrug resistant epilepsyFocal cortical dysplasiaMalformations of cortical developmentMachine learning Contents 1 .,Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.org/10.1016/j.nicl.2016.02.0132213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
"There are multiple re-sources in the neurology community that utilize these cloud resources, such as http://ieeg.org (Kini et al., 2015 ), Human Connectome Project (Van Essen et al., 2013 ), the European EEG database ( http://epilepsy- database.eu )(Klatt et al., 2012 )a n dL O N II D A( Dinov et al., 2010 ).",OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
"Over the past 4 years, our team of neuroscience and computer sci- ence experts has established a cloud-based resource, http://IEEG.org , that we believe can be a potential solution to these challenges.",Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
Beijing: JMLR: Workshop and Conference Proceed- ings http://jmlr.csail.mit.edu/proceedings/papers/v32/ahmed14.pdf .,Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.org/10.1006/nimg.2002.1312 .,OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
"http://dx.doi.org/10.1016/S1053- 8119(03)00226-X .Asano, E., Chugani, D.C., Muzik, O., et al., 2000.",OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.org/10.1212/WNL.54.10.1976 .,Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.org/10.1371/ journal.pone.0107401 .,Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.org/10.1093/brain/aws019 .,Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
"Epilepsia 41 (3), 342–351 http://www.ncbi.nlm.nih.gov/pubmed/10714408 .",Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
"10 (3), 133 –134http://www.ncbi.nlm.nih.gov/pubmed/ 24419681 .",Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.org/ 10.1093/cercor/bhq291 .,Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
"77 (3), 436 –446http://www.ncbi.nlm.nih.gov/pubmed/25546153 .A c c e s s e d June 24, 2015.",Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.org/10.1006/nimg.,OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.org/10.1148/radiology.214.3.r00mr40657 .,Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
"8, 411. http://dx.doi.org/10.3389/fnins.2014.00411 .",Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.org/10.1038/nm.2615 .,OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
"NeuroImage 9 (2), 179 –194http://www.ncbi.nlm.nih.",Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
"2011, 7981 –7984 http://www.ncbi.nlm.nih.gov/pubmed/22256192 .",Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
Brain awv130 http://dx.doi.org/10.1093/ brain/awv130 .,Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
"Epilepsia 54 (Suppl 2(2009)), 71 –74http://www.ncbi.nlm.nih.gov/ pubmed/23646976 .",Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
"25 (3), 450 –462http://www.ncbi.nlm.nih.gov/pubmed/15037472 .",Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.org/10.1007/s10334-010-0205-z .,Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.org/10.1109/TSMC.,Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.org/10.1016/j.eplepsyres.2014.09.006 .,OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.org/10.1016/j.neuroimage.2005.,OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
"4, 131http://www.pubmedcentral.nih.gov/articlerender.",Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.org/10.1111/j.1528-1167.2012.03564.x .,Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
"4 (1), 42 –53http://www.ncbi.nlm.nih.gov/pubmed/15620856 .",Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.org/10.1212/WNL.48.4.1018 .,Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
"365 (10), 919 –926http://www.ncbi.nlm.nih.gov/pubmed/21899452 .",Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
"Pediatr .1 4( 1 ) ,6 8 –80 http://www.ncbi.nlm.nih.gov/pubmed/24866708 .",Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.org/10.1006/nimg.1999.0534 .,OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
"9), 9 –18http://www.ncbi.nlm.nih.gov/pubmed/19761449 .",Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.org/10.3174/ajnr.A3081 .,Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
The power button sign: a newly described Central Sulcal pattern on surface rendering MR Images of type 2 focal cortical dyspla-sia.Radiology 140773. http://dx.doi.org/10.1148/radiol.14140773 .,Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.org/10.1684/epd.2014.0695 .,Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.org/10.1109/TMI.2007.893284 .,Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.org/10.5698/1535-7597-14.3.121 .,Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.org/10.1016/j.nicl.2015.05.009 .,OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
"18 (1), 42 –68http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 2779548&tool=pmcentrez&rendertype=abstract Accessed January 25, 2016.",OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.org/10.1016/j.clinph.2006.12.002 .,OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
"1 http://www.researchgate.net/publication/264713589_Blur_estimation_at_ the_gray-white_matter_boundary_for_focal_cortical_dysplasia_in_magnetic_resonance_imaging Accessed January 20, 2015.",Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
"http://www.ncbi.nlm.nih.gov/pubmed/7600083 .A c c e s s e dJ a n u - ary 21, 2015.",Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.org/10.1109/TIP.2002.,Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.org/10.1109/TPAMI.,Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
"6, 77 –92.http://dx.doi.org/10.1016/S1361-8415 (02)00052-X .",OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.org/10.4103/1817-1745.40593 .,Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.org/10.1212/01.wnl.0000334752.41807.2f .,Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
"UpToDate ,Inc. 2015. http://www.uptodate.com/contents/overview-of-the-management-of-epilepsy-in- adults .",Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://www.ncbi.nlm.nih.gov/pubmed/10825348 .,Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.org/10.1186/s40478-015-0191-5 .,Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.org/10.1371/journal.pone.0016430 .,Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.org/10.1002/ mrm.10268.,Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.org/10.1111/epi.12350 .,Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
"J. Neurosci .1 7( 1 8 ) ,7 0 7 9 –7102 http://www.ncbi.",Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.org/10.1523/ JNEUROSCI.4154-05.2006 .,Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
"Brain 134 (Pt 10), 2844 –2854 http://www.ncbi.nlm.nih.gov/pubmed/21893591 .",OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
"26 (8), 1051 –1058 http://www.ncbi.nlm.nih.gov/pubmed/23558575 .",Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.org/10.1002/ana.24407 .,Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
"4, 43. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.org/10.1111/epi.,Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.org/10.1016/j.eplepsyres.,OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
"105 (3), 337 –348http://www.ncbi.nlm.nih.gov/pubmed/23587673 .",Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
"http://dx.doi.org/10.1016/j.schres.2007.03.031 .Xiaoxia, Qu, Platisa, L., Despotovic, I., et al., 2014.",OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
3321 –3324 http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
865 –870http://dx.doi.org/ 10.1109/ISBI.2011.5872541 .,OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.org/10.1109/TMI.,Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
"NeuroImage Clin .4 ,3 5 –44http://www.pubmedcentral.",Non-OADS,/arxiv_data1/oa_pdf/8c/3d/main.PMC4833048.pdf
http://dx.doi.org/10.1016/j.mgene.2016.03.008 2214-5400/© 2016 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/11/01/main.PMC4833050.pdf
"12 (6), 915 –921 (http://www.ncbi.nlm.nih.gov/pubmed/9169350 (April 11, 2015)).",Non-OADS,/arxiv_data1/oa_pdf/11/01/main.PMC4833050.pdf
"15 (3), 108 –113 ( http://www.pubmedcentral.nih.gov/ articlerender.fcgi?artid=2922626&tool=pmcentrez&rendertype=abstract (May 1, 2015)).",OADS,/arxiv_data1/oa_pdf/11/01/main.PMC4833050.pdf
"164 (1), 75 –82 (http://www.ncbi.nlm.nih.gov/pubmed/21051524 (April 20, 2015)).",Non-OADS,/arxiv_data1/oa_pdf/11/01/main.PMC4833050.pdf
"Meta Gene 2, 646 –650 ( http://www.pubmedcentral.nih.",OADS,/arxiv_data1/oa_pdf/11/01/main.PMC4833050.pdf
"33 (5), 979–988 ( http://www.ncbi.nlm.nih.gov/pubmed/15358739 (May 3, 2015)).",Non-OADS,/arxiv_data1/oa_pdf/11/01/main.PMC4833050.pdf
"Na- ture 367 (6460), 284 –287 ( http://www.ncbi.nlm.nih.gov/pubmed/8161378 (April 10, 2015)).",Non-OADS,/arxiv_data1/oa_pdf/11/01/main.PMC4833050.pdf
"13 (15), 1633 –1639 ( http://www.ncbi.nlm.nih.gov/ pubmed/15175274 (October 29, 2014)).",Non-OADS,/arxiv_data1/oa_pdf/11/01/main.PMC4833050.pdf
"Diabetes 51 (7), 2294 –2300 ( http://www.ncbi.nlm.nih.",Non-OADS,/arxiv_data1/oa_pdf/11/01/main.PMC4833050.pdf
"44 (4), 831 –846 (http://www.ncbi.nlm.nih.gov/pubmed/9286287 (June 27, 2015)).",Non-OADS,/arxiv_data1/oa_pdf/11/01/main.PMC4833050.pdf
"87 (6), 2460 –2466 ( http://www.ncbi.nlm.nih.gov/pubmed/ 12050200 (April 21, 2015)).",Non-OADS,/arxiv_data1/oa_pdf/11/01/main.PMC4833050.pdf
"19 (9), 1545 –1550 ( http://www.pubmedcentral.nih.gov/articlerender.",Non-OADS,/arxiv_data1/oa_pdf/11/01/main.PMC4833050.pdf
"Haematologica 95 (5), 752 –759 ( http://www.pubmedcentral.nih.gov/articlerender.",Non-OADS,/arxiv_data1/oa_pdf/11/01/main.PMC4833050.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Meta-analysis T2DMGenePolymorphismIL-10 1.,Non-OADS,/arxiv_data1/oa_pdf/97/62/main.PMC4833051.pdf
http://dx.doi.org/10.1016/j.mgene.2016.02.006 2214-5400/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/97/62/main.PMC4833051.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/97/62/main.PMC4833051.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Gp r o t e i n β-polypeptide 3 PolymorphismOverweightObesityMeta-analysis 1.,Non-OADS,/arxiv_data1/oa_pdf/b5/83/main.PMC4833052.pdf
http://dx.doi.org/10.1016/j.mgene.2016.03.002 2214-5400/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b5/83/main.PMC4833052.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b5/83/main.PMC4833052.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Chronic kidney disease SNP analysis Combined sequence and sequence-structurebased methodsFGF23CYP24A1VDR 1.,Non-OADS,/arxiv_data1/oa_pdf/e1/e5/main.PMC4833053.pdf
http://dx.doi.org/10.1016/j.mgene.2016.03.005 2214-5400/© 2016 Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/e1/e5/main.PMC4833053.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e1/e5/main.PMC4833053.pdf
"Materials and methods Initially, the SNPs and their related sequences of FGF23, CYP24A1 and VDR genes were retrieved from the National Center for Biotechnol- ogy Information (NCBI) database of SNPs, dbSNP ( http://www.ncbi.",OADS,/arxiv_data1/oa_pdf/e1/e5/main.PMC4833053.pdf
SIFT The human nsSNP which is available in dbSNP was analyzed by sorting intolerance from tolerant ( http://sift.jcvi.org/www/SIFT_ dbSNP.html ).,OADS,/arxiv_data1/oa_pdf/e1/e5/main.PMC4833053.pdf
Oncotarget http://dx.doi.org/10.18632/oncotarget.,OADS,/arxiv_data1/oa_pdf/e1/e5/main.PMC4833053.pdf
Molecules 21. http://dx.doi.org/10.3390/molecules21010095 .,OADS,/arxiv_data1/oa_pdf/e1/e5/main.PMC4833053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Primary microcephalyWDR62 Brain evolution HomininMCPH 1.,Non-OADS,/arxiv_data1/oa_pdf/86/14/main.PMC4833054.pdf
http://dx.doi.org/10.1016/j.mgene.2016.02.005 2214-5400/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/86/14/main.PMC4833054.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/14/main.PMC4833054.pdf
Sequence acquisition The closest putative paralogs of human WDR62 are determined by paralog prediction at Ensembl 72: June 2013 ( http://www.ensembl.,OADS,/arxiv_data1/oa_pdf/86/14/main.PMC4833054.pdf
"The orthologous protein sequences of human WDR62/MAPKBP1/WDR16 were extracted from protein data- bases available at Ensembl and NCBI ( http://www.ncbi.nlm.nih.gov ) by using BLASTP and Bidirectional best hit strategy BLASTP ( Altschul et al., 1990; Pruitt et al., 2007 ).",OADS,/arxiv_data1/oa_pdf/86/14/main.PMC4833054.pdf
"The complete genomic sequencesof archaic humans, the Neanderthals and Denisovans was downloaded from Max Planck Institute for Evolutionary Anthropology website (http://www.eva.mpg.de /) in binary SAM (BAM) ﬁle format with 50× and 30× sequence coverage, respectively ( Meyer et al., 2012; Prufer et al., 2014 ).",OADS,/arxiv_data1/oa_pdf/86/14/main.PMC4833054.pdf
"These three polymorphic sites were also examined in HapMap data ( International HapMap et al., 2010 ) and CEPH Stanford HGDP data ( http://spsmart.cesga.es /).",OADS,/arxiv_data1/oa_pdf/86/14/main.PMC4833054.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Idiopathic dilated cardiomyopathyRETN geneSingle nucleotide polymorphismAssociationPakistan 1.,Non-OADS,/arxiv_data1/oa_pdf/07/5c/main.PMC4833058.pdf
http://dx.doi.org/10.1016/j.mgene.2016.03.006 2214-5400/© 2016 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/07/5c/main.PMC4833058.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/07/5c/main.PMC4833058.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/51/msv077.PMC4833065.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/0b/f0/msv079.PMC4833066.pdf
"Here, we performed a comprehensive proteome and tran- scriptome analysis and established a large data set (availableonhttp://hydra.cos.uni-hei delberg.de genome browser ,l a s t accessed April 3, 2015), which should be suited to monitorimmediate, early and late responses in the regeneration pro-cess of Hydra.",OADS,/arxiv_data1/oa_pdf/0b/f0/msv079.PMC4833066.pdf
"Transcriptome data were additionally norma l i z e da n dc e n t e r e da r o u n dz e r o with R’s ( http://www.r-project.org/index.html , last accessed April 3, 2015) scale function to account for the different read counts in the different data sets.",OADS,/arxiv_data1/oa_pdf/0b/f0/msv079.PMC4833066.pdf
"Heat map was plotted with heatmap.2 function from gplots package ( http://cran.r-project.org/web/packages/gplots/index.html , last accessed April 3, 2015).",OADS,/arxiv_data1/oa_pdf/0b/f0/msv079.PMC4833066.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/d2/msv096.PMC4833080.pdf
Supplementary Material Supplementary material and ﬁgures S1–S4 a r ea v a i l a b l ea t Molecular Biology and Evolution online ( http://www.mbe.,Non-OADS,/arxiv_data1/oa_pdf/19/d2/msv096.PMC4833080.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivaties License http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in anymedium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.DOI: 10.1179 /1573658X15Y.0000000004 Journal of Social Distress and the Homeless 2016 VOL.25 NO.1 1",Non-OADS,/arxiv_data1/oa_pdf/b4/a0/ysdh-25-001.PMC4833089.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Horan JM, Mallonee S. Injury Surveillance.",Non-OADS,/arxiv_data1/oa_pdf/75/e6/injuryprev-2015-041812.PMC4833094.pdf
2001. http://www.who.int/violence_injury_ prevention/publications/surveillance/surveillance_guidelines/en/ (accessed 8 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/75/e6/injuryprev-2015-041812.PMC4833094.pdf
http://stacks.cdc.gov/view/cdc/11940 (accessed 8 Jul 2015).,OADS,/arxiv_data1/oa_pdf/75/e6/injuryprev-2015-041812.PMC4833094.pdf
"Aarhus, Denmark: The Interaction Design Foundation, 2014. https://www.interaction-design.org/encyclopedia/data_visualization_for_human_perception.html (accessed 8 Jul 2015).",Non-OADS,/arxiv_data1/oa_pdf/75/e6/injuryprev-2015-041812.PMC4833094.pdf
Nat Methods 2013;10:687. http://www.nature.com/nmeth/journal/v10/n8/full/nmeth.2571.html (accessed 8 Jul 2015).,OADS,/arxiv_data1/oa_pdf/75/e6/injuryprev-2015-041812.PMC4833094.pdf
http://vis.pnnl.gov/pdf/RD_ Agenda_VisualAnalytics.pdf (accessed 8 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/75/e6/injuryprev-2015-041812.PMC4833094.pdf
http://kosara.net/publications/Kosara_IV_2007.html (accessed 8 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/75/e6/injuryprev-2015-041812.PMC4833094.pdf
"Tableau Software, Inc., 2007. http://www.tableau.com/sites/default/ ﬁles/ whitepapers/visual-analysis-for-everyone.pdf (accessed 30 Jul 2015).",Non-OADS,/arxiv_data1/oa_pdf/75/e6/injuryprev-2015-041812.PMC4833094.pdf
"Institute of Health Metrics and Evaluation, 2015. http://ghdx.healthdata.org/ (accessed 10 Aug 2015).",Non-OADS,/arxiv_data1/oa_pdf/75/e6/injuryprev-2015-041812.PMC4833094.pdf
2011. http://www.tableau.com/sites/default/ ﬁles/ whitepapers/ssbi-jul12 –11.pdf (accessed 30 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/75/e6/injuryprev-2015-041812.PMC4833094.pdf
"Geneva: World Health Organization, 2001. http://www.who.int/healthinfo/paper31.pdf (accessed 10 Aug 2015).",Non-OADS,/arxiv_data1/oa_pdf/75/e6/injuryprev-2015-041812.PMC4833094.pdf
"http://www.cdc.gov/injury/wisqars 18 Sims JN, Isokpehi RD, Cooper GA, et al.",OADS,/arxiv_data1/oa_pdf/75/e6/injuryprev-2015-041812.PMC4833094.pdf
Available at http://www.wma.net/en/ 30publications/10policies/b3/17c.pdf (last accessed 27 October 2015).,Non-OADS,/arxiv_data1/oa_pdf/58/98/BCP-81-246.PMC4833154.pdf
Available athttp://www.fda.gov/downloads/Drugs/Guidances/UCM204959.pdf (last accessed 27 October 2015).,Non-OADS,/arxiv_data1/oa_pdf/58/98/BCP-81-246.PMC4833154.pdf
Available at http://www.ema.europa.eu/docs/en_GB /document_library/ Scienti ﬁc_guideline/2009/09/WC500003123.pdf (last accessed 27 October 2015).,Non-OADS,/arxiv_data1/oa_pdf/58/98/BCP-81-246.PMC4833154.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3d/95/mzv123.PMC4833201.pdf
"http://www.health.gov.sk.ca/ lean-contract (16 February 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/3d/95/mzv123.PMC4833201.pdf
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE= reference&D=ovfto&NEWS=N&AN=00005110-201411000-00010.,Non-OADS,/arxiv_data1/oa_pdf/3d/95/mzv123.PMC4833201.pdf
http://onlinelibrary.wiley.com/o/cochrane/clcentral/ articles/185/CN-00917185/frame.html.,OADS,/arxiv_data1/oa_pdf/3d/95/mzv123.PMC4833201.pdf
"Rockville, MD: Agency for Healthcare Research and Quality, 2014. http://www.ahrq.gov/news/newsroom/ speech/sp120114.html (4 February 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/3d/95/mzv123.PMC4833201.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/69/92/mzw002.PMC4833203.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/09/4c/ppa-10-511.PMC4833356.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 511–521Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  511OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S9714 3Analysis of spontaneous inquiries about suspected  adverse drug reactions posted by the general  public on the electronic Japanese bulletin board  “Yahoo!",Non-OADS,/arxiv_data1/oa_pdf/09/4c/ppa-10-511.PMC4833356.pdf
"In 2012, such a patient  reporting scheme was implemented on the website of the Pharmaceuticals and Medicine correspondence: Akira Dobashi education and research institute  of information science, Tokyo  University of Pharmacy and life  sciences, 1432-1 horinouchi, hachioji,  Tokyo 192-0392, Japan Tel +81 42 676 3082 Fax +81 42 670 7067 email dobashi@toyaku.ac.j p Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Dobashi et al Running head recto: Spontaneous inquiries about suspected adverse drug reactions DOI: http://dx.doi.org/10.2147/PPA.S97143",Non-OADS,/arxiv_data1/oa_pdf/09/4c/ppa-10-511.PMC4833356.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/09/4c/ppa-10-511.PMC4833356.pdf
Available from: http://www.pmda.,Non-OADS,/arxiv_data1/oa_pdf/09/4c/ppa-10-511.PMC4833356.pdf
Available from: http://consumers.cochrane.org/ sites/consumers.cochrane.org/files/uploads/10%20May%202010%20 Report%20Direct%20Patient%20Reporting%20of%20ADRs.pdf.,OADS,/arxiv_data1/oa_pdf/09/4c/ppa-10-511.PMC4833356.pdf
Available from:  https://yellowcard.mhra.gov.uk/yellowcards/reportmediator /.,Non-OADS,/arxiv_data1/oa_pdf/09/4c/ppa-10-511.PMC4833356.pdf
Available from: https://www.lareb.,Non-OADS,/arxiv_data1/oa_pdf/09/4c/ppa-10-511.PMC4833356.pdf
Available from: https://www.accessdata.fda.gov/ scripts/ medwatch /index.cfm?action =consumer.reporting 1.,OADS,/arxiv_data1/oa_pdf/09/4c/ppa-10-511.PMC4833356.pdf
Available from: https://www.pmda.,Non-OADS,/arxiv_data1/oa_pdf/09/4c/ppa-10-511.PMC4833356.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/1a/ee/amep-7-241.PMC4833357.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/1a/ee/amep-7-241.PMC4833357.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2016:7 241–242Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.com Dove press 241 P E R S P E C T I V E Sopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S102111Improving basic life support training for medical  students Mariam Lami   Pooja Nair   Karishma Gadhvi Faculty of Medicine, Imperial College  London, London, UKAbstract:  Questions have been raised about basic life support (BLS) training in medical edu - cation.",Non-OADS,/arxiv_data1/oa_pdf/1a/ee/amep-7-241.PMC4833357.pdf
"Currently, most of the medical schools Correspondence: Mariam Lami   Department of Medicine, South  Kensington Campus, Imperial College,   Sir Alexander Fleming Building,   Exhibition Road, London SW7 2AZ, UK   Tel +44 20 7589 5111 Email mariam.lami11@imperial.ac.ukJournal name: Advances in Medical Education and Practice Article Designation: PERSPECTIVES Y ear: 2016 V olume: 7 Running head verso: Lami et al Running head recto: Improving BLS training for medical students DOI: http://dx.doi.org/10.2147/AMEP .S102111",Non-OADS,/arxiv_data1/oa_pdf/1a/ee/amep-7-241.PMC4833357.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-   reviewed, open access journal that aims to present and publish research   on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/1a/ee/amep-7-241.PMC4833357.pdf
Visit http://www.dovepress.com/testimonials.php to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/ee/amep-7-241.PMC4833357.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/48/48/ceor-8-077.PMC4833358.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/48/48/ceor-8-077.PMC4833358.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).ClinicoEconomics and Outcomes Research ClinicoEconomics and Outcomes Research 2016:8 77–85Dove press submit your manuscript | www.dovepress.co m Dove press  ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article 77 http: //dx.doi.org/10.2147/CEOR.S10160 7Productivity benefits of minimally invasive  surgery in patients with chronic sacroiliac  joint dysfunction Josh D saavoss1 lane Koenig1 Daniel J Cher2 1Kng health Consulting, llC,   Rockville, MD, 2si-BOn E, inc., san  Jose, C a, Usa Correspondence: lane Koenig   Kng health Consulting, llC,   15245 shady grove Road, suite 365,  Rockville, MD 20850, Usa   T el +1 240 403 0154   Email lane.koenig@knghealth.co mIntroduction:  Sacroiliac joint (SIJ) dysfunction is associated with a marked decrease in   quality of life.",Non-OADS,/arxiv_data1/oa_pdf/48/48/ceor-8-077.PMC4833358.pdf
Available from: http://digitalcommons.ilr.,Non-OADS,/arxiv_data1/oa_pdf/48/48/ceor-8-077.PMC4833358.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/48/48/ceor-8-077.PMC4833358.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/48/48/ceor-8-077.PMC4833358.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/55/d2/ijnrd-9-087.PMC4833359.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nephrology and Renovascular Disease 2016:9 87–94International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  87ORIg INal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJNRD.S10342 4conversion from temporary to tunneled  catheters by nephrologists: report of a single- center experience Bruno c silva camila e Rodrigues Regina cRM abdulkader Rosilene M elias Nephrology Division, hospital das  clínicas, University of são Paulo, são  Paulo, Brazil correspondence: Bruno c silva   Nephrology Division, University of são  Paulo, av.",Non-OADS,/arxiv_data1/oa_pdf/55/d2/ijnrd-9-087.PMC4833359.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/55/d2/ijnrd-9-087.PMC4833359.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/55/d2/ijnrd-9-087.PMC4833359.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f7/98/opth-10-649.PMC4833360.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 649–662Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  649Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S10070 8A medieval fallacy: the crystalline lens in the  center of the eye Christopher T Leffler1 Tamer M Hadi2 Akrithi Udupa1 Stephen G Schwartz3 Daniel Schwartz1 1Department of Ophthalmology,   virginia Commonwealth University,   Richmond, vA, 2Graduate School of  Medicine, University of T ennessee  Medical Center, Knoxville, TN,   3Bascom Palmer eye institute,   University of Miami Miller School  of Medicine, Miami, FL, USAObjective:  To determine whether, as most modern historians have written, ancient Greco-Roman  authors believed the crystalline lens is positioned in the center of the eye.",Non-OADS,/arxiv_data1/oa_pdf/f7/98/opth-10-649.PMC4833360.pdf
"Most historians  cite no specific textual passage to support the theory that ancients described the lens  as being located centrally.3–11,13–19,22–35 Some historians have attributed this view to  Galen of Pergamon (c. AD 129–199), a prominent Greek physician in the Roman  empire.15,16,18–32 In contrast, other historians report that Galen and Rufus of Ephesus  (AD 80–150), the premier anatomist of the era, positioned the lens anteriorly.1,2,6,9,12–14,36  According to this view, the lens was described as being located centrally in the works Correspondence: Christopher T Leffler Department of Ophthalmology,  virginia Commonwealth University,  401 N 11th St, Box 980209, Richmond,  vA 23298, USA Tel +1 804 828 9315 Fax +1 804 828 1010 email chrislefflermd@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Leffler et al Running head recto: Historical concept of the crystalline lens DOI: http://dx.doi.org/10.2147/OPTH.S100708",Non-OADS,/arxiv_data1/oa_pdf/f7/98/opth-10-649.PMC4833360.pdf
Available from: http://campus.udayton.,Non-OADS,/arxiv_data1/oa_pdf/f7/98/opth-10-649.PMC4833360.pdf
Avail - able from: http://www2.biusante.parisdescartes.fr/livanc/index.,Non-OADS,/arxiv_data1/oa_pdf/f7/98/opth-10-649.PMC4833360.pdf
Available from: http://deepblue.lib.umich.edu/ bitstream /handle/2027.42/95946/cgersh_1.pdf?sequence =1.,OADS,/arxiv_data1/oa_pdf/f7/98/opth-10-649.PMC4833360.pdf
"Available from:  https://archive.org/stream/sevenbooksofpaul02pauluoft#page/278/ mode/2u p. Accessed November 12, 2015.",Non-OADS,/arxiv_data1/oa_pdf/f7/98/opth-10-649.PMC4833360.pdf
Available from: http://cmg.bbaw.,Non-OADS,/arxiv_data1/oa_pdf/f7/98/opth-10-649.PMC4833360.pdf
"Available from: http://www.perseus.tufts.edu/hopper/morph?l =stefa %2Fnhn&la =greek&prior =ou)#Perseus:text:1999.04.0073:entry =stef a/nh-content s. Accessed November 12, 2015.",Non-OADS,/arxiv_data1/oa_pdf/f7/98/opth-10-649.PMC4833360.pdf
"Available from: http://biblehub.com/ greek/stephanon_4735.ht m. Accessed November 13, 2015.",Non-OADS,/arxiv_data1/oa_pdf/f7/98/opth-10-649.PMC4833360.pdf
Available  from: https://books.google.com/books?id =sTpfAAAAcAAJ&pg =P A388&lpg =PA388&dq =galen+sclerophthalmia&source =bl&ots=- TXg1hqZF_&sig =LE_1Lnxg3O2rEuh1s_bVAUse4UU&hl =en&sa= X&ved=0CCUQ6AEwAWoVChMIj5ibxPX5xgIVxI4NCh2Q1w-G# v=onepage&q =crystalline&f =false .,Non-OADS,/arxiv_data1/oa_pdf/f7/98/opth-10-649.PMC4833360.pdf
Available from: https://books.google.com/ books?id=CHA-AAAAcAAJ&q =crystalline#v =onepage&q =crystalli ne&f=false.,Non-OADS,/arxiv_data1/oa_pdf/f7/98/opth-10-649.PMC4833360.pdf
"Available from: https://archive.org/stream/acor- neliuscelsus00cels#page/404/mode/2u p. Accessed August 20, 2015.",OADS,/arxiv_data1/oa_pdf/f7/98/opth-10-649.PMC4833360.pdf
Available from: http://www.biusante.parisdescartes.fr/histoire/medica/ resultats/index.php?cote =45674x14&p =786&do=page.,Non-OADS,/arxiv_data1/oa_pdf/f7/98/opth-10-649.PMC4833360.pdf
"Available from: http://www.graeco- arabic-studies.org/single-text/text/kuehn-100/page/784.htm l. Accessed  October 26, 2015.",Non-OADS,/arxiv_data1/oa_pdf/f7/98/opth-10-649.PMC4833360.pdf
Available from: http://www.ncbi.nlm.nih.gov/ pmc/articles/PMC3066665 /.,Non-OADS,/arxiv_data1/oa_pdf/f7/98/opth-10-649.PMC4833360.pdf
"Available from: https://archive.org/details/dieaugenheilkund00avi c.  Accessed August 20, 2015.",Non-OADS,/arxiv_data1/oa_pdf/f7/98/opth-10-649.PMC4833360.pdf
Available from:  https://books.google.com/books?id =ImEsAAAAYAAJ&pg =PA40 - 3&lpg=PA403&dq =herophilus +%22center +of+the+eye%22+eye+ lens+-galen+-celsus&source =bl&ots=15Hj5jP69i&sig =qjKjorwhn Z2cZJph1GIlQnatSFA&hl =en&sa=X&ved=0CB4Q6AEwAGoVC hMI1ZDE9Kr3xgIVyryACh0r-wfc#v =onepage&q =herophilus%20 %22center%20of%20the%20eye%22%20eye%20lens%20-galen%2 - 0-celsus&f =false.,Non-OADS,/arxiv_data1/oa_pdf/f7/98/opth-10-649.PMC4833360.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/f7/98/opth-10-649.PMC4833360.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f7/98/opth-10-649.PMC4833360.pdf
Avail - able from: https://books.google.com/books?id =Ug6ywn-D9BgC&prin tsec=frontcover&source =gbs_ge_summary_r&cad =0#v=onepage&q& f=false.,Non-OADS,/arxiv_data1/oa_pdf/f7/98/opth-10-649.PMC4833360.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f5/ec/ijn-11-1461.PMC4833361.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 1461–1473International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1461OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10195 5evaluation of adipose-derived stem cells for tissue- engineered muscle repair construct-mediated repair  of a murine model of volumetric muscle loss injury Venu Kesireddy1,2 1Wake Forest Institute for  regenerative Medicine, Wake Forest  University Baptist Medical center,   Winston salem, N c, Usa; 2center  for craniofacial research, school of  Dentistry, University of T exas health  science center at houston, houston,   TX, UsaAbstract:  Volumetric muscle loss (VML) can occur from congenital defects, muscle wasting  diseases, civilian or military injuries, and as a result of surgical removal of muscle tissue  (eg, cancer), all of which can lead to irrevocable functional and cosmetic defects.",Non-OADS,/arxiv_data1/oa_pdf/f5/ec/ijn-11-1461.PMC4833361.pdf
"Keywords:  skeletal muscle regeneration, muscle-derived progenitor cells, immunomodulation,  paracrine signaling Introduction Although regeneration occurs throughout the animal kingdom, there are large disparities  in the degree of inherent regeneration capacity not only among species but also amid  tissue types.1,2 The field of regenerative medicine seeks to supplement or enable the  regenerative process across a variety of human tissues, thereby compensating for  limitations inherent in the self-repair potential of many critical organs and systems.3  Though skeletal muscle possesses a rather remarkable capacity for self-regeneration  in response to smaller injuries,4,5 disease, congenital defects, surgical side effects, and  trauma may all result in permanent defects in the appearance and, more importantly,  function of skeletal muscle.6,7 Deficits in this category, known as volumetric muscle  loss (VML),8 cannot be restored with existing therapies, including surgical repair  with flaps9 and physical therapy.8 Therefore, regenerative medicine technologies to correspondence: Venu Kesireddy center for craniofacial research,  Behavioral and Biomedical sciences  Building, school of Dentistry, University  of Texas health science center at  houston, 1941 east road, houston,  TX 77054, Usa Tel +1 713 486 2573 Fax +1 713 486 4372 email V enu.Kesireddy@uth.tmc.ed u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Kesireddy Running head recto: Evaluation of ADSCs in TEMR-mediated repair of VML injury in rodents DOI: http://dx.doi.org/10.2147/IJN.S101955",Non-OADS,/arxiv_data1/oa_pdf/f5/ec/ijn-11-1461.PMC4833361.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/f5/ec/ijn-11-1461.PMC4833361.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f5/ec/ijn-11-1461.PMC4833361.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/1f/2f/jpr-9-195.PMC4833362.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/1f/2f/jpr-9-195.PMC4833362.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Journal of Pain research 2016:9 195–205submit your manuscript | www.dovepress.co m Dove press  195 http: //dx.doi.org/10.2147/JPR.S10237 9novel method for assessing age-related  differences in the temporal summation of pain Kelly M naugle1 Yenisel cruz-almeida2,3 roger B Fillingim2,4 roland staud2,5 Joseph l riley iii2,4 1Department of Kinesiology, school  of Physical education and T ourism  Management, indiana University  –  Purdue University indianapolis,   indianapolis, in, 2Pain research and  intervention center of excellence,   University of Florida, 3Department  of aging and geriatric research,   college of Medicine, 4Department of  community Dentistry and Behavioral  science, 5Department of Medicine,   college of Medicine, University of  Florida, gainesville, Fl, Usa correspondence: Kelly M naugle   Department of Kinesiology, school  of Physical education, T ourism and  Management, indiana University – Purdue  University indianapolis, 901 West new  Y ork street, indianapolis, in 46202, Usa   T el +1 317 274 0601   Fax +1 317 278 2041   email kmnaugle@iupui.ed uAbstract:  Temporal summation (TS) of pain protocols typically involve the delivery of brief  repetitive noxious stimuli held at a constant intensity and measuring the consequent increase  in the perceived intensity of pain sensations.",Non-OADS,/arxiv_data1/oa_pdf/1f/2f/jpr-9-195.PMC4833362.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/1f/2f/jpr-9-195.PMC4833362.pdf
Visit  http://www.dovepress.com/testimonials.php to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/2f/jpr-9-195.PMC4833362.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ea/17/ndt-12-795.PMC4833363.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2016:12 795–800Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  795OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S9013 4impact of anxiety symptoms on outcomes of  depression: an observational study in asian  patients Diego Novick1 William Montgomery2 Jaume aguado3 Xiaomei Peng4 Josep Maria haro3 1eli lilly and company, Windlesham,   surrey, UK; 2eli lilly australia  Pty ltd,   West ryde, N sW, australia; 3Parc   sanitari sant Joan de Déu, ciBersaM,    Universitat de Barcelona, Barcelona,    spain; 4eli lilly and company,   indianapolis,  iN, UsaObjective:  To investigate the impact of anxiety symptoms on depression outcomes in Asian  patients with major depressive disorder (MDD) (n =714).",Non-OADS,/arxiv_data1/oa_pdf/ea/17/ndt-12-795.PMC4833363.pdf
"The presence of anxiety symptoms in individuals with major depressive disorder  (MDD) has long been proposed as an indicator of poor treatment response and a  worse prognosis.5 Findings, however, have been mixed; some studies report that  response rates in patients with anxious depression were not significantly lower than  response rates in those with nonanxious depression,6–8 while other studies found  treatment to be less effective in patients with anxious depression compared with those  with nonanxious depression.9–11 More recently, the debate was rekindled by findings  from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study,  in which patients with anxious depression were found to be less likely to respond to correspondence: Diego Novick eli lilly and company, lilly research  centre, erl Wood Manor, Windlesham,  surrey gU20 6Ph, UK Tel +44 1276 483 832 Fax +44 1276 483 192 email novick_diego@lilly.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Novick et al Running head recto: Impact of anxiety on depression outcomes DOI: http://dx.doi.org/10.2147/NDT.S90134",Non-OADS,/arxiv_data1/oa_pdf/ea/17/ndt-12-795.PMC4833363.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/ea/17/ndt-12-795.PMC4833363.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/17/ndt-12-795.PMC4833363.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/83/42/jir-9-027.PMC4833364.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/83/42/jir-9-027.PMC4833364.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Journal of Inflammation Research 2016:9 27–38Journal of Inflammation Research Dove press submit your manuscript | www.dovepress.co m Dove press  27RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JIR.S8691 7Hypoglycemic agents and potential   anti-inflammatory activity vishal Kothari1 John A Galdo2 Suresh T Mathews3 1Department of Nutrition and  Dietetics, Boshell Diabetes and  Metabolic Diseases Research  Program, Auburn University,   Auburn, 2Department of Pharmacy  Practice, 3Department of Nutrition  and Dietetics, Samford University,   Birmingham, AL, USA Correspondence: Suresh T Mathews   Department of Nutrition and Dietetics,  Samford University, 800 Lakeshore Drive,  Birmingham, AL 35229, USA   T el +1 205 726 4511   Fax +1 205 726 2666   email smathew1@samford.ed uAbstract:  Current literature shows an association of diabetes and secondary complications  with chronic inflammation.",Non-OADS,/arxiv_data1/oa_pdf/83/42/jir-9-027.PMC4833364.pdf
"Journal of Inflammation Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-inflammation-research-journa lThe Journal of Inflammation Research is an international, peer-reviewed  open-access journal that welcomes laboratory and clinical findings on the  molecular basis, cell biology and pharmacology of inflammation including  original research, reviews, symposium reports, hypothesis formation and  commentaries on: acute/chronic inflammation; mediators of inflamma -tion; cellular processes; molecular mechanisms; pharmacology and novel  anti-inflammatory drugs; clinical conditions involving inflammation.",Non-OADS,/arxiv_data1/oa_pdf/83/42/jir-9-027.PMC4833364.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/83/42/jir-9-027.PMC4833364.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/76/91/copd-11-747.PMC4833365.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 747–754International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  747OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S9696 9effect of inhaled drugs on anxiety and depression  in patients with chronic obstructive pulmonary  disease: a prospective observational study Min Kyung hyun1 na rae lee2 eun Jin Jang3 Jae-Joon Yim4 Chang-hoon lee4 1Department of Preventive Medicine,   College of Korean Medicine, Dongguk  University, gyeongju, republic of  Korea; 2national evidence-based  healthcare Collaborating agency,   seoul, republic of Korea; 3Department  of Information statistics, College of  natural science, andong national  University, andong, republic of  Korea; 4Division of Pulmonary and  Critical Care Medicine, Department  of Internal Medicine, seoul national  University College of Medicine, seoul  national University hospital, seoul,   republic of KoreaObjective:  We investigated the effect of treatment with inhaled drugs on changes in mood,  focusing on depression and anxiety during treatment in patients with newly diagnosed chronic  obstructive pulmonary disease (COPD).",Non-OADS,/arxiv_data1/oa_pdf/76/91/copd-11-747.PMC4833365.pdf
"The TORCH trial reported that treatment with this drug com - bination reduced exacerbations and improved the health status in COPD patients,2  as well as reduced the annual lung function decline rate in a post hoc analysis.3 The  UPLIFT trial showed that LAMAs also improved symptoms, exercise tolerance, and  health-related quality of life, and decreased exacerbations in COPD patients.4Correspondence: Chang-hoon lee Division of Pulmonary and Critical  Care Medicine, Department of Internal  Medicine, seoul national University  College of Medicine, seoul national  University hospital, 101 Daehak-ro,  Jongno-gu, seoul 03080, republic of  Korea Tel +82 2 2072 4743 Fax +82 2 7629 662 email kauri670@empal.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Hyun et al Running head recto: COPD treatment and HADS score DOI: http://dx.doi.org/10.2147/COPD.S96969",Non-OADS,/arxiv_data1/oa_pdf/76/91/copd-11-747.PMC4833365.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/76/91/copd-11-747.PMC4833365.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/76/91/copd-11-747.PMC4833365.pdf
Available from: http://www.goldcopd.org/ guidelines-global-strategy-for-diagnosis-management.html.,Non-OADS,/arxiv_data1/oa_pdf/76/91/copd-11-747.PMC4833365.pdf
Available from: http://www.nice.,Non-OADS,/arxiv_data1/oa_pdf/76/91/copd-11-747.PMC4833365.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1e/95/dddt-10-1379.PMC4833366.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1379–1388Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1379Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9753 0Functionalized d-form self-assembling peptide  hydrogels for bone regeneration Bin he1 Yunsheng Ou1 ao Zhou1 shuo chen1 Weikang Zhao1 Jinqiu Zhao2 hong li3 Y ong Zhu1 Zenghui Zhao1 Dianming Jiang1 1Department of Orthopedics,   2Department of infectious Diseases,   The First affiliated hospital of  chongqing Medical University,   chongqing, People’s republic of  china; 3school of Physical science  and T echnology, sichuan University,   chengdu, People’s republic of chinaAbstract:  Bone defects are very common in orthopedics, and there is great need to develop  suitable bone grafts for transplantation in vivo.",Non-OADS,/arxiv_data1/oa_pdf/1e/95/dddt-10-1379.PMC4833366.pdf
"Although bone tissues have some regenerative ability, the healing of the large bone  defects and load-bearing bone defects require bone grafts to provide mechanical  support and induce bone induction as well as conduction.4,5 It is widely accepted that  with good osteogenic, osteoinductive, and osteoconductive ability, autologous grafts  (eg, iliac crest autologous graft) remain the gold standard for bone transplantation.6  However, they have some limitations, including the limited availability, pain, donor  site morbidity, and the mismatch between harvested bone grafts as well as defect  sites.7,8 Allogeneic bone grafts (eg, demineralized bone matrix [DBM]) serve as an  alternative to repair bone defects and are limited by the suboptimal osteoactivity  when compared with autologous grafts, the risk of disease transmission, and immune  rejection.1 As to synthetic bone repair material scaffolds, they are mainly divided  into polymers, bioceramics, metal materials, bioglass, and composite materials.3,9  However, there are still some drawbacks (eg, low osteoinductivity and osteocon - ductivity, the difficulty in degradation or even nondegradation) for their application  in bone regeneration.9,10correspondence: Dianming Jiang Department of Orthopedics, The First  Affiliated Hospital of Chongqing Medical  University, number 1 Yi Xue Yuan road,  Yuzhong District, chongqing 400016,  People’s republic of china Tel +86 23 8901 1212 Fax +86 23 8901 1212 email jdm571026@vip.163.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: He et al Running head recto: d-form self-assembling peptide hydrogels for bone regeneration DOI: http://dx.doi.org/10.2147/DDDT.S97530",Non-OADS,/arxiv_data1/oa_pdf/1e/95/dddt-10-1379.PMC4833366.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/1e/95/dddt-10-1379.PMC4833366.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1e/95/dddt-10-1379.PMC4833366.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/4d/15/ceg-9-089.PMC4833367.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/4d/15/ceg-9-089.PMC4833367.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical and Experimental Gastroenterology 2016:9 89–95Clinical and Experimental Gastroenterology Dove press submit your manuscript | www.dovepress.co m Dove press  89MEthodolo Gyopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/CEG.S10121 9Automated image analysis in the study of  collagenous colitis Anne-Marie Kanstrup  Fiehn1,2 Martin Kristensson3 Ulla Engel4 lars Kristian Munck5,6 Susanne holck4 Peter Johan heiberg Engel1,6 1department of Pathology, Roskilde  hospital, Roskilde, 2department of  Pathology, Copenhagen University  hospital, Rigshospitalet, Copenhagen,   3digital Pathology, Visiopharm,   hørsholm, 4department of  Pathology, Copenhagen University  hospital, hvidovre, 5department of  Gastroenterology, Koege hospital,   Koege, 6Faculty of health and Medical  Sciences, University of Copenhagen,   Copenhagen, denmark Correspondence: Anne-Marie Kanstrup  Fiehn   department of Pathology, Copenhagen  University hospital, Rigshospitalet,  Frederik V’s Vej 11, 2100 Copenhagen,  denmark   tel +45 3070 8392   Fax +45 4635 2983   Email anne-marie.kanstrup.fiehn.01@ regionh.d kPurpose:  The aim of this study was to develop an automated image analysis software to measure  the thickness of the subepithelial collagenous band in colon biopsies with collagenous colitis  (CC) and incomplete CC (CCi).",Non-OADS,/arxiv_data1/oa_pdf/4d/15/ceg-9-089.PMC4833367.pdf
"Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-and-experimental-gastroenterology-journa lClinical and Experimental Gastroenterology is an international, peer- reviewed, open access journal, publishing all aspects of gastroenterology  in the clinic and laboratory, including: Pathology, pathophysiology  of gastrointestinal disease; Investigation and treatment of gastointes - tinal disease; Pharmacology of drugs used in the alimentary tract; Immunology/genetics/genomics related to gastrointestinal disease.",Non-OADS,/arxiv_data1/oa_pdf/4d/15/ceg-9-089.PMC4833367.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/15/ceg-9-089.PMC4833367.pdf
The full terms of this license are available at https://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/81/ec/prbm-9-061.PMC4833368.pdf
"com/terms.ph p and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/81/ec/prbm-9-061.PMC4833368.pdf
"For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Psychology Research and Behavior Management Psychology Research and Behavior Management 2016:9 61–70Dove press submit your manuscript | www.dovepress.co m Dove press  ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article 61 http: //dx.doi.org/10.2147/PRBM.S9634 5early father–daughter relationship and  demographic determinants of spousal   marital satisfaction ahmad alsheikh ali1 Fawzi shaker Daoud2 1counseling Psychology Program,   Faculty of educational sciences,   hashemite University, 2Department  of Psychology, Faculty of arts  and sciences, al-ahliyya amman  University, amman, Jordan correspondence: ahmad alsheikh ali   counseling Psychology Program, Faculty  of educational sciences, hashemite  University, PO Box 330127, Zarqa 13133,  Jordan   Tel +962 5 390 3333   Fax +962 5 382 6613   email huniv@hu.edu.j o     Fawzi shaker Daoud   al-ahliyya amman University, PO Box  211, al salt Road, amman 19328, Jordan   Tel +962 7 9668 7770   email ftaimah@gmail.co mAbstract:  This study examined several dimensions of early father–daughter relationship as  predictors of marital satisfaction among 494 respondents.",Non-OADS,/arxiv_data1/oa_pdf/81/ec/prbm-9-061.PMC4833368.pdf
"Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/psychology-research-and-behavior-management-journa lPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and  its application in behavior management to develop improved outcomes  in the clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/81/ec/prbm-9-061.PMC4833368.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/81/ec/prbm-9-061.PMC4833368.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0b/d6/cia-11-415.PMC4833369.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 415–422Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  415OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S10130 2height and sex is strongly associated with radial  augmentation index in Korean patients with  never-treated hypertension Kye Taek Ahn Kwang-In Park Mi Joo Kim Jin Kyung Oh Ji hye han hee Jin Kwon seon-Ah Jin Jun-hyung Kim Jae-hyeong Park Jae-hwan lee si Wan Choi In-Whan seong Jin-Ok Jeong Department of Internal Medicine,   Division of Cardiology, Chungnam  national University hospital,   Chungnam national University  school of Medicine, Daejeon,   republic of KoreaObjectives:  Central hemodynamics may better represent the load imposed on the coronary and  cerebral arteries and thereby bear a stronger relationship to cardiovascular outcomes.",Non-OADS,/arxiv_data1/oa_pdf/0b/d6/cia-11-415.PMC4833369.pdf
"A recent large study reported that height is inversely and inde - pendently related to central hemodynamics, including AIx.10 However, most of these  results are derived from patients with established disease (ie, hypertension, end-stage  renal disease, or coronary artery disease), and conflicting opinions that the increased Correspondence: Jin-Ok Jeong Department of Internal Medicine,  Division of Cardiology, Chungnam  national University hospital, Chungnam  national University school of Medicine,  282 Munhwa-ro, Jung-gu, Daejeon 35015,  republic of Korea Tel +82 42 280 8227 Fax +82 42 280 8238 email jojeong@cnu.ac.k r Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Ahn et al Running head recto: Association of height and sex with radial AIx in never-treated HTN patients  DOI: http://dx.doi.org/10.2147/CIA.S101302",Non-OADS,/arxiv_data1/oa_pdf/0b/d6/cia-11-415.PMC4833369.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/0b/d6/cia-11-415.PMC4833369.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/0b/d6/cia-11-415.PMC4833369.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/fa/d2/ijn-11-1475.PMC4833371.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 1475–1482International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1475OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10025 3The role of surfactants in the formulation of  elastic liposomal gels containing a synthetic opioid  analgesic sima singh1,* harsh Vardhan1,* Niranjan g Kotla2 Balaji Maddiboyina3 Dinesh sharma4 Thomas J Webster5,6 1school of Pharmaceutical sciences,   lovely Professional University,   Phagwara, India; 2center for  research in Medical Devices,   National University of Ireland,   galway, Ireland; 3Department of  Pharmaceutics, Vishwabharathi  college of Pharmaceutical sciences,   guntur, India; 4ranbaxy laboratory  ltd, gurgaon, India; 5Department of  chemical engineering, Northeastern  University, Boston, M a, Usa; 6center  of excellence for advanced Materials  research, King abdulaziz University,   Jeddah, saudi arabia *These authors contributed equally  to this workAbstract:  Transdermal drug delivery systems have made significant contributions to the medical  community, but have yet to completely substitute oral or parenteral delivery.",Non-OADS,/arxiv_data1/oa_pdf/fa/d2/ijn-11-1475.PMC4833371.pdf
"Greater flexibility of elastic liposomal correspondence: Thomas J Webster Department of chemical engineering,  Northeastern University, 360 huntington  avenue, 02115-2989, Boston, Ma, Usa Tel +1 617 373 6585 email th.webster@neu.ed u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Singh et al Running head recto: Role of surfactants in formulation of elastic liposomal gels DOI: http://dx.doi.org/10.2147/IJN.S100253",Non-OADS,/arxiv_data1/oa_pdf/fa/d2/ijn-11-1475.PMC4833371.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/fa/d2/ijn-11-1475.PMC4833371.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fa/d2/ijn-11-1475.PMC4833371.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/16/63/dddt-10-1365.PMC4833373.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1365–1377Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1365Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9553 3Per-residue energy decomposition pharmacophore  model to enhance virtual screening in drug  discovery: a study for identification of reverse  transcriptase inhibitors as potential anti-hiV agents Favourite n cele Muthusamy ramesh Mahmoud es soliman Molecular Modelling and Drug Design  research group, school of health  sciences, University of KwaZulu- natal, Durban, south africaAbstract:  A novel virtual screening approach is implemented herein, which is a further  improvement of our previously published “target-bound pharmacophore modeling approach”.",Non-OADS,/arxiv_data1/oa_pdf/16/63/dddt-10-1365.PMC4833373.pdf
"HIV -1 is the most infectious and prevalent globally.2  Worldwide statistics by the American foundation for AIDS Research reported that  sub-Saharan Africa is the most affected region, with approximately 70% of adults and  91% of children HIV positive.3  HIV -1 reverse transcriptase (RT) is currently an essential target for US Food and  Drug Administration (FDA) approved HIV -1 therapy4 and a prominent target of many  approved anti-HIV drugs that are key components of highly active antiretroviral correspondence: Mahmoud es soliman Molecular Modelling and Drug Design  research group, school of health  sciences, University of KwaZulu-natal,  Westville campus, Private Bag X54001,  Durban 4000, south africa Tel +27 031 260 7413 Fax +27 031 260 7792 email soliman@ukzn.ac.z a Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Cele et al Running head recto: Molecular modeling study on HIV RT inhibitors as anti-HIV agents DOI: http://dx.doi.org/10.2147/DDDT.S95533",Non-OADS,/arxiv_data1/oa_pdf/16/63/dddt-10-1365.PMC4833373.pdf
Available  from http://arxiv.org/ftp/arxiv/papers/1209/1209.2793.pd f.  39.,Non-OADS,/arxiv_data1/oa_pdf/16/63/dddt-10-1365.PMC4833373.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/16/63/dddt-10-1365.PMC4833373.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/16/63/dddt-10-1365.PMC4833373.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/59/00/ndt-12-787.PMC4833374.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 787–793Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  787OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10301 5suicidal behavior and self-harm in girls with eating  disorders Jiri Koutek Jana Kocourkova iva Dudova Department of child Psychiatry,   charles University second Faculty  of Medicine, University hospital  Motol, Prague, czech republicAbstract:  Comorbid psychopathology, including self-harm and suicidal behavior, is often  found in patients with eating disorders.",Non-OADS,/arxiv_data1/oa_pdf/59/00/ndt-12-787.PMC4833374.pdf
"The examination of suicidal behavior and self-harm in adolescent  patients with eating disorders is clinically relevant because they are risk factors for sui - cidal behavior in adulthood.9 Mayes et al6 reported a higher correlation between suicidal  ideation and suicidal attempt in bulimia compared to anorexia nervosa.correspondence: Jiri Koutek Department of child Psychiatry, charles  University second Faculty of Medicine,  University hospital Motol, V Uvalu 84,  15006 Prague, czech republic Tel +420 224 433 403 Fax +420 224 433 420 email jiri.koutek@lfmotol.cuni.c z Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Koutek et al Running head recto: Suicidal behavior and self-harm in eating disorders DOI: http://dx.doi.org/10.2147/NDT.S103015",Non-OADS,/arxiv_data1/oa_pdf/59/00/ndt-12-787.PMC4833374.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/59/00/ndt-12-787.PMC4833374.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/59/00/ndt-12-787.PMC4833374.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e9/a6/tcrm-12-563.PMC4833375.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 563–574Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  563Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S8114 4Patient considerations and drug selection in the  treatment of idiopathic pulmonary fibrosis Maria A Trawinska1 Ruwani D Rupesinghe1 Simon P Hart1,2 1Hull and east Y orkshire Hospitals  NHS Trust, 2Hull Y ork Medical School,   Academic Respiratory Medicine,   Castle Hill Hospital, Cottingham,   east Y orkshire, UKAbstract:  Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease of  unknown cause.",Non-OADS,/arxiv_data1/oa_pdf/e9/a6/tcrm-12-563.PMC4833375.pdf
"Data from the  Office for National Statistics included “post inflammatory fibrosis,” while data from  The Health Improvement Network database included cryptogenic fibrosing alveolitis Correspondence: Simon P Hart Hull York Medical School, Academic  Respiratory Medicine, Castle Hill  Hospital, Castle Road, Cottingham,  east Yorkshire HU16 5JQ, UK Tel +44 1482 624 067 email s.hart@hull.ac.u k Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Trawinska et al Running head recto: Treatment of IPF DOI: http://dx.doi.org/10.2147/TCRM.S81144",Non-OADS,/arxiv_data1/oa_pdf/e9/a6/tcrm-12-563.PMC4833375.pdf
"Available from: http://www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements /ucm418991.ht m. Accessed December 16,  2015.",Non-OADS,/arxiv_data1/oa_pdf/e9/a6/tcrm-12-563.PMC4833375.pdf
"Available from: http://www.fda.gov/NewsEvents/Newsroom/Press  Announcements/ucm418994.ht m. Accessed December 16, 2015.",Non-OADS,/arxiv_data1/oa_pdf/e9/a6/tcrm-12-563.PMC4833375.pdf
"Available from: https://www.scottishmedicines.org.uk/ SMC_Advice/Advice/1076_15_nintedanib_Ofev/nintedanib_Ofe v.  Accessed December 16, 2015.",Non-OADS,/arxiv_data1/oa_pdf/e9/a6/tcrm-12-563.PMC4833375.pdf
Available from: http://www.england.nhs.uk/ourwork/pe/sdm/tools- sdm/pda /.,Non-OADS,/arxiv_data1/oa_pdf/e9/a6/tcrm-12-563.PMC4833375.pdf
Available  from: http://patient.info/forums/discuss/browse/pulmonary-fibrosis- 1760.,Non-OADS,/arxiv_data1/oa_pdf/e9/a6/tcrm-12-563.PMC4833375.pdf
Available from: http://www.nice.org.uk/guidance/qs7 9.,Non-OADS,/arxiv_data1/oa_pdf/e9/a6/tcrm-12-563.PMC4833375.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/e9/a6/tcrm-12-563.PMC4833375.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e9/a6/tcrm-12-563.PMC4833375.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a7/6c/dddt-10-1389.PMC4833376.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1389–1397Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1389Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9498 3andrographolide inhibits growth of human T -cell  acute lymphoblastic leukemia Jurkat cells by  downregulation of Pi3K/aKT and upregulation of  p38 MaPK pathways Tingfang Yang1 shuluan Yao2 Xianfeng Zhang3 Yan guo2 1Department of Pediatrics, Jining  no 1 People’s hospital, shandong  Province, People’s republic of china;   2Department of respiratory Medicine,   Jining Medical University affiliated  hospital, shandong Province, People’s  republic of china; 3Department of  Psychiatry, Jining Psychiatric hospital,   shandong Province, People’s republic  of chinaAbstract:  T-cell acute lymphoblastic leukemia (T-ALL) as a prevalent hematologic malignancy  is one of the most common malignant tumors worldwide in children.",Non-OADS,/arxiv_data1/oa_pdf/a7/6c/dddt-10-1389.PMC4833376.pdf
"AKT phosphorylation subsequently activates mammalian target of  rapamycin and downstream molecules, such as 70 kd S6 protein kinases (P70S6K) and correspondence: Tingfang Yang Department of Pediatrics, Jining no 1  People’s hospital, 6 Jiankang road, Jining  city, shandong Province 272011, People’s  republic of china Tel +86 537 225 3104 email ytfang88@ 126.co mJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Y ang et al Running head recto: Andrographolide inhibits growth of human T-cell acute lymphoblastic leukemia DOI: http://dx.doi.org/10.2147/DDDT.S94983",Non-OADS,/arxiv_data1/oa_pdf/a7/6c/dddt-10-1389.PMC4833376.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/a7/6c/dddt-10-1389.PMC4833376.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a7/6c/dddt-10-1389.PMC4833376.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1c/ef/ijwh-8-093.PMC4833377.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2016:8 93–102International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  93OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S9872 2sociocultural determinants of home delivery in  ethiopia: a qualitative study Mirgissa Kaba1 T esfaye Bulto2 Zergu Tafesse2 Wassie lingerh2 Ismael ali2 1Department of Preventive Medicine,   school of Public Health, addis ababa  University, 2Integrated Family Health  Program, John snow, Inc., addis ababa,   ethiopiaBackground:  Maternal health remains a major public health problem in Ethiopia.",Non-OADS,/arxiv_data1/oa_pdf/1c/ef/ijwh-8-093.PMC4833377.pdf
"Keywords:  maternal health service, utilization of maternal health, antenatal care, cultural  determinants Introduction Pregnancy and childbirth is a mark of identity and determines a women’s status in a  family and community.1 In addition, pregnancy and childbirth represents life transition  that affects the identity of a woman and the relationship between communities and  continuity of life.2 Such an important life event, however, is associated with suffering,  morbidity, and death of the mother and causes family disruption.3–5 Early diagnosis,  professional follow-up during pregnancy, and skilled assistance during labor and deliv - ery are important measures to lower maternal and newborn mortality and morbidity.5,6  Globally, uninterrupted measures have been taken over the years, including the global correspondence: Mirgissa Kaba Department of Preventive Medicine,  school of Public Health, addis ababa  University, PO Box 9086, addis ababa,  ethiopia email mirgissk@yahoo.co m Journal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2016 Volume: 8 Running head verso: Kaba et al Running head recto: Sociocultural determinants of home delivery in Ethiopia DOI: http://dx.doi.org/10.2147/IJWH.S98722",Non-OADS,/arxiv_data1/oa_pdf/1c/ef/ijwh-8-093.PMC4833377.pdf
Available from:  http://www.psypress.com/the-maternal-lineage-978041568164 3 3.,Non-OADS,/arxiv_data1/oa_pdf/1c/ef/ijwh-8-093.PMC4833377.pdf
Available from: http://www.biomedcentral.com/1471- 2393/13/ 5  24.,Non-OADS,/arxiv_data1/oa_pdf/1c/ef/ijwh-8-093.PMC4833377.pdf
Available from: http://www.biomedcentral.com/1471-2393/14/16 1,Non-OADS,/arxiv_data1/oa_pdf/1c/ef/ijwh-8-093.PMC4833377.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/1c/ef/ijwh-8-093.PMC4833377.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1c/ef/ijwh-8-093.PMC4833377.pdf
Avail - able from: http://dx.doi.org/10.1155/2015/49318 4  27.,Non-OADS,/arxiv_data1/oa_pdf/1c/ef/ijwh-8-093.PMC4833377.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p and  incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/28/cd/jpr-9-207.PMC4833378.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Journal of Pain Research 2016:9 207–213submit your manuscript | www.dovepress.co m Dove press  207 http: //dx.doi.org/10.2147/JPR.S10277 8Validation of the hanyang Pain Scale for clerical  workers with musculoskeletal pain Ki young oh department of Physical Medicine  and Rehabilitation, Soonchunhyang  University Cheonan hospital,   Cheonan, Republic of Korea Correspondence: Ki young oh   department of Physical Medicine and  Rehabilitation, Soonchunhyang University  Cheonan hospital, Bongmyeong- dong, dongnam-gu, Cheonan,  Chungcheongnam-do 330-721, Republic  of Korea   tel +82 41 570 3884   Fax +82 41 570 2776   email okokykkh@schmc.ac.k rPurpose:  The visual analog scale (V AS) is the most widely used scale for pain assessment.",Non-OADS,/arxiv_data1/oa_pdf/28/cd/jpr-9-207.PMC4833378.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/28/cd/jpr-9-207.PMC4833378.pdf
Visit  http://www.dovepress.com/testimonials.php to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/28/cd/jpr-9-207.PMC4833378.pdf
Avail - able from: http://www.iasp-pain.org/Taxonomy /.,Non-OADS,/arxiv_data1/oa_pdf/28/cd/jpr-9-207.PMC4833378.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/bd/7a/ijn-11-1483.PMC4833379.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 1483–1500International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1483OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9744 5Electrospun silk fibroin/poly(lactide-co- ε- caprolactone) nanofibrous scaffolds for bone  regeneration Zi Wang1,* Ming lin1,* Qing Xie1 hao sun1 Yazhuo huang1 DanDan Zhang1 Zhang Yu1 Xiaoping Bi1 Junzhao chen1 Jing Wang2 Wodong shi1 Ping gu1 Xianqun Fan1 1Department of Ophthalmology,   Ninth People’s hospital, shanghai  Jiao Tong University School of  Medicine, 2Biomaterials and Tissue  Engineering Laboratory, College of  Chemistry & Chemical Engineering  and Biotechnology, Donghua  University, Shanghai, People’s Republic  of china *These authors contributed equally  to this workBackground:  Tissue engineering has become a promising therapeutic approach for bone  regeneration.",Non-OADS,/arxiv_data1/oa_pdf/bd/7a/ijn-11-1483.PMC4833379.pdf
"639, shanghai 200011, People’s  Republic of China Tel +86 21 2327 1699*5587 Fax +86 21 6313 7148 email guping2009@hotmail.com;   fanxq@sh163.netJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Wang et al Running head recto: Nanofibrous scaffolds for bone regeneration DOI: http://dx.doi.org/10.2147/IJN.S97445",Non-OADS,/arxiv_data1/oa_pdf/bd/7a/ijn-11-1483.PMC4833379.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/bd/7a/ijn-11-1483.PMC4833379.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bd/7a/ijn-11-1483.PMC4833379.pdf
"This is an Open Access article distributed under th e terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f6/7a/dsv038.PMC4833416.pdf
"Anchoring of unassigned scaffolds Unmapped reads of ‘Perennial ’,‘Dempsey ’, and 120 RILs were aligned to ‘CM334 ’unassigned scaffolds v.1.55 (http://peppergenome.snu.ac.kr/, accessed 7 December 2015).",Non-OADS,/arxiv_data1/oa_pdf/f6/7a/dsv038.PMC4833416.pdf
http://statgen.ncsu.edu/qtlcart/WQTLCart.htm.,OADS,/arxiv_data1/oa_pdf/f6/7a/dsv038.PMC4833416.pdf
"This is an Open Access article distributed under th e terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8f/41/dsv039.PMC4833417.pdf
"To improve the overall performance of the implementation, several advanced tools for high-performance pro ﬁling were used during the development (in particular, Paraver http://www.bsc.es/computer- sciences/performance-tools/parav er and Extrae http://www.bsc.es/ computer-sciences/extrae).",Non-OADS,/arxiv_data1/oa_pdf/8f/41/dsv039.PMC4833417.pdf
"Paired and unpaired RNA-seq simulated datasets comparison We have used two popular programs for the simulations of paired and unpaired reads from the human transcriptome: BEERS (http://www.cbil.upenn.edu/BEERS/), a simulator speci ﬁcally devised to produce mRNA populations 17and also the popular dwgsim 0.1.8 from SAM- tools (http://sourceforge.net/apps /mediawiki/dnaa/index.php?title= Whole_Genome_Simulation).",OADS,/arxiv_data1/oa_pdf/8f/41/dsv039.PMC4833417.pdf
All the FastQ ﬁle generated in the simulations and the BAM ﬁles generated in the benchmarking are available at: http://bioinfo.cipf.es/publications/supplementary_material.,OADS,/arxiv_data1/oa_pdf/8f/41/dsv039.PMC4833417.pdf
"Real RNA-seq datasets comparison To test short- and long-read alignment with real data, two differentdatasets from Sequence Read Archive (SRA) were used, and the ﬁrst dataset tested was SRR364003 (http://www.ncbi.nlm.nih.gov/sra?term=SRR364003) sequenced with Illumina HiSeq 2000 platformand contained 81.6 million single and paired-end short reads of100 nt length; the second dataset was built by combining the two runs of SRX025091 (http://www.ncbi.nlm.nih.gov/sra?term=SRX025091) sequenced using the Roche 454 GS FLX platform; in total, a datasetof 1.26 million of single-end reads of about sequences, 600 nt long,was obtained.",OADS,/arxiv_data1/oa_pdf/8f/41/dsv039.PMC4833417.pdf
Documentation and software areavailable at: https://github.com/opencb/hpg-aligner/wiki.,OADS,/arxiv_data1/oa_pdf/8f/41/dsv039.PMC4833417.pdf
This work has been carriedout in the context of the HPC4G initiative (http://www.hpc4g.org)and the Bull-CIPF Chair for Computational Genomics.,Non-OADS,/arxiv_data1/oa_pdf/8f/41/dsv039.PMC4833417.pdf
"This is an Open Access article distributed under th e terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/88/77/dsv040.PMC4833418.pdf
"sanger.ac.uk/family/MYB#tabview=tab0) and the cDNA sequences ofR2R3-MYB genes of Arabidopsis were used to search the B. napus ESTs in the NCBI dbEST (http://www.ncbi.nlm.nih.gov/dbEST/index.html, release 01012013), with an e-value cut-off lower than 10 −4.",OADS,/arxiv_data1/oa_pdf/88/77/dsv040.PMC4833418.pdf
"Phylogenetic tree reconstruction and bioinformatic analysis The MYB genes of representative species were identi ﬁed using a previ- ously constructed domain alignment (from the Pfam database version27.0) to query the proteome of representative species in Phytozome(http://www.phytozome.com/, v9.0).",OADS,/arxiv_data1/oa_pdf/88/77/dsv040.PMC4833418.pdf
Motif analysis of BnaMYBs was determined by using Pro-site program (http://prosite.expasy.org/prosite.html) and SMART tool(http://smart.embl-heidelberg.de).,OADS,/arxiv_data1/oa_pdf/88/77/dsv040.PMC4833418.pdf
The respective domains of MYBproteins were aligned using ClutsalX1.83 and illustrated by Boxshade(http://www.ch.embnet.org/software/BOX_form.html).,OADS,/arxiv_data1/oa_pdf/88/77/dsv040.PMC4833418.pdf
The putativeorthologue of each BnaMYB was identi ﬁed by the InParanoid server v. 8.0 (http://inparanoid.sbc.su.se/cgi-bin/blast_search.cgi).,OADS,/arxiv_data1/oa_pdf/88/77/dsv040.PMC4833418.pdf
Promoter cloning and dual luciferase assay Young leaves of N. benthamiana or canola seedlings were harvested for DNA isolation through the 2% CTAB method.14Primers for amp- liﬁcation of promoter regions were designed through a BLAST search against the SOL Genomics Network database (http://solgenomics.net/tools/blast) based on orthologous published sequences of Nicotiana tabacum and/or Arabidopsis .Promoter regions of canola genes were retrieved from B. napus database (http://www.genoscope.cns.fr/ brassicanapus/).,OADS,/arxiv_data1/oa_pdf/88/77/dsv040.PMC4833418.pdf
"In addition, the 3 ′ region of R2 in canola R2R3-MYBs contains a highly conservedLRPD motif, which was also observed in R2R3-MYBs from Populus trichocarpa 21and sugar beet.19 To infer the evolutionary relationship of canola R2R3-MYBs to those of other representative crops and model plants and trace the ori-gin and expansion of R2R3-MYB genes, we searched putative MYBgenes in representative, lower species using Pfam seed sequences inPhytozome (http://www.phytozome.net).",Non-OADS,/arxiv_data1/oa_pdf/88/77/dsv040.PMC4833418.pdf
bNumbers of ESTs identi ﬁed from the dbEST database (http://www.ncbi.nlm.nih.gov/dbEST/index.html).,OADS,/arxiv_data1/oa_pdf/88/77/dsv040.PMC4833418.pdf
"cDetected by InParanoid, http://inparanoid.sbc.su.se/cgi-bin/index.cgi.",OADS,/arxiv_data1/oa_pdf/88/77/dsv040.PMC4833418.pdf
Introduction `The genus Quercus is a major forest tree genus with 300 –600 spe- cies spread throughout the world (http://www.mobot.org/MOBOT/research/APweb/orders/fagale sweb.htm#Fagales).,Non-OADS,/arxiv_data1/oa_pdf/01/56/dsw001.PMC4833419.pdf
"This is an Open Access article distributed under th e terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/01/56/dsw001.PMC4833419.pdf
"Composite map construction We constructed a composite map from the eight parental maps, withthe LPmerge software developed by Endelman and Plomion, 34which is available as an R package https://cran.r-project.org/web/packages/LPmerge/index.html.",OADS,/arxiv_data1/oa_pdf/01/56/dsw001.PMC4833419.pdf
"For assessment of the goodness-of- ﬁt for the composite map, LPmerge computes a root-mean-squareerror (RMSE) per LG by comparing the position (in cM) of all markerson the composite map with that on the component maps (http://w3.pierroton.inra.fr/cgi-bin/cmap/viewer?ref_map_set_acc=51&ref_map_accs=-1).",OADS,/arxiv_data1/oa_pdf/01/56/dsw001.PMC4833419.pdf
Web portal Quercus portal: https://w3.pierroton.inra.fr/QuercusPortal/ CMap Comparative Map Viewer for the composite LGs: http://w3.pierroton.inra.fr/cgi-bin/cmap/viewer?,Non-OADS,/arxiv_data1/oa_pdf/01/56/dsw001.PMC4833419.pdf
ref_map_set_acc=51&ref_map_accs=-1 CMap Comparative Map Viewer for different parental LGs:http://w3.pierroton.inra.fr/cgi-bin/ cmap/map_details?ref_map_set_acc=47; ref_map_accs=1251;comparative_maps=1%3dmap_acc%3d1287;highlight= %22s_1BHPHQ_1326%22122 Multipedigree high-density genetic map in oak,Non-OADS,/arxiv_data1/oa_pdf/01/56/dsw001.PMC4833419.pdf
"This is an Open Access article distributed under th e terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e1/92/dsw002.PMC4833420.pdf
Metagenomic reads from DK 2and ES2populations were downloaded from http://public.genomics.org.cn.,OADS,/arxiv_data1/oa_pdf/e1/92/dsw002.PMC4833420.pdf
Filter-passedreads from the US 4population were downloaded from the HMP DACC (http://www.hmpdacc.org).,OADS,/arxiv_data1/oa_pdf/e1/92/dsw002.PMC4833420.pdf
"The dietary intake information of the 12 countries was collectedfrom the Food and Agriculture Organization Corporate Statistical(FAOSTAT) database (http://faostat3.fao.org/home/, as of June 2015).Details on the food data have been described in the Supplementary Text.",OADS,/arxiv_data1/oa_pdf/e1/92/dsw002.PMC4833420.pdf
"Generation of a JPGM and integrated gene catalog merged reference gene set of human gut microbiomes The integrated gene catalog (IGC),19which was constructed from metagenomic data of >1,000 gut microbiomes from DK, ES, US,and CN were downloaded from http://meta.genomics.cn/metagene/ meta/home.",OADS,/arxiv_data1/oa_pdf/e1/92/dsw002.PMC4833420.pdf
http://www.who.int/gho/ncd/risk_factors/ overweight/en/ and Life expectancy http://apps.who.int/gho/data/node.,OADS,/arxiv_data1/oa_pdf/e1/92/dsw002.PMC4833420.pdf
"This is an Open Access article distributed under th e terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b2/28/dsw003.PMC4833421.pdf
"This is an Open Access article distributed under th e terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/44/52/dsw005.PMC4833423.pdf
Correlogram analyses Correlograms were plotted for the binned data using ‘corrgram ’ R-package (http://cran.r-project.org/web/packages/corrgram/index.html).,OADS,/arxiv_data1/oa_pdf/44/52/dsw005.PMC4833423.pdf
"Accordingly, equation (2) can be rewritten as Y¼TBQ TþðHQTþFÞ which de ﬁnes the ﬁnal PLS regression model, Y¼TCTþF/C3 where CT=BQTandF*=HQT+F ‘PLS ’R-package was used for this (http://cran.r-project.org/web/ packages/pls/index.html).",OADS,/arxiv_data1/oa_pdf/44/52/dsw005.PMC4833423.pdf
"This is an Open Access article distributed under th e terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/49/f7/dsw006.PMC4833424.pdf
"51598 (http://www.broadinstitute.org/software/discovar/blog/) and FERMI, v1.1.",OADS,/arxiv_data1/oa_pdf/49/f7/dsw006.PMC4833424.pdf
"Then, repetitive sequences were detected and masked by RepeatMasker(http://www.repeatmasker.org) against known repetitive sequences inRepbase (http://www.girinst.org/repbase/) and novel repetitive sequencesfound in the ﬁrst step.",OADS,/arxiv_data1/oa_pdf/49/f7/dsw006.PMC4833424.pdf
3.031 with a Rfam 11.0 (http://rfam.xfam.org) database.,OADS,/arxiv_data1/oa_pdf/49/f7/dsw006.PMC4833424.pdf
"Genomic protein-coding genes of ‘Nagirizaki ’,‘Wakaba ’, and ‘Zanpa ’were predicted using a MAKER pipeline 32as follows: Repetitive sequences were de- tected and masked using a combination of RepeatModeller (http://www.repeatmasker.org/RepeatModeler.html), RECON, 33Repeat- Masker (http://www.repeatmasker.org) and RepeatRunner (https://github.com/Yandell-Lab/RepeatRunner).",OADS,/arxiv_data1/oa_pdf/49/f7/dsw006.PMC4833424.pdf
The training set for ‘Nagir- izaki ’was built using BRAKER1 (http://exon.gatech.edu/genemark/ braker1.html) with the RNA-Seq data.,OADS,/arxiv_data1/oa_pdf/49/f7/dsw006.PMC4833424.pdf
"For assumption of the functions of the predicted protein-coding genes, database searches were carried out against the NCBI ’s non- redundant (nr) protein database (http://www.ncbi.nlm.nih.gov) andthe protein sequences of Arabidopsis thaliana (TAIR10) (https ://www.arabidopsis.org), O. sativa (RAP-DB) (http://rapdb.dna.affrc.",OADS,/arxiv_data1/oa_pdf/49/f7/dsw006.PMC4833424.pdf
"go.jp), S. bicolor ,B. distachyon ,Setaria italica ,Triticum aestivum, Zea mays (Phytozome, v10) (http://phytozome.jgi.doe.gov), and Hor- deum vulgare (Ensembl Plants) (http://plants.ensembl.org).",Non-OADS,/arxiv_data1/oa_pdf/49/f7/dsw006.PMC4833424.pdf
Domain searches were performed usingInterProScan 40against the InterPro (http://www.ebi.ac.uk/interpro/) database with an E-value cut-off of 1.0.,OADS,/arxiv_data1/oa_pdf/49/f7/dsw006.PMC4833424.pdf
Synteny plots were made using a perl scriptand the gnuplot program (http://www.gnuplot.info).,OADS,/arxiv_data1/oa_pdf/49/f7/dsw006.PMC4833424.pdf
The entire results from the mapping ofthe metabolic pathways are available on the ‘Zoysia Genome Data- base ’at http://zoysia.kazusa.or.jp.,OADS,/arxiv_data1/oa_pdf/49/f7/dsw006.PMC4833424.pdf
"Concordance Between BeamF3 and MRI-neuronavigated Target  Sites for Repetitive Transcranial Magnetic Stimulation of the Left  Dorsolateral Prefrontal Cortex Arsalan Mir-Moghtadaeia, Ruth Caballerob,e, Peter Friedb, Michael D. Foxb,c,d, Katherine  Leea, Peter Giacobbeg,i, Zafiris J. Daskalakisf,g,h, Daniel M. Blumbergerf,g,h, and Jonathan  Downarf,g,i,* aFaculty of Arts and Sciences, University of Toronto, Canada bBerenson-Allen Center for Noninvasive Brain Stimulation, Department of Neurology, Beth Israel  Deaconess Medical Center, Harvard Medical School, Boston, MA, USA cDepartment of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston,  MA, USA dAthinoula A. Martinos Center for Biomedical Imaging, Harvard Medical School, Boston, MA, USA eBioengineering and Telemedicine Centre, ETSI Telecomunicación, Universidad Politécnica de  Madrid, Spain fInstitute of Medical Science, University of Toronto, Canada gDepartment of Psychiatry, University of Toronto, Canada This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/85/9e/nihms775955.PMC4833442.pdf
http://dx.doi.org/10.1016/j.brs.,OADS,/arxiv_data1/oa_pdf/85/9e/nihms775955.PMC4833442.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier .com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2014.11.038 2225-4110/Copyright ©2014, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/87/97/main.PMC4833457.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier .com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2015.01.003 2225-4110/Copyright ©2015, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/48/3c/main.PMC4833458.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Traditional and Complementary Medicine 6 (2016) 168 e171,Non-OADS,/arxiv_data1/oa_pdf/48/3c/main.PMC4833458.pdf
Available from: http://www.carstens-stiftung.de/core-hom/index.,OADS,/arxiv_data1/oa_pdf/48/3c/main.PMC4833458.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier .com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2014.11.037 2225-4110/Copyright ©2014, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/11/10/main.PMC4833459.pdf
2010:5. http://dx.doi.org/10.3402/ljm.v5i0.4637 .,OADS,/arxiv_data1/oa_pdf/11/10/main.PMC4833459.pdf
2008;8:27. http://dx.doi.org/10.1186/1472-6882-8-27 .,Non-OADS,/arxiv_data1/oa_pdf/11/10/main.PMC4833459.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier .com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2014.12.004 2225-4110/Copyright ©2015, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/95/39/main.PMC4833460.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier .com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2015.01.002 2225-4110/Copyright ©2015, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/56/5e/main.PMC4833461.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Traditional and Complementary Medicine 6 (2016) 193 e197,Non-OADS,/arxiv_data1/oa_pdf/56/5e/main.PMC4833461.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier .com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2014.11.039 2225-4110/Copyright ©2014, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/7c/bc/main.PMC4833462.pdf
2014. http://dx.doi.org/10.1007/s11655-014- 1742-5 .,Non-OADS,/arxiv_data1/oa_pdf/7c/bc/main.PMC4833462.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier .com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2014.12.002 2225-4110/Copyright ©2014, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/92/2e/main.PMC4833463.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier .com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2014.12.005 2225-4110/Copyright ©2014, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/6c/cf/main.PMC4833464.pdf
Gao D. Antioxidant Therapies for Hypolipidemia and Hyperglycemia ; 2012 [Accessed 09.06.14] http://dx.doi.org/10.5772/47432 .,Non-OADS,/arxiv_data1/oa_pdf/6c/cf/main.PMC4833464.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier .com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2015.01.004 2225-4110/Copyright ©2015, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/21/f2/main.PMC4833466.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Traditional and Complementary Medicine 6 (2016) 140 e145,Non-OADS,/arxiv_data1/oa_pdf/21/f2/main.PMC4833466.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier .com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2014.11.034 2225-4110/Copyright ©2014, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/be/99/main.PMC4833467.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a3/7c/main.PMC4833469.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/).Photoacoustics  4  (2016)  36–42 Contents  lists  available  at  ScienceDirect Photoacoustics journal  homepage:  www.else  vie  r.com/locate  /pacs,Non-OADS,/arxiv_data1/oa_pdf/a3/7c/main.PMC4833469.pdf
"Quate,  A  scanning  acoustic  microscope,  IEEE  Ultrasonics Symposium  (1973)  18–21,  doi:http://dx.doi.org/10.1109/ULTSYM.1973.196138 .",Non-OADS,/arxiv_data1/oa_pdf/a3/7c/main.PMC4833469.pdf
Available by  subscription only from http://www.redbook.,Non-OADS,/arxiv_data1/oa_pdf/56/cf/97.PMC4833480.pdf
Available from  https://www.toujeo.com.,Non-OADS,/arxiv_data1/oa_pdf/12/2e/86.PMC4833483.pdf
More  information about these measures  can be found on the NQF’s website  (http://www.qualityforum.org).,Non-OADS,/arxiv_data1/oa_pdf/0e/4e/105.PMC4833484.pdf
Available from  https://www.ama-assn.org/ssl3/ecomm/ PolicyFinderForm.pl?site=www.ama-assn.,Non-OADS,/arxiv_data1/oa_pdf/c1/dd/115.PMC4833485.pdf
Available at: https://clinicaltrials.gov/ct2/show/NCT02022579?term=6702&rank=2 [accessed Feb 15 2016].,Non-OADS,/arxiv_data1/oa_pdf/2c/98/NBM-29-631.PMC4833667.pdf
"1574 Biophysical Journal 110, 1574–1581, April 12, 2016http://dx.doi.org/10.1016/j.bpj.2016.02.035 /C2112016 Biophysical Society This is an open access article under the CC BY-NC-ND license ( http:// creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/aa/38/main.PMC4833779.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/71/6e/12325_2016_Article_295.PMC4833794.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit tothe original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/3b/f5/12325_2016_Article_299.PMC4833795.pdf
2008. http://www.who.int/gho/ publications/world_health_statistics/EN_WHS08_Full.pdf .,Non-OADS,/arxiv_data1/oa_pdf/3b/f5/12325_2016_Article_299.PMC4833795.pdf
https://www.nhlbi.nih.,Non-OADS,/arxiv_data1/oa_pdf/3b/f5/12325_2016_Article_299.PMC4833795.pdf
http://www.nicedsu.org.uk/ TSD2%20General%20meta%20analysis%20corrected % 2015April2014.pdf .,Non-OADS,/arxiv_data1/oa_pdf/3b/f5/12325_2016_Article_299.PMC4833795.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/62/fc/12325_2016_Article_297.PMC4833797.pdf
http://www.aao.org .,Non-OADS,/arxiv_data1/oa_pdf/62/fc/12325_2016_Article_297.PMC4833797.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/79/4c/40265_2016_Article_564.PMC4833799.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/bb/51/12325_2016_Article_301.PMC4833801.pdf
Available from: http://www.ema.europa.eu/docs/en_ GB/document_library/EPAR_-_Scientiﬁc_Discussion/ human/000607/WC500043692.pdf .,Non-OADS,/arxiv_data1/oa_pdf/bb/51/12325_2016_Article_301.PMC4833801.pdf
Available from: http://www.ema.europa.eu/docs/en_ GB/document_library/EPAR_-_Product_Information/ human/000607/WC500043695.pdf .,Non-OADS,/arxiv_data1/oa_pdf/bb/51/12325_2016_Article_301.PMC4833801.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/ce/05/12325_2016_Article_298.PMC4833802.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/95/1c/12325_2016_Article_291.PMC4833807.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/38/2a/main.PMC4833828.pdf
E-mail  address:  tnebreda@gmail.com  (T.  Nebreda).Contents  lists  available  at  ScienceDirect IDCases jo  u  rn  al  ho  m  epag  e:  ww  w.els  evier  .c  om  /lo  cat  e/idc  r http://dx.doi.org/10.1016/j.idcr.2016.02.0102214-2509/ /C223 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/38/2a/main.PMC4833828.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/38/2a/main.PMC4833828.pdf
The  M.  caprae  isolate corresponded  to  spoligotype  SIT646  in  the  international  SITVIT database  and  SB0416  in  the  Mycobacterium  bovis  spoligotype database  (http://www.Mbovis.org ).,OADS,/arxiv_data1/oa_pdf/38/2a/main.PMC4833828.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8c/dc/main.PMC4833829.pdf
E-mail  address:  libia.zeze@insa.min-saude.pt  (L.  Ze´-Ze´).Contents  lists  available  at  ScienceDirect IDCases jo  u  rn  al  ho  m  epag  e:  ww  w.els  evier  .c  om  /lo  cat  e/idc  r http://dx.doi.org/10.1016/j.idcr.2016.03.004 2214-2509/ /C223  2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/8c/dc/main.PMC4833829.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8c/dc/main.PMC4833829.pdf
http://dx.doi.org/10.1371/jour- nal.pntd.0001477 .,Non-OADS,/arxiv_data1/oa_pdf/8c/dc/main.PMC4833829.pdf
http://dx.doi.org/10.1371/journal.pntd.0002636 .,Non-OADS,/arxiv_data1/oa_pdf/8c/dc/main.PMC4833829.pdf
http://dx.doi.org/ 10.3201/eid1408.080287 .,Non-OADS,/arxiv_data1/oa_pdf/8c/dc/main.PMC4833829.pdf
http://dx.doi.org/10.1056/NEJMoa0805715 .,OADS,/arxiv_data1/oa_pdf/8c/dc/main.PMC4833829.pdf
http://dx.doi.org/10.2807/ 1560-7917.ES2014.19.9.20720 .,Non-OADS,/arxiv_data1/oa_pdf/8c/dc/main.PMC4833829.pdf
http://dx.doi.org/10.1016/j.medmal.2014.04.008 .,OADS,/arxiv_data1/oa_pdf/8c/dc/main.PMC4833829.pdf
"Washington:  World  Health  Organization;  2015, http://www.paho.org/hq/index.ph p?option=com_docman&task=doc_ download&Itemid=&gid=32405&lang=en  [accessed  22.12.16].",Non-OADS,/arxiv_data1/oa_pdf/8c/dc/main.PMC4833829.pdf
N  Eng  J  Med  2016.  http://dx.doi.org/ 10.1056/NEJMp1602708 .,OADS,/arxiv_data1/oa_pdf/8c/dc/main.PMC4833829.pdf
http://dx.doi.org/10.1016/S0140-6736(16)00320-2 .,OADS,/arxiv_data1/oa_pdf/8c/dc/main.PMC4833829.pdf
Virol  J  2013;10(1):311.  http://dx.doi.org/10.1186/1743-422X-10-311 .,Non-OADS,/arxiv_data1/oa_pdf/8c/dc/main.PMC4833829.pdf
http://dx.doi.org/10.1016/ S0140-6736(16)00320-2 .,OADS,/arxiv_data1/oa_pdf/8c/dc/main.PMC4833829.pdf
Mol  Biol  Evol  2013;30(12):2725– 9.  http://dx.doi.org/10.1093/molbev/mst197 .,Non-OADS,/arxiv_data1/oa_pdf/8c/dc/main.PMC4833829.pdf
http://dx.doi.org/10.1016/ j.tmaid.2016.01.008 .L.,OADS,/arxiv_data1/oa_pdf/8c/dc/main.PMC4833829.pdf
"E-mail: info@enricospugnini.netCase Report DOI: http://dx.doi.org/10.4314/ovj.v6i1.10 Submitted: 19/01/2016 Accepted: 08/04/2016 Published: 15/04/201 6 A case of advanced second-degree atrioventricular block in a fe rret secondary  to lymphoma F. Menicagli1, A. Lanza1, F. Sbrocca1, A. Baldi2 and E.P.",Non-OADS,/arxiv_data1/oa_pdf/bd/b5/OpenVetJ-6-68.PMC4833871.pdf
http://www.openveterinaryjournal.com F .,Non-OADS,/arxiv_data1/oa_pdf/bd/b5/OpenVetJ-6-68.PMC4833871.pdf
http://www.openveterinaryjournal.com F .,Non-OADS,/arxiv_data1/oa_pdf/bd/b5/OpenVetJ-6-68.PMC4833871.pdf
Database accession: All ChIP-seq and RNA-seq data can be downloaded from the NCBI Gene Expression Omnibus (GEO) (http://www.ncbi.nlm.nih.gov/geo/) under accession numberGSE60477.,OADS,/arxiv_data1/oa_pdf/c3/96/onc2015261a.PMC4833872.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)FUS –ERG modulates ATRA signaling AM Sotoca et al 1976 Oncogene (2016) 1965 –1976 © 2016 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/c3/96/onc2015261a.PMC4833872.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)RNF31 degrades p53 in breast cancer cells J Zhu et al 1964 Oncogene (2016) 1955 –1964 © 2016 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/e0/d6/onc2015260a.PMC4833873.pdf
( bandc) Densitometry was used to quantify the phosphorylation levels using the Image J analysis software (http://imagej.nih.gov/ij/index.html).Role of integrin α11β1 in NSCLC R Navab et al 1902 Oncogene (2016) 1899 –1908 © 2016 Macmillan Publishers Limited,OADS,/arxiv_data1/oa_pdf/b3/fa/onc2015254a.PMC4833874.pdf
The background-corrected SHG images were analyzed using a novel relative linearity index that we have developed based on established texture analysis53available as a plugin for the freeware Image J analysis software (http://imagej.nih.gov/ij/index.html).,OADS,/arxiv_data1/oa_pdf/b3/fa/onc2015254a.PMC4833874.pdf
"The data reported in this paper have been deposited into the Gene Expression Omnibus (GEO) database, http://ncbi.nlm.nih.gov/geo/ (accession no.",OADS,/arxiv_data1/oa_pdf/b3/fa/onc2015254a.PMC4833874.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)Role of integrin α11β1 in NSCLC R Navab et al 1908 Oncogene (2016) 1899 –1908 © 2016 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/b3/fa/onc2015254a.PMC4833874.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/4a/5a/jjm-09-01-18952.PMC4833879.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/5e/7c/jjm-09-01-28280.PMC4833887.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/94/08/main.PMC4833889.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.01.008,OADS,/arxiv_data1/oa_pdf/94/08/main.PMC4833889.pdf
1936-5233/16 http://dx.doi.org/10.1016/j.tranon.2016.01.005,Non-OADS,/arxiv_data1/oa_pdf/8c/83/main.PMC4833890.pdf
"To explore the relationship between HIC1 expression and the methylation status of CRCs, we interrogated the relevant dataset recently available fromthe TCGA consortium ( https://tcga-data.nci.nih.gov/tcga/ ;2 7 7 specimens in total; the dataset was designated TCGA 450K; see Supplementary Materials and Methods for details).",OADS,/arxiv_data1/oa_pdf/8c/83/main.PMC4833890.pdf
"Additionally, the obtained gene se t was evaluated using the Enricher gene library online tool ( http://amp.pharm.mssm.edu/Enrichr/ ) [49].",OADS,/arxiv_data1/oa_pdf/8c/83/main.PMC4833890.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.01.006,OADS,/arxiv_data1/oa_pdf/c4/9a/main.PMC4833891.pdf
http://dx.doi.org/10.1016/j.jtcvs.2005.12.057 .,OADS,/arxiv_data1/oa_pdf/c4/9a/main.PMC4833891.pdf
http://dx.doi.org/ 10.1038/nrd2137 .,Non-OADS,/arxiv_data1/oa_pdf/c4/9a/main.PMC4833891.pdf
http://dx.doi.org/10.1016/j.ccr.2006.03.030 .,OADS,/arxiv_data1/oa_pdf/c4/9a/main.PMC4833891.pdf
http://dx.doi.org/10.1002/mabi.201100181 .,Non-OADS,/arxiv_data1/oa_pdf/c4/9a/main.PMC4833891.pdf
http://dx.doi.org/10.1165/rcmb.2006-0466OC .,OADS,/arxiv_data1/oa_pdf/c4/9a/main.PMC4833891.pdf
http://dx.doi.org/10.1158/0008-5472.CAN-10-3919 .,Non-OADS,/arxiv_data1/oa_pdf/c4/9a/main.PMC4833891.pdf
http://dx.doi.org/10.1038/nature12634 .,Non-OADS,/arxiv_data1/oa_pdf/c4/9a/main.PMC4833891.pdf
http://dx.doi.org/10.1158/0008-5472.CAN-12-3630 .,Non-OADS,/arxiv_data1/oa_pdf/c4/9a/main.PMC4833891.pdf
http://dx.doi.org/10.1158/2159-8290.CD-13-0253 .,Non-OADS,/arxiv_data1/oa_pdf/c4/9a/main.PMC4833891.pdf
"Front Biol 8,5 0–59.http://dx.doi.org/10.1007/s11515-012-1198-y .",OADS,/arxiv_data1/oa_pdf/c4/9a/main.PMC4833891.pdf
"BMC Genet 10, 63. http://dx.doi.org/10.1186/1471-2156-10-63 .",OADS,/arxiv_data1/oa_pdf/c4/9a/main.PMC4833891.pdf
http://dx.doi.org/10.1002/jcb.20235 .,Non-OADS,/arxiv_data1/oa_pdf/c4/9a/main.PMC4833891.pdf
"JP h a r mS c i 96,3 4 1 –350.http://dx.doi.org/10.1002/jps.20803 .",Non-OADS,/arxiv_data1/oa_pdf/c4/9a/main.PMC4833891.pdf
http://dx.doi.org/10.1111/j.1432-0436.2006.00069.x .,Non-OADS,/arxiv_data1/oa_pdf/c4/9a/main.PMC4833891.pdf
http://dx.doi.org/10.1038/nm.1790 .,OADS,/arxiv_data1/oa_pdf/c4/9a/main.PMC4833891.pdf
"Cell Stem Cell 14, 306–321.http://dx.doi.org/10.1016/j.stem.2014.02.002 .",OADS,/arxiv_data1/oa_pdf/c4/9a/main.PMC4833891.pdf
http://dx.doi.org/10.1038/nrclinonc.2009.44 .,OADS,/arxiv_data1/oa_pdf/c4/9a/main.PMC4833891.pdf
http://dx.doi.org/10.1158/2159-8290.CD-12-0095 .,Non-OADS,/arxiv_data1/oa_pdf/c4/9a/main.PMC4833891.pdf
"Expert Opin Ther Targets 10, 613 –625.http://dx.doi.org/10.1517/14728222.10.4.613 .",Non-OADS,/arxiv_data1/oa_pdf/c4/9a/main.PMC4833891.pdf
http://dx.doi.org/10.1158/0008-5472.CAN-12-2241 .,Non-OADS,/arxiv_data1/oa_pdf/c4/9a/main.PMC4833891.pdf
"Annu Rev Genet 42, 301 –334.http://dx.doi.org/10.1146/annurev.genet.41.110306.130350 .",Non-OADS,/arxiv_data1/oa_pdf/c4/9a/main.PMC4833891.pdf
"Nature 385,7 4 0 –743.http://dx.doi.org/10.1038/385740a0 .",Non-OADS,/arxiv_data1/oa_pdf/c4/9a/main.PMC4833891.pdf
http://dx.doi.org/10.1038/ncomms2946 .,Non-OADS,/arxiv_data1/oa_pdf/c4/9a/main.PMC4833891.pdf
http://dx.doi.org/10.1038/35020592 .,Non-OADS,/arxiv_data1/oa_pdf/c4/9a/main.PMC4833891.pdf
http://dx.doi.org/10.1016/j.stem.2008.02.009 .,OADS,/arxiv_data1/oa_pdf/c4/9a/main.PMC4833891.pdf
Biochim Biophys Acta .http://dx.doi.org/10.1016/j.bbagrm.2014.03.007 .,OADS,/arxiv_data1/oa_pdf/c4/9a/main.PMC4833891.pdf
Cancer Metastasis Rev .http://dx.doi.org/10.1007/s10555-015-9556-2 .,Non-OADS,/arxiv_data1/oa_pdf/c4/9a/main.PMC4833891.pdf
http://dx.doi.org/10.1016/j.ccr.2005.11.004 .,OADS,/arxiv_data1/oa_pdf/c4/9a/main.PMC4833891.pdf
http://dx.doi.org/10.1158/0008-5472.CAN-09-2008 .,Non-OADS,/arxiv_data1/oa_pdf/c4/9a/main.PMC4833891.pdf
http://dx.doi.org/10.1101/gad.1032902 .,Non-OADS,/arxiv_data1/oa_pdf/c4/9a/main.PMC4833891.pdf
http://dx.doi.org/10.1016/j.cell.2013.10.018 .98 mRNA Processing in Poorly Differentiated NSCLC Geles et al.,OADS,/arxiv_data1/oa_pdf/c4/9a/main.PMC4833891.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/97/ed/main.PMC4833892.pdf
1936-5233/16 http://dx.doi.org/10.1016/j.tranon.2015.12.003,Non-OADS,/arxiv_data1/oa_pdf/97/ed/main.PMC4833892.pdf
"Adv Neurosci .http://dx.doi.org/10.1155/2015/372856 [Article ID 372856, 13 pages].",OADS,/arxiv_data1/oa_pdf/97/ed/main.PMC4833892.pdf
http://dx.doi.org/10.1016/S1470-2045(12)70431-X [Epub 2012 Oct 8].,OADS,/arxiv_data1/oa_pdf/97/ed/main.PMC4833892.pdf
http://dx.doi.org/10.1016/S1470-2045(12)70324-8 Epub 2012 Aug 13.,Non-OADS,/arxiv_data1/oa_pdf/97/ed/main.PMC4833892.pdf
http://dx.doi.org/10.1002/cncr.23805 .,Non-OADS,/arxiv_data1/oa_pdf/97/ed/main.PMC4833892.pdf
1936-5233/16 http://dx.doi.org/10.1016/j.tranon.2016.02.001,Non-OADS,/arxiv_data1/oa_pdf/0b/04/main.PMC4833893.pdf
http://www.partek.com ; 2014.,Non-OADS,/arxiv_data1/oa_pdf/0b/04/main.PMC4833893.pdf
http://www.geneontology.org ; 2014.,Non-OADS,/arxiv_data1/oa_pdf/0b/04/main.PMC4833893.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.01.001,OADS,/arxiv_data1/oa_pdf/4a/9d/main.PMC4833894.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/c6/3a/jjm-09-01-29237.PMC4833945.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/53/c1/jjm-09-01-26732.PMC4833956.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/40/3a/jjm-09-01-29384.PMC4833962.pdf
"ZFN Cloning in pP15A, kanaR The nucleotide sequences coding for the left and right  ZFP arrays were downloaded from http://zifit.partners.",OADS,/arxiv_data1/oa_pdf/40/3a/jjm-09-01-29384.PMC4833962.pdf
"Furthermore, the obligate heterodimeric  FokI variants, ELD/KKR, were obtained from Addgene:  pCLR2070 and Addgene: pCLR2068 (https://www.ad - dgene.org/).",Non-OADS,/arxiv_data1/oa_pdf/40/3a/jjm-09-01-29384.PMC4833962.pdf
"In response to this shift, theteam at My Cancer Genome ,http://www.mycancergenome.org/ [1] ,a project spearheaded at the Vanderbilt-Ingram Cancer Center, hasdeveloped a pathway-based approach to education and knowledge curation for precision cancer medicine.",Non-OADS,/arxiv_data1/oa_pdf/29/3f/main.PMC4833964.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/29/3f/main.PMC4833964.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.03.001,OADS,/arxiv_data1/oa_pdf/29/3f/main.PMC4833964.pdf
Individual pathway figures for each cell signaling pathway can be found on the My Cancer Genome website at http://www.MyCancerGenome.org/content/pathways [6] .,OADS,/arxiv_data1/oa_pdf/29/3f/main.PMC4833964.pdf
http://dx.doi.org/10.1056/NEJMoa1210093 .,OADS,/arxiv_data1/oa_pdf/29/3f/main.PMC4833964.pdf
"N Engl J Med 372(1), 30–39.http://dx.doi.org/10.1056/NEJMoa1412690 .",OADS,/arxiv_data1/oa_pdf/29/3f/main.PMC4833964.pdf
http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm313008.htm; 2012.,Non-OADS,/arxiv_data1/oa_pdf/29/3f/main.PMC4833964.pdf
My Cancer Genome .http://www.mycancergenome.,Non-OADS,/arxiv_data1/oa_pdf/29/3f/main.PMC4833964.pdf
My Cancer Genome .http://www.mycancergenome.org/sitemap .,Non-OADS,/arxiv_data1/oa_pdf/29/3f/main.PMC4833964.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/40/7e/main.PMC4833965.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.02.002,OADS,/arxiv_data1/oa_pdf/40/7e/main.PMC4833965.pdf
Available at: http://ctep.cancer.gov/protocolDevelopment/ electronic_applications/ctc.htm .,Non-OADS,/arxiv_data1/oa_pdf/40/7e/main.PMC4833965.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/10/main.PMC4833966.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.02.003,OADS,/arxiv_data1/oa_pdf/af/10/main.PMC4833966.pdf
Microarray data were analyzed with the Limma packagefrom Bioconductor ( http://www.bioconductor.org )[19].,OADS,/arxiv_data1/oa_pdf/af/10/main.PMC4833966.pdf
Microarraydata are available at the GEO ( http://www.ncbi.nlm.nih.gov/geo/ ) under accession number GSE62813.,OADS,/arxiv_data1/oa_pdf/af/10/main.PMC4833966.pdf
More detailed information can be found at http://www.ncbi.nlm.nih.gov/geo/ .140 Global Risk Score to Predict Tumor Recurrence Risk Dekervel et al.,OADS,/arxiv_data1/oa_pdf/af/10/main.PMC4833966.pdf
More detailed information can be found at http://www.ncbi.nlm.nih.gov/geo/ .,Non-OADS,/arxiv_data1/oa_pdf/af/10/main.PMC4833966.pdf
http://dx.doi.org/10.1097/2F01.SLA.0000055224.68432.80 .,Non-OADS,/arxiv_data1/oa_pdf/af/10/main.PMC4833966.pdf
http://dx.doi.org/ 10.1016/j.jhep.2015.02.007 .,OADS,/arxiv_data1/oa_pdf/af/10/main.PMC4833966.pdf
"Hepatology 62(2), 440 –451 [ http://onlinelibrary.wiley.",Non-OADS,/arxiv_data1/oa_pdf/af/10/main.PMC4833966.pdf
http://dx.doi.org/ 10.1016/j.tranon.2015.11.006 .,OADS,/arxiv_data1/oa_pdf/af/10/main.PMC4833966.pdf
"Hepatobiliary Pancreat Dis Int 14(5), 477 –484 [ http://www.hbpdint.com/EN/Y2015/V14/I5/477 ].",Non-OADS,/arxiv_data1/oa_pdf/af/10/main.PMC4833966.pdf
http://dx.doi.org/10.1016/j.jhep.2015.10.015 [[Epub ahead of print] PubMed PMID: 26505120].,OADS,/arxiv_data1/oa_pdf/af/10/main.PMC4833966.pdf
"JS u r gR e s 200(1), 82 –90.http://dx.doi.org/10.1016/ j.jss.2015.06.069 .",OADS,/arxiv_data1/oa_pdf/af/10/main.PMC4833966.pdf
http://dx.doi.org/ 10.1002/hep.20375 .,Non-OADS,/arxiv_data1/oa_pdf/af/10/main.PMC4833966.pdf
http://dx.doi.org/10.1158/0008-5472.CAN-10-2607 .,Non-OADS,/arxiv_data1/oa_pdf/af/10/main.PMC4833966.pdf
http://dx.doi.org/10.1056/NEJMoa0804525 .,OADS,/arxiv_data1/oa_pdf/af/10/main.PMC4833966.pdf
http://dx.doi.org/10.1371/journal.pmed.1001770 .,Non-OADS,/arxiv_data1/oa_pdf/af/10/main.PMC4833966.pdf
http://dx.doi.org/10.1053/j.gastro.2011.02.006 .,OADS,/arxiv_data1/oa_pdf/af/10/main.PMC4833966.pdf
http://dx.doi.org/10.1053/j.gastro.2013.03.051 .,OADS,/arxiv_data1/oa_pdf/af/10/main.PMC4833966.pdf
http://dx.doi.org/10.1053/j.gastro.2013.01.021 .,OADS,/arxiv_data1/oa_pdf/af/10/main.PMC4833966.pdf
http://dx.doi.org/ 10.1016/j.canlet.2012.10.021 .,OADS,/arxiv_data1/oa_pdf/af/10/main.PMC4833966.pdf
http://dx.doi.org/10.1186/2Fgb-2004-5-10-r80 .,Non-OADS,/arxiv_data1/oa_pdf/af/10/main.PMC4833966.pdf
http://dx.doi.org/ 10.1073/2Fpnas.0506580102 .,OADS,/arxiv_data1/oa_pdf/af/10/main.PMC4833966.pdf
http://dx.doi.org/10.1158/2F0008-5472.CAN-08-0742 .,Non-OADS,/arxiv_data1/oa_pdf/af/10/main.PMC4833966.pdf
http://dx.doi.org/10.1093/bioinformatics/ btg382 .Translational Oncology Vol.,Non-OADS,/arxiv_data1/oa_pdf/af/10/main.PMC4833966.pdf
"Hepatology 45,4 2–52.http://dx.doi.org/10.1002/hep.21467 .",Non-OADS,/arxiv_data1/oa_pdf/af/10/main.PMC4833966.pdf
http://dx.doi.org/ 10.1016/S0168-8278(02)00360-4 .,OADS,/arxiv_data1/oa_pdf/af/10/main.PMC4833966.pdf
"Clin Cancer Res 20(8), 2159–2168 [ http://clincancerres.aacrjournals.",Non-OADS,/arxiv_data1/oa_pdf/af/10/main.PMC4833966.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/fd/main.PMC4833967.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.02.004,OADS,/arxiv_data1/oa_pdf/ed/fd/main.PMC4833967.pdf
Available from: http://www.who.int/mediacentre/ factsheets/fs300/en/.,Non-OADS,/arxiv_data1/oa_pdf/be/04/CMJ-128-816.PMC4833989.pdf
Available from: http://www.who.int/healthinfo/ global_burden_disease/2004_report_update/en/.,Non-OADS,/arxiv_data1/oa_pdf/be/04/CMJ-128-816.PMC4833989.pdf
Available from: http://www.cochrane‑handbook.org/.,OADS,/arxiv_data1/oa_pdf/b4/2e/CMJ-128-826.PMC4833991.pdf
Available from: http://www.cdc.gov/ mmwr/preview/mmwrhtml/rr6002a1.htm?s_cid&rr6002a1_e.,OADS,/arxiv_data1/oa_pdf/97/b8/CMJ-128-835.PMC4833992.pdf
Available at http://ghdx.healthdata.org/record/china-global-burden- disease-study-2010-gbd-2010-results-1990-2010.,Non-OADS,/arxiv_data1/oa_pdf/c3/83/CMJ-128-839.PMC4833993.pdf
"For a nonredundant bacterial database, we downloaded  the complete genome set of version 20140829 from NCBI  (http://www.ncbi.nlm.nih.gov/ ).",OADS,/arxiv_data1/oa_pdf/85/d1/CMJ-128-877.PMC4834002.pdf
"For the nonredundant  viral database, we chose 100 different viruses that are  associated with human health based on version R194 from  GenBank ( http://www.ncbi.nlm.nih.gov/genbank ).",OADS,/arxiv_data1/oa_pdf/85/d1/CMJ-128-877.PMC4834002.pdf
Statistical analysis We used the software named SoapCoverage from the SOAP  website  (http://soap.genomics.org.cn/ ) to calculate the depth  and coverage of each position.,OADS,/arxiv_data1/oa_pdf/85/d1/CMJ-128-877.PMC4834002.pdf
Available from: http://apps.who.int/iris/bitstream/10665/85321/1/9789241505727_ eng.pdf.,OADS,/arxiv_data1/oa_pdf/88/82/CMJ-128-890.PMC4834004.pdf
Available from: http://www.cochrane‑handbook.,OADS,/arxiv_data1/oa_pdf/9a/39/CMJ-128-963.PMC4834015.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0b/14/jjm-09-01-29766.PMC4834024.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/5f/da/jjm-09-01-26627.PMC4834025.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/3a/ed/jjm-09-01-29331.PMC4834027.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/b1/fd/jjm-09-01-29483.PMC4834028.pdf
http://dx.doi.org/10.1016/j.stemcr.2016.02.001 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a7/7d/main.PMC4834033.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, ﬁve ﬁgures, and one table and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2016.02.001 .",OADS,/arxiv_data1/oa_pdf/a7/7d/main.PMC4834033.pdf
"Stem Cell Reports Report OSKM Induce Extraembryonic Endoderm Stem Cells in Parallel to Induced Pluripotent Stem Cells Anthony Parenti,1,2Michael A. Halbisen,2Kai Wang,3Keith Latham,3and Amy Ralston1,2,* 1Program in Cell and Molecular Biology, Michigan State University, East Lansing, MI 48824, USA 2Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI 48824, USA 3Department of Animal Sciences, Michigan State University, East Lansing, MI 48824, USA *Correspondence: aralston@msu.edu http://dx.doi.org/10.1016/j.stemcr.2016.02.003 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/27/d6/main.PMC4834035.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, four ﬁgures, and one table and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2016.",OADS,/arxiv_data1/oa_pdf/27/d6/main.PMC4834035.pdf
"Stem Cell Reports Article Activation of GLP-1 Receptor Promotes Bone Marrow Stromal Cell Osteogenic Differentiation through b-Catenin Jingru Meng,1,5Xue Ma,1,5Ning Wang,1,5Min Jia,1Long Bi,2Yunying Wang,3Mingkai Li,1Huinan Zhang,1 Xiaoyan Xue,1Zheng Hou,1Ying Zhou,1Zhibin Yu,3Gonghao He,4,6and Xiaoxing Luo1,* 1Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi’an 710032, China 2Institute of Orthopaedics & Traumatology, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, China 3Department of Aerospace Physiology, Fourth Military Medical University, Xi’an 710032, China 4Department of Pharmacy, Kunming General Hospital of Chengdu Military Region, Kunming 650032, China 5Co-ﬁrst author 6Co-senior author *Correspondence: xxluo3@fmmu.edu.cn http://dx.doi.org/10.1016/j.stemcr.2016.02.002 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/09/83/main.PMC4834036.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, seven ﬁgures and one table and can be found with thisarticle online at http://dx.doi.org/10.1016/j.stemcr.2016.02.002 .",OADS,/arxiv_data1/oa_pdf/09/83/main.PMC4834036.pdf
Measurements were made using bespoke digital imaging software (http://www.VisionResearch.org) that allowed accurate linear measurements to be made (Figure 1).,OADS,/arxiv_data1/oa_pdf/10/f5/eye2015280a.PMC4834037.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/Retinal vessel growth is retarded by high oxygen saturation RBR Moreton et al 581 Eye",Non-OADS,/arxiv_data1/oa_pdf/10/f5/eye2015280a.PMC4834037.pdf
http://dx.doi.org/10.1016/j.stemcr.2016.02.006 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9d/37/main.PMC4834039.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, four ﬁgures, and one table and can be found with thisarticle online at http://dx.doi.org/10.1016/j.stemcr.2016.02.006 .",OADS,/arxiv_data1/oa_pdf/9d/37/main.PMC4834039.pdf
"Stem Cell Reports Report P2Y4 Nucleotide Receptor in Neuronal Precursors Induces Glutamatergic Subtype Markers in Their Descendant Neurons Youichi Uda,1Shuai Xu,1Takafumi Matsumura,1and Yoshinori Takei2,* 1Department of Genomic Drug Discovery Science 2Department of Nanobio Drug Discovery Science Graduate School of Pharmaceutical Science, Kyoto University, 46-29 Shimo-adachi-cho, Yoshida, Sakyo-ku, Kyoto 606-8501, Japan *Correspondence: ytakei@pharm.kyoto-u.ac.jp http://dx.doi.org/10.1016/j.stemcr.2016.02.007 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",OADS,/arxiv_data1/oa_pdf/f5/a1/main.PMC4834041.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures and two ﬁgures and can be found with this article on- line at http://dx.doi.org/10.1016/j.stemcr.2016.02.007 .,Non-OADS,/arxiv_data1/oa_pdf/f5/a1/main.PMC4834041.pdf
"Stem Cell Reports Article Estradiol Facilitates Functional Integration of iPSC-Derived Dopaminergic Neurons into Striatal Neuronal Circuits via Activation of Integrin a5b1 Kaneyasu Nishimura,1,4Daisuke Doi,1Bumpei Samata,1Shigeo Murayama,2Tsuyoshi Tahara,3 Hirotaka Onoe,3and Jun Takahashi1,* 1Department of Clinical Application, Center for iPS Cell Research and Application (CiRA), Kyoto University, 53 Shogoin kawahara-cho, Sakyo-ku, Kyo to 606-8507, Japan 2Department of Neuropathology, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Itabashi-ku, Tokyo 173-0015, Japan 3Bio-function Imaging Team, RIKEN Center for Life Science Technologies, Kobe 650-0047, Japan 4Present address: Department of Medical Biochemistry and Biophysics, Karolinska Institute, 171 77, Stockholm, Sweden *Correspondence: jbtaka@cira.kyoto-u.ac.jp http://dx.doi.org/10.1016/j.stemcr.2016.02.008 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",OADS,/arxiv_data1/oa_pdf/93/22/main.PMC4834042.pdf
"0586, Kyoto University; http://www.anim.med.kyoto-u.",Non-OADS,/arxiv_data1/oa_pdf/93/22/main.PMC4834042.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes four ﬁgures and three tablesand can be found with this article online at http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/93/22/main.PMC4834042.pdf
"Stem Cell Reports Article AnEWS-FLI1 -Induced Osteosarcoma Model Unveiled a Crucial Role of Impaired Osteogenic Differentiation on Osteosarcoma Development Shingo Komura,1,2Katsunori Semi,1,3Fumiaki Itakura,1Hirofumi Shibata,1Takatoshi Ohno,2Akitsu Hotta,1,3 Knut Woltjen,1,4Takuya Yamamoto,1,3,5Haruhiko Akiyama,2and Yasuhiro Yamada1,3,* 1Laboratory of Stem Cell Oncology, Department of Life Science Frontiers, Center for iPS Cell Research and Application (CiRA), Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan 2Department of Orthopaedic Surgery, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan 3Institute for Integrated Cell-Material Sciences (WPI-iCeMS), Kyoto University, Kyoto 606-8507, Japan 4Hakubi Center for Advanced Research, Kyoto University, Kyoto 606-8501, Japan 5AMED-CREST, AMED 1-7-1 Otemach, Chiyodaku, Tokyo 100-0004, Japan *Correspondence: y-yamada@cira.kyoto-u.ac.jp http://dx.doi.org/10.1016/j.stemcr.2016.02.009 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/5e/11/main.PMC4834047.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, ﬁve ﬁgures, and four tables and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/5e/11/main.PMC4834047.pdf
"Stem Cell Reports Report NAP-2 Secreted by Human NK Cells Can Stimulate Mesenchymal Stem/Stromal Cell Recruitment Catarina R. Almeida,1,2,4,*Hugo R. Caires,1,2,3Daniela P. Vasconcelos,1,2,3and Ma ´rio A. Barbosa1,2,3 1i3S - Instituto de Investigac ¸a˜o e Inovac ¸a˜o em Sau ´de, Universidade do Porto, Rua Alfredo Allen, 208, 4200-135 Porto, Portugal 2INEB - Instituto de Engenharia Biome ´dica, Universidade do Porto, Rua Alfredo Allen, 208, 4200-135 Porto, Portugal 3ICBAS - Instituto de Cie ˆncias Biome ´dicas Abel Salazar, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal 4Present address: Department of Medical Sciences and Institute for Biomedicine – iBiMED, University of Aveiro, 3810-193 Aveiro, Portugal *Correspondence: catalmeida0@gmail.com http://dx.doi.org/10.1016/j.stemcr.2016.02.012 This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/84/d9/main.PMC4834048.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes two ﬁgures and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.2016.,Non-OADS,/arxiv_data1/oa_pdf/84/d9/main.PMC4834048.pdf
"Stem Cell Reports Article Retinal Organoids from Pluripotent Stem Cells Efﬁciently Recapitulate Retinogenesis Manuela Vo ¨lkner,1Marlen Zscha ¨tzsch,1Maria Rostovskaya,2Rupert W. Overall,3Volker Busskamp,3 Konstantinos Anastassiadis,2and Mike O. Karl1,3,* 1German Center for Neurodegenerative Diseases (DZNE) Dresden, 01307 Dresden, Germany 2Stem Cell Engineering, Biotechnology Center (BIOTEC), TU Dresden, 01307 Dresden, Germany 3CRTD - Center for Regenerative Therapies Dresden, Technische Universita ¨t Dresden, 01307 Dresden, Germany *Correspondence: mike.karl@dzne.de http://dx.doi.org/10.1016/j.stemcr.2016.03.001 SUMMARY The plasticity of pluripotent stem cells provides new possibilities for studying development, degeneration, and regeneration.",Non-OADS,/arxiv_data1/oa_pdf/76/92/main.PMC4834051.pdf
"6 j525–538 jApril 12, 2016 jª2016 The Authors 525 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/76/92/main.PMC4834051.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, seven ﬁgures, and three tables and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/76/92/main.PMC4834051.pdf
"Edvard Smith,8Alena Sala /C20sova´,4Magnus Westgren,9Erik Sundstro ¨m,10Per Uhle ´n,4Ernest Arenas,4 Christer Sylve ´n,1Karl Tryggvason,2,11Matthias Corbascio,3Oscar E. Simonson,3,13Cecilia O ¨sterholm,3,7,13 and Karl-Henrik Grinnemo3,7,13,* 1Division of Cardiology, Department of Medicine 2Division of Matrix Biology, Department of Medical Biochemistry and Biophysics 3Division of Cardiothoracic Surgery and Anesthesiology, Department of Molecular Medicine and Surgery 4Division of Molecular Neurobiology, Department of Medical Biochemistry and Biophysics Karolinska Institutet, 17177 Stockholm, Sweden 5Cardiovascular & Metabolic Diseases, Innovative Medicines and Early Development, AstraZeneca R&D, 43150 Mo ¨lndal, Sweden 6Division of Hematology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, 17177 Stockholm, Sweden 7Cell Therapy Institute, Nova Southeastern University, Fort Lauderdale, FL 33314, USA 8Department of Laboratory Medicine 9CLINTEC, Division of Obstetrics and Gynecology 10Division of Neurodegeneration, Department of Neurobiology, Care Sciences and Society Karolinska Institutet, Karolinska University Hospital, 17177 Stockholm, Sweden 11Duke-NUS Graduate Medical School, Durham, NC 27710, USA 12Co-ﬁrst author 13Co-senior author *Correspondence: karl-henrik.grinnemo@karolinska.se http://dx.doi.org/10.1016/j.stemcr.2016.02.014 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/a4/0a/main.PMC4834052.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, two ﬁgures, and one movie and can be found withthis article online at http://dx.doi.org/10.1016/j.stemcr.2016.",Non-OADS,/arxiv_data1/oa_pdf/a4/0a/main.PMC4834052.pdf
4.http://dx.doi.org/10.1101/cshperspect.a015750 .,Non-OADS,/arxiv_data1/oa_pdf/a4/0a/main.PMC4834052.pdf
http://dx.doi.org/10.1016/j.stemcr.2016.02.013 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/de/main.PMC4834053.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, six ﬁgures, and one table and can be found with thisarticle online at http://dx.doi.org/10.1016/j.stemcr.2016.02.013 .",OADS,/arxiv_data1/oa_pdf/b1/de/main.PMC4834053.pdf
Cell Rep. http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/b1/de/main.PMC4834053.pdf
"Stem Cell Reports Article Lysophosphatidic Acid Receptor Is a Functional Marker of Adult Hippocampal Precursor Cells Tara L. Walker,1Rupert W. Overall,1Steffen Vogler,2Alex M. Sykes,3Susann Ruhwald,1Daniela Lasse,2 Muhammad Ichwan,1Klaus Fabel,1,2and Gerd Kempermann1,2,* 1CRTD – Center for Regenerative Therapies Dresden, Technische Universita ¨t Dresden, Dresden 01307, Germany 2German Center for Neurodegenerative Diseases (DZNE) Dresden, Dresden 01307, Germany 3Max Planck Institute for Molecular Cell Biology and Genetics, Dresden 01307, Germany *Correspondence: gerd.kempermann@crt-dresden.de http://dx.doi.org/10.1016/j.stemcr.2016.03.002 SUMMARY Here, we show that the lysophosphatidic acid receptor 1 (LPA 1) is expressed by a deﬁned population of type 1 stem cells and type 2a precursor cells in the adult mouse dentate gyrus.",Non-OADS,/arxiv_data1/oa_pdf/71/b6/main.PMC4834054.pdf
"6 j552–565 jApril 12, 2016 jª2016 The Authors This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/71/b6/main.PMC4834054.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, ﬁve ﬁgures, and four tables and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/71/b6/main.PMC4834054.pdf
http://dx.doi.org/10.3791/1543 .,Non-OADS,/arxiv_data1/oa_pdf/71/b6/main.PMC4834054.pdf
"Stem Cell Reports Correction Activation of GLP-1 Receptor Promotes Bone Marrow Stromal Cell Osteogenic Differentiation through b-Catenin Jingru Meng, Xue Ma, Ning Wang, Min Jia, Long Bi, Yunying Wang, Mingkai Li, Huinan Zhang, Xiaoyan Xue, Zheng Hou, Ying Zhou, Zhibin Yu, Gonghao He, and Xiaoxing Luo * *Correspondence: xxluo3@fmmu.edu.cn http://dx.doi.org/10.1016/j.stemcr.2016.03.010 (Stem Cell Reports 6, April 12, 2016, http://dx.doi.org/10.1016/j.stemcr.2016.02.002 ) The commercial source of GLP-1 antibody was inadvertently omitted in the Supplemental Information of the original pa- per published online on March 3, 2016.",Non-OADS,/arxiv_data1/oa_pdf/14/56/main.PMC4834056.pdf
"Stem Cell Reports Resource Dynamic T ranscriptional and Epigenetic Regulation of Human Epidermal Keratinocyte Differentiation Alessia Cavazza,1Annarita Miccio,2Oriana Romano,3Luca Petiti,4Guidantonio Malagoli Tagliazucchi,3 Clelia Peano,4Marco Severgnini,4Ermanno Rizzi,4Gianluca De Bellis,4Silvio Bicciato,3 and Fulvio Mavilio3,5,* 1Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA 2Imagine Institute, 75015 Paris, France 3Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy 4Institute for Biomedical Technologies, National Research Council, 20132 Milan, Italy 5Genethon, 1bis rue de l’Internationale, 91002 Evry, France *Correspondence: fmavilio@genethon.fr http://dx.doi.org/10.1016/j.stemcr.2016.03.003 SUMMARY Human skin is maintained by the differentiation and maturation of interfollicular stem and progenitors cells.",Non-OADS,/arxiv_data1/oa_pdf/b8/c9/main.PMC4834057.pdf
"6 j618–632 jApril 12, 2016 jª2016 The Authors This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/b8/c9/main.PMC4834057.pdf
"ACCESSION NUMBERS The DeepCAGE, ChIP-seq, and microarray data were deposited in the Gene Expression Omnibus ( http://www.ncbi.nlm.nih.gov/ geo/) under accession number GEO: GSE64328.",OADS,/arxiv_data1/oa_pdf/b8/c9/main.PMC4834057.pdf
MLV integration sites sequencing data were deposited in the Sequence Read Archive (http://www.ncbi.nlm.nih.gov/sra ) under accession number SRA: SRP051203.,OADS,/arxiv_data1/oa_pdf/b8/c9/main.PMC4834057.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, six ﬁgures, and one table and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2016.03.003 .",OADS,/arxiv_data1/oa_pdf/b8/c9/main.PMC4834057.pdf
"CAPZA3 -PLCζ promoter analysis   To determine whether the low expression of  CAPZA3  and PLCζ  were linked to changes in the shared  promoter region of these two genes, sequence analysis  of promoter region (661bp) was performed on genomic  DNA of one infertile man with low expression level of  these two genes and then was blasted with database   sequence in NCBI site (http://www.ncbi.nlm.nih.gov).",OADS,/arxiv_data1/oa_pdf/78/2f/IJBMS-19-281.PMC4834118.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/e2/a5/jjm-09-01-27997.PMC4834128.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/46/d2/jjm-09-01-26069.PMC4834129.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/59/69/jjm-09-01-30682.PMC4834130.pdf
<https://www.researchgate.ne t/publication/267672776_ A_multi-compartmental_model_generally _applicable_to_physiologically-based_ pharmacokinetics_Astra-Zeneca_UK >(1997).,Non-OADS,/arxiv_data1/oa_pdf/a7/e5/PSP4-5-201.PMC4834131.pdf
Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website (http://www.wileyonlinelibrary.com/psp4)Predicting Local vs Systemic Inhaled Drug Exposure Boger et al .,OADS,/arxiv_data1/oa_pdf/a7/e5/PSP4-5-201.PMC4834131.pdf
Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website (http://www.wileyonlinelibrary.com/psp4)Translational Model for 5-FU in Children With Brain Tumors Daryani et al.,Non-OADS,/arxiv_data1/oa_pdf/e4/91/PSP4-5-211.PMC4834132.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/21/c0/jjm-09-01-29314.PMC4834133.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/33/84/jjm-09-01-29246.PMC4834134.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/92/b1/jjm-09-01-26157.PMC4834135.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/b8/27/jjm-09-01-26460.PMC4834140.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/bb/98/jjm-09-01-28291.PMC4834141.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/6c/f6/jjm-09-01-28594.PMC4834142.pdf
[cited 2006]; Available from: URL:  http://apps.who.int/bmi/index.jsp?introPage=intro_ 3.html  17.,OADS,/arxiv_data1/oa_pdf/90/e6/ARYA-12-018.PMC4834177.pdf
[cited 2015];  Available from: URL:   http://www.ats.ucla.edu/stat/seminars/svy_intro/  19.,Non-OADS,/arxiv_data1/oa_pdf/90/e6/ARYA-12-018.PMC4834177.pdf
[cited 2009]; Available from: URL:  http://www.who.int/mediacentre/factsheets/fs311/en/   21.,OADS,/arxiv_data1/oa_pdf/90/e6/ARYA-12-018.PMC4834177.pdf
[cite d  2015 Mar 3]; Available from: URL:   http://www.hscic.gov.uk/catalogue/PUB16988/obes  -phys-acti-diet-eng-2015-qual.pdf  26.,Non-OADS,/arxiv_data1/oa_pdf/90/e6/ARYA-12-018.PMC4834177.pdf
[cited  2006]; Available from: URL:   http://www.nber.org/papers/w12352  30.,Non-OADS,/arxiv_data1/oa_pdf/90/e6/ARYA-12-018.PMC4834177.pdf
[cited  2008 Nov]; Available from: URL:   http://www.who.int/medicines/areas/traditional/con  gress/congress_background_info/en/  6.,OADS,/arxiv_data1/oa_pdf/e4/07/ARYA-12-035.PMC4834179.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/f6/a6/hepatmon-16-01-32528.PMC4834183.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/b6/df/hepatmon-16-01-32215.PMC4834187.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/29/af/hepatmon-16-01-32703.PMC4834189.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/3a/21/hepatmon-16-01-31278.PMC4834190.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/b5/8f/hepatmon-16-01-32971.PMC4834196.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/56/ab/hepatmon-16-01-34897.PMC4834197.pdf
"Developmental Cognitive  Neuroscience  18  (2016)  89–100 Contents  lists  available  at  ScienceDirect Developmental  Cognitive  Neuroscience j  o  ur  nal  ho  me  pa  ge:  http://www.elsevier.com/locate/dcn Functional connectivity of  the  amygdala  and  subgenual  cingulate during  cognitive reappraisal of  emotions  in  children  with  MDD history  is  associated  with  rumination Eric  R.  Murphya,∗,  Deanna  M.  Barcha,b,c,d,  David  Pagliacciob,c,  Joan  L.  Lubya, Andy C. Beldena aDepartment  of  Psychiatry,  Washington  University  in  St.  Louis,  660  South  Euclid  Avenue,  St.  Louis,  MO  63110,  USA bThe  Program  in  Neuroscience,  Washington  University  in  St.  Louis,  660  South  Euclid  Avenue,  St.  Louis,  MO  63110,  USA cDepartment  of  Psychology,  Washington  University  in  St.  Louis,  One  Brookings  Drive,  St.  Louis,  MO  63130,  USA dDepartment  of  Radiology,  Washington  University  in  St.  Louis,  660  South  Euclid  Avenue,  St.  Louis,  MO  63110,  USA a r t  i  c  l  e  i  n  f  o Article history: Received  17  April  2015 Received  in  revised  form  16  October  2015 Accepted  13  November  2015 Available  online  28  November  2015 Keywords:Functional connectivity RuminationCognitive reappraisal AmygdalaSubgenual cingulatea b  s  t  r  a  c  t Major Depressive Disorder (MDD)  is  characterized  by  poor  emotion  regulation.",Non-OADS,/arxiv_data1/oa_pdf/30/bb/main.PMC4834229.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/30/bb/main.PMC4834229.pdf
"This  period  also  marks  increased  use  of  cognitive emotion  regulation  strategies,  which  increase  over  a  protracted period, with  even  late  adolescents  using  fewer  strategies  than adults  (Garnefski  and  Kraaij,  2006 ),  though  patterns  of  cogni- tive  strategy  use  are  similar  between  late  childhood  and  early http://dx.doi.org/10.1016/j.dcn.2015.11.003 1878-9293/© 2015  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/30/bb/main.PMC4834229.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/30/bb/main.PMC4834229.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the online version, at  http://dx.doi.org/10.1016/j.dcn.2015.11.003 .",OADS,/arxiv_data1/oa_pdf/30/bb/main.PMC4834229.pdf
"Emotion 1  (3),  276–298,  http://dx.doi.org/10.1037/1528-3542.1.3.276 .",Non-OADS,/arxiv_data1/oa_pdf/30/bb/main.PMC4834229.pdf
"NeuroImage  17  (1), 184–200,  http://dx.doi.org/10.1006/nimg.2002.1174 .",Non-OADS,/arxiv_data1/oa_pdf/30/bb/main.PMC4834229.pdf
"108  (3),  607–620,  http://dx.doi.org/10.1016/j.jecp.2010.08.006 .",OADS,/arxiv_data1/oa_pdf/30/bb/main.PMC4834229.pdf
"1  (3),  324–337,  http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/30/bb/main.PMC4834229.pdf
"35 (5),  1981–1996,  http://dx.doi.org/10.1002/hbm.22307 .",Non-OADS,/arxiv_data1/oa_pdf/30/bb/main.PMC4834229.pdf
"Developmental Cognitive Neuroscience  18  (2016)  26–33 Contents  lists  available  at  ScienceDirect Developmental  Cognitive  Neuroscience jo  ur  nal  ho  me  pag  e:  http://www.elsevier.com/locate/dcn Selective  attention neutralizes the  adverse  effects  of  low socioeconomic  status on memory in  9-month-old  infants Julie  Markanta,∗,  Laura  K.  Ackermanb,  Kate  Nussenbaumb,  Dima  Amsob aDepartment  of  Psychology,  Tulane  University,  USA bCognitive,  Linguistic,  &  Psychological  Sciences,  Brown  University,  USA a r t i c l  e  i  n  f  o Article history: Received  28  May  2015 Received  in  revised  form  29  October  2015 Accepted  30  October  2015 Available  online  10  November  2015 Keywords:Selective attention InfancySocioeconomic status MemoryResiliencea b s t r  a  c  t Socioeconomic status (SES) has a  documented  impact  on  brain  and  cognitive  development.",Non-OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"Selective  attention  involves  modulation  of  visual cortex  activity,  with  enhanced  processing  of  attended  stimuli  and http://dx.doi.org/10.1016/j.dcn.2015.10.009 1878-9293/© 2015  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"Cognition 133, 201–210, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"53, 371–399, http://dx.doi.org/10.1146/annurev.psych.53.",Non-OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"51,  1484–1525, http://dx.doi.org/10.1016/j.visres.2011.04.012 .",OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"22,  53–67,  http://dx.doi.org/10.1002/icd.1770 .",Non-OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"35, 29–35,  http://dx.doi.org/10.1016/j.infbeh.2011.09.007 .",OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"Neuropsychology  22  (3),  293–300,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"102  (5), 1927–1956,  http://dx.doi.org/10.2307/41724610 .",Non-OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"18,  193–222,  http://dx.doi.org/10.1146/annurev.ne.18.",Non-OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"47  (5),  1263–1279, http://dx.doi.org/10.1037/a0023875 .",Non-OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"59  (2), 77–92,  http://dx.doi.org/10.1037/0003-066X.59.2.77 .",Non-OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"1186,  174–189,  http://dx.doi.org/10.1111/j.1749-6632.2009.05336.x .",Non-OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"58,  145–173,  http://dx.doi.org/10.1146/annurev.psych.58.",Non-OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"13  (2),  65–73,  http://dx.doi.org/10.1016/j.tics.2008.11.003 .",OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"PLoS  One  6  (5),  1–8,  http://dx.doi.org/10.1371/ journal.pone.0018712 .",Non-OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"PLoS  ONE  8  (12), e80954,  http://dx.doi.org/10.1371/journal.pone.0080954 .",Non-OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"16 (11),  841–845,  http://dx.doi.org/10.1111/j.1467-9280.2005.01623.x .",Non-OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"6 (238), 1–12, http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"16,  926–940,  http://dx.doi.org/10.1111/ desc.12084 .",Non-OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"Cognition  131,  195–204,  http://dx.doi.org/ 10.1016/j.cognition.2014.01.006 .",Non-OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"Psychobiol.,  http://dx.doi.org/10.1002/dev.21375 .",Non-OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"Mem.,  http://dx.doi.org/10.1016/j.nlm.2015.02.",OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"53 (2),  185–204,  http://dx.doi.org/10.1037/0003-066X.53.2.185 .",Non-OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"75  (5),  1373–1386,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"57,  535–551,  http://dx.doi.org/10.1002/dev.",Non-OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"18  (5),  http://dx.doi.org/10.1038/nn.3983 .",Non-OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"21, 349–368,  http://dx.doi.org/10.1016/j.cogdev.2006.01.007 .",OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"9  (6),  642–654,  http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"6  (November),  307, http://dx.doi.org/10.3389/fnhum.2012.00307 .",Non-OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"15,  516–527, http://dx.doi.org/10.1111/j.1467-7687.2012.01147.x .",Non-OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"10  (4),  464–480, http://dx.doi.org/10.1111/j.1467-7687.2007.00600.x .",Non-OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"32,  3–25,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"2,  211–228,  http://dx.doi.org/10.1080/ 02643298508252866 .",Non-OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"17  (5), 888–896, http://dx.doi.org/10.1037/0278-7393.17.5.888 .",Non-OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"16  (5),  665–675,  http://dx.doi.org/10.1111/desc.",Non-OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"PLoS  One  7  (4),  e35744, http://dx.doi.org/10.1371/journal.pone.0035744 .",Non-OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"12  (4),  634–646,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"22  (1),  125–133,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/d8/dc/main.PMC4834267.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Extracellular Vesicles 2016, 5: 25355 - http://dx.doi.org/10.3402/jev.v5.25355 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/86/44/JEV-5-25355.PMC4834364.pdf
"2 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 25355 - http://dx.doi.org/10.3402/jev.v5.25355",OADS,/arxiv_data1/oa_pdf/86/44/JEV-5-25355.PMC4834364.pdf
"A border drawn with a hydrophobic pen (Vector Laboratories, Burlington, CA, USA) was used toExtensive surface protein profiles of extracellular vesicles Citation: Journal of Extracellular Vesicles 2016, 5: 25355 - http://dx.doi.org/10.3402/jev.v5.25355 3 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/86/44/JEV-5-25355.PMC4834364.pdf
"4 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 25355 - http://dx.doi.org/10.3402/jev.v5.25355",OADS,/arxiv_data1/oa_pdf/86/44/JEV-5-25355.PMC4834364.pdf
"Antibody details are listed in Supplementary Table 1 of Supplementary Material.Extensive surface protein profiles of extracellular vesicles Citation: Journal of Extracellular Vesicles 2016, 5: 25355 - http://dx.doi.org/10.3402/jev.v5.25355 5 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/86/44/JEV-5-25355.PMC4834364.pdf
"6 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 25355 - http://dx.doi.org/10.3402/jev.v5.25355",OADS,/arxiv_data1/oa_pdf/86/44/JEV-5-25355.PMC4834364.pdf
"A Venn diagram (f) compares surface proﬁles of patient CLL cells and their EV .Extensive surface protein profiles of extracellular vesicles Citation: Journal of Extracellular Vesicles 2016, 5: 25355 - http://dx.doi.org/10.3402/jev.v5.25355 7 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/86/44/JEV-5-25355.PMC4834364.pdf
"8 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 25355 - http://dx.doi.org/10.3402/jev.v5.25355",OADS,/arxiv_data1/oa_pdf/86/44/JEV-5-25355.PMC4834364.pdf
"Over-confluent growth of cells was avoided during EV production, and the medium was collected and clarified by procedures that minimized damage to cells.Any apoptotic bodies or platelets were removed fromExtensive surface protein profiles of extracellular vesicles Citation: Journal of Extracellular Vesicles 2016, 5: 25355 - http://dx.doi.org/10.3402/jev.v5.25355 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/86/44/JEV-5-25355.PMC4834364.pdf
"2013;2:20304, http://dx.doi.org/10.3402/jev.v2i0.20304 12.",Non-OADS,/arxiv_data1/oa_pdf/86/44/JEV-5-25355.PMC4834364.pdf
"J Extracell Vesicles.2015;4:27522, http://dx.doi.org/10.3402/jev.v4.27522 13.",OADS,/arxiv_data1/oa_pdf/86/44/JEV-5-25355.PMC4834364.pdf
"10 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 25355 - http://dx.doi.org/10.3402/jev.v5.25355",OADS,/arxiv_data1/oa_pdf/86/44/JEV-5-25355.PMC4834364.pdf
"2009; 4:e5219, doi: http://dx.doi.org/10.1371/journal.pone.0005219 31.",Non-OADS,/arxiv_data1/oa_pdf/86/44/JEV-5-25355.PMC4834364.pdf
"2006;Chapter3:Unit 3.22, doi: http://dx.doi.org/10.1002/0471143030 32.",OADS,/arxiv_data1/oa_pdf/86/44/JEV-5-25355.PMC4834364.pdf
"2015;4:26883, http://dx.doi.org/10.3402/jev.v4.26883 35.",Non-OADS,/arxiv_data1/oa_pdf/86/44/JEV-5-25355.PMC4834364.pdf
"2013;2:19671, doi:http://dx.doi.org/10.3402/jev.v2i0.19671 45.",Non-OADS,/arxiv_data1/oa_pdf/86/44/JEV-5-25355.PMC4834364.pdf
"2011;55:e3322, doi: http://dx.doi.org/10.3791/3322 49. de Jong OG, Verhaar MC, Chen Y , Vader P, Gremmels H, Posthuma G, et al.",OADS,/arxiv_data1/oa_pdf/86/44/JEV-5-25355.PMC4834364.pdf
"2012;1:18396, doi: http://dx.doi.org/10.3402/jev.v1i0.18396 50.",Non-OADS,/arxiv_data1/oa_pdf/86/44/JEV-5-25355.PMC4834364.pdf
"Proteome proﬁling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differentialExtensive surface protein profiles of extracellular vesicles Citation: Journal of Extracellular Vesicles 2016, 5: 25355 - http://dx.doi.org/10.3402/jev.v5.25355 11 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/86/44/JEV-5-25355.PMC4834364.pdf
"2015;4:26659, doi: http://dx.doi.org/10.3402/jev.v4.",Non-OADS,/arxiv_data1/oa_pdf/86/44/JEV-5-25355.PMC4834364.pdf
"2014;9:e103310, doi: http://dx.doi.org/10.1371/journal.pone.0103310 76.",Non-OADS,/arxiv_data1/oa_pdf/86/44/JEV-5-25355.PMC4834364.pdf
"12 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 25355 - http://dx.doi.org/10.3402/jev.v5.25355",OADS,/arxiv_data1/oa_pdf/86/44/JEV-5-25355.PMC4834364.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/44/39/hepatmon-16-01-31245.PMC4834379.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.Dear Editor, Vitamin D has been identified as an immune-modulator  due to its immunomodulatory effects on cells of the im - mune system during the last decade.",Non-OADS,/arxiv_data1/oa_pdf/31/e6/hepatmon-16-01-35525.PMC4834380.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/60/c6/hepatmon-16-01-32354.PMC4834381.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/93/52/hepatmon-16-01-34483.PMC4834416.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Infection Ecology and Epidemiology 2016, 6: 31099 - http://dx.doi.org/10.3402/iee.v6.31099 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/8e/9d/IEE-6-31099.PMC4834417.pdf
"2 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 31099 - http://dx.doi.org/10.3402/iee.v6.31099",Non-OADS,/arxiv_data1/oa_pdf/8e/9d/IEE-6-31099.PMC4834417.pdf
"TBEV: tick-borne encephalitis virus; LIV: louping ill virus; CSFV: classical swine fever virus; USUV: Usutu vi rus; WNV: West Nile virus; DENV: dengue virus; YFV: yellow fever virus; JEV: Japanese encephalitis virus; IgG: immuno globulin of subtype G; ELISA: enzyme-linked imm unosorbent assay; SNT: seroneutralisation test; IFA: immunofluorescence assay; HIT: ha emagglutination inhibition test; PRNT: plaque reduction neutralisation test; Bold /C30positive result, not bold /C30negative or borderline result, NEG: negative result; /: no result due to bad quality or lack of volume sample.TBEV serology in Flemish wild boar Citation: Infection Ecology and Epidemiology 2016, 6: 31099 - http://dx.doi.org/10.3402/iee.v6.31099 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/8e/9d/IEE-6-31099.PMC4834417.pdf
Availablefrom: http://stud.epsilon.slu.se [cited 17 November 2014].,Non-OADS,/arxiv_data1/oa_pdf/8e/9d/IEE-6-31099.PMC4834417.pdf
Available from: http://www.natuurenbos.be/nl-BE/natuurbeleid/soortenbeleid/ ziekten [cited 11 November 2015].,Non-OADS,/arxiv_data1/oa_pdf/8e/9d/IEE-6-31099.PMC4834417.pdf
"4 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 31099 - http://dx.doi.org/10.3402/iee.v6.31099",Non-OADS,/arxiv_data1/oa_pdf/8e/9d/IEE-6-31099.PMC4834417.pdf
"Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 259 e260 http://dx.doi.org/10.1016/j.ipej.2016.02.002 0972-6292/Copyright ©2016, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/ab/7b/main.PMC4834421.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ab/7b/main.PMC4834421.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/91/95/aapm-06-01-32360.PMC4834422.pdf
"Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 249 e250 http://dx.doi.org/10.1016/j.ipej.2016.02.003 0972-6292/Copyright ©2016, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/29/b4/main.PMC4834423.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/29/b4/main.PMC4834423.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/43/58/aapm-06-01-30071.PMC4834424.pdf
"Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 245 e248 http://dx.doi.org/10.1016/j.ipej.2016.02.001 0972-6292/Copyright ©2016, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/da/c5/main.PMC4834425.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/da/c5/main.PMC4834425.pdf
"Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 255 e258 http://dx.doi.org/10.1016/j.ipej.2015.11.004 0972-6292/Copyright ©2015, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/3c/7c/main.PMC4834426.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3c/7c/main.PMC4834426.pdf
"Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 251 e254 http://dx.doi.org/10.1016/j.ipej.2016.02.004 0972-6292/Copyright ©2016, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/85/76/main.PMC4834427.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/85/76/main.PMC4834427.pdf
Rev Esp Cardiol 2010;63:1444 e51.http://www.revespcardiol.org/en/ linkresolver/alteraciones-conduccion-auriculoventricularpredictores-necesidad/13188306/ .,Non-OADS,/arxiv_data1/oa_pdf/85/76/main.PMC4834427.pdf
Circulation2007;116:2005 e11.http://circ.ahajournals.org/content/116/18/ 2005.long .,Non-OADS,/arxiv_data1/oa_pdf/85/76/main.PMC4834427.pdf
J Cardiovasc Electrophysiol1993;4:253 e62.http://www.ncbi.nlm.nih.gov/pubmed/ 8269297 .,Non-OADS,/arxiv_data1/oa_pdf/85/76/main.PMC4834427.pdf
Circulation 2001;103:1102 e8.http://circ.ahajourn als.org/content/103/ 8/1102.long .indian pacing and electrophy siology journal 15 (2015) 251 e254 254,Non-OADS,/arxiv_data1/oa_pdf/85/76/main.PMC4834427.pdf
"Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 261 e264 http://dx.doi.org/10.1016/j.ipej.2016.03.001 0972-6292/Copyright ©2016, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/5a/4d/main.PMC4834438.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/4d/main.PMC4834438.pdf
"Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 227 e235 http://dx.doi.org/10.1016/j.ipej.2016.02.012 0972-6292/Copyright ©2016, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/0f/c6/main.PMC4834439.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0f/c6/main.PMC4834439.pdf
"Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 265 e267 http://dx.doi.org/10.1016/j.ipej.2016.02.014 0972-6292/Copyright ©2016, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/bb/a8/main.PMC4834440.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bb/a8/main.PMC4834440.pdf
JCardiovasc Electrophysiol 2015 Oct 15. http://dx.doi.org/ 10.1111/jce.12857 [Epub ahead of print].indian pacing and electrophy siology journal 15 (2015) 265 e267 267,Non-OADS,/arxiv_data1/oa_pdf/bb/a8/main.PMC4834440.pdf
"Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 236 e244 http://dx.doi.org/10.1016/j.ipej.2016.02.006 0972-6292/Copyright ©2016, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/da/f2/main.PMC4834441.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/da/f2/main.PMC4834441.pdf
Available at: http://www.cms.gov/medicare- coverage-database/details/ncd-details.aspx?,Non-OADS,/arxiv_data1/oa_pdf/da/f2/main.PMC4834441.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/a4/01/aapm-06-01-32101.PMC4834447.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/60/ad/nihms774440.PMC4834450.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.vaccine.2015.02.042 .",OADS,/arxiv_data1/oa_pdf/60/ad/nihms774440.PMC4834450.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/c7/6e/10.1177_2325967116642433.PMC4834467.pdf
"Warning letter to IntelliCell Biosciences, Inc. March 13, 2012. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ 2012/ucm297245.htm.",Non-OADS,/arxiv_data1/oa_pdf/c7/6e/10.1177_2325967116642433.PMC4834467.pdf
"Ottawa, ON: Royal College of Physicians and Surgeons of Canada, 2015.  http://www.royalcollege.ca/portal/page/portal/rc/canmeds/ framework (accessed 31 August 2015).",Non-OADS,/arxiv_data1/oa_pdf/d4/23/10.1177_2050312116643907.PMC4834470.pdf
"Can J Psychiatry 2009; 54(3): 35–45, http://www.ncbi.nlm.nih.gov/pubmed/19321021  4.",Non-OADS,/arxiv_data1/oa_pdf/d4/23/10.1177_2050312116643907.PMC4834470.pdf
"Aust Fam Physician 2007; 36(10): 877–880,  http://www.ncbi.nlm.nih.gov/pubmed/17925914  36.",Non-OADS,/arxiv_data1/oa_pdf/d4/23/10.1177_2050312116643907.PMC4834470.pdf
"Can Fam Physician 2008; 54: 234–235,  http://www.ncbi.nlm.nih.gov/pubmed/18272641  43.",Non-OADS,/arxiv_data1/oa_pdf/d4/23/10.1177_2050312116643907.PMC4834470.pdf
"Can J Psychiatry 2006; 51(8): 512–522, http://www.ncbi.nlm.nih.gov/pubmed/16933588  49.",Non-OADS,/arxiv_data1/oa_pdf/d4/23/10.1177_2050312116643907.PMC4834470.pdf
"Acad Med 2006;  81(1): 86–93, http://www.ncbi.nlm.nih.gov/pubmed/16377827  58.",Non-OADS,/arxiv_data1/oa_pdf/d4/23/10.1177_2050312116643907.PMC4834470.pdf
"J Bone Joint Surg Am 2004; 86-A: 1579–1586, http://www.ncbi.nlm.nih.gov/ pubmed/15252111  59.",Non-OADS,/arxiv_data1/oa_pdf/d4/23/10.1177_2050312116643907.PMC4834470.pdf
"v10i.4387, http://med-ed-online.net/index.php/meo/article/view/4387/4569  62.",Non-OADS,/arxiv_data1/oa_pdf/d4/23/10.1177_2050312116643907.PMC4834470.pdf
"Patient Educ Couns 2013; 91: 243–248, http://dx.doi.org/10.1016/j.pec.2012.11.006  69.",OADS,/arxiv_data1/oa_pdf/d4/23/10.1177_2050312116643907.PMC4834470.pdf
"Health Commun 2014, http://dx.doi.org/10.1080/10410236.",Non-OADS,/arxiv_data1/oa_pdf/d4/23/10.1177_2050312116643907.PMC4834470.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/51/ad/10.1177_2048004016634149.PMC4834471.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non- commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.BIOPRESERVATION AND BIOBANKING Volume 14, Number 2, 2016Mary Ann Liebert, Inc.DOI: 10.1089/bio.2015.0088 172",Non-OADS,/arxiv_data1/oa_pdf/47/0e/bio.2015.0088.PMC4834486.pdf
Armstrong et al 201 National Psoriasis Foundation Web site (https://www.psoriasis.org)  is an important source of guidance for how to overcome insurance hurdles.,Non-OADS,/arxiv_data1/oa_pdf/87/40/10.1177_1203475415623508.PMC4834511.pdf
"The Web site includes a variety of resources, including sample letters for requesting information regarding how to appeal a denial, submitting an appeal for the denial of a claim, or requesting an external review by the state insurance commission (https://www.psoriasis.org/access-   care/insurance-center/appeal-a-claim/sample-letters).",Non-OADS,/arxiv_data1/oa_pdf/87/40/10.1177_1203475415623508.PMC4834511.pdf
"The National Psoriasis Foundation Web site also includes a sec-tion reviewing biologic drug manufacturer programs, which may be a source of financial support for patients who are uninsured, are unable to afford the medication despite insur - ance, or have Medicare or Medicaid coverage (https://www.psoriasis.org/access-care/insurance/financial-assistance/bio - logics).",Non-OADS,/arxiv_data1/oa_pdf/87/40/10.1177_1203475415623508.PMC4834511.pdf
"Listings of private foundations that provide financial assistance with high out-of-pocket costs, which may include copays, are also available on the Web site (https://www.psoriasis .org/access-care/insurance/ financial-assistance/copay).",Non-OADS,/arxiv_data1/oa_pdf/87/40/10.1177_1203475415623508.PMC4834511.pdf
"Finally, although practical challenges with insurance approval exist, they can be overcome with an organized demonstration of clear clinical need (https://www.psoriasis.org/health-care-providers/working-with-health-plans).",Non-OADS,/arxiv_data1/oa_pdf/87/40/10.1177_1203475415623508.PMC4834511.pdf
Available  at: http://clinicaltrials.gov/ct2/show/NCT01722331.,Non-OADS,/arxiv_data1/oa_pdf/87/40/10.1177_1203475415623508.PMC4834511.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License ( <http://creativecommons.org/licenses/by-nc/4.0/ >) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.JOURNAL OF WOMEN’S HEALTH Volume 25, Number 4, 2016Mary Ann Liebert, Inc.DOI: 10.1089/jwh.2015.5287 340",Non-OADS,/arxiv_data1/oa_pdf/38/ce/jwh.2015.5287.PMC4834525.pdf
Available at: http://www.nimh.nih.gov/research-priorities/scientiﬁc- meetings/2011/post-traumatic-stress-disorder-ptsd-risk- prediction/index.shtml.,Non-OADS,/arxiv_data1/oa_pdf/38/ce/jwh.2015.5287.PMC4834525.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncom-mercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.ASTROBIOLOGY Volume 16, Number 3, 2016Mary Ann Liebert, Inc.DOI: 10.1089/ast.2015.1441 201",Non-OADS,/arxiv_data1/oa_pdf/e8/d5/ast.2015.1441.PMC4834528.pdf
"In the ﬁrst call of Horizon 2020 (2014), the topic Space exploration and science (with a total budget of 4 M e) focused on Mars data evaluation and on the deﬁnition of a European sample curation facility for sample return mis-sions (see http://www.euro-c ares.com), in addition to dedicated technology developments.",Non-OADS,/arxiv_data1/oa_pdf/e8/d5/ast.2015.1441.PMC4834528.pdf
"For 15 years, EANA has organized anannual workshop on astrobiology, providing a tangible fo- rum for interaction and collaboration, and is very active in the area of education through the ABC-Net lecture courses,a live teleteaching program performed in cooperation with ESA, interconnecting several European universities (Hor- neck and Rettberg, 2007) (see http://eana-net.eu/education.html).",Non-OADS,/arxiv_data1/oa_pdf/e8/d5/ast.2015.1441.PMC4834528.pdf
Other ongoing signiﬁcant initiatives include the European Astrobiology Campus (EAC—an Erasmus +strategic partnership) that will be active for the period 2014–2016 (see http://astrobiology-campus.eu/about-eac-2).,Non-OADS,/arxiv_data1/oa_pdf/e8/d5/ast.2015.1441.PMC4834528.pdf
European early-career astrobiologists are also organizing their networking through the Astrobiology Graduates in Eu- rope (AbGradE) association (see http://eana-net.eu/AbGradE/ about.html).,Non-OADS,/arxiv_data1/oa_pdf/e8/d5/ast.2015.1441.PMC4834528.pdf
Back- ground picture: M51 Hubble Remix (http://apod.nasa.gov/apod/ap080614.html).,Non-OADS,/arxiv_data1/oa_pdf/e8/d5/ast.2015.1441.PMC4834528.pdf
"For the European planetary science community, the European Planetary Net- work Europlanet was founded in 2005 with the aim of acting as a platform for the exchange of ideas, personnel, tools, anddata (see http://www.europlanet-eu.org).",Non-OADS,/arxiv_data1/oa_pdf/e8/d5/ast.2015.1441.PMC4834528.pdf
State of the art Almost 200 organic molecules have been detected as gaseous species in space (http://astrochymist.org/ astrochymist_mole.html).,OADS,/arxiv_data1/oa_pdf/e8/d5/ast.2015.1441.PMC4834528.pdf
"Of course, much data already exists, both from observations ( e.g., the plethora of cometary molecules observed in cometary comae, seehttp://astrochymist.org/astrochymist_comet.html) and from laboratory experiments.",Non-OADS,/arxiv_data1/oa_pdf/e8/d5/ast.2015.1441.PMC4834528.pdf
"For optimal accomplishment of thesuggested research key objectives, it is necessary to initiate more interdisciplinary cooperation between all these dif- ferent research directions and facilities on a larger scale.Part of this work has already been accomplished via EANA (http://www.eana-net.eu).",Non-OADS,/arxiv_data1/oa_pdf/e8/d5/ast.2015.1441.PMC4834528.pdf
"Due to all these possibilities that allow industry to reduce energy use, employ sustainable processes, and develop novel energy sources, products, and procedures, many countries worldwide are nowinvesting large amounts of money to support this development, applied to endeavors on Earth and in space ( e.g., the German biotechnology program of BMBF—https://www.biotechnolo-gie2020plus.de; http://www.planetaryresources.com).",Non-OADS,/arxiv_data1/oa_pdf/e8/d5/ast.2015.1441.PMC4834528.pdf
"Available online at http://www.almaobservatory.org/press-room/ press-releases/771-revolutionar y-alma-image-reveals-planetary- genesis Altermann, W. and Wotherspoon, J.McD.",Non-OADS,/arxiv_data1/oa_pdf/e8/d5/ast.2015.1441.PMC4834528.pdf
Available online at http://carex-eu.ameos.net/carex- roadmap-for-research-on-life-in-extreme-environments.htmlCAREX.,Non-OADS,/arxiv_data1/oa_pdf/e8/d5/ast.2015.1441.PMC4834528.pdf
"Available online at http://carex-eu.ameos.net/activities/ carex-forum-on-applications.html Chan, Y., Lacap, D.C., Lau, M.C., Ha, K.Y., Warren-Rhodes, K.A., Cockell, C.S., Cowan, D.A., McKay, C.P., and Point- ing, S.B.",Non-OADS,/arxiv_data1/oa_pdf/e8/d5/ast.2015.1441.PMC4834528.pdf
"Available online at http://www.gwu.edu/ *spi/assets/docs/ EarthX_COSPAR2011.pdf Eigen, M. (1971) Self organization of matter and the evolution of biological macromolecules.",OADS,/arxiv_data1/oa_pdf/e8/d5/ast.2015.1441.PMC4834528.pdf
"Available at http://www.esa.int/About_Us/ESA_Publications/ESA_Publicat ions_Brochures/ESA_BR-315_ Towards_a_Science-led_One_ESA Hoehler, T.M.",Non-OADS,/arxiv_data1/oa_pdf/e8/d5/ast.2015.1441.PMC4834528.pdf
"Available online at http://mase.esf.org Maurette, M. (2006) Micrometeorites and the Mysteries of Our Origins , Springer, Berlin.",Non-OADS,/arxiv_data1/oa_pdf/e8/d5/ast.2015.1441.PMC4834528.pdf
"Available online at http://mepag.nasa.gov/ reports.cfm?expand=science Mills, D.B., Ward, L.M., Jones, C., Sweeten, B., Forth, M., Treusch, A.H., and Canﬁeld, D.E.",OADS,/arxiv_data1/oa_pdf/e8/d5/ast.2015.1441.PMC4834528.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/e6/33/aapm-06-01-33434.PMC4834529.pdf
Competing Interests All authors have completed the Uni ﬁed Competing Interest form at http://www.icmje.org/c oi_disclosure.pdf (available on request from the corresponding author).,Non-OADS,/arxiv_data1/oa_pdf/d2/46/BCP-81-0878.PMC4834603.pdf
Supporting Information Additional Supporting Information may be found in the online version of this article at the publisher ’s web-site: http://onlinelibrary.wiley.com/doi/10.1111/bcp.,Non-OADS,/arxiv_data1/oa_pdf/d2/46/BCP-81-0878.PMC4834603.pdf
"[18]Forexample ,thisensures thatwhen rotating amolecule relative tothesurface ,itsbond distances andbond angles donotchange .Thisapproach has proven tobechemically accurate inpredicting equilibria for[*]Dr.G.Piccini, M.Alessio, Prof. Dr.J.Sauer Institut f(o[z[rChemie, Humboldt-U niversit(o[[wt Unter denLinden 6,10099 Berlin (Germany ) E-mail :js@chemie.hu -berlin.de Dr.G.Piccini Present address :Departm entofChemistry andApplied Biosciences ETH Zurich, c/oUSICampus ViaGiuseppe Buffi 13,6900 Lugano, Ticino (Switzerla nd) Supportin ginformation forthisarticle canbefound under : http://dx.do i.org/10.1002/a nie.2016015 34.",Non-OADS,/arxiv_data1/oa_pdf/16/86/ANIE-55-5235.PMC4834608.pdf
"Available from URL: http://www.nice.org .uk/Guidance/CG178 Noguera A., Ballesta P ., Baeza I., et al.",Non-OADS,/arxiv_data1/oa_pdf/7e/59/APPY-8-154.PMC4834614.pdf
"Review Article J Gastric Cancer 2016;16(1):1 -7  http://dx.doi.org/10.5230/jgc.2016.16.1.1 Copyrights © 2016 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction Infection with the Epstein-Barr virus (EBV), a ubiquitous  oncogenic g-type herpes virus, is implicated in the etiology of  several lymphoid and epithelial malignancies, including Burkitt ’s  lymphoma, Hodgkin ’s lymphoma, nasal NK/T cell lymphoma,  nasopharyngeal carcinoma, and a subset of gastric carcinomas  (GCs).1-3 EBV-associated GC (EBVaGC) is defined as the mono- clonal proliferation of carcinoma cells with latent EBV infection, which can be demonstrated by in situ hybridization targeted at EBV-encoded small RNA (EBER).",Non-OADS,/arxiv_data1/oa_pdf/de/fb/jgc-16-1.PMC4834615.pdf
"Original Article J Gastric Cancer 2016;16(1):14-20  http://dx.doi.org/10.5230/jgc.2016.16.1.14 Copyrights © 2016 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction For many years, Japanese and Korean surgeons have em- phasized the importance of major gastrectomies with extensive lymphadenectomies as a part of curative treatment for gastric  cancer.",Non-OADS,/arxiv_data1/oa_pdf/48/65/jgc-16-14.PMC4834616.pdf
"Original Article J Gastric Cancer 2016;16(1):21-27  http://dx.doi.org/10.5230/jgc.2016.16.1.21 Copyrights © 2016 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction Gastric cancer (GC) is one of the most common types of ma- lignancy and is the third most frequent cause of cancer-related  deaths worldwide.1 Recently, several anticancer drugs and surgical  techniques have been developed for the treatment of GC; how-ever, the prognosis of patients with advanced GC remains poor.",Non-OADS,/arxiv_data1/oa_pdf/3b/95/jgc-16-21.PMC4834617.pdf
"Original Article J Gastric Cancer 2016;16(1):28-33  http://dx.doi.org/10.5230/jgc.2016.16.1.28 Copyrights © 2016 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction Despite an overall decline in the incidence of gastric car- cinoma, it remains the second leading cause of cancer-related  deaths worldwide, with the highest prevalence in Korea.1 A major  complication of gastric carcinoma is post-gastrectomy duodenal stump leakage, which can lead to intra-abdominal abscess, sepsis,  and even death.",Non-OADS,/arxiv_data1/oa_pdf/8e/2d/jgc-16-28.PMC4834618.pdf
"Original Article J Gastric Cancer 2016;16(1):34-42  http://dx.doi.org/10.5230/jgc.2016.16.1.34 Copyrights © 2016 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction Endoscopic submucosal dissection (ESD) is accepted as the  primary treatment for early gastric cancer (EGC) lesions that  meet the absolute indications for resection and can be considered as an investigational treatment for lesions that meet the expanded  indications and have a negligible risk of lymph node metasta - sis.1,2 After ESD for EGC lesions that meet the final pathological  curability criteria for ESD indications, long-term outcomes are  favorable and comparable between both criteria for absolute and  expanded indications.",Non-OADS,/arxiv_data1/oa_pdf/33/28/jgc-16-34.PMC4834619.pdf
"Original Article J Gastric Cancer 2016;16(1):43-50  http://dx.doi.org/10.5230/jgc.2016.16.1.43 Copyrights © 2016 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction As the average life expectancy for elderly persons is increas- ing dramatically in many parts of the world,1,2 many countries are  expected to develop what is known as super-aged societies in the  near future.",Non-OADS,/arxiv_data1/oa_pdf/92/4a/jgc-16-43.PMC4834620.pdf
Available from: http://www.who.int/gho/publications/world_ health_statistics/2014/en/.,Non-OADS,/arxiv_data1/oa_pdf/92/4a/jgc-16-43.PMC4834620.pdf
Available from: http://kosis.kr/.,Non-OADS,/arxiv_data1/oa_pdf/92/4a/jgc-16-43.PMC4834620.pdf
"Case Report J Gastric Cancer 2016;16(1):51-53  http://dx.doi.org/10.5230/jgc.2016.16.1.51 Copyrights © 2016 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction Natural orifice transluminal endoscopic surgery (NOTES) was  introduced as a new approach and surgical procedures can be  performed primarily through natural orifices, such as the mouth,  anus, or vagina.",Non-OADS,/arxiv_data1/oa_pdf/42/de/jgc-16-51.PMC4834621.pdf
"Case Report J Gastric Cancer 2016;16(1):54-57  http://dx.doi.org/10.5230/jgc.2016.16.1.54 Copyrights © 2016 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction Gastrointestinal intussusception in adults is a rare condi- tion and represents only 5% of all intussusceptions.1 Ileo-ileal  and colo-colic intussusceptions are the most common types of  gastrointestinal intussusceptions in adults.",Non-OADS,/arxiv_data1/oa_pdf/76/49/jgc-16-54.PMC4834622.pdf
"Case Report J Gastric Cancer 2016;16(1):58-62  http://dx.doi.org/10.5230/jgc.2016.16.1.58 Copyrights © 2016 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction Gastrointestinal stromal tumors (GISTs) are the most common  primary mesenchymal neoplasms of the gastrointestinal tract.1  Although GISTs may occur throughout the gastrointestinal tract,  approximately 60% of them originate in the stomach and 30%  in the small intestine.2 GISTs usually appear as a discrete well- circumscribed but non-encapsulated mass with variable gross appearances, growing as intraluminal, extraluminal, or combina- tion forms.",Non-OADS,/arxiv_data1/oa_pdf/c7/1b/jgc-16-58.PMC4834623.pdf
"Original Article J Gastric Cancer 2016;16(1):8 -13  http://dx.doi.org/10.5230/jgc.2016.16.1.8 Copyrights © 2016 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction The Journal of Gastric Cancer (JGC) has been the official  journal of the Korean Gastric Cancer Association since 2001.",Non-OADS,/arxiv_data1/oa_pdf/3f/0f/jgc-16-8.PMC4834624.pdf
"The following were retrieved or analyzed from the data in  the journal ’s biography, which are available at http://www.jgc- online.org/and the Web of Science Core Collection database [cited  2016 Jan 30]: the number of citable and non-citable articles; the number of original articles supported by grants; the editorial  board members ’ national origins; the authors ’ national origins;  the total citations; the impact factors; the citing authors ’ national  origins; the source titles of citing articles; and the Hirsch index  (h-index).",Non-OADS,/arxiv_data1/oa_pdf/3f/0f/jgc-16-8.PMC4834624.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/4a/8b/aapm-06-01-27515.PMC4834662.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/78/ae/aapm-06-01-32509.PMC4834663.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/b9/a9/aapm-06-01-30326.PMC4834664.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/75/47/aapm-06-01-31046.PMC4834665.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c6/4f/main.PMC4834672.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 455–457 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2014.11.003 1319-0164 ª2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/c6/4f/main.PMC4834672.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c6/4f/main.PMC4834672.pdf
"17 (2015) 44, http://dx.doi.org/10.1186/ s12968-015-0148-7 .",Non-OADS,/arxiv_data1/oa_pdf/2b/a1/main.PMC4834673.pdf
"Sinda Zarrouk-Mahjoub Genomics Platform, Pasteur Institute of Tunis, Tunisia 27 March 2016 http://dx.doi.org/10.1016/j.ymgmr.2016.03.008 2214-4269/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/2b/a1/main.PMC4834673.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2b/a1/main.PMC4834673.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/87/ef/main.PMC4834674.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 413–420 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.01.012 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/87/ef/main.PMC4834674.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/87/ef/main.PMC4834674.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ce/24/main.PMC4834676.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 458–462 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2014.11.005 1319-0164 ª2014 Production and hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/ce/24/main.PMC4834676.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ce/24/main.PMC4834676.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: β-Thalassemia Compound heterozygousβ +/β0mutation Amniotic ﬂuid Nucleotide sequencing 1.,Non-OADS,/arxiv_data1/oa_pdf/8e/2a/main.PMC4834677.pdf
Contents lists available at ScienceDirect Molecular Genetics and Metabolism Reports journal homepage: www.elsevier.com/locate/ymgmr http://dx.doi.org/10.1016/j.ymgmr.2016.04.002 2214-4269/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8e/2a/main.PMC4834677.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8e/2a/main.PMC4834677.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 381–387 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.01.003 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/ff/bf/main.PMC4834678.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ff/bf/main.PMC4834678.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ff/bf/main.PMC4834678.pdf
"Aprepitant, which are more effective in controlling and even preventing nausea and vomit-ing ( http://www.cancer.gov/cancertopics/pdq/supportivecare/ nausea/HealthProfessional/page 6 Accessed June 2008, Poli- Bigelli et al., 2003; Richard et al., 1999; Kaiser, 2005 ).",Non-OADS,/arxiv_data1/oa_pdf/ff/bf/main.PMC4834678.pdf
"Guidelines for the management of CINV that integrate clinical research into practices have been developed by reputa- ble institutions including; the Multinational Association of Supportive Care in Cancer ( MASCC ), (http://www.mascc.",Non-OADS,/arxiv_data1/oa_pdf/ff/bf/main.PMC4834678.pdf
http://dx.doi.org/ 10.1200/JCO.2010.34.4614 .,OADS,/arxiv_data1/oa_pdf/ff/bf/main.PMC4834678.pdf
http://dx.doi.org/10.1634/theoncol- ogist.12-9-1143 .,Non-OADS,/arxiv_data1/oa_pdf/ff/bf/main.PMC4834678.pdf
http://dx.doi.org/10.1016/S1470- 2045(05)70284-9 .,OADS,/arxiv_data1/oa_pdf/ff/bf/main.PMC4834678.pdf
< http://www.nehi.net/writable/publication_ﬁles/ﬁle/cpg_ report_ﬁnal.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/ff/bf/main.PMC4834678.pdf
"4, 54. http:// dx.doi.org/10.1186/1748-5908-4-54 ,< http://www.ncbi.nlm.nih.",Non-OADS,/arxiv_data1/oa_pdf/ff/bf/main.PMC4834678.pdf
http://dx.doi.org/ 10.1007/s11606-006-0075-2 .,Non-OADS,/arxiv_data1/oa_pdf/ff/bf/main.PMC4834678.pdf
< http://www.mascc.org/antiemetic-guide- lines> (accessed June 2008).,Non-OADS,/arxiv_data1/oa_pdf/ff/bf/main.PMC4834678.pdf
< http://www.cancer.gov/cancertopics/pdq/ supportivecare/nausea/HealthProfessional/page > 1 (accessed June 2008).,Non-OADS,/arxiv_data1/oa_pdf/ff/bf/main.PMC4834678.pdf
http://dx.doi.org/10.1007/s11096-010-9454-1 .,Non-OADS,/arxiv_data1/oa_pdf/ff/bf/main.PMC4834678.pdf
"Cancer, 97(12), 3090-3098, < http://www.ncbi.nlm.nih.gov/pubmed/12784346 >.",Non-OADS,/arxiv_data1/oa_pdf/ff/bf/main.PMC4834678.pdf
"Oncol., < http://jcoascopubs.org/content/17/9/2971.full >.Roila, F., Del Favero, A., Gralla, R.J., Tonato, M., 1998.",Non-OADS,/arxiv_data1/oa_pdf/ff/bf/main.PMC4834678.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Cardiac hypertrophyDiastolic dysfunctionEnzyme replacement therapy Glycosaminoglycans Mucopolysaccharidosis VIPulmonary functionMolecular Genetics and Metabolism Reports 7 (2016) 63 –69 Abbreviations: MPS, mucopolysaccharidosis; ASB, N-acetylgalactosamine 4-sulfatase; GAG, glycosaminoglycan; ERT, enzyme replacement therapy; Galsulfase, recombinant human N- acetylgalactosamine 4-sulfatase; Zscore, standard deviation score; 6MWT, 6-minute walk test; 3MSCT, 3-minute stair climb test; FVC, Forced vital capacity; FEV 1, forced expiratory volume in 1 s; E/A, ratio between early and late (atrial) ventricular ﬁlling velocity; LVMI, left ventricular mass index; IVSd, interventricular septum thickness in diastole; LVPWd, left ventricular posterior wall thickness in diastole; LVM, left ventricular mass; BMD, bone mineral density; HAZ, height-for-age; DXA, dual energy x-ray absorptio metry; PTA, pure-tone audiometry; AC, air conduction; BC, bone conduction; HAQ, Health Assessment Questionnaire; CHAQ, Childhood Health Assessment Questionnaire.",Non-OADS,/arxiv_data1/oa_pdf/af/8c/main.PMC4834679.pdf
http://dx.doi.org/10.1016/j.ymgmr.2016.04.003 2214-4269/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/af/8c/main.PMC4834679.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/8c/main.PMC4834679.pdf
http://dx.doi.org/10.1016/j.jsps.2013.12.012,OADS,/arxiv_data1/oa_pdf/51/a5/main.PMC4834680.pdf
"Biomed.. http://dx.doi.org/10.1016/ j.rbmo.2013.07.005 , Epub ahead of print.",OADS,/arxiv_data1/oa_pdf/51/a5/main.PMC4834680.pdf
"Sinda Zarrouk-Mahjoub Genomics Platform, Pasteur Institute of Tunis, Tunisia 29 March 2016Molecular Genetics and Metabolism Reports 7 (2016) 50 http://dx.doi.org/10.1016/j.ymgmr.2016.03.011 2214-4269/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/20/94/main.PMC4834681.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/94/main.PMC4834681.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c6/d2/main.PMC4834682.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 444–452 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.01.016 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/c6/d2/main.PMC4834682.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c6/d2/main.PMC4834682.pdf
http://dx.doi.org/ 10.1016/j.arabjc.2011.08.012 .,OADS,/arxiv_data1/oa_pdf/c6/d2/main.PMC4834682.pdf
< http://www.ich.org/ﬁleadmin/Public_Web_Site/ICH_Prod- ucts/Guidelines/Quality/Q2_R1/Step4/Q2_R1__Guideline.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/c6/d2/main.PMC4834682.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/76/a9/main.PMC4834683.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 437–443 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.01.015 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/76/a9/main.PMC4834683.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/76/a9/main.PMC4834683.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 388–396 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.01.013 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/c8/4d/main.PMC4834684.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/4d/main.PMC4834684.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/4d/main.PMC4834684.pdf
< http://www.moh.gov.sg/content/moh_web/ home/our_healthcare_system/Healthcare_Services/Hospitals.html > (accessed 7.09.14).,Non-OADS,/arxiv_data1/oa_pdf/c8/4d/main.PMC4834684.pdf
< http://www.ahrq.gov/research/ﬁndings/factsheets/ errors-safety/aderia/index.html > (accessed 12.04.14).,Non-OADS,/arxiv_data1/oa_pdf/c8/4d/main.PMC4834684.pdf
< http://www.moh.gov.,Non-OADS,/arxiv_data1/oa_pdf/c8/4d/main.PMC4834684.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 421–428 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2014.11.007 1319-0164 ª2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/23/16/main.PMC4834685.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/23/16/main.PMC4834685.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/23/16/main.PMC4834685.pdf
Commun.http://dx.doi.org/10.1039/C3CC42914H .,Non-OADS,/arxiv_data1/oa_pdf/23/16/main.PMC4834685.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 371–376 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2014.11.006 1319-0164 ª2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/53/92/main.PMC4834686.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/53/92/main.PMC4834686.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/53/92/main.PMC4834686.pdf
Res..http://dx.doi.org/10.1155/2010/915296 .376 J. Jose et al.,OADS,/arxiv_data1/oa_pdf/53/92/main.PMC4834686.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 397–404 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.01.014 1319-0164 ª2015 Production and hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/d9/9a/main.PMC4834687.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/9a/main.PMC4834687.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/9a/main.PMC4834687.pdf
"These demographics have driven overall pharmaceutical expenditure to increase by around 10% from 2010 to 2012 ( http://www.pressbox.co.uk/detailed/Business/ Generics_to_Scale_High_in_Saudi_Arabian_Pharmaceutical_ Market_664609.html , 2011) and is expected to continue putting pressure on the Saudi economy in the future.",Non-OADS,/arxiv_data1/oa_pdf/d9/9a/main.PMC4834687.pdf
"With over $100 billion worth of innovator drugs losing their patent protection between 2010 and 2014, it is essential forcountries to develop their generic drug manufacturing capabil- ities to take advantage of this new market ( http://www.report- linker.com/ci02261/Generic-Drug.html , 2012).",Non-OADS,/arxiv_data1/oa_pdf/d9/9a/main.PMC4834687.pdf
< http://assets.aarp.org/rgcenter/health/phys_generic.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/d9/9a/main.PMC4834687.pdf
< http://old.sfda.gov.sa/NR/rdonlyres/ 6A114B70-4201-46EF-B4C7-127FD66D3314/0/BioequivalenceRe-quirementGuidelines.pdf .,Non-OADS,/arxiv_data1/oa_pdf/d9/9a/main.PMC4834687.pdf
< http://www.bttrading.org/downloads/ Saudi%20Arabian%20Budget%202012.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/d9/9a/main.PMC4834687.pdf
< http://www.abpi.org.uk/industry-info/knowl- edge-hub/global-industry/pages/industry-market-.aspx >.,Non-OADS,/arxiv_data1/oa_pdf/d9/9a/main.PMC4834687.pdf
< http://www.gabionline.net/ layout/set/print/content/view/full/2211 >.,Non-OADS,/arxiv_data1/oa_pdf/d9/9a/main.PMC4834687.pdf
"142 (11), 896. www.annals.org Downloaded From: < http://annals.org/on 11/04/2014Common- wealth Fund >.",Non-OADS,/arxiv_data1/oa_pdf/d9/9a/main.PMC4834687.pdf
< http://www.efpia.eu/sites/www.,Non-OADS,/arxiv_data1/oa_pdf/d9/9a/main.PMC4834687.pdf
"WHO, The WHO Factsheet No 335, (internet), 2009 December, (cited on 2012 August 3), < http://www.who.int/mediacentre/factsheets/ fs335/en/ >.404 H.O.",Non-OADS,/arxiv_data1/oa_pdf/d9/9a/main.PMC4834687.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/54/main.PMC4834688.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 377–380 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.01.001 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/5a/54/main.PMC4834688.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/54/main.PMC4834688.pdf
"Production and hosting by Elsevier Figure 1 Potential therapeutic targets to slow or prevent the spread of tau pathology in the brain ( Pooler et al., 2013 ).Saudi Pharmaceutical Journal (2015) 23, 405–406 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.01.017 1319-0164 ª2015 The Author.",Non-OADS,/arxiv_data1/oa_pdf/f8/c6/main.PMC4834689.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f8/c6/main.PMC4834689.pdf
"Therapy 6, 29. http://dx.doi.org/10.1186/ alzrt259 .",Non-OADS,/arxiv_data1/oa_pdf/f8/c6/main.PMC4834689.pdf
"Therapy 5, 49. http://dx.doi.org/10.1186/alzrt214 .",Non-OADS,/arxiv_data1/oa_pdf/f8/c6/main.PMC4834689.pdf
http://dx.doi.org/10.1016/j.jsps.2014.04.002,OADS,/arxiv_data1/oa_pdf/9c/fc/main.PMC4834691.pdf
"49 (1), 1–5, http://dx.doi.org/10.1016/ j.jsps.2014.02.010 .",OADS,/arxiv_data1/oa_pdf/9c/fc/main.PMC4834691.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 429–436 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.01.007 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/7b/35/main.PMC4834692.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/35/main.PMC4834692.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/35/main.PMC4834692.pdf
http://dx.doi.org/10.1016/j.jsps.2013.12.013,OADS,/arxiv_data1/oa_pdf/3d/5f/main.PMC4834693.pdf
< http://www.buchi.com >.,Non-OADS,/arxiv_data1/oa_pdf/3d/5f/main.PMC4834693.pdf
< http://www.pharma- info.net/reviews/spray-drying-review >.,Non-OADS,/arxiv_data1/oa_pdf/3d/5f/main.PMC4834693.pdf
< http://www.scolr.- com/lit/PMPS_2003_1.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/3d/5f/main.PMC4834693.pdf
< http://www.dspace.mit.edu/ bitstream/handle/1721.1/7480/ MEBCS009.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/3d/5f/main.PMC4834693.pdf
Today: Technol.. http://dx.doi.org/10.1016/ j.ddtec.2011.10.002 .,OADS,/arxiv_data1/oa_pdf/3d/5f/main.PMC4834693.pdf
http://dx.doi.org/10.1016/j.ijpharm.2012.07.015 .,OADS,/arxiv_data1/oa_pdf/3d/5f/main.PMC4834693.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 366–370 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2014.11.014 1319-0164 ª2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/4e/60/main.PMC4834694.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/60/main.PMC4834694.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/60/main.PMC4834694.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 341–351 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2014.08.004 1319-0164 ª2015 Production and hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/72/f4/main.PMC4834695.pdf
< http://www.cancer.gov/cancertopics/drug- info/melanoma > (Accessed 17.02.13).,Non-OADS,/arxiv_data1/oa_pdf/72/f4/main.PMC4834695.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/66/e3/main.PMC4834719.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 407–412 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2014.11.009 1319-0164 ª2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/66/e3/main.PMC4834719.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/66/e3/main.PMC4834719.pdf
"Therefore,  access  was  obtained to  the  left  femoral  artery  and  the  contralateral  wire  was  snared  from http://dx.doi.org/10.1016/j.ijscr.2016.01.017 2210-2612/© 2016  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/be/6e/main.PMC4834720.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/39/8a/main.PMC4834721.pdf
Pathological anatomical diagnosis (PAD)Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2016.04.002 2211-7539/ &2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/39/8a/main.PMC4834721.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/39/8a/main.PMC4834721.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d7/78/ofw070.PMC4834739.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/96/9a/aapm-06-01-33886.PMC4834741.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/55/0b/aapm-06-01-32904.PMC4834742.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.Dear Editor, Pierre-Robin Syndrome (PRS) is characterized by micro - gnathia, glossoptosis, and a “u-shaped” cleft palate (1).",Non-OADS,/arxiv_data1/oa_pdf/30/55/aapm-06-01-33480.PMC4834743.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/15/6c/aapm-06-01-31210.PMC4834744.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.Inadequate access to antenatal care is still a major  concern in many developing countries, and reducing  pregnancy-related mortality is the main goal of national  and international organizations of maternal health (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/6b/d7/aapm-06-01-35506.PMC4834745.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/f8/de/aapm-06-01-32873.PMC4834746.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/36/18/gbu161.PMC4834761.pdf
Retrieved from https://www.mja.,Non-OADS,/arxiv_data1/oa_pdf/36/18/gbu161.PMC4834761.pdf
Retrieved from http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/36/18/gbu161.PMC4834761.pdf
Retrieved from http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/36/18/gbu161.PMC4834761.pdf
"Retrieved February 14, 2013, from http://www.ohri.ca/pro- grams/clinical_epidemiology/nosgen.pdf Williams, M., Baker, D., Parker, R., & Nurss, J.",Non-OADS,/arxiv_data1/oa_pdf/36/18/gbu161.PMC4834761.pdf
Available from: http://data.worldbank.org/indicator/SP.DYN.,OADS,/arxiv_data1/oa_pdf/9f/12/CMJ-128-571.PMC4834764.pdf
Available from: http://www.iofbonehealth.org/news/oste oporotic -fractures- cost-china%E2%80%99s-healthcare -system- close-10-billion-usd-annually.,Non-OADS,/arxiv_data1/oa_pdf/9f/12/CMJ-128-571.PMC4834764.pdf
The fALFF analysis was performed using the REST  software (http://resting-fmri.sourceforge.net).,OADS,/arxiv_data1/oa_pdf/44/cc/CMJ-128-593.PMC4834768.pdf
"A three-dimensional fast spoiled gradient recalled-echo  sequence covering the whole brain was used for structural  data acquisition with TR/TE/inversion time 6.5/2.1/400 ms,  FOV 256 mm × 256 mm, phase FOV 1, matrix 256 × 256,  slice thickness 1.0 mm, slice gap 0 mm,  number of signal  averages (NSA) 1, flip angle 15°, scan time 4 min 8 s. Data preprocessing SPM8 (http://www.fil.ion.ucl.ac.uk/spm/ ) was used for the  preprocessing of fMRI datasets.",OADS,/arxiv_data1/oa_pdf/0a/e4/CMJ-128-602.PMC4834769.pdf
"Single nucleotide polymorphism screening Based on Chinese Han population genetics data from  the database of SNPs (http://www.ncbi.nlm.nih.gov/SNP/;  the US National Center for Biotechnology Information), the  International HapMap Project  (http://www.hapmap.org/),  and previous studies,[15,16] the DRD3 SNP rs6280 locus was  selected for gene polymorphism analysis.",Non-OADS,/arxiv_data1/oa_pdf/40/53/CMJ-128-654.PMC4834778.pdf
National Cancer  Institute; 2014. http://www.seer.cancer.gov/statfacts/html/lungb.html.,Non-OADS,/arxiv_data1/oa_pdf/c1/26/CMJ-128-670.PMC4834781.pdf
"VCAlphaMed Press 1066-5099/2016/$30.00/0 http://dx.doi.org/ 10.1002/stem.2257 This is an open access article under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.",Non-OADS,/arxiv_data1/oa_pdf/58/b3/STEM-34-493.PMC4834794.pdf
"Sampleswere mounted in vectashield containing 4 0,6-diamidino-2-phe- nylindole (DAPI) (Vector Laboratories, Inc., Burlingame, CA,http://vectorlabs.com/vectashield-mounting-medium-with- dapi.html).",OADS,/arxiv_data1/oa_pdf/58/b3/STEM-34-493.PMC4834794.pdf
"Cornea sections of 8 lm were mounted onto Super- frost Plus Gold slides (Fisherscientiﬁc, Waltham, MA, http://www.thermoscientiﬁc.com/content/tfs/en/product/superfrost-plus-gold-slides.html) and incubated with chicken polyclonalto GFP antibody, at 1:1,000 (Abcam: 13970, Cambridge, MA,http://www.abcam.com/gfp-ant ibody-chip-grade-ab290.html) followed by secondary antibody (as above) anti chickenAlexa 488 (Life Technologies: A11039, South San Francisco,CA, https://webshop.ﬁshersci.com/insight2_uk/getProduct.do?productCode=10286672&resultSetPosition=0).",Non-OADS,/arxiv_data1/oa_pdf/58/b3/STEM-34-493.PMC4834794.pdf
"Total RNA was extracted using the RNA Easy Mini Kit (Qiagen, Gaithersburg, MD, https://www.qiagen.com/us /shop/sample-technologies/rna/ rna-preparation/rneasy-mini-kit), quantiﬁed and used in equal concentration of limbal and central corneal epithelium to gener- ate cDNA using a reverse transcriptase polymerase chain reac- tion (RT-PCR) kit according to the manufacturer’s protocol(Invitrogen, Grand Island, NY, http://www.thermoﬁsher.com/us/ en/home/life-science/pcr/reverse- transcription/rt-pcr.html).",Non-OADS,/arxiv_data1/oa_pdf/58/b3/STEM-34-493.PMC4834794.pdf
"The detached epithelialsheets were collected and incubated with 0.05% trypsin/ 0.03% EDTA (Life Technologies, Grand Island, NY, http://www.thermoﬁsher.com/order/catalog/product/25300054) at 37 8C for 10 minutes to isolate single cells using a spatula topeel off the corneal epithelium attached to the eyeball.The enzymatic reactions were stopped by adding CnT-50media supplemented with fetal calf serum (FCS) (Sigma, StLouis, MO, http://www.sigmaaldrich.com/catalog/product/ sigma/12133c?lang 5en&region 5US).",Non-OADS,/arxiv_data1/oa_pdf/58/b3/STEM-34-493.PMC4834794.pdf
"Colony Forming Assay Isolated epithelial cells from adult WT and Lhx2 cKO (6–10 weeks old) were seeded at 2,000 cells per well on Mitomycin C-treated (4lg/ml) mouse embryonic ﬁbroblast 3T3 feeder layer (Cell line: CCL-92) cultured in Dulbecco’s modiﬁed Eagle’s medium (LifeTechnologies, Grand Island, NY , http://www.thermoﬁsher.com/us/en/home/life-science/cell-cu lture/mammalian-cell-culture/ classical-media/dmem.html) containing 10% FCS in triplicateon six-well culture plates.",Non-OADS,/arxiv_data1/oa_pdf/58/b3/STEM-34-493.PMC4834794.pdf
"Corneal cells from adult WT and Lhx2 cKO (adult 6–9 weeks old) were iso- lated as described above and seeded at a density of 2.7 310 4 per square centimeter on tissue culture dishes coated with rat- tail I collagen (Life Technologies, Grand Island, NY, http://www.thermoﬁsher.com/order/catalog/product/A1048301) at a con- centration of 5 lg/cm 2.",Non-OADS,/arxiv_data1/oa_pdf/58/b3/STEM-34-493.PMC4834794.pdf
"For the detection of conjunctival tissue, sec- tions were processed as above and rabbit polyclonal Keratin15 antibody (Protein Tech Group, IL:10137-1-AP, Rosemont, IL,http://www.ptglab.com/Products/KRT15-Antibody-10137-1-AP .",Non-OADS,/arxiv_data1/oa_pdf/58/b3/STEM-34-493.PMC4834794.pdf
"Slides were stained in Schiff (Elec- tron Microscopy Sciences, PA, Hatﬁeld, PA, http://www.sigmaal-drich.com/catalog/product/sigma/3952016?lang=en&region=US) reagent, washed in tap water, and counterstained in Harris hae-motoxylin.",Non-OADS,/arxiv_data1/oa_pdf/58/b3/STEM-34-493.PMC4834794.pdf
Available from: http://vizhub.healthdata.org/gbd- compare/patterns Accessed 3 November 2015.,OADS,/arxiv_data1/oa_pdf/d3/2b/IDJ-66-99.PMC4834803.pdf
"LBP-related SHP PA programs and timelines are in Table S2, http://links.lww.com/BRS/B72, with setting and methodological details noted in the Supplement.There are three parts to this analysis: (1) Use and cost of pre-surgical nonoperative care, (2) trends in commercial SPH lumbar fusions, and (3) trends in HEDIS-defined back surgeries for SPH, PH, and national benchmarks.",Non-OADS,/arxiv_data1/oa_pdf/cb/4f/brs-41-810.PMC4834807.pdf
"Model coefficients explaining the use of total pre-lumbar fusion clinical services are in Table S4, http://links.lww.com/BRS/B72, with details on the modeling methodology, specifications, and diagnostics discussed in the Supplement.",Non-OADS,/arxiv_data1/oa_pdf/cb/4f/brs-41-810.PMC4834807.pdf
"The total cost model intercept value of $4338 represents the base case of the model variables and is the per-member mean of the total of standard allowed amounts of nonoperative patient management before either the SCR-PA or LBS-PA programs were implemented (Table S5, http://links.lww.com/BRS/B72).",Non-OADS,/arxiv_data1/oa_pdf/cb/4f/brs-41-810.PMC4834807.pdf
"Results are detailed in Tables S6 to S9, http://links.lww.com/BRS/B72, and summarized in Table 1.",OADS,/arxiv_data1/oa_pdf/cb/4f/brs-41-810.PMC4834807.pdf
"The model coefficients explaining episode length, in days, are in Table S10, http://links.lww.com/BRS/B72.",OADS,/arxiv_data1/oa_pdf/cb/4f/brs-41-810.PMC4834807.pdf
"Surgical Rate Trends Figure 1 shows the SHP rate of lumbar fusion surgeries, as defined for this study, for SHP Regions 1 and 2 (see Supple- ment, http://links.lww.com/BRS/B72).",Non-OADS,/arxiv_data1/oa_pdf/cb/4f/brs-41-810.PMC4834807.pdf
"rates over the 2007 to 2013 time interval (for methodologi- cal details see Supplement, Table S11, http://links.lww.com/ BRS/B72, http://links.lww.com/BRS/B72).",Non-OADS,/arxiv_data1/oa_pdf/cb/4f/brs-41-810.PMC4834807.pdf
Available at: http://www.abms.org/member- boards/specialty-subspecialty-certificates/.,Non-OADS,/arxiv_data1/oa_pdf/cb/4f/brs-41-810.PMC4834807.pdf
Available at: http://www.priorityhealth.com/ provider/manual/auths/ /C24/media/documents/medical-policies/ 91531.ashx.,Non-OADS,/arxiv_data1/oa_pdf/cb/4f/brs-41-810.PMC4834807.pdf
Available at: http://www.dartmouthat- las.org/downloads/reports/supply_sensitive.pdf.,OADS,/arxiv_data1/oa_pdf/cb/4f/brs-41-810.PMC4834807.pdf
Available at: http://www.uptodate.,Non-OADS,/arxiv_data1/oa_pdf/cb/4f/brs-41-810.PMC4834807.pdf
Available at: http://globenewswire.com/news-release/2012/10/19/ 498403/10009090/en/Unrealistic-Fear-of-Surgery-Prevents-People- From-Getting-Even-Basic-Back-Pain-Help.html.,Non-OADS,/arxiv_data1/oa_pdf/cb/4f/brs-41-810.PMC4834807.pdf
"2, Supplemental Digital Content 1, http://links.lww.com/JIT/A413).",Non-OADS,/arxiv_data1/oa_pdf/15/be/cji-39-140.PMC4834812.pdf
"S2, Supple- mental Digital Content 1, http://links.lww.com/JIT/A413) in some patients.",Non-OADS,/arxiv_data1/oa_pdf/15/be/cji-39-140.PMC4834812.pdf
"S3, Supple- mental Digital Content 1, http://links.lww.com/JIT/A413).",Non-OADS,/arxiv_data1/oa_pdf/15/be/cji-39-140.PMC4834812.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/da/fb/MOL2-10-566.PMC4834815.pdf
available at www.sciencedirect.com ScienceDirect www.elsevier.com /locate/molonc http://dx.doi.org/10.1016/j.molonc.2015.11.006 1574-7891/ ª2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/da/fb/MOL2-10-566.PMC4834815.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).MOLECULAR ONCOLOGY 10 (2016) 566 e574,Non-OADS,/arxiv_data1/oa_pdf/da/fb/MOL2-10-566.PMC4834815.pdf
"Copy number aberration analysis from WGS data Paired-end sequence reads were aligned to the human refer- ence genome GRCh37/hg19 using SMALT aligner (version0.7.1, http://www.sanger.ac.uk/resources/software/smalt/ ).",OADS,/arxiv_data1/oa_pdf/da/fb/MOL2-10-566.PMC4834815.pdf
"http://dx.doi.org/10.1126/scitranslmed.aab0021 , 302ra133.",Non-OADS,/arxiv_data1/oa_pdf/da/fb/MOL2-10-566.PMC4834815.pdf
http://dx.doi.org/10.1158/0008-5472.CAN-14-0934 .,Non-OADS,/arxiv_data1/oa_pdf/da/fb/MOL2-10-566.PMC4834815.pdf
http://dx.doi.org/10.1038/nm.3600 .,OADS,/arxiv_data1/oa_pdf/da/fb/MOL2-10-566.PMC4834815.pdf
http://dx.doi.org/ 10.1200/JCO.2010.33.3716 .,Non-OADS,/arxiv_data1/oa_pdf/da/fb/MOL2-10-566.PMC4834815.pdf
http://dx.doi.org/10.1038/nrclinonc.2013.253 .,OADS,/arxiv_data1/oa_pdf/da/fb/MOL2-10-566.PMC4834815.pdf
"http://dx.doi.org/ 10.1126/scitranslmed.3004742 , 162ra154.",Non-OADS,/arxiv_data1/oa_pdf/da/fb/MOL2-10-566.PMC4834815.pdf
http://dx.doi.org/ 10.1371/journal.pgen.1004271 eCollection 2014.,Non-OADS,/arxiv_data1/oa_pdf/da/fb/MOL2-10-566.PMC4834815.pdf
http://dx.doi.org/ 10.1038/nature12065 .,Non-OADS,/arxiv_data1/oa_pdf/da/fb/MOL2-10-566.PMC4834815.pdf
http://dx.doi.org/ 10.1038/ng.2396 .,Non-OADS,/arxiv_data1/oa_pdf/da/fb/MOL2-10-566.PMC4834815.pdf
"BMC Genomics 15, 1129. http://dx.doi.org/10.1186/1471-2164-15-1129 .",OADS,/arxiv_data1/oa_pdf/da/fb/MOL2-10-566.PMC4834815.pdf
This  is  an  open access article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d4/d5/main.PMC4834826.pdf
"Six  months  after  the  initiation  of  teriparatide  therapy, http://dx.doi.org/10.1016/j.ijscr.2016.02.028 2210-2612/© 2016  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/d4/d5/main.PMC4834826.pdf
THIS IS AN OPEN ACCESS ARTICLE UNDERTHE CC BY-NC-ND LICENSE ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).ISSN 2452-302X http://dx.doi.org/10.1016/j.jacbts.2016.01.009,Non-OADS,/arxiv_data1/oa_pdf/e4/b7/main.PMC4834896.pdf
This is an open access arti c l eu n d e rt h eC CB Y - N C - N Dl i c e n s e( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e4/b7/main.PMC4834896.pdf
http://dx.doi.org/10.1016/j.adro.2015.12.004 2452-1094/Copyright /C2112016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/d9/2a/main.PMC4834900.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Advances in Radiation Oncology (2016) 1, 67-75 www.advancesradonc.org",Non-OADS,/arxiv_data1/oa_pdf/d9/2a/main.PMC4834900.pdf
Available at: http://dx.doi.org/10.1137/0406 06612 .,Non-OADS,/arxiv_data1/oa_pdf/d9/2a/main.PMC4834900.pdf
THIS IS AN OPEN ACCESS ARTICLE UNDERTHE CC BY-NC-ND LICENSE ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).ISSN 2452-302X http://dx.doi.org/10.1016/j.jacbts.2016.01.003,Non-OADS,/arxiv_data1/oa_pdf/8d/4e/main.PMC4834906.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c6/d0/ndt-12-817.PMC4835112.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment Neuropsychiatric Disease and Treatment 2016:12 817–822Dove press submit your manuscript | www.dovepress.co m Dove press  OrigiNal researchopen access to scientific and medical research Open access Full T ext article 817 http: //dx.doi.org/10.2147/NDT .S10192 5Patients with depression display cytokine levels in  serum and cerebrospinal fluid similar to patients  with diffuse neurological symptoms without a  defined diagnosis Knut a hestad,1–3 Knut  engedal,4 Jon elling  Whist,1 Pål aukrust,5–9  Per g Farup,1,10 To m  eirik Mollnes,9,11–13 Thor  Ueland5,7,9 1Department of research, innlandet  hospital Trust, Brumunddal,   2Department of Psychology, Faculty  of social sciences and T echnology  Management, Norwegian University  of science and T echnology (NTNU),   Trondheim, 3Department of Public  health, hedmark University college,   elverum, 4Norwegian centre for  aging and health, Vestfold health  Trust, Tønsberg, 5research institute of  internal Medicine, 6section of clinical  immunology and infectious Diseases,   7institute of clinical Medicine, Oslo  University hospital rikshospitalet,   8K.g.",Non-OADS,/arxiv_data1/oa_pdf/c6/d0/ndt-12-817.PMC4835112.pdf
"First, several studies  have shown increased systemic levels of inflammatory cytokines and other inflam - matory markers in patients with depression,2,3 and a recent gene expression study in a correspondence: Knut a hestad Department of research, innlandet  hospital Trust, Post Box 104, 2381  Brumunddal, Norway email k nut.hestad@sykehuset-innlandet.n oJournal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Hestad et al Running head recto: Cytokine levels in both serum and CSF DOI: http://dx.doi.org/10.2147/NDT.S101925",Non-OADS,/arxiv_data1/oa_pdf/c6/d0/ndt-12-817.PMC4835112.pdf
Available from: http://www.who.int/mediacentre/factsheets/fs369/en /.,Non-OADS,/arxiv_data1/oa_pdf/c6/d0/ndt-12-817.PMC4835112.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/c6/d0/ndt-12-817.PMC4835112.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c6/d0/ndt-12-817.PMC4835112.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2d/c1/dddt-10-1399.PMC4835113.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1399–1410Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1399Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S10321 6acetogenins from Annona muricata  as potential  inhibitors of antiapoptotic proteins: a molecular  modeling study Priya antony ranjit Vijayan Department of Biology, college  of science, United arab emirates  University, al ain, abu Dhabi,   United  arab emiratesAbstract:  Apoptosis is a highly regulated process crucial for maintaining cellular homeostasis  and development.",Non-OADS,/arxiv_data1/oa_pdf/2d/c1/dddt-10-1399.PMC4835113.pdf
"These stimuli increase the permeability of the outer  mitochondrial membrane (OMM) and release cytochrome C into the cytoplasm, which correspondence: ranjit Vijayan Department of Biology, college of  science, United arab emirates University,  PO Box 15551, al ain, abu Dhabi,  United arab emirates Tel +971 3 713 6302 email ranjit.v@uaeu.ac.a e Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Antony and Vijayan Running head recto: Targeting antiapoptotic proteins DOI: http://dx.doi.org/10.2147/DDDT.S103216",Non-OADS,/arxiv_data1/oa_pdf/2d/c1/dddt-10-1399.PMC4835113.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/2d/c1/dddt-10-1399.PMC4835113.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2d/c1/dddt-10-1399.PMC4835113.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d0/32/amep-7-243.PMC4835114.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/d0/32/amep-7-243.PMC4835114.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2016:7 243–246Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.com Dove press 243 O R I G I N A L  R E S E A R C Hopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/AMEP .S102081Comparison of the number of supervisors on  medical student satisfaction during a child and  adolescent psychiatry rotation Kelly J Mascioli1 Catharine J Robertson1,2 Alan B Douglass1,3 1Department of Psychiatry, University  of Ottawa, Ottawa, ON, Canada;  2Department of Psychiatry, Children’s  Hospital of Eastern Ontario, Ottawa,  ON, Canada; 3Royal Ottawa Mental  Health Centre, University of Ottawa  Institute of Mental Health Research,  Ottawa, ON, CanadaBackground:  Traditionally, third-year medical students are assigned to one supervisor during  their 1-week rotation in child and adolescent psychiatry.",Non-OADS,/arxiv_data1/oa_pdf/d0/32/amep-7-243.PMC4835114.pdf
"At our university, students complete a 6-week psychiatry rotation – four of these in gen -Correspondence: Kelly J Mascioli Department of Psychiatry, University of  Ottawa, The Ottawa Hospital – General  Campus, 4418-501 Smyth Road, Ottawa,  ON K1H 8L6, Canada Tel +1 613 737 8955 Email kmasc034@uottawa.caJournal name: Advances in Medical Education and Practice Article Designation: ORIGINAL RESEARCH Y ear: 2016 V olume: 7 Running head verso: Mascioli et al Running head recto: Comparison of number of supervisors on medical student satisfaction DOI: http://dx.doi.org/ 10.2147/AMEP .S102081",Non-OADS,/arxiv_data1/oa_pdf/d0/32/amep-7-243.PMC4835114.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f7/2d/ndt-12-809.PMC4835115.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 809–815Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  809OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10208 9relationship between quality of life and restless  legs syndrome among a community-dwelling  population in Japan Kazutoshi Kubo1 Norio sugawara1,2 ayako Kaneda1 ippei Takahashi3 Kazuhiko Nakamura1 shigeyuki Nakaji3 Norio Yasui-Furukori1 1Department of Neuropsychiatry,   hirosaki University school of  Medicine, hirosaki, 2Department of  Psychiatry, aomori Prefectural center  for Mental health and Welfare,   aomori, 3Department of social  Medicine, hirosaki University school  of Medicine, hirosaki, JapanObjectives:  Restless legs syndrome (RLS) is a sensorimotor disturbance that causes the  production of impulses and dysesthesia and makes the patients feel as though they must move  their lower extremities.",Non-OADS,/arxiv_data1/oa_pdf/f7/2d/ndt-12-809.PMC4835115.pdf
"Because the diagnostic criteria of RLS were proposed by the International  Restless Legs Syndrome Study Group (IRLSSG) of the National Institutes of Health,  several studies on the prevalence of RLS have been carried out.1 The prevalence  of RLS, as reported from population-based studies, ranges from 5.5% to 9.6% in  Western countries and from ~0.9% to 4.0% in Japan.2–9 Although cultural and ethnic  differences might affect the differences between Japan and Western countries, the  causes for this lower rate of susceptibility among Japanese individuals have not  been established.correspondence: Norio sugawara Department of Psychiatry, aomori  Prefectural center for Mental health and  Welfare, 353-92 sawabe sannai, aomori  038-0031, aomori, Japan Tel +81 177 87 3951 Fax +81 177 87 3956 email nsuga3@yahoo.co.j p Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Kubo et al Running head recto: Quality of life and restless legs syndrome DOI: http://dx.doi.org/10.2147/NDT.S102089",Non-OADS,/arxiv_data1/oa_pdf/f7/2d/ndt-12-809.PMC4835115.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/f7/2d/ndt-12-809.PMC4835115.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f7/2d/ndt-12-809.PMC4835115.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/19/6a/tcrm-12-575.PMC4835116.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 575–583Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  575ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S10303 9application of surgical navigation in styloidectomy  for treating eagle’s syndrome geng Dou1 Yu Zhang1 Chunlin Zong2 Yuanli Chen2 Yuxuan guo2 lei Tian2 1The First Brigade of students,   2state Key laboratory of Military  stomatology, national Clinical  Research Center for Oral Diseases,   shaanxi Key laboratory of Oral  Diseases, Department of Cranio-facial  Trauma and Orthognathic surgery,   school of stomatology, The Fourth  Military Medical University, Xi’an,   People’s Republic of ChinaPurpose:  The present study aimed to evaluate the feasibility, accuracy, and clinical effect of  intraoperative navigation for resection of elongated styloid process (ESP) in Eagle’s syndrome.",Non-OADS,/arxiv_data1/oa_pdf/19/6a/tcrm-12-575.PMC4835116.pdf
"The surgical management of ESP consists of two major procedures: the  transoral approach and the extraoral cervical approach.2,3Correspondence: lei Tian state Key laboratory of Military  stomatology, national Clinical Research  Center for Oral Diseases, shaanxi Key  laboratory of Oral Diseases, Department  of Cranio-facial Trauma and Orthognathic  surgery, school of stomatology, The  Fourth Military Medical University,  145 West Changle Road, Xi’an 710032,  People’s Republic of China Tel +86 2984 776109 Fax +86 2984 776097 email tianleison@163.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Dou et al Running head recto: Surgical navigation in styloidectomy for treating Eagle’s syndrome DOI: http://dx.doi.org/10.2147/TCRM.S103039",Non-OADS,/arxiv_data1/oa_pdf/19/6a/tcrm-12-575.PMC4835116.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/19/6a/tcrm-12-575.PMC4835116.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/19/6a/tcrm-12-575.PMC4835116.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/40/b8/dddt-10-1443.PMC4835117.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1443–1451Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1443Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9466 6Xyloketal-derived small molecules show protective  effect by decreasing mutant huntingtin protein  aggregates in Caenorhabditis elegans  model of  huntington’s disease Yixuan Zeng,1,2,* Wenyuan  guo,1,* guangqing Xu,3  Qinmei Wang,4 luyang Feng,1,2  simei long,1 Fengyin liang,1  Yi huang,1 Xilin lu,1 shichang  li,5 Jiebin Zhou,5 Jean-Marc  Burgunder,6 Jiyan Pang,5  Zhong Pei1,2 1Department of neurology, national  Key clinical Department and Key  Discipline of neurology, guangdong Key  laboratory for Diagnosis and Treatment  of Major neurological Disease, The First  affiliated hospital, sun Yat-sen University,   2guangzhou center, chinese huntington’s  Disease network, 3Department of  rehabilitation, The First affiliated hospital,  4Key laboratory on assisted circulation,   Ministry of health, Department of  cardiovascular Medicine of the First  affiliated hospital, 5school of chemistry  and chemical engineering, sun Yat-sen  University, guangzhou, guangdong, People’s  republic of china; 6swiss huntington’s  Disease center, Department of neurology,   University of Bern, Bern, switzerland *These authors contributed equally to this  workAbstract:  Huntington’s disease is an autosomal-dominant neurodegenerative disorder, with  chorea as the most prominent manifestation.",Non-OADS,/arxiv_data1/oa_pdf/40/b8/dddt-10-1443.PMC4835117.pdf
"For example, the interaction of protein Rhes with  mHtt might improve mouse behavior in HD mouse model.7 Glyceradehyde-3-phosphate correspondence: Zhong Pei Department of Neurology, The First Affiliated  hospital, sun Yat-sen University, no 58,  Zhong shan 2nd road, guangzhou, 510080,  People’s republic of china Tel +86 20 8775 5766 ext 8282 Fax +86 20 8733 5935 email peizhong@mail.sysu.edu.c n Jiyan Pang school of chemistry and chemical engineering,  sun Yat-sen University, no 135, Xingang road,  guangzhou 510275, People’s republic of china Tel/fax +86 20 8403 6554 email cespjy@mail.sysu.edu.c n Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Zeng et al Running head recto: Protective effect of xyloketal-derived molecules in Huntington’s disease DOI: http://dx.doi.org/10.2147/DDDT.S94666",Non-OADS,/arxiv_data1/oa_pdf/40/b8/dddt-10-1443.PMC4835117.pdf
"The crystal structure of Htt36Q3H-EX1-C1 (Pro - tein Data Bank code 4FE8), a trimer of MBP-Htt36Q3H-EX1,  was retrieved from the PDB ( http://www.pdb.org /).",OADS,/arxiv_data1/oa_pdf/40/b8/dddt-10-1443.PMC4835117.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/40/b8/dddt-10-1443.PMC4835117.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/40/b8/dddt-10-1443.PMC4835117.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/bb/f2/ijn-11-1517.PMC4835118.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 1517–1535International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1517OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10114 1labeling of mesenchymal stem cells for MrI  with single-cell sensitivity angela ariza de  schellenberger1 harald Kratz1 Tracy D Farr2,3 Norbert löwa4 ralf hauptmann1 susanne Wagner1 Matthias Taupitz1 Jörg schnorr1 eyk a schellenberger1 1Department of radiology,   2Department of experimental  Neurology, center for stroke  research Berlin, charité –  Universitätsmedizin Berlin, Berlin,   germany; 3school of life sciences,   University of Nottingham, Medical  school, Nottingham, UK; 4Department  of Biomagnetic signals, Physikalisch- T echnische Bundesanstalt Berlin,   Berlin, germanyAbstract:  Sensitive cell detection by magnetic resonance imaging (MRI) is an important tool  for the development of cell therapies.",Non-OADS,/arxiv_data1/oa_pdf/bb/f2/ijn-11-1517.PMC4835118.pdf
"Keywords:  magnetic field microdistortions, single-cell imaging, mesenchymal stem cells,  VSOP, MCP, Resovist® Introduction Many clinical studies (clinicaltrials.gov) exploit the immunomodulatory and  regenerative capacities1–6 of multipotent mesenchymal stem cells (MSC).7,8 However,  the role of MSC in regenerative medicine is not fully understood and their direct or  paracrine effects remain to be clarified.9,10 In addition, parameters such as cell injec - tion site and dose, cell survival, and cell engraftment require optimization in some  disease models.11–15 For these reasons, monitoring of cell therapies is of high clinical relevance  and, despite several challenges to overcome, magnetic resonance imaging (MRI)  continues to be the method of choice, offering high tissue penetration depth and  spatial resolution in comparison with alternative methods.16,17 Drawbacks of MRI  such as low specificity due to unspecific signal from phagocytosed injected cells,  dead cells, or local hemorrhage14,18,19 have been shown to limit the use of MRI for cell correspondence: angela ariza de  schellenberger Department of radiology, charité –  Universitätsmedizin Berlin, charitéplatz 1,   10117 Berlin, germany Tel +49 30 4 5053 9356 email angela.ariza@charite.d e Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Ariza de Schellenberger et al Running head recto: Single-cell MRI of MSC DOI: http://dx.doi.org/10.2147/IJN.S101141",Non-OADS,/arxiv_data1/oa_pdf/bb/f2/ijn-11-1517.PMC4835118.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/bb/f2/ijn-11-1517.PMC4835118.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bb/f2/ijn-11-1517.PMC4835118.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e8/07/ott-9-2099.PMC4835119.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2099–2109OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2099Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10146 5simple models based on gamma-glutamyl  transpeptidase and platelets for predicting survival  in hepatitis B-associated hepatocellular carcinoma Qing Pang Jian-Bin Bi Zhi-Xin Wang Xin-sen Xu Kai Qu run-chen Miao Wei chen Yan-Yan Zhou chang liu Department of hepatobiliary surgery,   the First affiliated hospital of Medical  college, Xi’an Jiaotong University,   shaanxi Province, People’s republic  of chinaBackground:  Several hepatic cirrhosis-derived noninvasive models have been developed to  predict the incidence and outcomes of hepatocellular carcinoma (HCC).",Non-OADS,/arxiv_data1/oa_pdf/e8/07/ott-9-2099.PMC4835119.pdf
"However, till date, both the two curative methods correspondence: chang liu Department of hepatobiliary surgery,  the First Affiliated Hospital of Medical  college, Xi’an Jiaotong University,  no 277 West Yan-ta road, Xi’an 710061,  shaanxi Province, People’s republic  of china Tel +86 29 8265 3900 Fax +86 29 8265 3905 email liuchangdoctor@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Pang et al Running head recto: Gamma-glutamyl transpeptidase, platelets, and HCC DOI: http://dx.doi.org/10.2147/OTT.S101465",Non-OADS,/arxiv_data1/oa_pdf/e8/07/ott-9-2099.PMC4835119.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e8/07/ott-9-2099.PMC4835119.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/07/ott-9-2099.PMC4835119.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2e/ef/ott-9-2143.PMC4835120.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2143–2151OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2143Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10000 3Metastasis-associated lung adenocarcinoma  transcript 1 promotes the proliferation of chondro- sarcoma cell via activating notch-1 signaling pathway Fengqin Xu1,* Zhi-qiang Zhang2,* Y ong-chao Fang2 Xiao-lei li2 Yu sun2 chuan-zhi Xiong2 lian-qi Yan2 Qiang Wang2 1Department of Orthopaedics,   hongquan hospital, 2Department of  Orthopaedics, subei People’s hospital,   Yangzhou, Jiangsu Province, People’s  republic of china *These authors contributed equally  to this workBackground:  Metastasis-associated lung adenocarcinoma transcript 1 (MALAT-1) is identified  to be overexpressed in several cancers.",Non-OADS,/arxiv_data1/oa_pdf/2e/ef/ott-9-2143.PMC4835120.pdf
"Interestingly, Notch can serve as the apparently opposite func - tions in tumor development, such as an oncogene or a tumor suppressor, a repressor, correspondence: Qiang Wang Department of Orthopaedics, subei  People’s hospital, no 98 nantong West  road, Yangzhou 225001, Jiangsu Province,  People’s republic of china Tel +86 514 8793 7618 email w_wangq@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Xu et al Running head recto: MALAT-1 promotes the proliferation of chondrosarcoma cell DOI: http://dx.doi.org/10.2147/OTT.S100003",Non-OADS,/arxiv_data1/oa_pdf/2e/ef/ott-9-2143.PMC4835120.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/2e/ef/ott-9-2143.PMC4835120.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2e/ef/ott-9-2143.PMC4835120.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/40/a7/ijgm-9-073.PMC4835121.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/40/a7/ijgm-9-073.PMC4835121.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of General Medicine 2016:9 73–78International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  73OrIGInal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJGM.S9314 8Differences in genotype frequencies of salt- sensitive genes between fishing and nonfishing  communities in Japan Masanori harada1 Taro Takeshima2 Masanobu Okayama2,3 eiji Kajii2 1Department for support of rural  Health Care, Yamaguchi Grand  Medical Center, Hofu, Yamaguchi,   2Division of community and Family  Medicine, center for community  Medicine, Jichi Medical University,   Shimotsuke, 3Division of community  Medicine and Medical education,   Kobe University Graduate School of  Medicine, Kobe, Japan correspondence: Masanobu Okayama   Division of community Medicine and  Medical Education, Kobe University  Graduate School of Medicine,  2-1-5 Arata-cho, Hyogo-ku, Kobe, Hyogo,  652-0032, Japan   T el +81 78 382 6732   Fax +81 78 382 6283   email okayama@jichi.ac.j pPurpose:  To identify the differences in genotype frequencies of salt-sensitive genes between  residents of fishing communities (FCs) and nonfishing communities (NFCs).",Non-OADS,/arxiv_data1/oa_pdf/40/a7/ijgm-9-073.PMC4835121.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/40/a7/ijgm-9-073.PMC4835121.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/40/a7/ijgm-9-073.PMC4835121.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b5/cb/ppa-10-549.PMC4835122.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 549–560Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  549Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10315 6weight-based dosing in medication use: what  should we know?",Non-OADS,/arxiv_data1/oa_pdf/b5/cb/ppa-10-549.PMC4835122.pdf
"However, for the sake of safety and  efficacy, weight-based dosing method is needed for particular population and also speci -Correspondence: Quan Zhou Department of Pharmacy, The Second  Affiliated Hospital, School of Medicine,  Zhejiang University, 88 Jiefang Road,  Shangcheng, Hangzhou 310009, Zhejiang,  People’s Republic of China Tel +86 571 8778 4615 Fax +86 571 8702 2776 email zhouquan142602@zju.edu.c n Journal name: Patient Preference and Adherence Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Pan et al Running head recto: Weight-based dosing DOI: http://dx.doi.org/10.2147/PPA.S103156",Non-OADS,/arxiv_data1/oa_pdf/b5/cb/ppa-10-549.PMC4835122.pdf
Available from: https://www.ecri.org/components/ PSOCore /Pages/PSONav0214.asp x.,Non-OADS,/arxiv_data1/oa_pdf/b5/cb/ppa-10-549.PMC4835122.pdf
"Available from: http://www.drugs.com/cons/ fraxiparine.htm l. Accessed December 19, 2015.",Non-OADS,/arxiv_data1/oa_pdf/b5/cb/ppa-10-549.PMC4835122.pdf
"Available from: http://www.rxlist.com/lovenox-drug/ indications-dosage.ht m. Accessed December 19, 2015.",Non-OADS,/arxiv_data1/oa_pdf/b5/cb/ppa-10-549.PMC4835122.pdf
Available from: http://www.rxlist.com/zyvox-drug/indications-dosage.,Non-OADS,/arxiv_data1/oa_pdf/b5/cb/ppa-10-549.PMC4835122.pdf
"Available from: http://www.rxlist.com/zemplar-drug/indications- dosage.ht m. Accessed December 19, 2015.",Non-OADS,/arxiv_data1/oa_pdf/b5/cb/ppa-10-549.PMC4835122.pdf
"Available from: http://www.rxlist.com/remicade-drug.ht m.  Accessed December 19, 2015.",Non-OADS,/arxiv_data1/oa_pdf/b5/cb/ppa-10-549.PMC4835122.pdf
"Available from: http://www.rxlist.com/herceptin-drug/indications- dosage.ht m. Accessed February 19, 2016.",Non-OADS,/arxiv_data1/oa_pdf/b5/cb/ppa-10-549.PMC4835122.pdf
Available from: http://www.rxlist.com/perjeta-drug/indications-dosage.,Non-OADS,/arxiv_data1/oa_pdf/b5/cb/ppa-10-549.PMC4835122.pdf
"Available from: http://www.rxlist.com/novoseven- drug/ indications -dosage.ht m. Accessed December 19, 2015.",Non-OADS,/arxiv_data1/oa_pdf/b5/cb/ppa-10-549.PMC4835122.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/b5/cb/ppa-10-549.PMC4835122.pdf
"Available from: http://patientsafetyauthority.org/ADVISORIES/ AdvisoryLibrary/2009/mar6(1)/Pages/10.asp x. Accessed March 17,  2016.",Non-OADS,/arxiv_data1/oa_pdf/b5/cb/ppa-10-549.PMC4835122.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f5/49/ndt-12-823.PMC4835123.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 823–832Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  823OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10047 4The influence of childhood abuse, adult life events,  and affective temperaments on the well-being  of the general, nonclinical adult population Y oshiaki Kanai1,2 Y oshikazu Takaesu1 Yukiei Nakai3 Masahiko ichiki1 Mitsuhiko sato1 Yasunori Matsumoto1 Jun ishikawa1 Yasuyuki Ono1 akiko Murakoshi1 Hajime Tanabe4 ichiro Kusumi3 Takeshi inoue1 1Department of Psychiatry, Tokyo  Medical University, 2Department of  Palliative Medicine, The University of  T okyo Hospital, T okyo, 3Department  of Psychiatry, Hokkaido University  Graduate School of Medicine,   Sapporo, 4Department of Clinical  Human Sciences, Graduate School  of Humanities and Social Sciences,   Shizuoka University, Shizuoka, JapanBackground:  Previous studies have shown the effects of childhood abuse, life events, and  temperaments on well-being (positive affect) and ill-being (negative affect).",Non-OADS,/arxiv_data1/oa_pdf/f5/49/ndt-12-823.PMC4835123.pdf
"Accordingly, the effects of various factors that may influence mental  health should be investigated on not only negative affect but also positive affect.correspondence: Takeshi inoue Department of Psychiatry, Tokyo  Medical University, 6-7-1, Nishishinjuku,  Shinjuku-ku, Tokyo 160-0023, Japan Tel +81 3 3342 6111 Fax +81 3 3340 4499 email tinoue@tokyo-med.ac.j p Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Kanai et al Running head recto: Childhood abuse, life events, and temperaments on well-being DOI: http://dx.doi.org/10.2147/NDT.S100474",Non-OADS,/arxiv_data1/oa_pdf/f5/49/ndt-12-823.PMC4835123.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/f5/49/ndt-12-823.PMC4835123.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f5/49/ndt-12-823.PMC4835123.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8d/08/dddt-10-1411.PMC4835124.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1411–1418Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1411Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S10245 9Pharmacokinetics of the evogliptin/metformin  extended-release (5/1,000 mg) fixed-dose  combination formulation compared to the  corresponding loose combination, and food effect  in healthy subjects su-jin rhee1,* seung hwan lee1,2,* seo hyun Y oon1 Joo-Y oun cho1 in-Jin Jang1 Kyung-sang Yu1 1Department of clinical Pharmacology  and Therapeutics, seoul national  University college of Medicine and  hospital, 2clinical Trials center, seoul  national University hospital, seoul,   republic of Korea *These authors contributed equally  to this workAbstract:  A new fixed-dose combination formulation of evogliptin 5 mg and metformin  extended-release (XR) 1,000 mg (FDC_EVO5/MET1000) was developed to improve medica - tion adherence for type 2 diabetes mellitus.",Non-OADS,/arxiv_data1/oa_pdf/8d/08/dddt-10-1411.PMC4835124.pdf
"Furthermore, DPP-4 inhibitor has been reported to posi - tively affect metabolic abnormalities such as obesity, hypertension, and dyslipidemia, correspondence: Kyung-sang Yu Department of clinical Pharmacology and  Therapeutics, seoul national University  college of Medicine and hospital,  seoul national University hospital, 101  Daehak-ro, Jongno-gu, seoul 110-744,  republic of Korea Tel +82 2 2072 1920 Fax +82 2 742 9252 email ksyu@snu.ac.k r Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Rhee et al Running head recto: Pharmacokinetics of a fixed-dose combination of evogliptin and metformin XR DOI: http://dx.doi.org/10.2147/DDDT.S102459",Non-OADS,/arxiv_data1/oa_pdf/8d/08/dddt-10-1411.PMC4835124.pdf
"Available from: http://apps.who.int/prequal/info_general/documents/ TRS929/WHO_TRS_929_annex5FDCs.pd f. Accessed March 5,  2016.",OADS,/arxiv_data1/oa_pdf/8d/08/dddt-10-1411.PMC4835124.pdf
Available from: http://www.mfds.go.kr/ index.do?mid =695&pageNo =81&seq =714&cmd =v.,OADS,/arxiv_data1/oa_pdf/8d/08/dddt-10-1411.PMC4835124.pdf
Available from: http://www.accessdata.,OADS,/arxiv_data1/oa_pdf/8d/08/dddt-10-1411.PMC4835124.pdf
"Available from: http://www.fda.gov/ downloads/drugs/guidancecomplianceregulatoryinformation/guid - ances/ucm389370.pd f. Accessed March 5, 2016.",Non-OADS,/arxiv_data1/oa_pdf/8d/08/dddt-10-1411.PMC4835124.pdf
"Available from: http://www.ema.europa.eu/docs/en_GB/ document_library/Scientific_guideline/2010/01/WC500070039.pd f.  Accessed March 5, 2016.$   7LPHK0HDQFRQFHQWUDWLRQRI HYRJOLSWLQJ/ 7LPHK%         0HDQFRQFHQWUDWLRQRI PHWIRUPLQJ/ )HGQ   )DVWHGQ  Figure 3 Mean plasma concentration-time profiles.",OADS,/arxiv_data1/oa_pdf/8d/08/dddt-10-1411.PMC4835124.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/8d/08/dddt-10-1411.PMC4835124.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/08/dddt-10-1411.PMC4835124.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a1/e8/ppa-10-531.PMC4835125.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 531–538Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  531OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S9282 4non-adherence to inhaled corticosteroids and  the risk of asthma exacerbations in children erwin c Vasbinder1 svetlana V Belitser2 Patrick c souverein2 liset van Dijk3 Arnold g Vulto1 Patricia M lA van den Bemt1 1erasmus University Medical  center, Department of hospital  Pharmacy, rotterdam, 2Division  of Pharmacoepidemiology and clinical  Pharmacology, Utrecht institute for  Pharmaceutical sciences, Utrecht  University, 3niVel, Utrecht,   the netherlandsBackground:  Non-adherence to inhaled corticosteroids (ICSs) is a major risk factor for poor  asthma control in children.",Non-OADS,/arxiv_data1/oa_pdf/a1/e8/ppa-10-531.PMC4835125.pdf
"The aim of ICS  treatment is reaching and maintaining good asthma control, which is characterized by  a low frequency and severity of asthma symptoms, no limitation of physical activities,  and a limited need for reliever/rescue treatment with SABA.2 In clinical trials, ICS  has proved to be effective, reducing exacerbations by 55% compared to placebo or  SABA alone.3 However, more than half of the childhood population (6–16  years) with  doctor-diagnosed asthma has insufficient control according to the Global Initiative  for Asthma (GINA) recommendations.4 As a result of poor asthma control, asthma  exacerbations needing hospitalization occur with an estimated incidence of one to two  per 1,000 child-years (data from the USA).5,6correspondence: Patricia MlA van  den Bemt erasmus University Medical center,  Department of hospital Pharmacy,  nc-212, PO Box 2040, 3000 cA  rotterdam, the netherlands Tel +31 10 703 3202 Fax +31 10 703 2400 email p.vandenbemt@erasmusmc.n l Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Vasbinder et al Running head recto: Non-adherence to ICS and the risk of asthma exacerbations DOI: http://dx.doi.org/10.2147/PPA.S92824",Non-OADS,/arxiv_data1/oa_pdf/a1/e8/ppa-10-531.PMC4835125.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/a1/e8/ppa-10-531.PMC4835125.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/84/67/ijwh-8-103.PMC4835126.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2016:8 103–117International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  103OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S10220 1Female genital mutilation/cutting: changes and  trends in knowledge, attitudes, and practices  among health care professionals in The gambia adriana Kaplan Marcusán1–3 laura riba singla3 Mass laye3 Dodou M secka3 Mireia Utzet4 Marie-alix le charles3 1social Knowledge Transfer/Parc de  recerca U aB – santander, Universitat  autònoma de Barcelona, Barcelona,   spain; 2Interdisciplinary group for  the study and Prevention of Harmful  Traditional Practices, Department  of social and cultural anthropology,   Universitat autònoma de Barcelona,   Barcelona, spain; 3Wassu gambia  Kafo, Fajara F section, The gambia;   4africa and latin america research  group, Unit of Biostatistics, Faculty  of Medicine, Universitat autònoma de  Barcelona, Barcelona, spainBackground:  Female genital mutilation/cutting (FGM/C) is a harmful traditional practice that  affects two out of three girls in The Gambia, seriously threatening their life and well-being with  severe health consequences.",Non-OADS,/arxiv_data1/oa_pdf/84/67/ijwh-8-103.PMC4835126.pdf
"Keywords:  female genital mutilation/cutting, The Gambia, health care professionals, knowledge,  attitudes, practices, changes, trends, sexual and reproductive health Introduction Female genital mutilation/cutting (FGM/C) refers to all procedures involving injury,  partial or total removal of the female genital organs for non-therapeutic reasons.1 The  practice is concentrated in 29 countries of sub-Saharan Africa, the Middle and Far East;  and the United Nations Children’s Fund (UNICEF) estimates it affects between 125 and  140 million women in the world.2 Today’s demographic trends associated with the migra - tory reality and other globalization processes have contributed to the extent of FGM/C  worldwide, making it an international phenomenon that transcends geography.correspondence: adriana Kaplan  Marcusán Department of social and cultural  anthropology, Wassu-UaB Foundation,  Universitat autònoma de Barcelona,  Bellaterrra 08193, spain Tel +34 649 205 108 Fax +34 935 868 799 email adriana.kaplan@uab.ca t Journal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2016 Volume: 8 Running head verso: Kaplan Marcusán et al Running head recto: Female genital mutilation/cutting in The Gambia: changes and trends DOI: http://dx.doi.org/10.2147/IJWH.S102201",Non-OADS,/arxiv_data1/oa_pdf/84/67/ijwh-8-103.PMC4835126.pdf
"Available from: http://www.unfpa.org/publications/eliminating-female- genital-mutilation-interagency-statemen t. Accessed February 8, 2016.",Non-OADS,/arxiv_data1/oa_pdf/84/67/ijwh-8-103.PMC4835126.pdf
"Available from:  http://www.unicef.org/publications/index_69875.htm l. Accessed  February 8, 2016.",Non-OADS,/arxiv_data1/oa_pdf/84/67/ijwh-8-103.PMC4835126.pdf
"Available from: http://data.unicef.org/ corecode/uploads/document6/uploaded_country_profiles/corecode/222/ Countries/FGMC_GMB.pd f. Accessed February 8, 2016.",Non-OADS,/arxiv_data1/oa_pdf/84/67/ijwh-8-103.PMC4835126.pdf
"Available from: http://www.childinfo.org/files/MICS4_ Gambia_2010_FinalReport_Eng.pd f. Accessed February 8, 2016.",Non-OADS,/arxiv_data1/oa_pdf/84/67/ijwh-8-103.PMC4835126.pdf
Available from: http://www.who.int/reproductivehealth/ publications/fgm/rhr_hrp_10_16/en /.,Non-OADS,/arxiv_data1/oa_pdf/84/67/ijwh-8-103.PMC4835126.pdf
"Available from: http://www.unicef.org/mena/ MENA-Final_English_FGM_summary.pd f. Accessed February 8,  2016.",Non-OADS,/arxiv_data1/oa_pdf/84/67/ijwh-8-103.PMC4835126.pdf
"Available from: http://www.undp.org/content/ dam/undp/library/corporate/HDR/2014HDR/HDR-2014-English.pd f.  Accessed February 8, 2016.",Non-OADS,/arxiv_data1/oa_pdf/84/67/ijwh-8-103.PMC4835126.pdf
"Available from:  http://www.oecd.org/dev/development-gender/BrochureSIGI2015- web.pd f. Accessed February 8, 2016.",Non-OADS,/arxiv_data1/oa_pdf/84/67/ijwh-8-103.PMC4835126.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/84/67/ijwh-8-103.PMC4835126.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/84/67/ijwh-8-103.PMC4835126.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/24/d2/ijn-11-1501.PMC4835127.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 1501–1516International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1501OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10294 5Nicotinamide polymeric nanoemulsified systems:  a quality-by-design case study for a sustained  antimicrobial activity ahmed s Zidan1,2 Osama aa ahmed1,3 Bader M aljaeid1 1Department of Pharmaceutics  and Industrial Pharmacy, Faculty of  Pharmacy, King abdulaziz University,   Jeddah, Kingdom of saudi arabia;   2Department of Pharmaceutics  and Industrial Pharmacy, Faculty of  Pharmacy, Zagazig University, Zagazig,   3Department of Pharmaceutics  and Industrial Pharmacy, Faculty  of Pharmacy, Minia University,   Minia, egyptAbstract:  Nicotinamide, the amide form of vitamin B3, was demonstrated to combat some of  the antibiotic-resistant infections that are increasingly common around the world.",Non-OADS,/arxiv_data1/oa_pdf/24/d2/ijn-11-1501.PMC4835127.pdf
"In addition, it has significant  anti-inflammatory, antimicrobial, and radio-sensitizing activities.1–3 Recent studies  have reported considerable efficacy of nicotinamide to eradicate both Mycobacterium  tuberculosis  and AIDS, the two organisms responsible for 35% of most deaths due to  AIDS.4 Following oral dosing, nicotinamide is readily absorbed from all portions of  the gastrointestinal tract5 and metabolized into N-methylnicotinamide and nicotinamide correspondence: ahmed s Zidan Department of Pharmaceutics and  Industrial Pharmacy, Faculty of  Pharmacy, King abdulaziz University,  PO Box 80260, Jeddah 21589, Kingdom  of saudi arabia Tel +966 564 26 6682 Fax +966 12 695 1696 email aszidan@kau.edu.s a Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Zidan et al Running head recto: QbD study for nicotinamide polymeric nanoemulsified systems DOI: http://dx.doi.org/10.2147/IJN.S102945",Non-OADS,/arxiv_data1/oa_pdf/24/d2/ijn-11-1501.PMC4835127.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/24/d2/ijn-11-1501.PMC4835127.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/24/d2/ijn-11-1501.PMC4835127.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/17/e2/ott-9-2121.PMC4835128.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2121–2129OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2121Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10090 5ABCB1  and ABCC2  and the risk of distant  metastasis in Thai breast cancer patients treated  with tamoxifen insee sensorn,1,* chonlaphat  sukasem,2,* ekaphop sirachainan,3  Montri chamnanphon,2  ekawat Pasomsub,4 narumol  Trachu,5 Porntip supavilai,1  Darawan Pinthong,1 sansanee  Wongwaisayawan6 1Department of Pharmacology, Faculty  of science, Mahidol University, 2Division  of Pharmacogenomics and Personalized  Medicine, Department of Pathology,  Faculty of Medicine, ramathibodi  hospital, Mahidol University, 3Division  of Medical Oncology, Department  of Medicine, Faculty of Medicine,  ramathibodi hospital, Mahidol  University, 4Division of Virology,  Department of Pathology, Faculty  of Medicine, ramathibodi hospital,  Mahidol University, 5research center,  Faculty of Medicine, ramathibodi  hospital, 6Division of anatomical  Pathology, Department of Pathology,  Faculty of Medicine, ramathibodi  hospital, Mahidol University,  Bangkok, Thailand *These authors contributed equally  to this workBackground:  Genetic polymorphisms of drug-metabolizing enzymes and transporters have  been extensively studied with regard to tamoxifen treatment outcomes.",Non-OADS,/arxiv_data1/oa_pdf/17/e2/ott-9-2121.PMC4835128.pdf
"However, several lines of inconsistent evidence have been reported.4–14 In addition to correspondence: sansanee  Wongwaisayawan Division of anatomical Pathology,  Department of Pathology, Faculty  of Medicine, ramathibodi hospital,  Mahidol University, 270 rama 6 road,  ratchathewi, Bangkok 10400, Thailand Tel +66 2 201 1436 Fax +66 2 354 7266 email sansanee.won@mahidol.ac.t h  Darawan Pinthong Department of Pharmacology, Faculty of  science, Mahidol University, 272 rama  6 road, ratchathewi, Bangkok 10400,  Thailand Tel +66 2 201 5642 Fax +66 2 354 7157 email darawan.pin@mahidol.ac.t h Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Sensorn et al Running head recto: Gene polymorphisms and the risk of distant metastasis DOI: http://dx.doi.org/10.2147/OTT.S100905",Non-OADS,/arxiv_data1/oa_pdf/17/e2/ott-9-2121.PMC4835128.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/17/e2/ott-9-2121.PMC4835128.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/17/e2/ott-9-2121.PMC4835128.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/68/2d/ndt-12-801.PMC4835129.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 801–807Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  801OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S9964 4sleep deprivation disturbed regional brain activity  in healthy subjects: evidence from a functional  magnetic resonance-imaging study li Wang Yin chen Ying Yao Yu Pan Yi sun Department of Neurology, sir  run run shaw hospital, school  of Medicine, Zhejiang University,   hangzhou, People’s republic of chinaObjective:  The aim of this study was to use amplitude of low-frequency fluctuation (ALFF)  to explore regional brain activities in healthy subjects after sleep deprivation (SD).",Non-OADS,/arxiv_data1/oa_pdf/68/2d/ndt-12-801.PMC4835129.pdf
"Sleep deprivation (SD),  widespread in today’s society, is a sleep-loss status generally caused by personal  or environmental reasons.1 SD can lead to a series of changes in emotional balance,  and has a detrimental effect on cognitive function, attention, learning, and working  memory.2–5 Long-term SD duration is associated with exaggerated neural reactivity,  multisystemic and multiorganic dysfunction, and negative metabolic, psychological,  physiological, or even behavioral reactivity.1,6–8 Many studies have been carried out in short-term SD (24 hours), and found that SD  adversely affects brain function and cognitive domains.9,10 A previous study employ - ing resting-state functional magnetic resonance imaging (rs-fMRI) to explore brain- activation patterns by acupuncture stimuli during SD status found that sanyinjiao (SP6)  elicits greater and anatomically different activations in the salience network than those  of sham stimuli.11 rs-fMRI studies have found altered functional connectivity in the correspondence: Yi sun Department of Neurology, sir run run  shaw hospital, school of Medicine,  Zhejiang University, 3 east Qingchun  road, Jianggan, hangzhou, Zhejiang  310016, People’s republic of china Tel +86 571 8600 6774 email yisun_doctor@sina.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Wang et al Running head recto: Brain disturbance from sleep deprivation DOI: http://dx.doi.org/10.2147/NDT.S99644",Non-OADS,/arxiv_data1/oa_pdf/68/2d/ndt-12-801.PMC4835129.pdf
"All subjects met the  following criteria, as in previous studies:1,15,28 1) no symp - toms associated with sleep disorders and no history of any  psychiatric or neurologic disorders; 2) right-handed; 3)  good  sleeping habits; 4) good sleep onset and/or maintenance, and  no history of swing shift, shift work, sleep complaints, or  other sleep disorders; 5) regular dietary habits, and had not  consumed any stimulants, alcohol, tea, cigarettes, medica - tions, or caffeine for at least 3 months prior to the study;  6) no foreign implants in the body, and no inborn or other  acquired diseases; 7) moderate body shape and weight;  and 8) Pittsburgh Sleep Quality Index score ,5. research design and procedures To evaluate sleep status, all subjects were monitored for  1 week by wearing a Fitbit Flex tracker ( http://help.fitbit.co m).28  Each of the subjects underwent the session twice randomly.",Non-OADS,/arxiv_data1/oa_pdf/68/2d/ndt-12-801.PMC4835129.pdf
"fMri data analysis Based on the MatLab 2012a (MathWorks, Natick, MA,  USA), data preprocessing was performed by Data Processing  Assistant for Resting-State fMRI ( http://rfmri.org/DPARS F)  software, including Digital Imaging and Communication in  Medicine form transformation, slice timing, head-motion  correction, spatial normalization, and smooth.",OADS,/arxiv_data1/oa_pdf/68/2d/ndt-12-801.PMC4835129.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/68/2d/ndt-12-801.PMC4835129.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/68/2d/ndt-12-801.PMC4835129.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/bb/df/ott-9-2131.PMC4835130.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2131–2141OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2131Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9800 2Downregulation of VegF a inhibits proliferation,  promotes apoptosis, and suppresses migration  and invasion of renal clear cell carcinoma Fan-chang Zeng1,2 Ming-Qiang Zeng1 liang huang1 Y ong-lin li1 Ben-Min gao1 Jun-Jie chen1 rui-Zhi Xue1 Zheng-Yan Tang1 1Department of Urology, Xiangya  hospital, central south University,   changsha, 2Department of Urology,   hainan general hospital, haikou,   People’s republic of chinaObjective:  The aim of this study was to investigate the effects of vascular endothelial growth  factor A (VEGFA) on cell proliferation, apoptosis, migration, and invasion in renal clear cell  carcinoma (RCCC).",Non-OADS,/arxiv_data1/oa_pdf/bb/df/ott-9-2131.PMC4835130.pdf
"Keywords:  786-O, siRNA, transfection, cell biological behavior, PI3K/AKT, Fuhrman grad - ing, AJCC staging, HK-2 Introduction Accounting for 2%–3% of all adult malignant tumors, renal cell carcinoma (RCC) is  the most lethal urologic cancer, and there are about 209,000 newly diagnosed RCC  and 102,000 deaths caused by RCC per year worldwide.1 If detected at early stages,  RCC can be cured surgically, but ~30% of patients have metastatic RCC at diagnosis,  while another 25%–30% of patients undergoing surgery will experience local or distant  recurrence, mainly to the bone and lung, and once metastasis develops, the prognosis of  RCC is poor with the 5-year survival rate of 0%–10%.1,2 There are several histological correspondence: Zheng-Yan Tang Department of Urology, Xiangya  hospital, central south University,  87 Xiangya road, changsha 410008,  People’s republic of china Tel +86 135 0731 8268 email xytzyan@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Zeng et al Running head recto: VEGFA and RCCC DOI: http://dx.doi.org/10.2147/OTT.S98002",Non-OADS,/arxiv_data1/oa_pdf/bb/df/ott-9-2131.PMC4835130.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/bb/df/ott-9-2131.PMC4835130.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/bb/df/ott-9-2131.PMC4835130.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b2/f2/clep-8-049.PMC4835131.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Epidemiology 2016:8 49–51Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  49Editorialopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/CLEP .S10444 8Helping everyone do better: a call for validation  studies of routinely recorded health data Vera Ehrenstein1 irene Petersen1,2 liam Smeeth3 Susan S Jick4 Eric i Benchimol5,6 Jonas F ludvigsson7,8 Henrik toft Sørensen1 1department of Clinical Epidemiology,   aarhus University Hospital,   aarhus, denmark; 2department  of Primary Care and Population  Health, University College london,   london, UK; 3department of  Non-Communicable disease  Epidemiology, london School of  Hygiene and tropical Medicine,   london, UK; 4Boston Collaborative  drug Surveillance Program, Boston  University School of Public Health,   Boston, M a, USa; 5department of  Pediatrics and School of Epidemiology,   Public Health and Preventive  Medicine, Faculty of Medicine,   University of ottawa, ottawa,   oN, Canada; 6institute for Clinical  Evaluative Sciences, toronto, oN,   Canada; 7department of Medical  Epidemiology and Biostatistics,   Karolinska institutet, Stockholm,   8department of Pediatrics, University  Hospital of Örebro, Sweden Correspondence: Vera Ehrenstein   department of Clinical Epidemiology,  aarhus University Hospital, 43–45 o lof  Palmes a llé, 8200 N aarhus, denmark   Email ve@clin.au.d kThere has been a surge of availability and use for research of routinely collected   electronic health data, such as electronic health records, health administrative data,  and disease registries.",Non-OADS,/arxiv_data1/oa_pdf/b2/f2/clep-8-049.PMC4835131.pdf
Available from: http://www.mini-sentinel.org /.,Non-OADS,/arxiv_data1/oa_pdf/b2/f2/clep-8-049.PMC4835131.pdf
Available from: http://www.pharmo.nl /.,Non-OADS,/arxiv_data1/oa_pdf/b2/f2/clep-8-049.PMC4835131.pdf
"Available from: http://apps.who.int/classifications/ icd11/browse/l-m/e n. Accessed December 7, 2015.",OADS,/arxiv_data1/oa_pdf/b2/f2/clep-8-049.PMC4835131.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/b2/f2/clep-8-049.PMC4835131.pdf
Available from: http://www.equator-network.org/ reporting-guidelines/stard /.,Non-OADS,/arxiv_data1/oa_pdf/b2/f2/clep-8-049.PMC4835131.pdf
Available from: http://www.equator-network.org/ reporting-guidelines/record /.,Non-OADS,/arxiv_data1/oa_pdf/b2/f2/clep-8-049.PMC4835131.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/88/5a/ndt-12-843.PMC4835132.pdf
